SNOMED_ConceptId,ConceptId_Description,LTC_Category,Resolved
6497000,Decreased body mass index (finding),BMI codes,0
35425004,Normal body mass index (finding),BMI codes,0
60621009,Body mass index (observable entity),BMI codes,0
162690006,On examination - obese (finding),BMI codes,0
162764001,On examination - weight greater than 20% below ideal (finding),BMI codes,0
162765000,On examination - weight 10-20% below ideal (finding),BMI codes,0
162769006,On examination - Underweight (finding),BMI codes,0
162863004,Body mass index 25-29 - overweight (finding),BMI codes,0
162864005,Body mass index 30+ - obesity (finding),BMI codes,0
190966007,Extreme obesity with alveolar hypoventilation (disorder),BMI codes,0
238131007,Overweight (finding),BMI codes,0
248342006,Underweight (finding),BMI codes,0
268915006,On examination - weight 10-20% over ideal (finding),BMI codes,0
268916007,On examination - weight greater than 20% over ideal (finding),BMI codes,0
275947003,On examination - overweight (finding),BMI codes,0
310252000,Body mass index less than 20 (finding),BMI codes,0
408512008,Body mass index 40+ - severely obese (finding),BMI codes,0
412768003,Body mass index 20-24 - normal (finding),BMI codes,0
414915002,Obese (finding),BMI codes,0
8.46931E+14,Baseline body mass index (observable entity),BMI codes,0
9.14721E+14,Obese class I (body mass index 30.0 - 34.9) (finding),BMI codes,0
9.14731E+14,Obese class II (body mass index 35.0 - 39.9) (finding),BMI codes,0
9.14741E+14,Obese class III (body mass index equal to or greater than 40.0) (finding),BMI codes,0
1755008,Old myocardial infarction (disorder),Chronic heart disease,0
4557003,Preinfarction syndrome (disorder),Chronic heart disease,0
5370000,Atrial flutter (disorder),Chronic heart disease,0
10335000,Chronic right-sided heart failure (disorder),Chronic heart disease,0
10633002,Acute congestive heart failure (disorder),Chronic heart disease,0
15990001,Acute myocardial infarction of posterolateral wall (disorder),Chronic heart disease,0
19057007,Status anginosus (disorder),Chronic heart disease,0
21470009,Syncope anginosa (disorder),Chronic heart disease,0
22298006,MI - myocardial infarction,Chronic heart disease,0
25106000,Impending infarction (disorder),Chronic heart disease,0
32413006,Transplantation of heart (procedure),Chronic heart disease,0
35928006,Nocturnal angina (disorder),Chronic heart disease,0
42343007,Congestive heart failure (disorder),Chronic heart disease,0
42402006,Kartagener syndrome (disorder),Chronic heart disease,0
42531007,Microinfarct of heart (disorder),Chronic heart disease,0
43736008,Rheumatic left ventricular failure (disorder),Chronic heart disease,0
46109009,Subendocardial ischemia (disorder),Chronic heart disease,0
48447003,Chronic heart failure (disorder),Chronic heart disease,0
49436004,Atrial fibrillation (disorder),Chronic heart disease,0
52035003,Acute anteroapical myocardial infarction (disorder),Chronic heart disease,0
53741008,Coronary arteriosclerosis (disorder),Chronic heart disease,0
54329005,Acute myocardial infarction of anterior wall (disorder),Chronic heart disease,0
56675007,Acute heart failure (disorder),Chronic heart disease,0
57054005,Acute myocardial infarction (disorder),Chronic heart disease,0
58612006,Acute myocardial infarction of lateral wall (disorder),Chronic heart disease,0
59021001,Angina decubitus (disorder),Chronic heart disease,0
62695002,Acute anteroseptal myocardial infarction (disorder),Chronic heart disease,0
63739005,Coronary occlusion (disorder),Chronic heart disease,0
65547006,Acute myocardial infarction of inferolateral wall (disorder),Chronic heart disease,0
66189004,Postmyocardial infarction syndrome (disorder),Chronic heart disease,0
67682002,Coronary artery atheroma (disorder),Chronic heart disease,0
70211005,Acute myocardial infarction of anterolateral wall (disorder),Chronic heart disease,0
70422006,Acute subendocardial infarction (disorder),Chronic heart disease,0
73795002,Acute myocardial infarction of inferior wall (disorder),Chronic heart disease,0
76593002,Acute myocardial infarction of inferoposterior wall (disorder),Chronic heart disease,0
79009004,Acute myocardial infarction of septum (disorder),Chronic heart disease,0
79955004,Chronic cor pulmonale (disorder),Chronic heart disease,0
84114007,Heart failure (disorder),Chronic heart disease,0
85232009,Left heart failure (disorder),Chronic heart disease,0
87837008,Chronic pulmonary heart disease (disorder),Chronic heart disease,0
88805009,Chronic congestive heart failure (disorder),Chronic heart disease,0
92506005,Biventricular congestive heart failure (disorder),Chronic heart disease,0
123642008,Right coronary artery occlusion (disorder),Chronic heart disease,0
128404006,Right heart failure (disorder),Chronic heart disease,0
129574000,Postoperative myocardial infarction (disorder),Chronic heart disease,0
134377004,Atrial fibrillation monitoring (regime/therapy),Chronic heart disease,0
134401001,Left ventricular systolic dysfunction (disorder),Chronic heart disease,0
161502000,History of myocardial infarct at age less than sixty (situation),Chronic heart disease,0
161503005,History of myocardial infarct at age greater than sixty (situation),Chronic heart disease,0
164889003,Electrocardiographic atrial fibrillation (finding),Chronic heart disease,0
164890007,Electrocardiographic atrial flutter (finding),Chronic heart disease,0
194802003,True posterior myocardial infarction (disorder),Chronic heart disease,0
194809007,Acute atrial infarction (disorder),Chronic heart disease,0
194821006,Coronary thrombosis not resulting in myocardial infarction (disorder),Chronic heart disease,0
194823009,Acute coronary insufficiency (disorder),Chronic heart disease,0
194828000,Angina (disorder),Chronic heart disease,0
194842008,Single coronary vessel disease (disorder),Chronic heart disease,0
194843003,Double coronary vessel disease (disorder),Chronic heart disease,0
194849004,Generalized ischemic myocardial dysfunction (disorder),Chronic heart disease,0
194856005,Subsequent myocardial infarction (disorder),Chronic heart disease,0
194857001,Subsequent myocardial infarction of anterior wall (disorder),Chronic heart disease,0
194858006,Subsequent myocardial infarction of inferior wall (disorder),Chronic heart disease,0
194863005,Atrial septal defect due to and following acute myocardial infarction (disorder),Chronic heart disease,0
194867006,Rupture of papillary muscle as current complication following acute myocardial infarction (disorder),Chronic heart disease,0
194868001,"Thrombosis of atrium, auricular appendage, and ventricle due to and following acute myocardial infarction (disorder)",Chronic heart disease,0
195080001,Atrial fibrillation and flutter (disorder),Chronic heart disease,0
195111005,Decompensated cardiac failure (disorder),Chronic heart disease,0
195112003,Compensated cardiac failure (disorder),Chronic heart disease,0
195114002,Acute left ventricular failure (disorder),Chronic heart disease,0
199007008,"Pre-existing hypertensive heart and renal disease complicating pregnancy, childbirth and the puerperium (disorder)",Chronic heart disease,0
225566008,Ischemic chest pain (finding),Chronic heart disease,0
233817007,Triple vessel disease of the heart (disorder),Chronic heart disease,0
233819005,Stable angina (disorder),Chronic heart disease,0
233821000,New onset angina (disorder),Chronic heart disease,0
233823002,Silent myocardial ischemia (disorder),Chronic heart disease,0
233825009,Acute Q wave infarction - anteroseptal (disorder),Chronic heart disease,0
233826005,Acute non-Q wave infarction - anteroseptal (disorder),Chronic heart disease,0
233827001,Acute Q wave infarction - anterolateral (disorder),Chronic heart disease,0
233828006,Acute non-Q wave infarction - anterolateral (disorder),Chronic heart disease,0
233829003,Acute Q wave infarction - inferior (disorder),Chronic heart disease,0
233830008,Acute non-Q wave infarction - inferior (disorder),Chronic heart disease,0
233832000,Acute non-Q wave infarction - inferolateral (disorder),Chronic heart disease,0
233838001,Acute posterior myocardial infarction (disorder),Chronic heart disease,0
233839009,Old anterior myocardial infarction (disorder),Chronic heart disease,0
233840006,Old inferior myocardial infarction (disorder),Chronic heart disease,0
233841005,Old lateral myocardial infarction (disorder),Chronic heart disease,0
233842003,Old posterior myocardial infarction (disorder),Chronic heart disease,0
233843008,Silent myocardial infarction (disorder),Chronic heart disease,0
233846000,Post-infarction ventricular septal defect (disorder),Chronic heart disease,0
233847009,Cardiac rupture due to and following acute myocardial infarction (disorder),Chronic heart disease,0
233885007,Post-infarction pericarditis (disorder),Chronic heart disease,0
233910005,Lone atrial fibrillation (disorder),Chronic heart disease,0
233911009,Non-rheumatic atrial fibrillation (disorder),Chronic heart disease,0
233924009,Heart failure as a complication of care (disorder),Chronic heart disease,0
233970002,Coronary artery stenosis (disorder),Chronic heart disease,0
251024009,Coronary graft stenosis (disorder),Chronic heart disease,0
276517000,Transient myocardial ischemia of newborn (disorder),Chronic heart disease,0
281091000,Ischemic myocardial dysfunction (disorder),Chronic heart disease,0
281093002,Hibernating myocardium (disorder),Chronic heart disease,0
282825002,Paroxysmal atrial fibrillation (disorder),Chronic heart disease,0
300995000,Exercise-induced angina (disorder),Chronic heart disease,0
300996004,Controlled atrial fibrillation (disorder),Chronic heart disease,0
304914007,Acute Q wave myocardial infarction (disorder),Chronic heart disease,0
307140009,Acute non-Q wave infarction (disorder),Chronic heart disease,0
308065005,History of myocardial infarction in last year (situation),Chronic heart disease,0
311792005,Postoperative transmural myocardial infarction of anterior wall (disorder),Chronic heart disease,0
311793000,Postoperative transmural myocardial infarction of inferior wall (disorder),Chronic heart disease,0
311796008,Postoperative subendocardial myocardial infarction (disorder),Chronic heart disease,0
312442005,History of atrial fibrillation (situation),Chronic heart disease,0
314116003,Post infarct angina (disorder),Chronic heart disease,0
314206003,Refractory heart failure (disorder),Chronic heart disease,0
314207007,Non-Q wave myocardial infarction (disorder),Chronic heart disease,0
314208002,Rapid atrial fibrillation (disorder),Chronic heart disease,0
315025001,Refractory angina (disorder),Chronic heart disease,0
315026000,Transient myocardial ischemia (disorder),Chronic heart disease,0
315287002,Diabetes mellitus insulin-glucose infusion in acute myocardial infarction (procedure),Chronic heart disease,0
315348000,Asymptomatic coronary heart disease (disorder),Chronic heart disease,0
367363000,Right ventricular failure (disorder),Chronic heart disease,0
371068009,Myocardial infarction with complication (disorder),Chronic heart disease,0
371807002,Atypical angina (disorder),Chronic heart disease,0
394659003,Acute coronary syndrome (disorder),Chronic heart disease,0
394710008,First myocardial infarction (disorder),Chronic heart disease,0
398274000,Coronary artery thrombosis (disorder),Chronic heart disease,0
399211009,History of myocardial infarction (situation),Chronic heart disease,0
399261000,History of coronary artery bypass grafting (situation),Chronic heart disease,0
401250009,Coronary heart disease monitoring first letter (finding),Chronic heart disease,0
401251008,Coronary heart disease monitoring second letter (finding),Chronic heart disease,0
401252001,Coronary heart disease monitoring third letter (finding),Chronic heart disease,0
401253006,Coronary heart disease monitoring verbal invitation (finding),Chronic heart disease,0
401303003,Acute ST segment elevation myocardial infarction (disorder),Chronic heart disease,0
401314000,Acute non-ST segment elevation myocardial infarction (disorder),Chronic heart disease,0
407596008,Echocardiogram shows left ventricular systolic dysfunction (finding),Chronic heart disease,0
408546009,Coronary artery bypass graft occlusion (disorder),Chronic heart disease,0
412787009,"Intellectual disability, congenital heart disease, blepharophimosis, blepharoptosis and hypoplastic teeth (disorder)",Chronic heart disease,0
413439005,Acute ischemic heart disease (disorder),Chronic heart disease,0
413838009,Chronic ischemic heart disease (disorder),Chronic heart disease,0
413844008,Chronic myocardial ischemia (disorder),Chronic heart disease,0
414024009,Disorder of coronary artery (disorder),Chronic heart disease,0
414545008,Ischemic heart disease (disorder),Chronic heart disease,0
414795007,Myocardial ischemia (disorder),Chronic heart disease,0
420300004,New York Heart Association Classification - Class I (finding),Chronic heart disease,0
420913000,New York Heart Association Classification - Class III (finding),Chronic heart disease,0
421704003,New York Heart Association Classification - Class II (finding),Chronic heart disease,0
422293003,New York Heart Association Classification - Class IV (finding),Chronic heart disease,0
426611007,Congestive heart failure due to valvular disease (disorder),Chronic heart disease,0
426749004,Chronic atrial fibrillation (disorder),Chronic heart disease,0
427665004,Paroxysmal atrial flutter (disorder),Chronic heart disease,0
428076002,History of atrial flutter (situation),Chronic heart disease,0
428196007,Mixed myocardial ischemia and infarction (disorder),Chronic heart disease,0
430396006,Chronic systolic dysfunction of left ventricle (disorder),Chronic heart disease,0
440028005,Permanent atrial fibrillation (disorder),Chronic heart disease,0
440059007,Persistent atrial fibrillation (disorder),Chronic heart disease,0
443502000,Atherosclerosis of coronary artery (disorder),Chronic heart disease,0
446221000,Heart failure with normal ejection fraction (disorder),Chronic heart disease,0
698377004,Coronary angioplasty planned (situation),Chronic heart disease,0
698378009,Coronary artery bypass graft operation planned (situation),Chronic heart disease,0
703164000,Acute ST segment elevation myocardial infarction of anterior wall (disorder),Chronic heart disease,0
703213009,Acute ST segment elevation myocardial infarction of inferior wall (disorder),Chronic heart disease,0
703272007,Heart failure with reduced ejection fraction (disorder),Chronic heart disease,0
703360004,Subsequent non-ST segment elevation myocardial infarction (disorder),Chronic heart disease,0
719678003,Non-obstructive atherosclerosis of coronary artery (disorder),Chronic heart disease,0
720448006,Typical atrial flutter (disorder),Chronic heart disease,0
735259005,"Congestive heart failure, hypertension, age 2, diabetes mellitus, stroke 2, vascular disease, age, sex category stroke risk score (observable entity)",Chronic heart disease,0
763008007,"Congestive heart failure, hypertension, age 75 years or older, diabetes mellitus and previous stroke or transient ischemic attack score (observable entity)",Chronic heart disease,0
788950000,Heart failure with mid range ejection fraction (disorder),Chronic heart disease,0
7.91E+11,Angina due to type 2 diabetes mellitus (disorder),Chronic heart disease,0
1.17051E+14,Chronic total occlusion of coronary artery (disorder),Chronic heart disease,0
1.20041E+14,Atrial fibrillation with rapid ventricular response (disorder),Chronic heart disease,0
1.43411E+14,Quality and Outcomes Framework heart failure quality indicator-related care invitation using preferred method of communication (procedure),Chronic heart disease,0
1.96371E+14,Atrial fibrillation resolved (finding),Chronic heart disease,1
2.48411E+14,Atrial fibrillation annual review (regime/therapy),Chronic heart disease,0
2.48461E+14,Coronary heart disease monitoring telephone invitation (regime/therapy),Chronic heart disease,0
7.11411E+14,Atrial fibrillation monitoring invitation (procedure),Chronic heart disease,0
7.11461E+14,Heart failure monitoring invitation (procedure),Chronic heart disease,0
7.15941E+14,Excepted from atrial fibrillation quality indicators - patient unsuitable (finding),Chronic heart disease,0
7.16091E+14,Excepted from coronary heart disease quality indicators - informed dissent (finding),Chronic heart disease,0
7.16181E+14,Atrial fibrillation monitoring third letter (procedure),Chronic heart disease,0
7.16621E+14,Heart failure monitoring third letter (procedure),Chronic heart disease,0
7.16721E+14,Atrial fibrillation monitoring telephone invitation (procedure),Chronic heart disease,0
7.16971E+14,Heart failure monitoring first letter (procedure),Chronic heart disease,0
7.16981E+14,Atrial fibrillation monitoring second letter (procedure),Chronic heart disease,0
7.17011E+14,Atrial fibrillation monitoring verbal invitation (procedure),Chronic heart disease,0
7.17111E+14,Excepted from coronary heart disease quality indicators - patient unsuitable (finding),Chronic heart disease,0
7.17191E+14,Heart failure monitoring second letter (procedure),Chronic heart disease,0
7.17221E+14,Atrial fibrillation monitoring first letter (procedure),Chronic heart disease,0
7.17381E+14,Excepted from atrial fibrillation quality indicators - informed dissent (finding),Chronic heart disease,0
7.17481E+14,Excepted from heart failure quality indicators - patient unsuitable (finding),Chronic heart disease,0
7.17491E+14,Excepted from heart failure quality indicators - informed dissent (finding),Chronic heart disease,0
7.17501E+14,Heart failure monitoring verbal invitation (procedure),Chronic heart disease,0
7.17531E+14,Heart failure monitoring telephone invitation (procedure),Chronic heart disease,0
7.93851E+14,"Congestive heart failure, hypertension, age 2, diabetes mellitus, stroke 2 - vascular disease, age, sex category stroke risk score (observable entity)",Chronic heart disease,0
8.10681E+14,Coronary microvascular disease (disorder),Chronic heart disease,0
1.08312E+15,Coronary heart disease monitoring invitation (procedure),Chronic heart disease,0
1.08313E+15,Coronary heart disease monitoring invitation email (procedure),Chronic heart disease,0
1.08511E+15,"Congestive heart failure, hypertension, age 75 years or older, diabetes mellitus and previous stroke or transient ischaemic attack score (observable entity)",Chronic heart disease,0
1.08945E+15,Acute nontransmural myocardial infarction (disorder),Chronic heart disease,0
1.11085E+15,Quality and Outcomes Framework atrial fibrillation quality indicator-related care invitation (procedure),Chronic heart disease,0
1.11088E+15,Quality and Outcomes Framework secondary prevention of coronary heart disease quality indicator-related care invitation (procedure),Chronic heart disease,0
1.11093E+15,Quality and Outcomes Framework heart failure quality indicator-related care invitation (procedure),Chronic heart disease,0
1.59649E+16,Atypical atrial flutter (disorder),Chronic heart disease,0
44785005,Minimal change disease (disorder),Chronic kidney disease,0
46177005,End-stage renal disease (disorder),Chronic kidney disease,0
48796009,Congenital nephrotic syndrome (disorder),Chronic kidney disease,0
52254009,Nephrotic syndrome (disorder),Chronic kidney disease,0
71192002,Peritoneal dialysis (procedure),Chronic kidney disease,0
90688005,Chronic renal failure syndrome (disorder),Chronic kidney disease,0
105502003,Dependence on renal dialysis (finding),Chronic kidney disease,0
175902000,Cadaveric renal transplant (procedure),Chronic kidney disease,0
180272001,Insertion of chronic ambulatory peritoneal dialysis catheter (procedure),Chronic kidney disease,0
197589005,Nephrotic syndrome with proliferative glomerulonephritis (disorder),Chronic kidney disease,0
197590001,Nephrotic syndrome with membranous glomerulonephritis (disorder),Chronic kidney disease,0
197591002,Nephrotic syndrome with membranoproliferative glomerulonephritis (disorder),Chronic kidney disease,0
197593004,"Nephrotic syndrome, minor glomerular abnormality (disorder)",Chronic kidney disease,0
197594005,"Nephrotic syndrome, focal and segmental glomerular lesions (disorder)",Chronic kidney disease,0
197595006,"Nephrotic syndrome, diffuse membranous glomerulonephritis (disorder)",Chronic kidney disease,0
197596007,"Nephrotic syndrome, diffuse mesangial proliferative glomerulonephritis (disorder)",Chronic kidney disease,0
197597003,"Nephrotic syndrome, diffuse endocapillary proliferative glomerulonephritis (disorder)",Chronic kidney disease,0
197598008,"Nephrotic syndrome, diffuse mesangiocapillary glomerulonephritis (disorder)",Chronic kidney disease,0
197599000,"Nephrotic syndrome, dense deposit disease (disorder)",Chronic kidney disease,0
197600002,"Nephrotic syndrome, diffuse crescentic glomerulonephritis (disorder)",Chronic kidney disease,0
197601003,Finnish congenital nephrotic syndrome (disorder),Chronic kidney disease,0
197603000,Nephrotic syndrome associated with another disorder (disorder),Chronic kidney disease,0
197604006,Nephrotic syndrome in amyloidosis (disorder),Chronic kidney disease,0
197605007,Nephrotic syndrome due to diabetes mellitus (disorder),Chronic kidney disease,0
197606008,Nephrotic syndrome in malaria (disorder),Chronic kidney disease,0
225230008,Chronic peritoneal dialysis (procedure),Chronic kidney disease,0
233575001,Intermittent hemodialysis (procedure),Chronic kidney disease,0
233578004,Continuous hemodialysis (procedure),Chronic kidney disease,0
233580005,Continuous venovenous hemodialysis (procedure),Chronic kidney disease,0
233581009,Hemofiltration (procedure),Chronic kidney disease,0
233583007,Continuous hemofiltration (procedure),Chronic kidney disease,0
233585000,Continuous venovenous hemofiltration (procedure),Chronic kidney disease,0
233586004,Hemodiafiltration (procedure),Chronic kidney disease,0
233587008,Intermittent hemodiafiltration (procedure),Chronic kidney disease,0
233590002,Continuous venovenous hemodiafiltration (procedure),Chronic kidney disease,0
236380004,Steroid-sensitive nephrotic syndrome (disorder),Chronic kidney disease,0
236381000,Steroid-resistant nephrotic syndrome (disorder),Chronic kidney disease,0
236382007,Steroid-dependent nephrotic syndrome (disorder),Chronic kidney disease,0
236384008,Congenital nephrotic syndrome with focal glomerulosclerosis (disorder),Chronic kidney disease,0
236385009,Drash syndrome (disorder),Chronic kidney disease,0
236434000,End stage renal failure untreated by renal replacement therapy (disorder),Chronic kidney disease,0
236435004,End stage renal failure on dialysis (disorder),Chronic kidney disease,0
238314006,Renewal of chronic ambulatory peritoneal dialysis catheter (procedure),Chronic kidney disease,0
238315007,Adjustment of chronic ambulatory peritoneal dialysis catheter (procedure),Chronic kidney disease,0
238316008,Aspiration of chronic ambulatory peritoneal dialysis catheter (procedure),Chronic kidney disease,0
238317004,Flushing of chronic ambulatory peritoneal dialysis catheter (procedure),Chronic kidney disease,0
238318009,Continuous ambulatory peritoneal dialysis (procedure),Chronic kidney disease,0
238319001,Continuous cycling peritoneal dialysis (procedure),Chronic kidney disease,0
238321006,Intermittent peritoneal dialysis (procedure),Chronic kidney disease,0
238323009,Night-time intermittent peritoneal dialysis (procedure),Chronic kidney disease,0
265764009,Renal dialysis (procedure),Chronic kidney disease,0
266549004,Nephrotic syndrome with minimal change glomerulonephritis (disorder),Chronic kidney disease,0
271418008,Chronic ambulatory peritoneal dialysis catheter procedure (procedure),Chronic kidney disease,0
278905001,Continuous ambulatory peritoneal dialysis diet (finding),Chronic kidney disease,0
302497006,Hemodialysis (procedure),Chronic kidney disease,0
363234001,Nephrotic syndrome secondary to systemic disease (disorder),Chronic kidney disease,0
385971003,Dialysis care (regime/therapy),Chronic kidney disease,0
427053002,Extracorporeal albumin hemodialysis (procedure),Chronic kidney disease,0
428648006,Automated peritoneal dialysis (procedure),Chronic kidney disease,0
431857002,Chronic kidney disease stage 4 (disorder),Chronic kidney disease,0
433146000,Chronic kidney disease stage 5 (disorder),Chronic kidney disease,0
708931003,Maintenance hemodialysis (procedure),Chronic kidney disease,0
714749008,Continuous renal replacement therapy (procedure),Chronic kidney disease,0
718330001,Hemodialysis care (regime/therapy),Chronic kidney disease,0
3.24441E+14,Chronic kidney disease stage 4 with proteinuria (disorder),Chronic kidney disease,0
3.24471E+14,Chronic kidney disease stage 4 without proteinuria (disorder),Chronic kidney disease,0
3.24501E+14,Chronic kidney disease stage 5 with proteinuria (disorder),Chronic kidney disease,0
3.24541E+14,Chronic kidney disease stage 5 without proteinuria (disorder),Chronic kidney disease,0
9.50181E+14,Chronic kidney disease with glomerular filtration rate category G4 and albuminuria category A1 (disorder),Chronic kidney disease,0
9.50211E+14,Chronic kidney disease with glomerular filtration rate category G4 and albuminuria category A2 (disorder),Chronic kidney disease,0
9.50231E+14,Chronic kidney disease with glomerular filtration rate category G4 and albuminuria category A3 (disorder),Chronic kidney disease,0
9.50251E+14,Chronic kidney disease with glomerular filtration rate category G5 and albuminuria category A1 (disorder),Chronic kidney disease,0
9.50291E+14,Chronic kidney disease with glomerular filtration rate category G5 and albuminuria category A2 (disorder),Chronic kidney disease,0
9.50311E+14,Chronic kidney disease with glomerular filtration rate category G5 and albuminuria category A3 (disorder),Chronic kidney disease,0
1.03547E+15,Dialysis therapy started by renal service (finding),Chronic kidney disease,0
805002,Pneumoconiosis caused by silica (disorder),Chronic respiratory disease,0
4981000,Panacinar emphysema (disorder),Chronic respiratory disease,0
8247009,Berylliosis (disorder),Chronic respiratory disease,0
8549006,Desquamative interstitial pneumonia (disorder),Chronic respiratory disease,0
10501004,Pulmonary alveolar proteinosis (disorder),Chronic respiratory disease,0
10713006,Diffuse interstitial rheumatoid disease of lung (disorder),Chronic respiratory disease,0
12295008,Bronchiectasis (disorder),Chronic respiratory disease,0
12428000,Intrinsic asthma without status asthmaticus (disorder),Chronic respiratory disease,0
13645005,Chronic obstructive lung disease (disorder),Chronic respiratory disease,0
14700006,Bauxite fibrosis of lung (disorder),Chronic respiratory disease,0
16003001,Giant bullous emphysema (disorder),Chronic respiratory disease,0
16838000,Mediastinal emphysema (disorder),Chronic respiratory disease,0
17996008,Pneumoconiosis caused by inorganic dust (disorder),Chronic respiratory disease,0
19242006,Pulmonary edema (disorder),Chronic respiratory disease,0
22607003,Asbestosis (disorder),Chronic respiratory disease,0
23022004,Tuberculous bronchiectasis (disorder),Chronic respiratory disease,0
24369008,Pulmonary sarcoidosis (disorder),Chronic respiratory disease,0
26427008,Chronic pulmonary histoplasmosis (disorder),Chronic respiratory disease,0
29422001,Coal workers' pneumoconiosis (disorder),Chronic respiratory disease,0
31387002,Exercise-induced asthma (disorder),Chronic respiratory disease,0
31898008,Paraseptal emphysema (disorder),Chronic respiratory disease,0
32544004,Chronic obliterative bronchiolitis caused by inhalation of chemical fumes AND/OR vapors (disorder),Chronic respiratory disease,0
34015007,Bakers' asthma (disorder),Chronic respiratory disease,0
39871006,Chronic respiratory failure (disorder),Chronic respiratory disease,0
40100001,Obliterative bronchiolitis (disorder),Chronic respiratory disease,0
40122008,Pneumoconiosis (disorder),Chronic respiratory disease,0
40527005,Idiopathic pulmonary hemosiderosis (disorder),Chronic respiratory disease,0
40640008,Massive fibrosis of lung co-occurrent and due to silicosis (disorder),Chronic respiratory disease,0
41553006,Detergent asthma (disorder),Chronic respiratory disease,0
42402006,Kartagener syndrome (disorder),Chronic respiratory disease,0
44274007,Lymphoid interstitial pneumonia (disorder),Chronic respiratory disease,0
45145000,Unilateral emphysema (situation),Chronic respiratory disease,0
46847001,Chronic pulmonary edema (disorder),Chronic respiratory disease,0
47515009,Simple silicosis (disorder),Chronic respiratory disease,0
49691004,Occupational bronchitis (disorder),Chronic respiratory disease,0
49840000,Complicated silicosis (disorder),Chronic respiratory disease,0
51277007,Stannosis (disorder),Chronic respiratory disease,0
51615001,Fibrosis of lung (disorder),Chronic respiratory disease,0
52571006,Chronic tracheobronchitis (disorder),Chronic respiratory disease,0
56968009,Asthma caused by wood dust (disorder),Chronic respiratory disease,0
57607007,Occupational asthma (disorder),Chronic respiratory disease,0
59903001,Acute obliterating bronchiolitis (disorder),Chronic respiratory disease,0
60125001,Perinatal interstitial emphysema (disorder),Chronic respiratory disease,0
61937009,Simple chronic bronchitis (disorder),Chronic respiratory disease,0
62371005,Pulmonary siderosis (disorder),Chronic respiratory disease,0
63088003,Allergic asthma without status asthmaticus (disorder),Chronic respiratory disease,0
63480004,Chronic bronchitis (disorder),Chronic respiratory disease,0
64667001,Interstitial pneumonia (disorder),Chronic respiratory disease,0
66987001,Congenital lobar emphysema (disorder),Chronic respiratory disease,0
67569000,Bronchopulmonary dysplasia of newborn (disorder),Chronic respiratory disease,0
67905004,Acute-on-chronic respiratory failure (disorder),Chronic respiratory disease,0
68328006,Centriacinar emphysema (disorder),Chronic respiratory disease,0
69454006,Chronic respiratory condition caused by fumes AND/OR vapors (disorder),Chronic respiratory disease,0
69921001,Broncholithiasis (disorder),Chronic respiratory disease,0
71193007,Fibrosis of lung caused by radiation (disorder),Chronic respiratory disease,0
74417001,Mucopurulent chronic bronchitis (disorder),Chronic respiratory disease,0
77593006,Congenital bronchiectasis (disorder),Chronic respiratory disease,0
77690003,Interstitial emphysema of lung (disorder),Chronic respiratory disease,0
78723001,Cannabinosis (disorder),Chronic respiratory disease,0
79955004,Chronic cor pulmonale (disorder),Chronic respiratory disease,0
83457000,Cylindrical bronchiectasis (disorder),Chronic respiratory disease,0
84409004,Fetid chronic bronchitis (disorder),Chronic respiratory disease,0
85761009,Byssinosis (disorder),Chronic respiratory disease,0
86092005,Cystic fibrosis with meconium ileus (disorder),Chronic respiratory disease,0
86555001,Cystic fibrosis of the lung (disorder),Chronic respiratory disease,0
87153008,Pulmonary alveolar microlithiasis (disorder),Chronic respiratory disease,0
87433001,Pulmonary emphysema (disorder),Chronic respiratory disease,0
87837008,Chronic pulmonary heart disease (disorder),Chronic respiratory disease,0
89549007,Catarrhal bronchitis (disorder),Chronic respiratory disease,0
90117007,Tuberculous fibrosis of lung (disorder),Chronic respiratory disease,0
90610005,Interstitial pulmonary fibrosis of prematurity (disorder),Chronic respiratory disease,0
93432008,Drug-induced asthma (disorder),Chronic respiratory disease,0
111901001,Bronchocentric granulomatosis (disorder),Chronic respiratory disease,0
129451001,Respiratory bronchiolitis associated interstitial lung disease (disorder),Chronic respiratory disease,0
129452008,Nonspecific interstitial pneumonia (disorder),Chronic respiratory disease,0
134498003,Budesonide+eformoterol fumarate 200/6mcg bth-act dry pdr inh,Chronic respiratory disease,0
134498003,Budesonide + formoterol fumarate 200/6mcg breath-actuated dry powder inhaler,Chronic respiratory disease,0
134510006,Product containing precisely montelukast (as montelukast sodium) 4 milligram/1 each conventional release chewable tablet (clinical drug),Chronic respiratory disease,0
135836000,End stage chronic obstructive airways disease (disorder),Chronic respiratory disease,0
183478001,Emergency hospital admission for asthma (procedure),Chronic respiratory disease,0
185086009,Chronic obstructive bronchitis (disorder),Chronic respiratory disease,0
187233002,Sarcoidosis of lung with sarcoidosis of lymph nodes (disorder),Chronic respiratory disease,0
190905008,Cystic fibrosis (disorder),Chronic respiratory disease,0
190909002,Cystic fibrosis with intestinal manifestations (disorder),Chronic respiratory disease,0
192658007,Giant cell interstitial pneumonitis (disorder),Chronic respiratory disease,0
195949008,Chronic asthmatic bronchitis (disorder),Chronic respiratory disease,0
195951007,Acute exacerbation of chronic obstructive airways disease (disorder),Chronic respiratory disease,0
195953005,Mixed simple and mucopurulent chronic bronchitis (disorder),Chronic respiratory disease,0
195957006,Chronic bullous emphysema (disorder),Chronic respiratory disease,0
195958001,Segmental bullous emphysema (disorder),Chronic respiratory disease,0
195959009,Zonal bullous emphysema (disorder),Chronic respiratory disease,0
195963002,Acute vesicular emphysema (disorder),Chronic respiratory disease,0
195967001,Asthma (disorder),Chronic respiratory disease,0
195977004,Mixed asthma (disorder),Chronic respiratory disease,0
195984007,Recurrent bronchiectasis (disorder),Chronic respiratory disease,0
195985008,Post-infective bronchiectasis (disorder),Chronic respiratory disease,0
196001008,Chronic obstructive pulmonary disease with acute lower respiratory infection (disorder),Chronic respiratory disease,0
196027008,Toxic bronchiolitis obliterans (disorder),Chronic respiratory disease,0
196028003,Chronic pulmonary fibrosis caused by chemical fumes (disorder),Chronic respiratory disease,0
196051003,Drug-induced interstitial lung disorder (disorder),Chronic respiratory disease,0
196053000,Chronic drug-induced interstitial lung disorders (disorder),Chronic respiratory disease,0
196115007,Pulmonary congestion and hypostasis (disorder),Chronic respiratory disease,0
196116008,Pulmonary hypostasis (disorder),Chronic respiratory disease,0
196125002,Diffuse interstitial pulmonary fibrosis (disorder),Chronic respiratory disease,0
196133001,Lung disease with systemic sclerosis (disorder),Chronic respiratory disease,0
196135008,Pulmonary amyloidosis (disorder),Chronic respiratory disease,0
197367007,Hepatic granulomas in berylliosis (disorder),Chronic respiratory disease,0
225057002,Brittle asthma (disorder),Chronic respiratory disease,0
233627004,Congenital cystic bronchiectasis (disorder),Chronic respiratory disease,0
233628009,Acquired bronchiectasis (disorder),Chronic respiratory disease,0
233629001,Idiopathic bronchiectasis (disorder),Chronic respiratory disease,0
233630006,Obstructive bronchiectasis (disorder),Chronic respiratory disease,0
233666007,Young's syndrome (disorder),Chronic respiratory disease,0
233675009,Toxic emphysema (disorder),Chronic respiratory disease,0
233678006,Childhood asthma (disorder),Chronic respiratory disease,0
233679003,Late onset asthma (disorder),Chronic respiratory disease,0
233683003,Hay fever with asthma (disorder),Chronic respiratory disease,0
233688007,Sulfite-induced asthma (disorder),Chronic respiratory disease,0
233691007,Asthmatic pulmonary eosinophilia (disorder),Chronic respiratory disease,0
233692000,Cryptogenic pulmonary eosinophilia (disorder),Chronic respiratory disease,0
233703007,Interstitial lung disease (disorder),Chronic respiratory disease,0
233713004,Seasonal cryptogenic organizing pneumonia with biochemical cholestasis (disorder),Chronic respiratory disease,0
233714005,Diffuse infiltrative lung disease (disorder),Chronic respiratory disease,0
233715006,Idiopathic diffuse pulmonary ossification (disorder),Chronic respiratory disease,0
233718008,Pulmonary tuberous sclerosis (disorder),Chronic respiratory disease,0
233725001,Drug-induced diffuse interstitial pulmonary fibrosis (disorder),Chronic respiratory disease,0
233726000,Localized pulmonary fibrosis (disorder),Chronic respiratory disease,0
233727009,Mediastinal radiation fibrosis (disorder),Chronic respiratory disease,0
233744008,Hilar lymph node sarcoidosis (disorder),Chronic respiratory disease,0
233749003,Complicated pneumoconiosis (disorder),Chronic respiratory disease,0
233761006,Subacute silicosis (disorder),Chronic respiratory disease,0
233767005,Stage 1 pulmonary sarcoidosis (disorder),Chronic respiratory disease,0
233768000,Stage 2 pulmonary sarcoidosis (disorder),Chronic respiratory disease,0
233769008,Stage 3 pulmonary sarcoidosis (disorder),Chronic respiratory disease,0
233770009,Stage 4 pulmonary sarcoidosis (disorder),Chronic respiratory disease,0
233771008,Endobronchial sarcoidosis (disorder),Chronic respiratory disease,0
233772001,Sarcoid pulmonary calcification (disorder),Chronic respiratory disease,0
235978006,Cystic fibrosis of pancreas (disorder),Chronic respiratory disease,0
238676008,Lofgrens syndrome (disorder),Chronic respiratory disease,0
240742009,Chronic pulmonary African histoplasmosis (disorder),Chronic respiratory disease,0
266355005,Bullous emphysema with collapse (disorder),Chronic respiratory disease,0
266356006,Atrophic (senile) emphysema (disorder),Chronic respiratory disease,0
266361008,Non-allergic asthma (disorder),Chronic respiratory disease,0
266368002,Post-inflammatory pulmonary fibrosis (disorder),Chronic respiratory disease,0
266370006,Trauma and postoperative pulmonary insufficiency (disorder),Chronic respiratory disease,0
277656005,Primary pulmonary hypoplasia (disorder),Chronic respiratory disease,0
277844007,Pulmonary lymphangioleiomyomatosis (disorder),Chronic respiratory disease,0
281239006,Exacerbation of asthma (disorder),Chronic respiratory disease,0
285381006,Acute infective exacerbation of chronic obstructive airways disease (disorder),Chronic respiratory disease,0
304527002,Acute asthma (disorder),Chronic respiratory disease,0
312453004,Asthma - currently active (finding),Chronic respiratory disease,0
313296004,Mild chronic obstructive pulmonary disease (disorder),Chronic respiratory disease,0
313297008,Moderate chronic obstructive pulmonary disease (disorder),Chronic respiratory disease,0
313299006,Severe chronic obstructive pulmonary disease (disorder),Chronic respiratory disease,0
319481006,Epinephrine 1:1000 500micrograms/0.5mL injection (product),Chronic respiratory disease,0
320099003,Albuterol 4mg m/r capsule,Chronic respiratory disease,0
320104002,Product containing precisely salbutamol 4 milligram/1 each conventional release oral tablet (clinical drug),Chronic respiratory disease,0
320106000,Product containing precisely salbutamol (as salbutamol sulfate) 2 milligram/1 each conventional release oral tablet (clinical drug),Chronic respiratory disease,0
320108004,Albuterol 2mg/5mL sugar free syrup,Chronic respiratory disease,0
320118009,Albuterol 500micrograms/1mL injection,Chronic respiratory disease,0
320119001,Albuterol 5mg/5mL intravenous infusion,Chronic respiratory disease,0
320136009,Salbutamol 100micrograms breath-actuated aerosol inhaler (product),Chronic respiratory disease,0
320139002,Albuterol 100micrograms CFC-free inhaler,Chronic respiratory disease,0
320141001,Albuterol 200micrograms breath-actuated dry powder inhaler,Chronic respiratory disease,0
320151000,Albuterol 100micrograms CFC-free breath-actuated aerosol inhaler,Chronic respiratory disease,0
320171009,Salbutamol 5mg/2.5mL nebulization unit (product),Chronic respiratory disease,0
320176004,Salbutamol 100micrograms inhaler (product),Chronic respiratory disease,0
320177008,Salbutamol 2.5mg/2.5mL nebulization unit (product),Chronic respiratory disease,0
320180009,Salbutamol 100mg/20mL nebulizer solution (product),Chronic respiratory disease,0
320201003,Terbutaline sulfate 500micrograms breath-actuated dry powder inhaler (product),Chronic respiratory disease,0
320203000,Product containing precisely terbutaline sulfate 5 milligram/1 each conventional release oral tablet (clinical drug),Chronic respiratory disease,0
320244004,Salmeterol 25mcg inhaler (product),Chronic respiratory disease,0
320250009,Salmeterol 50micrograms breath-actuated dry powder inhaler (product),Chronic respiratory disease,0
320258002,Product containing precisely bambuterol hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug),Chronic respiratory disease,0
320259005,Product containing precisely bambuterol hydrochloride 20 milligram/1 each conventional release oral tablet (clinical drug),Chronic respiratory disease,0
320263003,Eformoterol fumarate dihydrate 6micrograms breath-actuated dry powder inhaler (product),Chronic respiratory disease,0
320264009,Eformoterol fumarate dihydrate 12micrograms breath-actuated dry powder inhaler (product),Chronic respiratory disease,0
320274007,Salmeterol+fluticasone propionate 25micrograms/50micrograms CFC-free inhaler (product),Chronic respiratory disease,0
320275008,Salmeterol+fluticasone propionate 25micrograms/125micrograms CFC-free inhaler (product),Chronic respiratory disease,0
320276009,Salmeterol+fluticasone propionate 25micrograms/250micrograms CFC-free inhaler (product),Chronic respiratory disease,0
320277000,Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler (product),Chronic respiratory disease,0
320279002,Salmeterol+fluticasone propionate 50micrograms/250micrograms breath-actuated dry powder inhaler (product),Chronic respiratory disease,0
320280004,Salmeterol+fluticasone propionate 50micrograms/500micrograms breath-actuated dry powder inhaler (product),Chronic respiratory disease,0
320296001,Product containing precisely ephedrine hydrochloride 15 milligram/1 each conventional release oral tablet (clinical drug),Chronic respiratory disease,0
320297005,Product containing precisely ephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug),Chronic respiratory disease,0
320346000,Ipratropium bromide 250micrograms/1mL nebulizer solution (product),Chronic respiratory disease,0
320347009,Ipratropium bromide 500micrograms/2mL nebulizer solution (product),Chronic respiratory disease,0
320415003,Product containing precisely theophylline monohydrate (as theophylline sodium glycinate) 12 milligram/1 milliliter conventional release oral solution (clinical drug),Chronic respiratory disease,0
320445000,Salbutamol+ipratropium bromide 2.5mg/500micrograms nebulization unit (product),Chronic respiratory disease,0
320537007,Product containing precisely beclometasone dipropionate 100 microgram/1 actuation pressurized conventional release solution for inhalation (clinical drug),Chronic respiratory disease,0
320602002,Fluticasone propionate 50micrograms breath-actuated dry powder inhaler (product),Chronic respiratory disease,0
320603007,Fluticasone propionate 100micrograms breath-actuated dry powder inhaler (product),Chronic respiratory disease,0
320605000,Fluticasone propionate 500micrograms breath-actuated dry powder inhaler (product),Chronic respiratory disease,0
320610001,Fluticasone propionate 0.5mg/2mL nebulization unit (product),Chronic respiratory disease,0
320611002,Fluticasone propionate 2mg/2mL nebulization unit (product),Chronic respiratory disease,0
320614005,Fluticasone propionate 125micrograms CFC-free inhaler (product),Chronic respiratory disease,0
320615006,Fluticasone propionate 250micrograms CFC-free inhaler (product),Chronic respiratory disease,0
320618008,Fluticasone propionate 50micrograms CFC-free inhaler (product),Chronic respiratory disease,0
320667005,Product containing precisely ketotifen 1 milligram/1 each conventional release oral tablet (clinical drug),Chronic respiratory disease,0
320884002,Product containing precisely montelukast (as montelukast sodium) 10 milligram/1 each conventional release oral tablet (clinical drug),Chronic respiratory disease,0
320885001,Product containing precisely montelukast (as montelukast sodium) 5 milligram/1 each conventional release chewable tablet (clinical drug),Chronic respiratory disease,0
320889007,Product containing precisely zafirlukast 20 milligram/1 each conventional release oral tablet (clinical drug),Chronic respiratory disease,0
360470001,Chronic mucus hypersecretion (disorder),Chronic respiratory disease,0
367542003,Pulmonary eosinophilia (disorder),Chronic respiratory disease,0
370218001,Mild asthma (disorder),Chronic respiratory disease,0
370219009,Moderate asthma (disorder),Chronic respiratory disease,0
370220003,Occasional asthma (disorder),Chronic respiratory disease,0
370221004,Severe asthma (disorder),Chronic respiratory disease,0
371067004,Hepatopulmonary syndrome (disorder),Chronic respiratory disease,0
389145006,Allergic asthma (disorder),Chronic respiratory disease,0
395022009,Asthma night-time symptoms (finding),Chronic respiratory disease,0
398640008,Rheumatoid pneumoconiosis (disorder),Chronic respiratory disease,0
401193004,Asthma confirmed (situation),Chronic respiratory disease,0
405944004,Asthmatic bronchitis (disorder),Chronic respiratory disease,0
407674008,Aspirin-induced asthma (disorder),Chronic respiratory disease,0
408013007,Mometasone furoate 400micrograms breath-actuated dry powder inhaler (product),Chronic respiratory disease,0
408026006,Mometasone furoate 200micrograms breath-actuated dry powder inhaler (product),Chronic respiratory disease,0
408501008,Emergency hospital admission for chronic obstructive pulmonary disease (procedure),Chronic respiratory disease,0
410944008,Product containing precisely montelukast (as montelukast sodium) 4 milligram/1 sachet conventional release oral granules (clinical drug),Chronic respiratory disease,0
414538008,Ipratropium bromide 20mcg chlorofluorocarbon-free inhaler,Chronic respiratory disease,0
417152008,Langerhans cell histiocytosis of lung (disorder),Chronic respiratory disease,0
423889005,Non-immunoglobulin E mediated allergic asthma (disorder),Chronic respiratory disease,0
424643009,Atopic asthma,Chronic respiratory disease,0
425748003,Acute exacerbation of chronic bronchitis (disorder),Chronic respiratory disease,0
425969006,Exacerbation of intermittent asthma (disorder),Chronic respiratory disease,0
426705001,Diabetes mellitus co-occurrent and due to cystic fibrosis (disorder),Chronic respiratory disease,0
426896000,Chronic hypercapnic respiratory failure (disorder),Chronic respiratory disease,0
427022004,Liver disease due to cystic fibrosis (disorder),Chronic respiratory disease,0
427046006,Drug-induced pneumonitis (disorder),Chronic respiratory disease,0
427123006,Interstitial lung disease due to collagen vascular disease (disorder),Chronic respiratory disease,0
427679007,Mild intermittent asthma (disorder),Chronic respiratory disease,0
428173007,Chronic hypoxemic respiratory failure (disorder),Chronic respiratory disease,0
438773007,Recurrent pulmonary embolism (disorder),Chronic respiratory disease,0
445378003,Acute exacerbation of bronchiectasis (disorder),Chronic respiratory disease,0
700250006,Idiopathic pulmonary fibrosis (disorder),Chronic respiratory disease,0
703924000,Aclidinium bromide 375micrograms inhaler (product),Chronic respiratory disease,0
707511009,Uncomplicated mild persistent asthma (disorder),Chronic respiratory disease,0
708038006,Acute exacerbation of asthma (disorder),Chronic respiratory disease,0
708090002,Acute severe exacerbation of asthma (disorder),Chronic respiratory disease,0
708093000,Acute exacerbation of immunoglobulin E-mediated allergic asthma (disorder),Chronic respiratory disease,0
708094006,Acute exacerbation of intrinsic asthma (disorder),Chronic respiratory disease,0
708095007,Acute severe exacerbation of immunoglobin E-mediated allergic asthma (disorder),Chronic respiratory disease,0
708358003,Emergency asthma admission since last encounter (situation),Chronic respiratory disease,0
711379004,Interstitial lung disease due to connective tissue disease (disorder),Chronic respiratory disease,0
719218000,Cryptogenic organizing pneumonia,Chronic respiratory disease,0
733858005,Acute severe refractory exacerbation of asthma (disorder),Chronic respiratory disease,0
734904007,Life threatening acute exacerbation of asthma (disorder),Chronic respiratory disease,0
734905008,Moderate acute exacerbation of asthma (disorder),Chronic respiratory disease,0
737181009,Interstitial lung disease due to systemic disease (disorder),Chronic respiratory disease,0
6.41E+11,Intermittent asthma well controlled (finding),Chronic respiratory disease,0
2.4011E+13,Atrovent 20micrograms/actuation inhaler (Boehringer Ingelheim Ltd) (product),Chronic respiratory disease,0
9.9031E+13,Acute exacerbation of asthma co-occurrent with allergic rhinitis (disorder),Chronic respiratory disease,0
1.01011E+14,Bricanyl 2.5mg/5ml solution for injection ampoules (AstraZeneca) (product),Chronic respiratory disease,0
1.06511E+14,Salamol CFC-Free 100micrograms/actuation inhaler (IVAX Pharmaceuticals UK Ltd) (product),Chronic respiratory disease,0
1.61111E+14,Salbutamol 2mg/5ml oral solution sugar free (A A H Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
1.76011E+14,Slo-Phyllin 125mg capsules (Merck Pharmaceuticals) (product),Chronic respiratory disease,0
1.84211E+14,Nuelin SA 175mg tablets (Mylan) (product),Chronic respiratory disease,0
2.22311E+14,Ventolin Evohaler 100micrograms/actuation (GlaxoSmithKline) (product),Chronic respiratory disease,0
2.93991E+14,Very severe chronic obstructive pulmonary disease (disorder),Chronic respiratory disease,0
3.51411E+14,Atrovent 20micrograms/actuation Autohaler (Boehringer Ingelheim Ltd) (product),Chronic respiratory disease,0
3.75711E+14,Bambec 10mg tablets (AstraZeneca) (product),Chronic respiratory disease,0
3.98511E+14,Flixotide 125micrograms/actuation Evohaler (GlaxoSmithKline) (product),Chronic respiratory disease,0
4.08011E+14,Accolate 20mg tablets (AstraZeneca) (product),Chronic respiratory disease,0
4.08911E+14,Serevent 25micrograms/actuation inhaler (GlaxoSmithKline) (product),Chronic respiratory disease,0
4.53611E+14,Seretide 50 Evohaler (GlaxoSmithKline) (product),Chronic respiratory disease,0
4.54311E+14,Uniphyllin Continus 200mg tablets (Napp Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
4.56911E+14,Nuelin SA 250 tablets (Mylan) (product),Chronic respiratory disease,0
5.26071E+14,Arthropathy in cystic fibrosis (disorder),Chronic respiratory disease,0
5.33311E+14,Intal 5mg/actuation inhaler (Aventis Pharma) (product),Chronic respiratory disease,0
5.39811E+14,Seretide 250 Evohaler (GlaxoSmithKline) (product),Chronic respiratory disease,0
5.43711E+14,Slo-Phyllin 250mg capsules (Merck Pharmaceuticals) (product),Chronic respiratory disease,0
5.50511E+14,Phyllocontin Forte Continus 350mg tablets (Napp Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
5.97011E+14,Airomir 100micrograms/actuation inhaler (IVAX Pharmaceuticals UK Ltd) (product),Chronic respiratory disease,0
6.91211E+14,Bricanyl 500micrograms/1ml solution for injection ampoules (AstraZeneca) (product),Chronic respiratory disease,0
7.19811E+14,Singulair 10mg tablets (Organon Pharma (UK) Ltd) (product),Chronic respiratory disease,0
7.26611E+14,Flixotide 50micrograms/actuation Evohaler (GlaxoSmithKline) (product),Chronic respiratory disease,0
7.38811E+14,Bricanyl 5mg tablets (AstraZeneca) (product),Chronic respiratory disease,0
7.57611E+14,Salbutamol 100micrograms/actuation inhaler CFC free (Approved Prescription Services) (product),Chronic respiratory disease,0
7.76981E+14,Cirrhosis associated with cystic fibrosis (disorder),Chronic respiratory disease,0
7.92111E+14,Slo-Phyllin 60mg capsules (Merck Pharmaceuticals) (product),Chronic respiratory disease,0
8.10211E+14,Seretide 125 Evohaler (GlaxoSmithKline) (product),Chronic respiratory disease,0
8.47091E+14,Acute non-infective exacerbation of chronic obstructive pulmonary disease (disorder),Chronic respiratory disease,0
8.59041E+14,Exacerbation of cystic fibrosis (disorder),Chronic respiratory disease,0
8.66881E+14,Chronic asthma with fixed airflow obstruction (disorder),Chronic respiratory disease,0
8.66901E+14,Eosinophilic bronchitis (disorder),Chronic respiratory disease,0
8.86111E+14,Ventolin 5mg/5ml solution for injection ampoules (GlaxoSmithKline) (product),Chronic respiratory disease,0
8.92011E+14,Ventolin 2mg/5ml syrup (GlaxoSmithKline) (product),Chronic respiratory disease,0
8.92311E+14,Singulair Paediatric 5mg chewable tablets (Organon Pharma (UK) Ltd) (product),Chronic respiratory disease,0
1.06481E+15,Moderate acute exacerbation of asthma (disorder),Chronic respiratory disease,0
1.06482E+15,Life threatening acute exacerbation of asthma (disorder),Chronic respiratory disease,0
1.0867E+15,Life threatening acute exacerbation of allergic asthma (disorder),Chronic respiratory disease,0
1.08671E+15,Life threatening acute exacerbation of intrinsic asthma (disorder),Chronic respiratory disease,0
1.10391E+15,Severe asthma with fungal sensitisation (disorder),Chronic respiratory disease,0
2.83121E+15,Flixotide 250micrograms/actuation Evohaler (GlaxoSmithKline) (product),Chronic respiratory disease,0
2.89181E+15,Uniphyllin Continus 300mg tablets (Napp Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
2.89221E+15,Uniphyllin Continus 400mg tablets (Napp Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
2.92311E+15,Duovent inhaler (Boehringer Ingelheim Ltd) (product),Chronic respiratory disease,0
2.92411E+15,Pulmicort 200micrograms/actuation inhaler (AstraZeneca) (product),Chronic respiratory disease,0
3.11241E+15,Pulmicort Turbohaler 200 (AstraZeneca) (product),Chronic respiratory disease,0
3.11311E+15,Pulmicort Turbohaler 100 (AstraZeneca) (product),Chronic respiratory disease,0
3.11341E+15,Pulvinal Beclometasone Dipropionate 200micrograms/actuation dry powder inhaler (Trinity Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
3.17561E+15,Qvar 100 inhaler (IVAX Pharmaceuticals UK Ltd) (product),Chronic respiratory disease,0
3.17621E+15,Becotide 50 inhaler (GlaxoSmithKline) (product),Chronic respiratory disease,0
3.17681E+15,Qvar 50 inhaler (IVAX Pharmaceuticals UK Ltd) (product),Chronic respiratory disease,0
3.17741E+15,Qvar 50 Autohaler (IVAX Pharmaceuticals UK Ltd) (product),Chronic respiratory disease,0
3.17771E+15,Qvar 100 Autohaler (IVAX Pharmaceuticals UK Ltd) (product),Chronic respiratory disease,0
3.17861E+15,Becotide 100 inhaler (GlaxoSmithKline) (product),Chronic respiratory disease,0
3.17881E+15,Beclazone 100 inhaler (IVAX Pharmaceuticals UK Ltd) (product),Chronic respiratory disease,0
3.18381E+15,Flixotide 50micrograms/actuation Accuhaler (GlaxoSmithKline) (product),Chronic respiratory disease,0
3.18431E+15,Flixotide 100micrograms/actuation Accuhaler (GlaxoSmithKline) (product),Chronic respiratory disease,0
3.18491E+15,Flixotide 250micrograms/actuation Accuhaler (GlaxoSmithKline) (product),Chronic respiratory disease,0
3.18521E+15,Flixotide 500micrograms/actuation Accuhaler (GlaxoSmithKline) (product),Chronic respiratory disease,0
3.18601E+15,Asmasal 95micrograms/actuation Clickhaler (Celltech Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
3.18691E+15,Seretide 100 Accuhaler (GlaxoSmithKline) (product),Chronic respiratory disease,0
3.18721E+15,Seretide 250 Accuhaler (GlaxoSmithKline) (product),Chronic respiratory disease,0
3.18831E+15,Seretide 500 Accuhaler (GlaxoSmithKline) (product),Chronic respiratory disease,0
3.19031E+15,Becotide Rotacaps 100microgram (GlaxoSmithKline) (product),Chronic respiratory disease,0
3.20681E+15,Foradil 12microgram inhalation powder capsules with device (Novartis Pharmaceuticals UK Ltd) (product),Chronic respiratory disease,0
3.21421E+15,Ventolin Rotacaps 200microgram (GlaxoSmithKline) (product),Chronic respiratory disease,0
3.21431E+15,Airomir 100micrograms/actuation Autohaler (IVAX Pharmaceuticals UK Ltd) (product),Chronic respiratory disease,0
3.21531E+15,Salamol Easi-Breathe 100micrograms/actuation inhaler (IVAX Pharmaceuticals UK Ltd) (product),Chronic respiratory disease,0
3.21831E+15,Bricanyl 500micrograms/actuation Turbohaler (AstraZeneca) (product),Chronic respiratory disease,0
3.22101E+15,Ipratropium 250micrograms/ml nebuliser liquid 2ml unit dose vials (A A H Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
3.22241E+15,Atrovent 250micrograms/ml nebuliser liquid 2ml UDVs (Boehringer Ingelheim Ltd) (product),Chronic respiratory disease,0
3.22311E+15,Ipratropium 500microgram Steri-Neb (IVAX Pharmaceuticals UK Ltd) (product),Chronic respiratory disease,0
3.22531E+15,Ipratropium 250micrograms/ml nebuliser liquid 1ml unit dose vials (A A H Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
3.22641E+15,Atrovent 250micrograms/ml nebuliser liquid 1ml UDVs (Boehringer Ingelheim Ltd) (product),Chronic respiratory disease,0
3.22721E+15,Ipratropium 250microgram Steri-Neb (IVAX Pharmaceuticals UK Ltd) (product),Chronic respiratory disease,0
3.22871E+15,Pulmicort Turbohaler 400 (AstraZeneca) (product),Chronic respiratory disease,0
3.24351E+15,Oxis Turbohaler 6 (AstraZeneca) (product),Chronic respiratory disease,0
3.24501E+15,Oxis Turbohaler 12 (AstraZeneca) (product),Chronic respiratory disease,0
3.24801E+15,Bricanyl 250micrograms/actuation inhaler (AstraZeneca) (product),Chronic respiratory disease,0
3.28741E+15,Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
3.29131E+15,Amnivent-225 SR tablets (Ashbourne Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
3.29311E+15,"Aerolin 100micrograms/actuation Autohaler (3M Health Care Ltd, Pharmaceuticals Division) (product)",Chronic respiratory disease,0
3.29421E+15,Symbicort 100/6 Turbohaler (AstraZeneca) (product),Chronic respiratory disease,0
3.29461E+15,Symbicort 200/6 Turbohaler (AstraZeneca) (product),Chronic respiratory disease,0
3.34861E+15,Combivent inhaler (Boehringer Ingelheim Ltd) (product),Chronic respiratory disease,0
3.37821E+15,Spiriva 18microgram inhalation powder capsules with HandiHaler (Boehringer Ingelheim Ltd) (product),Chronic respiratory disease,0
3.37961E+15,Salbutamol 2mg/ml nebuliser liquid 2.5ml unit dose vials (A A H Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
3.38001E+15,Spiriva 18microgram inhalation powder capsules (Boehringer Ingelheim Ltd) (product),Chronic respiratory disease,0
3.38011E+15,Serevent 50micrograms/actuation Accuhaler (GlaxoSmithKline) (product),Chronic respiratory disease,0
3.38181E+15,Ventolin 5mg Nebules (GlaxoSmithKline) (product),Chronic respiratory disease,0
3.38271E+15,Ventolin 200micrograms/actuation Accuhaler (GlaxoSmithKline) (product),Chronic respiratory disease,0
3.38351E+15,Salamol 5mg Steri-Neb (IVAX Pharmaceuticals UK Ltd) (product),Chronic respiratory disease,0
3.38411E+15,Pulvinal Salbutamol 200micrograms/actuation dry powder inhaler (Trinity Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
3.38571E+15,Salbutamol 1mg/ml nebuliser liquid 2.5ml unit dose vials (A A H Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
3.38701E+15,Ventolin 2.5mg Nebules (GlaxoSmithKline) (product),Chronic respiratory disease,0
3.38751E+15,Salamol 2.5mg Steri-Neb (IVAX Pharmaceuticals UK Ltd) (product),Chronic respiratory disease,0
3.38911E+15,Flixotide 0.5mg/2ml Nebules (GlaxoSmithKline) (product),Chronic respiratory disease,0
3.39721E+15,Flixotide 2mg/2ml Nebules (GlaxoSmithKline) (product),Chronic respiratory disease,0
3.40601E+15,Combivent nebuliser liquid 2.5ml UDVs (Boehringer Ingelheim Ltd) (product),Chronic respiratory disease,0
3.40861E+15,Salbutamol 100micrograms/actuation inhaler (A A H Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
3.49721E+15,Tiotropium bromide 18microgram inhalation powder capsules (product),Chronic respiratory disease,0
3.49731E+15,Tiotropium bromide 18microgram inhalation powder capsules with device (product),Chronic respiratory disease,0
3.63391E+15,Bricanyl 5mg/2ml Respules (AstraZeneca) (product),Chronic respiratory disease,0
3.63541E+15,Pulmicort 0.5mg Respules (AstraZeneca) (product),Chronic respiratory disease,0
3.63651E+15,Pulmicort 1mg Respules (AstraZeneca) (product),Chronic respiratory disease,0
3.65451E+15,Budesonide 250micrograms/ml nebuliser liquid 2ml unit dose vials (product),Chronic respiratory disease,0
3.65461E+15,Budesonide 500micrograms/ml nebuliser liquid 2ml unit dose vials (product),Chronic respiratory disease,0
3.77761E+15,Zaditen 1mg tablets (Novartis Pharmaceuticals UK Ltd) (product),Chronic respiratory disease,0
4.02761E+15,Zaditen 1mg/5ml elixir (Novartis Pharmaceuticals UK Ltd) (product),Chronic respiratory disease,0
4.03031E+15,Ketotifen 1mg/5ml oral solution sugar free (product),Chronic respiratory disease,0
4.04381E+15,Asmanex 400micrograms/dose Twisthaler (Organon Pharma (UK) Ltd) (product),Chronic respiratory disease,0
4.04571E+15,Asmanex 200micrograms/dose Twisthaler (Organon Pharma (UK) Ltd) (product),Chronic respiratory disease,0
4.10701E+15,Tilade 2mg/actuation inhaler (Pantheon Healthcare Ltd) (product),Chronic respiratory disease,0
4.37381E+15,Symbicort 400/12 Turbohaler (AstraZeneca) (product),Chronic respiratory disease,0
4.37811E+15,Budesonide 400micrograms/actuation / Formoterol 12micrograms/actuation dry powder inhaler (product),Chronic respiratory disease,0
4.84391E+15,Ventolin 5mg/ml respirator solution (GlaxoSmithKline) (product),Chronic respiratory disease,0
4.86081E+15,Pulmicort 200micrograms/actuation inhaler with Nebuchamber (AstraZeneca) (product),Chronic respiratory disease,0
5.27791E+15,Ventolin Evohaler 100micrograms/actuation (PI) (Waymade Ltd) (product),Chronic respiratory disease,0
7.38991E+15,Atrovent 20micrograms/actuation inhaler CFC free (Boehringer Ingelheim Ltd) (product),Chronic respiratory disease,0
8.02461E+15,Budesonide 200micrograms/actuation dry powder inhalation cartridge with device (product),Chronic respiratory disease,0
8.03181E+15,Budelin Novolizer 200micrograms/dose inhalation powder (Mylan) (product),Chronic respiratory disease,0
8.15951E+15,Qvar Easi-Breathe 50micrograms/actuation inhaler (IVAX Pharmaceuticals UK Ltd) (product),Chronic respiratory disease,0
8.15971E+15,Qvar Easi-Breathe 100micrograms/actuation inhaler (IVAX Pharmaceuticals UK Ltd) (product),Chronic respiratory disease,0
9.00391E+15,Alvesco 80 inhaler (Altana Pharma Limited) (product),Chronic respiratory disease,0
9.00421E+15,Alvesco 160 inhaler (Altana Pharma Limited) (product),Chronic respiratory disease,0
9.00441E+15,Ciclesonide 160micrograms/actuation inhaler CFC free (product),Chronic respiratory disease,0
9.00451E+15,Ciclesonide 80micrograms/actuation inhaler CFC free (product),Chronic respiratory disease,0
9.04001E+15,Salbutamol 2.5mg Steripoules (Galen Ltd) (product),Chronic respiratory disease,0
9.04021E+15,Salbutamol 5mg Steripoules (Galen Ltd) (product),Chronic respiratory disease,0
9.11181E+15,Budelin Novolizer 200micrograms/dose inhalation powder refill (Mylan) (product),Chronic respiratory disease,0
9.11781E+15,Budesonide 200micrograms/actuation dry powder inhalation cartridge (product),Chronic respiratory disease,0
9.20491E+15,Easyhaler Salbutamol Sulphate 200micrograms/actuation dry powder inhaler (Ranbaxy (UK) Ltd) (product),Chronic respiratory disease,0
9.20521E+15,Easyhaler Salbutamol Sulphate 100micrograms/actuation dry powder inhaler (Ranbaxy (UK) Ltd) (product),Chronic respiratory disease,0
9.20741E+15,Salbutamol 100micrograms/actuation dry powder inhaler (product),Chronic respiratory disease,0
9.47891E+15,Tiotropium bromide 18microgram inhalation powder capsules (product),Chronic respiratory disease,0
9.47901E+15,Tiotropium bromide 18microgram inhalation powder capsules with device (product),Chronic respiratory disease,0
9.52511E+15,Easyhaler Beclometasone 200micrograms/actuation dry powder inhaler (Ranbaxy (UK) Ltd) (product),Chronic respiratory disease,0
9.62871E+15,Atimos Modulite 12micrograms/actuation inhaler (Trinity-Chiesi Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
9.65271E+15,Formoterol 12micrograms/actuation inhaler (product),Chronic respiratory disease,0
9.71411E+15,Tilade 2mg/actuation inhaler CFC free (sanofi-aventis) (product),Chronic respiratory disease,0
9.72021E+15,Nedocromil 2mg/actuation inhaler CFC free (product),Chronic respiratory disease,0
9.74291E+15,Omalizumab 150mg powder and solvent for solution for injection vials (product),Chronic respiratory disease,0
1.0073E+16,Serevent 25microgram/actuation Evohaler (GlaxoSmithKline) (product),Chronic respiratory disease,0
1.00739E+16,Easyhaler Budesonide 100micrograms/actuation dry powder inhaler (Ranbaxy (UK) Ltd) (product),Chronic respiratory disease,0
1.00744E+16,Easyhaler Budesonide 400micrograms/actuation dry powder inhaler (Ranbaxy (UK) Ltd) (product),Chronic respiratory disease,0
1.00746E+16,Easyhaler Budesonide 200micrograms/actuation dry powder inhaler (Ranbaxy (UK) Ltd) (product),Chronic respiratory disease,0
1.00756E+16,Salmeterol 25micrograms/actuation inhaler CFC free (product),Chronic respiratory disease,0
1.02728E+16,Budesonide 250micrograms/ml nebuliser liquid 2ml unit dose vials (A A H Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
1.02736E+16,Budesonide 250micrograms/ml nebuliser liquid 2ml unit dose vials (Teva UK Ltd) (product),Chronic respiratory disease,0
1.06177E+16,Clenil Modulite 50micrograms/actuation inhaler (Trinity-Chiesi Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
1.06182E+16,Clenil Modulite 100micrograms/actuation inhaler (Trinity-Chiesi Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
1.06193E+16,Clenil Modulite 200micrograms/actuation inhaler (Trinity-Chiesi Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
1.06196E+16,Clenil Modulite 250micrograms/actuation inhaler (Trinity-Chiesi Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
1.0621E+16,Beclometasone 200micrograms/actuation inhaler CFC free (product),Chronic respiratory disease,0
1.06211E+16,Beclometasone 250micrograms/actuation inhaler CFC free (product),Chronic respiratory disease,0
1.0676E+16,Acute severe exacerbation of mild persistent allergic asthma co-occurrent with allergic rhinitis (disorder),Chronic respiratory disease,0
1.06761E+16,Mild persistent asthma controlled (finding),Chronic respiratory disease,0
1.06764E+16,Moderate persistent asthma controlled (finding),Chronic respiratory disease,0
1.06927E+16,Aspirin exacerbated respiratory disease (disorder),Chronic respiratory disease,0
1.06928E+16,Asthma-chronic obstructive pulmonary disease overlap syndrome (disorder),Chronic respiratory disease,0
1.09275E+16,Ipramol Steri-Neb nebuliser solution 2.5ml unit dose vials (Teva UK Ltd) (product),Chronic respiratory disease,0
1.10055E+16,Budesonide 500micrograms/2ml nebuliser liquid unit dose vials (Accord Healthcare Ltd) (product),Chronic respiratory disease,0
1.10067E+16,Salbutamol 5mg/2.5ml nebuliser liquid unit dose vials (Accord Healthcare Ltd) (product),Chronic respiratory disease,0
1.11764E+16,Easyhaler Formoterol 12micrograms/dose dry powder inhaler (Ranbaxy (UK) Ltd) (product),Chronic respiratory disease,0
1.21469E+16,Spiriva Respimat 2.5micrograms/dose inhalation solution cartridge with device (Boehringer Ingelheim Ltd) (product),Chronic respiratory disease,0
1.21974E+16,Tiotropium bromide 2.5micrograms/dose solution for inhalation cartridge with device CFC free (product),Chronic respiratory disease,0
1.26262E+16,Formoterol 12microgram inhalation powder capsules with device (product),Chronic respiratory disease,0
1.29064E+16,Fostair 100micrograms/dose / 6micrograms/dose inhaler (Trinity-Chiesi Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
1.2911E+16,Beclometasone 100micrograms/dose / Formoterol 6micrograms/dose inhaler CFC free (product),Chronic respiratory disease,0
1.35335E+16,Salbulin Novolizer 100micrograms/dose inhalation powder (Mylan) (product),Chronic respiratory disease,0
1.35337E+16,Salbulin Novolizer 100micrograms/dose inhalation powder refill (Mylan) (product),Chronic respiratory disease,0
1.35661E+16,Salbutamol 100micrograms/dose dry powder inhalation cartridge (product),Chronic respiratory disease,0
1.35662E+16,Salbutamol 100micrograms/dose dry powder inhalation cartridge with device (product),Chronic respiratory disease,0
1.36263E+16,Salbutamol 2mg/5ml oral solution sugar free (Pinewood Healthcare) (product),Chronic respiratory disease,0
1.36632E+16,Aminophylline hydrate 225mg modified-release tablets (product),Chronic respiratory disease,0
1.3777E+16,Intal 5mg/dose inhaler CFC free (sanofi-aventis) (product),Chronic respiratory disease,0
1.38019E+16,Sodium cromoglicate 5mg/dose inhaler CFC free (product),Chronic respiratory disease,0
1.39531E+16,Pulmicort 200 Turbohaler (Doncaster Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
1.39689E+16,Ventolin 100micrograms/dose Evohaler (Doncaster Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
1.39981E+16,Seretide 125 Evohaler (Doncaster Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
1.46086E+16,Aminophylline hydrate 350mg modified-release tablets (product),Chronic respiratory disease,0
1.49595E+16,Budesonide 100micrograms/dose inhaler CFC free (product),Chronic respiratory disease,0
1.55349E+16,Salbutamol 1mg/ml / Ipratropium bromide 200micrograms/ml nebuliser liquid 2.5ml ampoules (product),Chronic respiratory disease,0
1.62411E+16,Seretide 500 Accuhaler (Lexon (UK) Ltd) (product),Chronic respiratory disease,0
1.62415E+16,Seretide 250 Evohaler (Lexon (UK) Ltd) (product),Chronic respiratory disease,0
1.7927E+16,Salbutamol 100micrograms/dose inhaler CFC free (Phoenix Healthcare Distribution Ltd) (product),Chronic respiratory disease,0
1.80807E+16,Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials (Fannin (UK) Ltd) (product),Chronic respiratory disease,0
1.80809E+16,Salbutamol 5mg/2.5ml nebuliser liquid unit dose vials (Fannin (UK) Ltd) (product),Chronic respiratory disease,0
1.8667E+16,Xolair 75mg/0.5ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) (product),Chronic respiratory disease,0
1.86673E+16,Xolair 150mg/1ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) (product),Chronic respiratory disease,0
1.86713E+16,Omalizumab 150mg/1ml solution for injection pre-filled syringes (product),Chronic respiratory disease,0
1.86714E+16,Omalizumab 75mg/0.5ml solution for injection pre-filled syringes (product),Chronic respiratory disease,0
1.95684E+16,Neovent 25micrograms/dose inhaler CFC free (Fannin UK Ltd) (product),Chronic respiratory disease,0
1.97373E+16,Clenil Modulite 100micrograms/dose inhaler (Mawdsley-Brooks & Company Ltd) (product),Chronic respiratory disease,0
1.97375E+16,Clenil Modulite 200micrograms/dose inhaler (Mawdsley-Brooks & Company Ltd) (product),Chronic respiratory disease,0
2.04344E+16,Salamol 100micrograms/dose Inhaler CFC free (Arrow Generics Ltd) (product),Chronic respiratory disease,0
2.09855E+16,Eklira 322micrograms/dose Genuair (Almirall Ltd) (product),Chronic respiratory disease,0
2.10194E+16,Flutiform 125micrograms/dose / 5micrograms/dose inhaler (Napp Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
2.10197E+16,Flutiform 250micrograms/dose / 10micrograms/dose inhaler (Napp Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
2.10206E+16,Flutiform 50micrograms/dose / 5micrograms/dose inhaler (Napp Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
2.11137E+16,Fluticasone 125micrograms/dose / Formoterol 5micrograms/dose inhaler CFC free (product),Chronic respiratory disease,0
2.11138E+16,Fluticasone 250micrograms/dose / Formoterol 10micrograms/dose inhaler CFC free (product),Chronic respiratory disease,0
2.11139E+16,Fluticasone 50micrograms/dose / Formoterol 5micrograms/dose inhaler CFC free (product),Chronic respiratory disease,0
2.172E+16,Ipratropium bromide 500micrograms/2ml nebuliser liquid unit dose vials (Focus Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
2.21065E+16,Montelukast 5mg chewable tablets sugar free (Actavis UK Ltd) (product),Chronic respiratory disease,0
2.21067E+16,Montelukast 10mg tablets (Actavis UK Ltd) (product),Chronic respiratory disease,0
2.21119E+16,Montelukast 10mg tablets (Teva UK Ltd) (product),Chronic respiratory disease,0
2.21126E+16,Montelukast 5mg chewable tablets sugar free (Teva UK Ltd) (product),Chronic respiratory disease,0
2.24971E+16,Montelukast 10mg tablets (Dr Reddy's Laboratories (UK) Ltd) (product),Chronic respiratory disease,0
2.26501E+16,Vertine 25micrograms/dose inhaler CFC free (Teva UK Ltd) (product),Chronic respiratory disease,0
2.36217E+16,Relvar Ellipta 184micrograms/dose / 22micrograms/dose inhaler (GlaxoSmithKline UK Ltd) (product),Chronic respiratory disease,0
2.3622E+16,Relvar Ellipta 92micrograms/dose / 22micrograms/dose inhaler (GlaxoSmithKline UK Ltd) (product),Chronic respiratory disease,0
2.36613E+16,Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
2.36614E+16,Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
2.45953E+16,Theophylline 50mg/5ml oral solution (product),Chronic respiratory disease,0
2.46446E+16,Anoro Ellipta 55micrograms/dose / 22micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) (product),Chronic respiratory disease,0
2.46455E+16,Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
2.52541E+16,DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Teva UK Ltd) (product),Chronic respiratory disease,0
2.52547E+16,DuoResp Spiromax 320micrograms/dose / 9micrograms/dose dry powder inhaler (Teva UK Ltd) (product),Chronic respiratory disease,0
2.61121E+16,Fostair NEXThaler 100micrograms/dose / 6micrograms/dose dry powder inhaler (Chiesi Ltd) (product),Chronic respiratory disease,0
2.61487E+16,Beclometasone 100micrograms/dose / Formoterol 6micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
2.75679E+16,Incruse Ellipta 55micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) (product),Chronic respiratory disease,0
2.78906E+16,Umeclidinium bromide 65micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
2.83572E+16,Duaklir 340micrograms/dose /12micrograms/dose Genuair (Almirall Ltd) (product),Chronic respiratory disease,0
2.8365E+16,Aclidinium bromide 396micrograms/dose / Formoterol 11.8micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
2.90942E+16,Cortiment 9mg modified-release tablets (Ferring Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
2.90949E+16,Budesonide 9mg modified-release tablets (product),Chronic respiratory disease,0
2.97821E+16,Sirdupla 25micrograms/dose / 125micrograms/dose inhaler (Mylan Ltd) (product),Chronic respiratory disease,0
2.97825E+16,Sirdupla 25micrograms/dose / 250micrograms dose inhaler (Mylan Ltd) (product),Chronic respiratory disease,0
2.99713E+16,Spiolto Respimat 2.5micrograms/dose / 2.5micrograms/dose inhalation solution cartridge with device (Boehringer Ingelheim Ltd) (product),Chronic respiratory disease,0
2.99872E+16,Tiotropium bromide 2.5micrograms/dose / Olodaterol 2.5micrograms/dose solution for inhalation cartridge with device CFC free (product),Chronic respiratory disease,0
3.09503E+16,AirFluSal Forspiro 50micrograms/dose / 500micrograms/dose dry powder inhaler (Sandoz Ltd) (product),Chronic respiratory disease,0
3.10631E+16,Fostair NEXThaler 200micrograms/dose / 6micrograms/dose dry powder inhaler (Chiesi Ltd) (product),Chronic respiratory disease,0
3.10634E+16,Fostair 200micrograms/dose / 6micrograms/dose inhaler (Chiesi Ltd) (product),Chronic respiratory disease,0
3.10874E+16,Beclometasone 200micrograms/dose / Formoterol 6micrograms/dose inhaler CFC free (product),Chronic respiratory disease,0
3.10875E+16,Beclometasone 200micrograms/dose / Formoterol 6micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
3.28986E+16,Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Actavis UK Ltd) (product),Chronic respiratory disease,0
3.2926E+16,Symbicort 200micrograms/dose / 6micrograms/dose inhaler (AstraZeneca UK Ltd) (product),Chronic respiratory disease,0
3.29607E+16,Budesonide 200micrograms/dose / Formoterol 6micrograms/dose inhaler (product),Chronic respiratory disease,0
3.35612E+16,Soltel 25micrograms/dose inhaler CFC free (Cipla EU Ltd) (product),Chronic respiratory disease,0
3.36797E+16,Aerivio Spiromax 50micrograms/dose / 500micrograms/dose dry powder inhaler (Teva UK Ltd) (product),Chronic respiratory disease,0
3.40236E+16,Sereflo 25micrograms/dose / 125micrograms/dose inhaler (Kent Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
3.40238E+16,Sereflo 25micrograms/dose / 250micrograms/dose inhaler (Kent Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
3.42153E+16,AirFluSal 25micrograms/dose / 125micrograms/dose inhaler (Sandoz Ltd) (product),Chronic respiratory disease,0
3.42155E+16,AirFluSal 25micrograms/dose / 250micrograms/dose inhaler (Sandoz Ltd) (product),Chronic respiratory disease,0
3.46757E+16,Aloflute 25micrograms/dose / 250micrograms/dose inhaler (Mylan Ltd) (product),Chronic respiratory disease,0
3.4677E+16,Aloflute 25micrograms/dose / 125micrograms/dose inhaler (Mylan Ltd) (product),Chronic respiratory disease,0
3.48121E+16,Fobumix 320/9 Easyhaler (Orion Pharma (UK) Ltd) (product),Chronic respiratory disease,0
3.49503E+16,Fobumix Easyhaler 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Orion Pharma (UK) Ltd) (product),Chronic respiratory disease,0
3.49506E+16,Fobumix Easyhaler 80micrograms/dose / 4.5micrograms/dose dry powder inhaler (Orion Pharma (UK) Ltd) (product),Chronic respiratory disease,0
3.49548E+16,Inhalvent 20micrograms/dose inhaler (Alissa Healthcare Research Ltd) (product),Chronic respiratory disease,0
3.49573E+16,Montelukast 10mg tablets (Almus Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
3.51012E+16,Theophylline 50mg/5ml oral suspension (product),Chronic respiratory disease,0
3.54301E+16,Kelhale 50micrograms/dose inhaler (Cipla EU Ltd) (product),Chronic respiratory disease,0
3.54303E+16,Kelhale 100micrograms/dose inhaler (Cipla EU Ltd) (product),Chronic respiratory disease,0
3.55153E+16,Fusacomb Easyhaler 50micrograms/dose / 500micrograms/dose dry powder inhaler (Orion Pharma (UK) Ltd) (product),Chronic respiratory disease,0
3.55155E+16,Fusacomb Easyhaler 50micrograms/dose / 250micrograms/dose dry powder inhaler (Orion Pharma (UK) Ltd) (product),Chronic respiratory disease,0
3.5594E+16,Combisal 25micrograms/dose / 50micrograms/dose inhaler (Aspire Pharma Ltd) (product),Chronic respiratory disease,0
3.55942E+16,Combisal 25micrograms/dose / 125micrograms/dose inhaler (Aspire Pharma Ltd) (product),Chronic respiratory disease,0
3.55944E+16,Combisal 25micrograms/dose / 250micrograms/dose inhaler (Aspire Pharma Ltd) (product),Chronic respiratory disease,0
3.56473E+16,Flutiform K-haler 125micrograms/dose / 5micrograms/dose breath actuated inhaler (Napp Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
3.56475E+16,Fluticasone 125micrograms/dose / Formoterol 5micrograms/dose breath actuated inhaler CFC free (product),Chronic respiratory disease,0
3.56476E+16,Fluticasone 50micrograms/dose / Formoterol 5micrograms/dose breath actuated inhaler CFC free (product),Chronic respiratory disease,0
3.56508E+16,Flutiform K-haler 50micrograms/dose / 5micrograms/dose breath actuated inhaler (Napp Pharmaceuticals Ltd) (product),Chronic respiratory disease,0
3.57747E+16,Jorveza 1mg orodispersible tablets (Dr. Falk Pharma UK Ltd) (product),Chronic respiratory disease,0
3.58242E+16,Budesonide 1mg orodispersible tablets sugar free (product),Chronic respiratory disease,0
3.59004E+16,Aminophylline 225mg modified-release tablets (product),Chronic respiratory disease,0
3.59005E+16,Aminophylline 250mg/10ml solution for injection ampoules (product),Chronic respiratory disease,0
3.59078E+16,Beclometasone 100micrograms/dose breath actuated inhaler (product),Chronic respiratory disease,0
3.59079E+16,Beclometasone 100micrograms/dose breath actuated inhaler CFC free (product),Chronic respiratory disease,0
3.5908E+16,Beclometasone 100micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
3.59081E+16,Beclometasone 100micrograms/dose inhaler CFC free (product),Chronic respiratory disease,0
3.59084E+16,Beclometasone 200micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
3.59085E+16,Beclometasone 200micrograms/dose inhaler (product),Chronic respiratory disease,0
3.59086E+16,Beclometasone 250micrograms/dose breath actuated inhaler (product),Chronic respiratory disease,0
3.59088E+16,Beclometasone 250micrograms/dose inhaler (product),Chronic respiratory disease,0
3.59092E+16,Beclometasone 50micrograms/dose breath actuated inhaler (product),Chronic respiratory disease,0
3.59093E+16,Beclometasone 50micrograms/dose breath actuated inhaler CFC free (product),Chronic respiratory disease,0
3.59095E+16,Beclometasone 50micrograms/dose inhaler (product),Chronic respiratory disease,0
3.59096E+16,Beclometasone 50micrograms/dose inhaler CFC free (product),Chronic respiratory disease,0
3.5912E+16,Budesonide 100micrograms/dose / Formoterol 6micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
3.59121E+16,Budesonide 100micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
3.59123E+16,Budesonide 200micrograms/dose / Formoterol 6micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
3.59124E+16,Budesonide 200micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
3.59127E+16,Budesonide 400micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
3.5916E+16,Terbutaline 2.5mg/5ml solution for injection ampoules (product),Chronic respiratory disease,0
3.59162E+16,Terbutaline 500micrograms/1ml solution for injection ampoules (product),Chronic respiratory disease,0
3.59163E+16,Terbutaline 500micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
3.59176E+16,Theophylline 175mg modified-release tablets (product),Chronic respiratory disease,0
3.59177E+16,Theophylline 200mg modified-release tablets (product),Chronic respiratory disease,0
3.59178E+16,Theophylline 250mg modified-release tablets (product),Chronic respiratory disease,0
3.59179E+16,Theophylline 250mg modified-release capsules (product),Chronic respiratory disease,0
3.5918E+16,Theophylline 300mg modified-release tablets (product),Chronic respiratory disease,0
3.59181E+16,Theophylline 400mg modified-release tablets (product),Chronic respiratory disease,0
3.59182E+16,Theophylline 60mg modified-release capsules (product),Chronic respiratory disease,0
3.59364E+16,Salbutamol 100micrograms/dose breath actuated inhaler (product),Chronic respiratory disease,0
3.59365E+16,Salbutamol 100micrograms/dose inhaler (product),Chronic respiratory disease,0
3.59366E+16,Salbutamol 200microgram inhalation powder blisters (product),Chronic respiratory disease,0
3.59372E+16,Salbutamol 95micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
3.5938E+16,Salmeterol 50microgram inhalation powder blisters (product),Chronic respiratory disease,0
3.59577E+16,Theophylline 125mg modified-release capsules (product),Chronic respiratory disease,0
3.60493E+16,Ipratropium bromide 20micrograms/dose inhaler (product),Chronic respiratory disease,0
3.60494E+16,Ipratropium bromide 40micrograms/dose inhaler (product),Chronic respiratory disease,0
3.60591E+16,Fluticasone 25micrograms/dose inhaler (product),Chronic respiratory disease,0
3.65654E+16,Fluticasone propionate 250micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
3.66032E+16,Soprobec 50micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) (product),Chronic respiratory disease,0
3.66034E+16,Soprobec 200micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) (product),Chronic respiratory disease,0
3.66036E+16,Soprobec 100micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) (product),Chronic respiratory disease,0
3.66038E+16,Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) (product),Chronic respiratory disease,0
3.66047E+16,Stalpex 50micrograms/dose / 500micrograms/dose dry powder inhaler (Glenmark Pharmaceuticals Europe Ltd) (product),Chronic respiratory disease,0
3.78429E+16,Ipravent 20micrograms/dose inhaler CFC free (Cipla EU Ltd) (product),Chronic respiratory disease,0
3.88945E+16,Ipratropium bromide 20micrograms/dose inhaler CFC free (product),Chronic respiratory disease,0
3.88954E+16,Mometasone 200micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
3.88956E+16,Mometasone 400micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
3.88959E+16,Salbutamol 500micrograms/1ml solution for injection ampoules (product),Chronic respiratory disease,0
3.88968E+16,Budesonide 200micrograms/dose / Formoterol 6micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
3.88974E+16,Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
3.88975E+16,Fluticasone propionate 250micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
3.88976E+16,Fluticasone propionate 100micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
3.88977E+16,Fluticasone propionate 500micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
3.88978E+16,Fluticasone propionate 100micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
3.88979E+16,Fluticasone propionate 50micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
3.90253E+16,Salbutamol 5mg/5ml solution for infusion ampoules (product),Chronic respiratory disease,0
3.91058E+16,Symbicort 100micrograms/dose / 3micrograms/dose pressurised inhaler (AstraZeneca UK Ltd) (product),Chronic respiratory disease,0
3.91094E+16,Salbutamol 2mg/5ml oral solution sugar free (product),Chronic respiratory disease,0
3.91109E+16,Fluticasone 50micrograms/dose inhaler CFC free (product),Chronic respiratory disease,0
3.9111E+16,Fluticasone 50micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free (product),Chronic respiratory disease,0
3.91111E+16,Fluticasone 125micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free (product),Chronic respiratory disease,0
3.91112E+16,Fluticasone 125micrograms/dose inhaler CFC free (product),Chronic respiratory disease,0
3.91113E+16,Fluticasone 250micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free (product),Chronic respiratory disease,0
3.91114E+16,Fluticasone 250micrograms/dose inhaler CFC free (product),Chronic respiratory disease,0
3.91127E+16,Salbutamol 100micrograms/dose breath actuated inhaler CFC free (product),Chronic respiratory disease,0
3.91129E+16,Formoterol 6micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
3.9113E+16,Formoterol 12micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
3.91132E+16,Salmeterol 50micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
3.91133E+16,Salbutamol 200micrograms/dose dry powder inhaler (product),Chronic respiratory disease,0
3.91136E+16,Salbutamol 100micrograms/dose inhaler CFC free (product),Chronic respiratory disease,0
3.91336E+16,Budesonide 100micrograms/dose / Formoterol 3micrograms/dose inhaler CFC free (product),Chronic respiratory disease,0
3.94183E+16,Sodium cromoglicate 100mg/5ml oral solution 5ml unit dose ampoules sugar free (product),Chronic respiratory disease,0
8.8053E+17,Lower respiratory infection caused by 2019-nCoV,Chronic respiratory disease,0
,Lung disease with Sjgren's disease (disorder),Chronic respiratory disease,0
56267009,Multi-infarct dementia (disorder),Dementia,0
90099008,Subcortical leukoencephalopathy (disorder),Dementia,0
7.11441E+14,Dementia monitoring invitation (procedure),Dementia,0
7.15821E+14,Dementia monitoring first letter (procedure),Dementia,0
7.16131E+14,Excepted from dementia quality indicators - informed dissent (finding),Dementia,0
7.16221E+14,Dementia monitoring verbal invitation (procedure),Dementia,0
7.16341E+14,Excepted from dementia quality indicators - patient unsuitable (finding),Dementia,0
7.16671E+14,Dementia monitoring third letter (procedure),Dementia,0
7.16991E+14,Dementia monitoring telephone invitation (procedure),Dementia,0
7.17471E+14,Dementia monitoring second letter (procedure),Dementia,0
9.38551E+14,Dementia medication review (procedure),Dementia,0
9.56841E+14,Dementia care plan agreed (finding),Dementia,0
9.56861E+14,Dementia care plan reviewed (situation),Dementia,0
9.56881E+14,Dementia care plan declined (situation),Dementia,0
9.56901E+14,Dementia care plan review declined (situation),Dementia,0
9.59461E+14,Dementia advance care plan review declined (situation),Dementia,0
1.0951E+15,Offer of dementia advance care planning review declined (situation),Dementia,0
1.09511E+15,Review of dementia advance care plan (procedure),Dementia,0
1.09512E+15,Dementia advance care plan agreed (finding),Dementia,0
1.1109E+15,Quality and Outcomes Framework dementia quality indicator-related care invitation (procedure),Dementia,0
2751001,Fibrocalculous pancreatic diabetes (disorder),Diabetes,0
4855003,Retinopathy due to diabetes mellitus (disorder),Diabetes,0
5368009,Drug-induced diabetes mellitus (disorder),Diabetes,0
5969009,Diabetes mellitus associated with genetic syndrome (disorder),Diabetes,0
8801005,Secondary diabetes mellitus (disorder),Diabetes,0
11530004,Brittle diabetes mellitus (finding),Diabetes,0
25093002,Disorder of eye due to diabetes mellitus (disorder),Diabetes,0
25412000,Microaneurysm of retinal artery due to diabetes mellitus (disorder),Diabetes,0
26298008,Ketoacidotic coma due to diabetes mellitus (disorder),Diabetes,0
39058009,Lumbosacral radiculoplexus neuropathy due to diabetes mellitus (disorder),Diabetes,0
43959009,Cataract of eye due to diabetes mellitus (disorder),Diabetes,0
44054006,Diabetes mellitus type 2 (disorder),Diabetes,0
46635009,Diabetes mellitus type 1 (disorder),Diabetes,0
48951005,Bullous disease due to diabetes mellitus (disorder),Diabetes,0
49455004,Polyneuropathy due to diabetes mellitus (disorder),Diabetes,0
49817004,Neonatal diabetes mellitus (disorder),Diabetes,0
50620007,Autonomic neuropathy due to diabetes mellitus (disorder),Diabetes,0
51002006,Diabetes mellitus associated with pancreatic disease (disorder),Diabetes,0
59276001,Proliferative retinopathy due to diabetes mellitus (disorder),Diabetes,0
62260007,Pretibial pigmental patches due to diabetes mellitus (disorder),Diabetes,0
70694009,Diabetes mellitus AND insipidus with optic atrophy AND deafness (disorder),Diabetes,0
73211009,Diabetes mellitus (disorder),Diabetes,0
74627003,Complication due to diabetes mellitus (disorder),Diabetes,0
75524006,Malnutrition related diabetes mellitus (disorder),Diabetes,0
83728000,"Polyglandular autoimmune syndrome, type 2 (disorder)",Diabetes,0
111552007,Diabetes mellitus without complication (disorder),Diabetes,0
111556005,Ketoacidosis without coma due to diabetes mellitus (disorder),Diabetes,0
126534007,Mixed sensorimotor polyneuropathy due to diabetes mellitus (disorder),Diabetes,0
127012008,Lipoatrophic diabetes (disorder),Diabetes,0
127013003,Disorder of kidney due to diabetes mellitus (disorder),Diabetes,0
127014009,Peripheral angiopathy due to diabetes mellitus (disorder),Diabetes,0
134395001,Diabetic retinopathy screening (procedure),Diabetes,0
134587001,Gliclazide 30mg modified-release tablet,Diabetes,0
134608004,Product containing precisely nateglinide 180 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
134609007,Product containing precisely nateglinide 120 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
134610002,Product containing precisely nateglinide 60 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
170745003,Diabetic on diet only (finding),Diabetes,0
170747006,Diabetic on insulin (finding),Diabetes,0
170763003,Diabetic - good control (finding),Diabetes,0
170766006,Loss of hypoglycemic warning due to diabetes mellitus,Diabetes,0
185756006,Diabetes monitoring first letter (procedure),Diabetes,0
185757002,Diabetes monitoring second letter (procedure),Diabetes,0
185758007,Diabetes monitoring third letter (procedure),Diabetes,0
185759004,Diabetes monitoring verbal invite (procedure),Diabetes,0
185760009,Diabetes monitoring telephone invite (procedure),Diabetes,0
190330002,Hyperosmolar coma due to type 1 diabetes mellitus (disorder),Diabetes,0
190331003,Hyperosmolar coma due to type 2 diabetes mellitus (disorder),Diabetes,0
190368000,Type I diabetes mellitus with ulcer (disorder),Diabetes,0
190372001,Type I diabetes mellitus maturity onset (disorder),Diabetes,0
190388001,Multiple complications due to type 2 diabetes mellitus (disorder),Diabetes,0
190389009,Type II diabetes mellitus with ulcer (disorder),Diabetes,0
190406000,Ketoacidosis due to malnutrition related diabetes mellitus (disorder),Diabetes,0
190411003,Multiple complications due to malnutrition related diabetes (disorder),Diabetes,0
190412005,Malnutrition-related diabetes mellitus without complications (disorder),Diabetes,0
190416008,Steroid-induced diabetes mellitus without complication (disorder),Diabetes,0
190447002,Steroid-induced diabetes (disorder),Diabetes,0
193141005,Mononeuritis multiplex due to diabetes mellitus (disorder),Diabetes,0
193183000,Acute painful neuropathy due to diabetes mellitus (disorder),Diabetes,0
193184006,Chronic painful neuropathy due to diabetes mellitus (disorder),Diabetes,0
193185007,Asymptomatic neuropathy due to diabetes mellitus (disorder),Diabetes,0
193349004,Preproliferative retinopathy due to diabetes mellitus (disorder),Diabetes,0
193350004,Advanced maculopathy due to diabetes mellitus (disorder),Diabetes,0
193489006,Iritis due to diabetes mellitus (disorder),Diabetes,0
197605007,Nephrotic syndrome due to diabetes mellitus (disorder),Diabetes,0
199223000,"Diabetes mellitus during pregnancy, childbirth and the puerperium (disorder)",Diabetes,0
199225007,Diabetes mellitus during pregnancy - baby delivered (disorder),Diabetes,0
199226008,Diabetes mellitus in the puerperium - baby delivered during current episode of care (disorder),Diabetes,0
199227004,Diabetes mellitus during pregnancy - baby not yet delivered (disorder),Diabetes,0
199228009,Diabetes mellitus in the puerperium - baby delivered during previous episode of care (disorder),Diabetes,0
199230006,Pre-existing type 2 diabetes mellitus (disorder),Diabetes,0
200687002,Cellulitis of foot due to diabetes mellitus (disorder),Diabetes,0
201250006,Ischemic ulcer of foot due to diabetes mellitus,Diabetes,0
201251005,Neuropathic ulcer of foot due to diabetes mellitus (disorder),Diabetes,0
201252003,Mixed diabetic ulcer - foot (disorder),Diabetes,0
201723002,Cheiroarthropathy due to diabetes mellitus (disorder),Diabetes,0
201724008,Neuropathic arthropathy due to diabetes mellitus (disorder),Diabetes,0
230572002,Neuropathy due to diabetes mellitus (disorder),Diabetes,0
230574001,Acute painful polyneuropathy due to diabetes mellitus (disorder),Diabetes,0
230575000,Chronic painful polyneuropathy due to diabetes mellitus (disorder),Diabetes,0
230577008,Mononeuropathy due to diabetes mellitus (disorder),Diabetes,0
230579006,Thoracic radiculopathy due to diabetes mellitus (disorder),Diabetes,0
232020009,Disorder of macula due to diabetes mellitus (disorder),Diabetes,0
232021008,Proliferative retinopathy with optic disc neovascularization due to diabetes mellitus,Diabetes,0
232022001,Proliferative retinopathy with neovascularization elsewhere than the optic disc due to diabetes mellitus,Diabetes,0
232023006,Traction detachment of retina due to diabetes mellitus (disorder),Diabetes,0
236499007,Microalbuminuric nephropathy due to diabetes mellitus (disorder),Diabetes,0
236500003,Proteinuric nephropathy due to diabetes mellitus (disorder),Diabetes,0
237599002,Insulin treated type 2 diabetes mellitus (disorder),Diabetes,0
237600004,Malnutrition-related diabetes mellitus - fibrocalculous (disorder),Diabetes,0
237601000,Secondary endocrine diabetes mellitus (disorder),Diabetes,0
237604008,"Maturity onset diabetes of the young, type 2 (disorder)",Diabetes,0
237608006,"Lipodystrophy, partial, with Rieger anomaly, short stature, and insulinopenic diabetes mellitus (disorder)",Diabetes,0
237610008,"Acrorenal field defect, ectodermal dysplasia, and lipoatrophic diabetes (disorder)",Diabetes,0
237613005,Hyperproinsulinemia (disorder),Diabetes,0
237618001,Insulin-dependent diabetes mellitus secretory diarrhea syndrome (disorder),Diabetes,0
237620003,Abnormal metabolic state due to diabetes mellitus (disorder),Diabetes,0
237621004,Severe hyperglycemia due to diabetes mellitus,Diabetes,0
237622006,Poor glycemic control (disorder),Diabetes,0
237627000,Pregnancy and type 2 diabetes mellitus (disorder),Diabetes,0
237632004,Hypoglycemic event due to diabetes,Diabetes,0
237633009,Hypoglycemia due to diabetes mellitus,Diabetes,0
237635002,Nocturnal hypoglycemia due to diabetes mellitus,Diabetes,0
237651005,Insulin resistance - type A (disorder),Diabetes,0
238981002,Disorder of soft tissue due to diabetes mellitus (disorder),Diabetes,0
238982009,Dermopathy due to diabetes mellitus (disorder),Diabetes,0
238984005,Rubeosis faciei due to diabetes mellitus (disorder),Diabetes,0
267467004,Diabetes mellitus (& [ketoacidosis]) (disorder),Diabetes,0
267471001,Diabetes + eye manifestation (& [cataract] or [retinopathy]) (disorder),Diabetes,0
267604001,Myasthenic syndrome due to diabetic mellitus (disorder),Diabetes,0
268519009,Diabetic - poor control (finding),Diabetes,0
276560009,Diabetes mellitus in neonate small for gestational age (disorder),Diabetes,0
280137006,Diabetic foot (disorder),Diabetes,0
284449005,Congenital total lipodystrophy (disorder),Diabetes,0
290002008,Brittle type I diabetes mellitus (finding),Diabetes,0
308105005,On examination-Right diabetic foot at risk (finding),Diabetes,0
308106006,On examination-Left diabetic foot at risk (finding),Diabetes,0
309426007,Glomerulopathy due to diabetes mellitus (disorder),Diabetes,0
310425007,Diabetes monitoring invitation (procedure),Diabetes,0
310505005,Hyperosmolar non-ketotic state due to diabetes mellitus (disorder),Diabetes,0
311782002,Advanced retinal disease due to diabetes mellitus (disorder),Diabetes,0
312903003,Mild nonproliferative retinopathy due to diabetes mellitus (disorder),Diabetes,0
312904009,Moderate nonproliferative retinopathy due to diabetes mellitus (disorder),Diabetes,0
312905005,Severe nonproliferative retinopathy due to diabetes mellitus (disorder),Diabetes,0
312906006,Non-high-risk proliferative retinopathy due to diabetes mellitus (disorder),Diabetes,0
312907002,High risk proliferative retinopathy due to diabetes mellitus (disorder),Diabetes,0
312908007,Quiescent proliferative retinopathy due to diabetes mellitus (disorder),Diabetes,0
312909004,Proliferative retinopathy with iris neovascularization due to diabetes mellitus,Diabetes,0
312910009,Diabetic vitreous hemorrhage,Diabetes,0
312910009,Vitreous hemorrhage due to diabetes mellitus,Diabetes,0
312912001,Macular edema due to diabetes mellitus (disorder),Diabetes,0
313435000,Type I diabetes mellitus without complication (disorder),Diabetes,0
313436004,Type II diabetes mellitus without complication (disorder),Diabetes,0
314010006,Diffuse exudative maculopathy due to diabetes mellitus (disorder),Diabetes,0
314011005,Focal exudative maculopathy due to diabetes mellitus (disorder),Diabetes,0
314014002,Ischemic maculopathy due to diabetes mellitus,Diabetes,0
314015001,Mixed maculopathy due to diabetes mellitus (disorder),Diabetes,0
314537004,Optic papillopathy due to diabetes mellitus (disorder),Diabetes,0
314771006,Type I diabetes mellitus with hypoglycemic coma (disorder),Diabetes,0
314893005,Arthropathy due to type 1 diabetes mellitus (disorder),Diabetes,0
314902007,Peripheral angiopathy due to type 2 diabetes mellitus (disorder),Diabetes,0
314903002,Arthropathy due to type 2 diabetes mellitus (disorder),Diabetes,0
314904008,Type II diabetes mellitus with neuropathic arthropathy (disorder),Diabetes,0
315051004,Diabetes resolved (finding),Diabetes,1
325218001,Product containing precisely glibenclamide 2.5 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
325219009,Product containing precisely glibenclamide 5 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
325242002,Product containing precisely gliclazide 80 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
325243007,Product containing precisely glipizide 5 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
325259007,Product containing precisely glimepiride 2 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
325261003,Product containing precisely glimepiride 1 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
325262005,Product containing precisely glimepiride 3 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
325263000,Product containing precisely glimepiride 4 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
325267004,Product containing precisely tolbutamide 500 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
325278007,Product containing precisely metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
325279004,Product containing precisely metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
326037007,Product containing precisely acarbose 50 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
326038002,Product containing precisely acarbose 100 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
326047005,Product containing precisely repaglinide 500 microgram/1 each conventional release oral tablet (clinical drug),Diabetes,0
326048000,Product containing precisely repaglinide 1 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
326049008,Product containing precisely repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
326061000,Product containing precisely pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
326062007,Product containing precisely pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
361216007,Femoral mononeuropathy due to diabetes mellitus (disorder),Diabetes,0
371087003,Ulcer of foot due to diabetes mellitus (disorder),Diabetes,0
374897009,Product containing precisely pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
386047000,Metformin hydrochloride 500mg m/r tablet (product),Diabetes,0
390834004,Nonproliferative retinopathy due to diabetes mellitus (disorder),Diabetes,0
390852004,Digital retinal screening (procedure),Diabetes,0
390890005,Refer to diabetic foot screener (procedure),Diabetes,0
394671009,On examination - Right diabetic foot at low risk (finding),Diabetes,0
394672002,On examination - Right diabetic foot at high risk (finding),Diabetes,0
394673007,On examination - Right diabetic foot - ulcerated (finding),Diabetes,0
394674001,On examination - Left diabetic foot - ulcerated (finding),Diabetes,0
394675000,On examination - Left diabetic foot at low risk (finding),Diabetes,0
394676004,On examination - Left diabetic foot at high risk (finding),Diabetes,0
394681008,On examination - Left diabetic foot at moderate risk (finding),Diabetes,0
394682001,On examination - Right diabetic foot at moderate risk (finding),Diabetes,0
394683006,Diabetic foot risk assessment (procedure),Diabetes,0
395204000,Hyperosmolar non-ketotic state due to type 2 diabetes mellitus (disorder),Diabetes,0
398140007,Post hypoglycemic hyperglycemia due to diabetes mellitus,Diabetes,0
399866003,Venous beading of retina due to diabetes mellitus (disorder),Diabetes,0
399871005,Visually threatening retinopathy due to diabetes mellitus (disorder),Diabetes,0
400780006,Insulin glargine (recombinant human insulin analogue) 100units/ml injection 3ml cartridge,Diabetes,0
400877001,Insulin glargine (recombinant human insulin analogue) 100units/ml injection 3ml pre-filled disposable injection device,Diabetes,0
401081006,Diabetic peripheral neuropathy screening (regime/therapy),Diabetes,0
401110002,Type 1 diabetes mellitus with persistent microalbuminuria (disorder),Diabetes,0
401191002,Diabetic foot examination (regime/therapy),Diabetes,0
407569005,Patient on maximal tolerated therapy for diabetes (finding),Diabetes,0
408394009,Under care of diabetic foot screener (finding),Diabetes,0
408409007,On examination - right eye background diabetic retinopathy (disorder),Diabetes,0
408410002,On examination - left eye background diabetic retinopathy (disorder),Diabetes,0
408411003,On examination - right eye preproliferative diabetic retinopathy (disorder),Diabetes,0
408412005,On examination - left eye preproliferative diabetic retinopathy (disorder),Diabetes,0
408413000,On examination - right eye proliferative diabetic retinopathy (disorder),Diabetes,0
408414006,On examination - left eye proliferative diabetic retinopathy (disorder),Diabetes,0
408539000,Insulin autoimmune syndrome (disorder),Diabetes,0
408540003,Diabetes mellitus caused by non-steroid drugs (disorder),Diabetes,0
409197000,Product containing precisely metformin hydrochloride 100 milligram/1 milliliter conventional release oral solution (clinical drug),Diabetes,0
409361001,Metformin hydrochloride 750mg m/r tablet (product),Diabetes,0
411533003,Metformin hydrochloride 1000mg m/r tablet,Diabetes,0
413183008,Diabetes mellitus caused by non-steroid drugs without complication (disorder),Diabetes,0
413597006,Attended diabetes structured education program (finding),Diabetes,0
414230000,Family/carer referral to diabetes structured education program (procedure),Diabetes,0
414890007,On examination - left chronic diabetic foot ulcer (finding),Diabetes,0
414894003,On examination - left eye stable treated proliferative diabetic retinopathy (disorder),Diabetes,0
414906009,On examination - right chronic diabetic foot ulcer (finding),Diabetes,0
414910007,On examination - right eye stable treated proliferative diabetic retinopathy (disorder),Diabetes,0
415270003,Referral to diabetes structured education program (procedure),Diabetes,0
416672007,Patient offered diabetes structured education program (situation),Diabetes,0
417677008,On examination - sight threatening diabetic retinopathy (disorder),Diabetes,0
419100001,Infection of foot due to diabetes mellitus (disorder),Diabetes,0
419873003,Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
420270002,Ketoacidosis due to type 1 diabetes mellitus (disorder),Diabetes,0
420279001,Renal disorder due to type 2 diabetes mellitus (disorder),Diabetes,0
420422005,Ketoacidosis due to diabetes mellitus (disorder),Diabetes,0
420436000,Mononeuropathy due to type 2 diabetes mellitus (disorder),Diabetes,0
420486006,Exudative maculopathy due to type 1 diabetes mellitus (disorder),Diabetes,0
420514000,Persistent proteinuria due to type 1 diabetes mellitus (disorder),Diabetes,0
420662003,Coma due to diabetes mellitus (disorder),Diabetes,0
420715001,Persistent microalbuminuria due to type 2 diabetes mellitus (disorder),Diabetes,0
420756003,Cataract of eye due to diabetes mellitus type 2 (disorder),Diabetes,0
420789003,Retinopathy due to type 1 diabetes mellitus (disorder),Diabetes,0
420825003,Gangrene due to type 1 diabetes mellitus (disorder),Diabetes,0
420918009,Mononeuropathy due to type 1 diabetes mellitus (disorder),Diabetes,0
421075007,Ketoacidotic coma due to type 1 diabetes mellitus (disorder),Diabetes,0
421326000,Neurological disorder with type 2 diabetes mellitus,Diabetes,0
421365002,Peripheral circulatory disorder due to type 1 diabetes mellitus (disorder),Diabetes,0
421468001,Disorder of nervous system due to type 1 diabetes mellitus (disorder),Diabetes,0
421631007,Gangrene due to type 2 diabetes mellitus (disorder),Diabetes,0
421750000,Ketoacidosis due to type 2 diabetes mellitus (disorder),Diabetes,0
421779007,Exudative maculopathy due to type 2 diabetes mellitus (disorder),Diabetes,0
421847006,Ketoacidotic coma due to type 2 diabetes mellitus (disorder),Diabetes,0
421893009,Renal disorder due to type 1 diabetes mellitus (disorder),Diabetes,0
421895002,Peripheral vascular disorder due to diabetes mellitus (disorder),Diabetes,0
421920002,Cataract of eye due to diabetes mellitus type 1 (disorder),Diabetes,0
421986006,Persistent proteinuria due to type 2 diabetes mellitus (disorder),Diabetes,0
422014003,Disorder due to type 2 diabetes mellitus (disorder),Diabetes,0
422034002,Retinopathy due to type 2 diabetes mellitus (disorder),Diabetes,0
422088007,Disorder of nervous system due to diabetes mellitus (disorder),Diabetes,0
422099009,Disorder of eye due to type 2 diabetes mellitus (disorder),Diabetes,0
422126006,Hyperosmolar coma due to diabetes mellitus (disorder),Diabetes,0
422166005,Peripheral circulatory disorder due to type 2 diabetes mellitus (disorder),Diabetes,0
422183001,Skin ulcer due to diabetes mellitus (disorder),Diabetes,0
422228004,Multiple complications due to type 1 diabetes mellitus (disorder),Diabetes,0
422275004,Gangrene due to diabetes mellitus (disorder),Diabetes,0
423962004,Product containing precisely sitagliptin (as sitagliptin phosphate) 25 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
424345005,Product containing precisely sitagliptin (as sitagliptin phosphate) 100 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
424513004,Product containing precisely sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
426705001,Diabetes mellitus co-occurrent and due to cystic fibrosis (disorder),Diabetes,0
426875007,Latent autoimmune diabetes mellitus in adult (disorder),Diabetes,0
429729007,Diabetic education completed (situation),Diabetes,0
441656006,Hyperglycemic crisis due to diabetes mellitus,Diabetes,0
443067000,Product containing precisely saxagliptin 2.5 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
443694000,Type II diabetes mellitus uncontrolled (finding),Diabetes,0
443713000,Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
444073006,Type I diabetes mellitus uncontrolled (finding),Diabetes,0
472969004,History of diabetes mellitus type 2 (situation),Diabetes,0
472970003,History of diabetes mellitus type 1 (situation),Diabetes,0
472972006,History of maturity onset diabetes mellitus in young (situation),Diabetes,0
609561005,MODY - maturity onset diabetes of young,Diabetes,0
609562003,"Maturity onset diabetes of the young, type 1 (disorder)",Diabetes,0
609563008,Pre-existing diabetes mellitus in pregnancy (disorder),Diabetes,0
609572000,"Maturity-onset diabetes of the young, type 5 (disorder)",Diabetes,0
703136005,Diabetes mellitus in remission (disorder),Diabetes,0
703137001,Type I diabetes mellitus in remission (disorder),Diabetes,0
703138006,Type II diabetes mellitus in remission (disorder),Diabetes,0
703679006,Product containing precisely dapagliflozin propanediol 5 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
703680009,Product containing precisely dapagliflozin propanediol 10 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
703682001,Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet (clinical drug),Diabetes,0
705072004,Diabetes monitoring invitation by short message service text messaging (procedure),Diabetes,0
713702000,Gastroparesis due to type 1 diabetes mellitus (disorder),Diabetes,0
713703005,Gastroparesis due to type 2 diabetes mellitus (disorder),Diabetes,0
713705003,Polyneuropathy due to type 1 diabetes mellitus (disorder),Diabetes,0
713706002,Polyneuropathy due to type 2 diabetes mellitus (disorder),Diabetes,0
719216001,Hypoglycemic coma due to type 2 diabetes mellitus,Diabetes,0
720504004,Not suitable for Diabetes Education and Self Management for Ongoing and Newly Diagnosed program (finding),Diabetes,0
724136006,Mastopathy due to diabetes mellitus (disorder),Diabetes,0
724810001,Radiculoplexoneuropathy due to diabetes mellitus (disorder),Diabetes,0
724997001,Lumbosacral plexopathy co-occurrent and due to diabetes mellitus (disorder),Diabetes,0
735200002,Absence of lower limb due to diabetes mellitus (disorder),Diabetes,0
739681000,Disorder of eye due to type 1 diabetes mellitus (disorder),Diabetes,0
762489000,Acute complication due to diabetes mellitus (disorder),Diabetes,0
763325000,Insulin resistance (disorder),Diabetes,0
769182000,Preproliferative retinopathy of left eye due to diabetes mellitus (disorder),Diabetes,0
769183005,Mild nonproliferative retinopathy of right eye due to diabetes mellitus (disorder),Diabetes,0
769184004,Mild nonproliferative retinopathy of left eye due to diabetes mellitus (disorder),Diabetes,0
769185003,Moderate nonproliferative retinopathy of right eye due to diabetes mellitus (disorder),Diabetes,0
769186002,Moderate nonproliferative retinopathy of left eye due to diabetes mellitus (disorder),Diabetes,0
769217008,Diabetic macular edema of right eye,Diabetes,0
769218003,Macular edema of left eye due to diabetes mellitus,Diabetes,0
769218003,Diabetic macular edema of left eye,Diabetes,0
769221001,Clinically significant macular edema of right eye due to diabetes mellitus (disorder),Diabetes,0
769222008,Clinically significant macular edema of left eye due to diabetes mellitus (disorder),Diabetes,0
769244003,Disorder of right macula due to diabetes mellitus (disorder),Diabetes,0
769245002,Disorder of left macula due to diabetes mellitus (disorder),Diabetes,0
816177009,Nonproliferative retinopathy of left eye due to diabetes mellitus (disorder),Diabetes,0
816178004,Nonproliferative retinopathy of right eye due to diabetes mellitus (disorder),Diabetes,0
7.91E+11,Angina due to type 2 diabetes mellitus (disorder),Diabetes,0
2.4471E+13,Type 2 diabetic on insulin (finding),Diabetes,0
2.4481E+13,Type 2 diabetic on diet only (finding),Diabetes,0
5.8011E+13,Actos 15mg tablets (Takeda UK Ltd) (product),Diabetes,0
7.1771E+13,Neuropathic arthropathy due to type 1 diabetes mellitus (disorder),Diabetes,0
1.04941E+14,Ischemia of retina due to type 1 diabetes mellitus,Diabetes,0
1.12991E+14,Lipoatrophic diabetes mellitus without complication (disorder),Diabetes,0
1.15811E+14,Metformin 850mg tablets (Alpharma Limited) (product),Diabetes,0
1.40391E+14,Ulcer of toe due to type 2 diabetes mellitus (disorder),Diabetes,0
1.43401E+14,Quality and Outcomes Framework diabetes mellitus quality indicator-related care invitation using preferred method of communication (procedure),Diabetes,0
1.57911E+14,Metformin 850mg tablets (Approved Prescription Services) (product),Diabetes,0
1.98121E+14,Hypoglycaemic warning impaired (disorder),Diabetes,0
1.98131E+14,Hypoglycaemic warning good (disorder),Diabetes,0
2.02611E+14,Metformin 500mg tablets (A A H Pharmaceuticals Ltd) (product),Diabetes,0
2.57011E+14,Metformin 500mg tablets (Generics (UK) Ltd) (product),Diabetes,0
2.76651E+14,Attended diabetes education and self management for ongoing and newly diagnosed structured programme (finding),Diabetes,0
2.79291E+14,Diabetes type 1 review (regime/therapy),Diabetes,0
2.79321E+14,Diabetes type 2 review (regime/therapy),Diabetes,0
3.06401E+14,Attended expert patient education versus routine treatment diabetes structured education programme (finding),Diabetes,0
3.06441E+14,Attended dose adjustment for normal eating diabetes structured education programme (finding),Diabetes,0
3.06471E+14,Dose adjustment for normal eating diabetes structured education programme completed (situation),Diabetes,0
3.06501E+14,Diabetes education and self management for ongoing and newly diagnosed structured programme completed (situation),Diabetes,0
3.06531E+14,Expert patient education versus routine treatment diabetes structured education programme completed (situation),Diabetes,0
3.06591E+14,Diabetes structured education programme declined (situation),Diabetes,0
3.06701E+14,Referral to dose adjustment for normal eating diabetes structured education programme (procedure),Diabetes,0
3.06741E+14,Referral to diabetes education and self management for ongoing and newly diagnosed diabetes structured programme (procedure),Diabetes,0
3.06771E+14,Referral to expert patient education versus routine treatment diabetes structured education programme (procedure),Diabetes,0
3.06861E+14,Did not attend diabetes structured education programme (finding),Diabetes,0
3.06931E+14,Did not complete diabetes structured education programme (situation),Diabetes,0
3.06961E+14,Did not complete dose adjustment for normal eating diabetes structured education programme (situation),Diabetes,0
3.06991E+14,Did not complete diabetes education and self management for ongoing and newly diagnosed structured programme (situation),Diabetes,0
3.07021E+14,Did not complete expert patient education versus routine treatment diabetes structured education programme (situation),Diabetes,0
3.07141E+14,Did not attend dose adjustment for normal eating diabetes structured education programme (finding),Diabetes,0
3.07171E+14,Did not attend diabetes education and self management for ongoing and newly diagnosed structured programme (finding),Diabetes,0
3.07201E+14,Did not attend expert patient education versus routine treatment diabetes structured education programme (finding),Diabetes,0
3.25011E+14,Metformin 850mg tablets (A A H Pharmaceuticals Ltd) (product),Diabetes,0
3.35621E+14,Maternally inherited diabetes mellitus (disorder),Diabetes,0
3.63211E+14,Glucophage 500mg tablets (Merck Pharmaceuticals) (product),Diabetes,0
3.65111E+14,Glucophage 850mg tablets (Merck Pharmaceuticals) (product),Diabetes,0
3.67011E+14,Diabetic foot screen (regime/therapy),Diabetes,0
3.78911E+14,Gliclazide 80mg tablets (A A H Pharmaceuticals Ltd) (product),Diabetes,0
3.85041E+14,Diabetes mellitus with multiple complications (disorder),Diabetes,0
3.85051E+14,Pre-existing diabetes mellitus (disorder),Diabetes,0
4.44311E+14,Glucobay 100 tablets (Bayer Plc) (product),Diabetes,0
4.46711E+14,Actos 30mg tablets (Takeda UK Ltd) (product),Diabetes,0
4.64111E+14,Glipizide 5mg tablets (Generics (UK) Ltd) (product),Diabetes,0
4.98911E+14,Gliclazide 80mg tablets (Alpharma Limited) (product),Diabetes,0
5.32411E+14,"Diabetes mellitus, adult onset, with no mention of complication (disorder)",Diabetes,0
5.33211E+14,Gliclazide 80mg tablets (Generics (UK) Ltd) (product),Diabetes,0
5.93911E+14,Metformin 500mg tablets (Sandoz Ltd) (product),Diabetes,0
6.22811E+14,Gliclazide 80mg tablets (C P Pharmaceuticals Ltd) (product),Diabetes,0
6.52411E+14,Minodiab 5mg tablets (Pfizer Ltd) (product),Diabetes,0
6.58011E+14,Diabetes mellitus with other specified manifestation (disorder),Diabetes,0
6.90811E+14,Metformin 500mg tablets (Kent Pharmaceuticals Ltd) (product),Diabetes,0
6.98511E+14,Glipizide 5mg tablets (Sandoz Ltd) (product),Diabetes,0
7.16031E+14,Excepted from diabetes quality indicators - informed dissent (finding),Diabetes,0
7.17421E+14,Excepted from diabetes quality indicators - patient unsuitable (finding),Diabetes,0
7.45911E+14,Diamicron 80mg tablets (Servier Laboratories Limited) (product),Diabetes,0
7.54101E+14,Type I diabetic dietary review (regime/therapy),Diabetes,0
7.54121E+14,Type II diabetic dietary review (regime/therapy),Diabetes,0
7.54461E+14,Referral to type I diabetes structured education programme (procedure),Diabetes,0
7.55491E+14,Diabetes structured education programme completed (situation),Diabetes,0
7.56381E+14,On examination - Left diabetic foot at increased risk (finding),Diabetes,0
7.56391E+14,On examination - Right diabetic foot at increased risk (finding),Diabetes,0
7.71571E+14,History of secondary diabetes mellitus (situation),Diabetes,0
7.73001E+14,Symptomatic diabetic peripheral neuropathy (disorder),Diabetes,0
7.75841E+14,Diabetic retinopathy detected by national screening programme (disorder),Diabetes,0
7.81161E+14,Referral to diabetes education and self management for ongoing and newly diagnosed structured programme declined (situation),Diabetes,0
7.81411E+14,Glucobay 50 tablets (Bayer Plc) (product),Diabetes,0
7.85311E+14,Metformin 500mg tablets (Sterwin Medicines) (product),Diabetes,0
7.95311E+14,Metformin 850mg tablets (Generics (UK) Ltd) (product),Diabetes,0
8.59811E+14,Metformin 850mg tablets (Kent Pharmaceuticals Ltd) (product),Diabetes,0
8.60981E+14,Referral to dose adjustment for normal eating diabetes structured education programme declined (situation),Diabetes,0
8.64711E+14,Tolbutamide 500mg tablets (Alpharma Limited) (product),Diabetes,0
8.82811E+14,Metformin 500mg tablets (Accord Healthcare Ltd) (product),Diabetes,0
8.89611E+14,Metformin 500mg tablets (Approved Prescription Services) (product),Diabetes,0
8.92811E+14,Gliclazide 80mg tablets (Approved Prescription Services) (product),Diabetes,0
8.94741E+14,Hypoglycaemic warning absent (disorder),Diabetes,0
9.09311E+14,Metformin 850mg tablets (Sandoz Ltd) (product),Diabetes,0
9.29811E+14,Gliclazide 80mg tablets (Sandoz Ltd) (product),Diabetes,0
9.38211E+14,Amaryl 2mg tablets (Aventis Pharma) (product),Diabetes,0
9.80411E+14,Young Townson FootSkin Scale for Diabetic Neuropathy risk level 1 (finding),Diabetes,0
9.80431E+14,Young Townson FootSkin Scale for Diabetic Neuropathy risk level 2 (finding),Diabetes,0
9.80451E+14,Young Townson FootSkin Scale for Diabetic Neuropathy risk level 3 high risk (finding),Diabetes,0
9.80471E+14,Young Townson FootSkin Scale for Diabetic Neuropathy risk level 4 high risk (finding),Diabetes,0
1.06691E+15,Diabetes monitoring short message service text message first invitation (procedure),Diabetes,0
1.06692E+15,Diabetes monitoring short message service text message second invitation (procedure),Diabetes,0
1.06693E+15,Diabetes monitoring short message service text message third invitation (procedure),Diabetes,0
1.0672E+15,Eating disorder co-occurrent with diabetes mellitus type 1 (disorder),Diabetes,0
1.08311E+15,Diabetes monitoring invitation email (procedure),Diabetes,0
1.09713E+15,Remote diabetes structured education and support programme commenced (situation),Diabetes,0
1.09714E+15,Remote diabetes structured education and support programme completed (situation),Diabetes,0
1.09801E+15,Did not commence remote structured diabetes education and support programme (situation),Diabetes,0
1.10235E+15,Ketosis-prone diabetes mellitus (disorder),Diabetes,0
1.10369E+15,Diabetes structured education programme offered (situation),Diabetes,0
1.10873E+15,Referral to online diabetes structured education programme (procedure),Diabetes,0
1.11092E+15,Quality and Outcomes Framework diabetes mellitus quality indicator-related care invitation (procedure),Diabetes,0
3.25591E+15,Humulin Isophane 100units/ml suspension for injection 10ml vials (Eli Lilly & Co Ltd) (product),Diabetes,0
3.25611E+15,Insulatard ge 100units/ml suspension for injection 10ml vials (Novo Nordisk Pharmaceuticals Ltd) (product),Diabetes,0
3.25841E+15,Insuman Basal 100units/ml suspension for injection 5ml vials (Aventis Pharma) (product),Diabetes,0
3.26081E+15,Humulin I Pen 100units/ml suspension for injection 3ml pre-filled pens (Eli Lilly and Company Ltd) (product),Diabetes,0
3.26141E+15,Insulatard InnoLet 100units/ml suspension for injection 3ml pre-filled pens (Novo Nordisk Ltd) (product),Diabetes,0
3.26201E+15,Insulatard FlexPen 100units/ml suspension for injection (Novo Nordisk Pharmaceuticals Ltd) (product),Diabetes,0
3.26301E+15,Insuman Comb 25 100units/ml suspension for injection 5ml vials (Aventis Pharma) (product),Diabetes,0
3.26371E+15,Insulatard Penfill 100units/ml suspension for injection 3ml cartridges (Novo Nordisk Pharmaceuticals Ltd) (product),Diabetes,0
3.26411E+15,Insuman Comb 25 100units/ml suspension for injection 3ml cartridges (Aventis Pharma) (product),Diabetes,0
3.26421E+15,Humulin Isophane 100units/ml suspension for injection 3ml cartridges (Eli Lilly & Co Ltd) (product),Diabetes,0
3.26501E+15,Insuman Basal 100units/ml suspension for injection 3ml cartridges (Aventis Pharma) (product),Diabetes,0
3.26681E+15,Hypurin Porcine 30/70 Mix 100units/ml suspension for injection 10ml vials (C P Pharmaceuticals Ltd) (product),Diabetes,0
3.27131E+15,Hypurin Bovine Neutral 100units/ml solution for injection 10ml vials (C P Pharmaceuticals Ltd) (product),Diabetes,0
3.27241E+15,Insuman Comb 50 100units/ml suspension for injection 3ml cartridges (Aventis Pharma) (product),Diabetes,0
3.27281E+15,Mixtard 50 Penfill 100units/ml suspension for injection 3ml cartridges (Novo Nordisk Pharmaceuticals Ltd) (product),Diabetes,0
3.27311E+15,Mixtard 30 Penfill 100units/ml suspension for injection 3ml cartridges (Novo Nordisk Pharmaceuticals Ltd) (product),Diabetes,0
3.27361E+15,Humulin M3 100units/ml suspension for injection 3ml cartridges (Eli Lilly & Co Ltd) (product),Diabetes,0
3.27391E+15,Insuman Comb 15 100units/ml suspension for injection 3ml cartridges (Aventis Pharma) (product),Diabetes,0
3.27481E+15,Humulin M3 100units/ml suspension for injection 10ml vials (Eli Lilly & Co Ltd) (product),Diabetes,0
3.27501E+15,Mixtard 30 ge 100units/ml suspension for injection 10ml vials (Novo Nordisk Pharmaceuticals Ltd) (product),Diabetes,0
3.27571E+15,Humalog Mix25 100units/ml suspension for injection 3ml cartridges (Eli Lilly & Co Ltd) (product),Diabetes,0
3.27601E+15,Humalog Mix25 Pen 100units/ml suspension for injection 3ml pre-filled pens (Eli Lilly and Company Ltd) (product),Diabetes,0
3.27691E+15,Humalog Mix50 Pen 100units/ml suspension for injection 3ml pre-filled pens (Eli Lilly and Company Ltd) (product),Diabetes,0
3.27721E+15,NovoMix 30 FlexPen 100units/ml suspension for injection 3ml pre-filled pens (Novo Nordisk Ltd) (product),Diabetes,0
3.27781E+15,NovoMix 30 Penfill 100units/ml suspension for injection 3ml cartridges (Novo Nordisk Pharmaceuticals Ltd) (product),Diabetes,0
3.27851E+15,Humalog Pen 100units/ml solution for injection 3ml pre-filled pens (Eli Lilly and Company Ltd) (product),Diabetes,0
3.27921E+15,NovoRapid Penfill 100units/ml solution for injection 3ml cartridges (Novo Nordisk Pharmaceuticals Ltd) (product),Diabetes,0
3.28001E+15,Hypurin Bovine Isophane 100units/ml suspension for injection 10ml vials (C P Pharmaceuticals Ltd) (product),Diabetes,0
3.28011E+15,Humalog 100units/ml solution for injection 10ml vials (Eli Lilly & Co Ltd) (product),Diabetes,0
3.28061E+15,Hypurin Bovine Lente 100units/ml suspension for injection 10ml vials (C P Pharmaceuticals Ltd) (product),Diabetes,0
3.28071E+15,NovoRapid 100units/ml solution for injection 10ml vials (Novo Nordisk Pharmaceuticals Ltd) (product),Diabetes,0
3.28221E+15,NovoRapid FlexPen 100units/ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd) (product),Diabetes,0
3.28321E+15,Lantus 100units/ml solution for injection 3ml pre-filled OptiSet pens (Sanofi) (product),Diabetes,0
3.28401E+15,Hypurin Porcine Isophane 100units/ml suspension for injection 10ml vials (C P Pharmaceuticals Ltd) (product),Diabetes,0
3.28421E+15,Lantus 100units/ml solution for injection 3ml cartridges (Aventis Pharma) (product),Diabetes,0
3.28431E+15,Humalog 100units/ml solution for injection 3ml cartridges (Eli Lilly & Co Ltd) (product),Diabetes,0
3.28501E+15,Hypurin Porcine Neutral 100units/ml solution for injection 10ml vials (C P Pharmaceuticals Ltd) (product),Diabetes,0
3.28791E+15,Lantus 100units/ml solution for injection 10ml vials (Aventis Pharma) (product),Diabetes,0
3.31131E+15,Humulin S 100units/ml solution for injection 3ml cartridges (Eli Lilly & Co Ltd) (product),Diabetes,0
3.31161E+15,Insuman Rapid 100units/ml solution for injection 3ml cartridges (Aventis Pharma) (product),Diabetes,0
3.31211E+15,Actrapid 100units/ml solution for injection 10ml vials (Novo Nordisk Pharmaceuticals Ltd) (product),Diabetes,0
3.31261E+15,Humulin S 100units/ml solution for injection 10ml vials (Eli Lilly & Co Ltd) (product),Diabetes,0
3.46861E+15,Insulin aspart 100units/ml solution for injection 3ml cartridges (product),Diabetes,0
3.46871E+15,Insulin aspart 100units/ml solution for injection 3ml pre-filled disposable devices (product),Diabetes,0
3.46881E+15,Insulin aspart biphasic 30/70 100units/ml suspension for injection 3ml cartridges (product),Diabetes,0
3.46891E+15,Insulin aspart biphasic 30/70 100units/ml suspension for injection 3ml pre-filled disposable devices (product),Diabetes,0
3.46911E+15,Insulin glargine 100units/ml solution for injection 3ml cartridges (product),Diabetes,0
3.46921E+15,Insulin glargine 100units/ml solution for injection 3ml pre-filled disposable devices (product),Diabetes,0
3.47071E+15,Insulin isophane biphasic human 30/70 100units/ml suspension for injection 10ml vials (product),Diabetes,0
3.47101E+15,Insulin isophane biphasic human 30/70 100units/ml suspension for injection 3ml pre-filled disposable devices (product),Diabetes,0
3.47171E+15,Insulin isophane biphasic human 50/50 100units/ml suspension for injection 3ml pre-filled disposable devices (product),Diabetes,0
3.47201E+15,Insulin isophane biphasic porcine 30/70 100units/ml suspension for injection 10ml vials (product),Diabetes,0
3.47251E+15,Insulin isophane human 100units/ml suspension for injection 10ml vials (product),Diabetes,0
3.47301E+15,Insulin isophane porcine 100units/ml suspension for injection 10ml vials (product),Diabetes,0
3.65061E+15,Starlix 60mg tablets (Novartis Pharmaceuticals UK Ltd) (product),Diabetes,0
3.66131E+15,Diamicron 30mg MR tablets (Servier Laboratories Limited) (product),Diabetes,0
4.02941E+15,Hypurin Porcine 30/70 Mix 100units/ml suspension for injection 3ml cartridges (C P Pharmaceuticals Ltd) (product),Diabetes,0
4.03311E+15,Insulin isophane biphasic porcine 30/70 100units/ml suspension for injection 3ml cartridges (product),Diabetes,0
4.03431E+15,Hypurin Porcine Isophane 100units/ml suspension for injection 3ml cartridges (C P Pharmaceuticals Ltd) (product),Diabetes,0
4.03491E+15,Hypurin Porcine Neutral 100units/ml suspension for injection 3ml cartridges (C P Pharmaceuticals Ltd) (product),Diabetes,0
4.05361E+15,Insulin isophane porcine 100units/ml suspension for injection 3ml cartridges (product),Diabetes,0
5.19941E+15,Actos 45mg tablets (Takeda UK Ltd) (product),Diabetes,0
7.58941E+15,Levemir FlexPen 100units/ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd) (product),Diabetes,0
7.58991E+15,Levemir Penfill 100units/ml solution for injection 3ml cartridges (Novo Nordisk Pharmaceuticals Ltd) (product),Diabetes,0
7.59421E+15,Insulin detemir 100units/ml solution for injection 3ml pre-filled disposable devices (product),Diabetes,0
7.59761E+15,Insulin detemir 100units/ml solution for injection 3ml cartridges (product),Diabetes,0
8.52421E+15,Gliclazide 40mg/5ml oral suspension (product),Diabetes,0
8.52431E+15,Gliclazide 80mg/5ml oral suspension (product),Diabetes,0
8.66391E+15,Metformin 250mg/5ml oral solution (product),Diabetes,0
8.66441E+15,Metformin 500mg/5ml oral suspension (product),Diabetes,0
8.66461E+15,Metformin 850mg/5ml oral solution (product),Diabetes,0
8.79671E+15,Metformin 850mg capsules (product),Diabetes,0
8.99071E+15,Glucophage SR 500mg tablets (Merck Pharmaceuticals) (product),Diabetes,0
8.99141E+15,Metformin 500mg modified-release tablets (product),Diabetes,0
9.43751E+15,Humulin M3 Pen 100units/ml suspension for injection 3ml pre-filled pens (Eli Lilly and Company Ltd) (product),Diabetes,0
9.52831E+15,Apidra 100units/ml solution for injection 3ml cartridges (sanofi-aventis) (product),Diabetes,0
9.52881E+15,Apidra 100units/ml solution for injection 10ml vials (sanofi-aventis) (product),Diabetes,0
9.53211E+15,Insulin glulisine 100units/ml solution for injection 3ml cartridges (product),Diabetes,0
9.55591E+15,Metformin 500mg tablets (Wockhardt UK Ltd) (product),Diabetes,0
9.55611E+15,Metformin 850mg tablets (Wockhardt UK Ltd) (product),Diabetes,0
9.75281E+15,Gliclazide 80mg tablets (Milpharm Ltd) (product),Diabetes,0
9.79731E+15,Metformin 500mg tablets (Almus Pharmaceutical Ltd) (product),Diabetes,0
9.79821E+15,Metformin 850mg tablets (Almus Pharmaceutical Ltd) (product),Diabetes,0
9.80191E+15,Gliclazide 80mg tablets (Almus Pharmaceutical Ltd) (product),Diabetes,0
1.00933E+16,Apidra 100units/ml solution for injection 3ml pre-filled OptiSet pens (Sanofi) (product),Diabetes,0
1.00972E+16,Insulin glulisine 100units/ml solution for injection 3ml pre-filled disposable devices (product),Diabetes,0
1.02738E+16,Glimepiride 1mg tablets (A A H Pharmaceuticals Ltd) (product),Diabetes,0
1.0274E+16,Glimepiride 2mg tablets (A A H Pharmaceuticals Ltd) (product),Diabetes,0
1.02743E+16,Glimepiride 3mg tablets (A A H Pharmaceuticals Ltd) (product),Diabetes,0
1.02745E+16,Glimepiride 4mg tablets (A A H Pharmaceuticals Ltd) (product),Diabetes,0
1.03449E+16,Humalog Mix50 100units/ml suspension for injection 3ml cartridges (Eli Lilly & Co Ltd) (product),Diabetes,0
1.05177E+16,Glimepiride 1mg tablets (Winthrop Pharmaceuticals UK Ltd) (product),Diabetes,0
1.07501E+16,Metformin 500mg/5ml oral solution sugar free (product),Diabetes,0
1.09223E+16,Competact 15mg/850mg tablets (Takeda UK Ltd) (product),Diabetes,0
1.09524E+16,Prandin 0.5mg tablets (Novo Nordisk Ltd) (product),Diabetes,0
1.09569E+16,Prandin 1mg tablets (Novo Nordisk Ltd) (product),Diabetes,0
1.09578E+16,Prandin 2mg tablets (Novo Nordisk Ltd) (product),Diabetes,0
1.09636E+16,Metformin 500mg/5ml oral solution sugar free (A A H Pharmaceuticals Ltd) (product),Diabetes,0
1.11481E+16,Levemir InnoLet 100units/ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd) (product),Diabetes,0
1.11492E+16,Glimepiride 1mg tablets (Teva UK Ltd) (product),Diabetes,0
1.11494E+16,Glimepiride 2mg tablets (Teva UK Ltd) (product),Diabetes,0
1.11496E+16,Glimepiride 3mg tablets (Teva UK Ltd) (product),Diabetes,0
1.11498E+16,Glimepiride 4mg tablets (Teva UK Ltd) (product),Diabetes,0
1.14737E+16,Januvia 100mg tablets (Merck Sharp & Dohme (UK) Ltd) (product),Diabetes,0
1.14941E+16,Exenatide 10micrograms/0.04ml solution for injection 2.4ml pre-filled disposable devices (product),Diabetes,0
1.14942E+16,Exenatide 5micrograms/0.02ml solution for injection 1.2ml pre-filled disposable devices (product),Diabetes,0
1.14946E+16,Byetta 10micrograms/0.04ml solution for injection 2.4ml pre-filled pens (AstraZeneca UK Ltd) (product),Diabetes,0
1.14948E+16,Byetta 5micrograms/0.02ml solution for injection 1.2ml pre-filled pens (AstraZeneca UK Ltd) (product),Diabetes,0
1.1933E+16,Lantus 100units/ml solution for injection 3ml pre-filled SoloStar pens (Sanofi) (product),Diabetes,0
1.21446E+16,Apidra 100units/ml solution for injection 3ml pre-filled SoloStar pens (Sanofi) (product),Diabetes,0
1.2798E+16,Metformin 1g/5ml oral solution (product),Diabetes,0
1.28137E+16,Metformin 5mg/5ml oral solution (product),Diabetes,0
1.34116E+16,Galvus 50mg tablets (Novartis Pharmaceuticals UK Ltd) (product),Diabetes,0
1.34123E+16,Eucreas 50mg/1000mg tablets (Novartis Pharmaceuticals UK Ltd) (product),Diabetes,0
1.34126E+16,Eucreas 50mg/850mg tablets (Novartis Pharmaceuticals UK Ltd) (product),Diabetes,0
1.34129E+16,Vildagliptin 50mg tablets (product),Diabetes,0
1.3413E+16,Metformin 1g / Vildagliptin 50mg tablets (product),Diabetes,0
1.34131E+16,Metformin 850mg / Vildagliptin 50mg tablets (product),Diabetes,0
1.37486E+16,Glucophage SR 750mg tablets (Merck Serono Ltd) (product),Diabetes,0
1.37564E+16,Metformin 500mg tablets (Tillomed Laboratories Ltd) (product),Diabetes,0
1.37578E+16,Metformin 850mg tablets (Tillomed Laboratories Ltd) (product),Diabetes,0
1.38778E+16,Humalog KwikPen 100units/ml solution for injection 3ml pre-filled pens (Eli Lilly and Company Ltd) (product),Diabetes,0
1.38847E+16,Humalog Mix25 KwikPen 100units/ml suspension for injection 3ml pre-filled pens (Eli Lilly and Company Ltd) (product),Diabetes,0
1.38849E+16,Humalog Mix50 KwikPen 100units/ml suspension for injection 3ml pre-filled pens (Eli Lilly and Company Ltd) (product),Diabetes,0
1.41839E+16,Bolamyn SR 500mg tablets (Teva UK Ltd) (product),Diabetes,0
1.53345E+16,Edicil MR 30mg tablets (Ratiopharm UK Ltd) (product),Diabetes,0
1.53678E+16,Glucophage SR 1000mg tablets (Merck Serono Ltd) (product),Diabetes,0
1.54112E+16,Metformin 1g oral powder sachets sugar free (product),Diabetes,0
1.54113E+16,Metformin 500mg oral powder sachets sugar free (product),Diabetes,0
1.56031E+16,Humulin R 500units/ml solution for injection 20ml vials (Imported (United States)) (product),Diabetes,0
1.56114E+16,Insulin human 500units/ml solution for injection 20ml vials (product),Diabetes,0
1.58586E+16,Victoza 6mg/ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd) (product),Diabetes,0
1.58591E+16,Liraglutide 18mg/3ml solution for injection pre-filled disposable devices (product),Diabetes,0
1.59841E+16,Metformin 500mg/5ml oral solution sugar free (Accord Healthcare Ltd) (product),Diabetes,0
1.5993E+16,Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) (product),Diabetes,0
1.65303E+16,Humalog Mix25 100units/ml suspension for injection 10ml vials (Eli Lilly and Company Ltd) (product),Diabetes,0
1.66775E+16,Zicron 40mg tablets (Bristol Laboratories Ltd) (product),Diabetes,0
1.6702E+16,Gliclazide 40mg tablets (product),Diabetes,0
1.70605E+16,Janumet 50mg/1000mg tablets (Merck Sharp & Dohme (UK) Ltd) (product),Diabetes,0
1.70718E+16,Metformin 1g / Sitagliptin 50mg tablets (product),Diabetes,0
1.71993E+16,Gliclazide 80mg tablets (Sovereign Medical Ltd) (product),Diabetes,0
1.76085E+16,Humulin I KwikPen 100units/ml suspension for injection 3ml pre-filled pens (Eli Lilly and Company Ltd) (product),Diabetes,0
1.76095E+16,Humulin M3 KwikPen 100units/ml suspension for injection 3ml pre-filled pens (Eli Lilly and Company Ltd) (product),Diabetes,0
1.79701E+16,Metformin 500mg/5ml oral solution sugar free (Almus Pharmaceuticals Ltd) (product),Diabetes,0
1.81419E+16,Metabet SR 500mg tablets (Morningside Healthcare Ltd) (product),Diabetes,0
1.81503E+16,Insuman Comb 25 100units/ml suspension for injection 3ml pre-filled SoloStar pens (Sanofi) (product),Diabetes,0
1.83096E+16,Acarbose 50mg tablets (A A H Pharmaceuticals Ltd) (product),Diabetes,0
1.83098E+16,Acarbose 100mg tablets (A A H Pharmaceuticals Ltd) (product),Diabetes,0
1.85963E+16,Onglyza 2.5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) (product),Diabetes,0
1.88856E+16,Metabet SR 1000mg tablets (Morningside Healthcare Ltd) (product),Diabetes,0
1.91798E+16,Repaglinide 2mg tablets (Teva UK Ltd) (product),Diabetes,0
1.92748E+16,Bydureon 2mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) (product),Diabetes,0
1.92754E+16,Exenatide 2mg powder and solvent for suspension for injection vials (product),Diabetes,0
1.92999E+16,Repaglinide 500microgram tablets (Actavis UK Ltd) (product),Diabetes,0
1.93081E+16,Glucient SR 500mg tablets (Consilient Health Ltd) (product),Diabetes,0
1.93544E+16,Insuman Basal 100units/ml suspension for injection 3ml pre-filled SoloStar pens (Sanofi) (product),Diabetes,0
1.93613E+16,Pioglitazone 15mg tablets (A A H Pharmaceuticals Ltd) (product),Diabetes,0
1.93615E+16,Pioglitazone 30mg tablets (A A H Pharmaceuticals Ltd) (product),Diabetes,0
1.94735E+16,Pioglitazone 45mg tablets (A A H Pharmaceuticals Ltd) (product),Diabetes,0
1.94928E+16,Trajenta 5mg tablets (Boehringer Ingelheim Ltd) (product),Diabetes,0
1.95252E+16,Linagliptin 5mg tablets (product),Diabetes,0
1.95702E+16,NovoRapid FlexTouch 100units/ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd) (product),Diabetes,0
2.01148E+16,Januvia 50mg tablets (Merck Sharp & Dohme (UK) Ltd) (product),Diabetes,0
2.01151E+16,Januvia 25mg tablets (Merck Sharp & Dohme (UK) Ltd) (product),Diabetes,0
2.03578E+16,Pioglitazone 45mg tablets (Actavis UK Ltd) (product),Diabetes,0
2.05525E+16,Diagemet XL 500mg tablets (Genus Pharmaceuticals Ltd) (product),Diabetes,0
2.12082E+16,Jentadueto 2.5mg/850mg tablets (Boehringer Ingelheim Ltd) (product),Diabetes,0
2.12085E+16,Jentadueto 2.5mg/1000mg tablets (Boehringer Ingelheim Ltd) (product),Diabetes,0
2.1245E+16,Linagliptin 2.5mg / Metformin 1g tablets (product),Diabetes,0
2.12451E+16,Linagliptin 2.5mg / Metformin 850mg tablets (product),Diabetes,0
2.13669E+16,Glimepiride 6mg/5ml oral suspension (product),Diabetes,0
2.14098E+16,Metabet SR 500mg tablets (Actavis UK Ltd) (product),Diabetes,0
2.16095E+16,Forxiga 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) (product),Diabetes,0
2.16098E+16,Forxiga 10mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) (product),Diabetes,0
2.17056E+16,Komboglyze 2.5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) (product),Diabetes,0
2.17114E+16,Saxagliptin 2.5mg / Metformin 1g tablets (product),Diabetes,0
2.17115E+16,Saxagliptin 2.5mg / Metformin 850mg tablets (product),Diabetes,0
2.17633E+16,Pioglitazone 15mg tablets (Teva UK Ltd) (product),Diabetes,0
2.17642E+16,Pioglitazone 30mg tablets (Teva UK Ltd) (product),Diabetes,0
2.17645E+16,Pioglitazone 45mg tablets (Teva UK Ltd) (product),Diabetes,0
2.19285E+16,Tresiba Penfill 100units/ml solution for injection 3ml cartridges (Novo Nordisk Ltd) (product),Diabetes,0
2.193E+16,Tresiba FlexTouch 100units/ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd) (product),Diabetes,0
2.19319E+16,Tresiba FlexTouch 200units/ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd) (product),Diabetes,0
2.19395E+16,Insulin degludec 100units/ml solution for injection 3ml cartridges (product),Diabetes,0
2.19396E+16,Insulin degludec 100units/ml solution for injection 3ml pre-filled disposable devices (product),Diabetes,0
2.19397E+16,Insulin degludec 200units/ml solution for injection 3ml pre-filled disposable devices (product),Diabetes,0
2.1941E+16,Lyxumia 20micrograms/0.2ml solution for injection 3ml pre-filled pens (Sanofi) (product),Diabetes,0
2.19415E+16,Lyxumia 10micrograms/0.2ml solution for injection 3ml pre-filled pens (Sanofi) (product),Diabetes,0
2.19537E+16,Lyxumia 10micrograms/0.2ml solution for injection 3ml pre-filled pen and Lyxumia 20micrograms/0.2ml solution for injection 3ml pre-filled pen (Sanofi) (product),Diabetes,0
2.19946E+16,Lixisenatide 10micrograms/0.2ml solution for injection 3ml pre-filled disposable devices (product),Diabetes,0
2.19947E+16,Lixisenatide 10micrograms/0.2ml solution for injection 3ml pre-filled disposable devices and Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices (product),Diabetes,0
2.19948E+16,Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices (product),Diabetes,0
2.2225E+16,Laaglyda MR 60 mg tablets (Consilient Health Ltd) (product),Diabetes,0
2.22261E+16,Gliclazide 60mg modified-release tablets (product),Diabetes,0
2.23088E+16,Bolamyn SR 1000mg tablets (Teva UK Ltd) (product),Diabetes,0
2.36326E+16,Vipdomet 12.5mg/1000mg tablets (Takeda UK Ltd) (product),Diabetes,0
2.36341E+16,Vipidia 6.25mg tablets (Takeda UK Ltd) (product),Diabetes,0
2.3636E+16,Vipidia 12.5mg tablets (Takeda UK Ltd) (product),Diabetes,0
2.36363E+16,Vipidia 25mg tablets (Takeda UK Ltd) (product),Diabetes,0
2.36372E+16,Alogliptin 12.5mg / Metformin 1g tablets (product),Diabetes,0
2.36373E+16,Alogliptin 12.5mg tablets (product),Diabetes,0
2.36374E+16,Alogliptin 25mg tablets (product),Diabetes,0
2.36375E+16,Alogliptin 6.25mg tablets (product),Diabetes,0
2.40181E+16,Xigduo 5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) (product),Diabetes,0
2.40185E+16,Xigduo 5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) (product),Diabetes,0
2.40546E+16,Dapagliflozin 5mg / Metformin 1g tablets (product),Diabetes,0
2.40547E+16,Dapagliflozin 5mg / Metformin 850mg tablets (product),Diabetes,0
2.40883E+16,Invokana 300mg tablets (Janssen-Cilag Ltd) (product),Diabetes,0
2.40886E+16,Invokana 100mg tablets (Janssen-Cilag Ltd) (product),Diabetes,0
2.41045E+16,Canagliflozin 300mg tablets (product),Diabetes,0
2.45682E+16,Sukkarto SR 1000mg tablets (Morningside Healthcare Ltd) (product),Diabetes,0
2.45684E+16,Sukkarto SR 500mg tablets (Morningside Healthcare Ltd) (product),Diabetes,0
2.52388E+16,Jardiance 10mg tablets (Boehringer Ingelheim Ltd) (product),Diabetes,0
2.52397E+16,Jardiance 25mg tablets (Boehringer Ingelheim Ltd) (product),Diabetes,0
2.52905E+16,Empagliflozin 10mg tablets (product),Diabetes,0
2.52906E+16,Empagliflozin 25mg tablets (product),Diabetes,0
2.62096E+16,NovoRapid PumpCart 100units/ml solution for injection 1.6ml cartridges (Novo Nordisk Ltd) (product),Diabetes,0
2.66558E+16,Insulin aspart 100units/ml solution for injection 1.6ml cartridges (product),Diabetes,0
2.80225E+16,Vokanamet 50mg/850mg tablets (Janssen-Cilag Ltd) (product),Diabetes,0
2.80244E+16,Vokanamet 50mg/1000mg tablets (Janssen-Cilag Ltd) (product),Diabetes,0
2.80492E+16,Canagliflozin 50mg / Metformin 1g tablets (product),Diabetes,0
2.80493E+16,Canagliflozin 50mg / Metformin 850mg tablets (product),Diabetes,0
2.80543E+16,Xultophy 100units/ml / 3.6mg/ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd) (product),Diabetes,0
2.82796E+16,Insulin degludec 100units/ml / Liraglutide 3.6mg/ml solution for injection 3ml pre-filled disposable devices (product),Diabetes,0
2.84158E+16,Metformin 500mg/5ml oral solution sugar free (Focus Pharmaceuticals Ltd) (product),Diabetes,0
2.84207E+16,Vamju 30mg modified-release tablets (AMCo) (product),Diabetes,0
2.84209E+16,Vamju 60mg modified-release tablets (AMCo) (product),Diabetes,0
2.8426E+16,Bydureon 2mg powder and solvent for prolonged-release suspension for injection pre-filled pens (AstraZeneca UK Ltd) (product),Diabetes,0
2.84402E+16,Exenatide 2mg powder and solvent for suspension for injection pre-filled disposable devices (product),Diabetes,0
2.8461E+16,Trulicity 0.75mg/0.5ml solution for injection pre-filled pens (Eli Lilly and Company Ltd) (product),Diabetes,0
2.84623E+16,Trulicity 1.5mg/0.5ml solution for injection pre-filled pens (Eli Lilly and Company Ltd) (product),Diabetes,0
2.87896E+16,Dulaglutide 0.75mg/0.5ml solution for injection pre-filled disposable devices (product),Diabetes,0
2.87897E+16,Dulaglutide 1.5mg/0.5ml solution for injection pre-filled disposable devices (product),Diabetes,0
2.89268E+16,Humalog KwikPen 200units/ml solution for injection 3ml pre-filled pens (Eli Lilly and Company Ltd) (product),Diabetes,0
2.89897E+16,Insulin lispro 200units/ml solution for injection 3ml pre-filled disposable devices (product),Diabetes,0
2.98668E+16,Toujeo 300units/ml solution for injection 1.5ml pre-filled SoloStar pens (Sanofi) (product),Diabetes,0
2.99036E+16,Insulin glargine 300units/ml solution for injection 1.5ml pre-filled disposable devices (product),Diabetes,0
3.00121E+16,Glucient SR 750mg tablets (Consilient Health Ltd) (product),Diabetes,0
3.00123E+16,Glucient SR 1000mg tablets (Consilient Health Ltd) (product),Diabetes,0
3.01718E+16,Abasaglar KwikPen 100units/ml solution for injection 3ml pre-filled pens (Eli Lilly and Company Ltd) (product),Diabetes,0
3.01722E+16,Abasaglar 100units/ml solution for injection 3ml cartridges (Eli Lilly and Company Ltd) (product),Diabetes,0
3.01734E+16,Synjardy 5mg/850mg tablets (Boehringer Ingelheim Ltd) (product),Diabetes,0
3.01741E+16,Synjardy 5mg/1000mg tablets (Boehringer Ingelheim Ltd) (product),Diabetes,0
3.0175E+16,Synjardy 12.5mg/850mg tablets (Boehringer Ingelheim Ltd) (product),Diabetes,0
3.01757E+16,Synjardy 12.5mg/1000mg tablets (Boehringer Ingelheim Ltd) (product),Diabetes,0
3.03181E+16,Empagliflozin 12.5mg / Metformin 1g tablets (product),Diabetes,0
3.03182E+16,Empagliflozin 12.5mg / Metformin 850mg tablets (product),Diabetes,0
3.03183E+16,Empagliflozin 5mg / Metformin 1g tablets (product),Diabetes,0
3.03184E+16,Empagliflozin 5mg / Metformin 850mg tablets (product),Diabetes,0
3.07633E+16,Metformin 500mg modified-release tablets (Almus Pharmaceuticals Ltd) (product),Diabetes,0
3.09824E+16,Bilxona 30mg modified-release tablets (Accord Healthcare Ltd) (product),Diabetes,0
3.3548E+16,Metformin 1g/5ml oral solution sugar free (Colonis Pharma Ltd) (product),Diabetes,0
3.35508E+16,Metformin 1g/5ml oral solution sugar free (product),Diabetes,0
3.35509E+16,Metformin 850mg/5ml oral solution sugar free (product),Diabetes,0
3.37477E+16,Saxenda 6mg/ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd) (product),Diabetes,0
3.37662E+16,Zicron PR 30mg tablets (Bristol Laboratories Ltd) (product),Diabetes,0
3.4043E+16,Fiasp FlexTouch 100units/ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd) (product),Diabetes,0
3.40432E+16,Fiasp Penfill 100units/ml solution for injection 3ml cartridges (Novo Nordisk Ltd) (product),Diabetes,0
3.40434E+16,Fiasp 100units/ml solution for injection 10ml vials (Novo Nordisk Ltd) (product),Diabetes,0
3.45524E+16,Meijumet 500mg modified-release tablets (Medreich Plc) (product),Diabetes,0
3.45528E+16,Meijumet 750mg modified-release tablets (Medreich Plc) (product),Diabetes,0
3.45533E+16,Meijumet 1000mg modified-release tablets (Medreich Plc) (product),Diabetes,0
3.48236E+16,Gliclazide 40mg tablets (Teva UK Ltd) (product),Diabetes,0
3.49569E+16,Gliclazide 40mg tablets (Almus Pharmaceuticals Ltd) (product),Diabetes,0
3.52143E+16,Humulin R KwikPen 500units/ml solution for injection 3ml pre-filled pens (Imported (United States)) (product),Diabetes,0
3.52168E+16,Humalog Junior KwikPen 100units/ml solution for injection 3ml pre-filled pens (Eli Lilly and Company Ltd) (product),Diabetes,0
3.55475E+16,Yaltormin SR 500mg tablets (Wockhardt UK Ltd) (product),Diabetes,0
3.5548E+16,Yaltormin SR 750mg tablets (Wockhardt UK Ltd) (product),Diabetes,0
3.55483E+16,Yaltormin SR 1000mg tablets (Wockhardt UK Ltd) (product),Diabetes,0
3.57764E+16,Insulin lispro Sanofi 100units/ml solution for injection 10ml vials (Sanofi) (product),Diabetes,0
3.57765E+16,Insulin lispro Sanofi 100units/ml solution for injection 3ml cartridges (Sanofi) (product),Diabetes,0
3.57768E+16,Insulin lispro Sanofi 100units/ml solution for injection 3ml pre-filled pens (Sanofi) (product),Diabetes,0
3.5849E+16,Metuxtan SR 500mg tablets (Accord Healthcare Ltd) (product),Diabetes,0
3.6047E+16,Insulin aspart 100units/ml solution for injection 10ml vials (product),Diabetes,0
3.60471E+16,Insulin glargine 100units/ml solution for injection 10ml vials (product),Diabetes,0
3.60472E+16,Insulin glulisine 100units/ml solution for injection 10ml vials (product),Diabetes,0
3.60473E+16,Insulin isophane human 100units/ml suspension for injection 3ml cartridges (product),Diabetes,0
3.60474E+16,Insulin isophane human 100units/ml suspension for injection 3ml pre-filled disposable devices (product),Diabetes,0
3.60476E+16,Insulin lispro 100units/ml solution for injection 10ml vials (product),Diabetes,0
3.60477E+16,Insulin lispro 100units/ml solution for injection 3ml cartridges (product),Diabetes,0
3.60478E+16,Insulin lispro 100units/ml solution for injection 3ml pre-filled disposable devices (product),Diabetes,0
3.60828E+16,Semglee 100units/ml solution for injection 3ml pre-filled pens (Mylan) (product),Diabetes,0
3.66183E+16,Suliqua 100units/ml / 50micrograms/ml solution for injection 3ml pre-filled SoloStar pens (Sanofi) (product),Diabetes,0
3.66206E+16,Suliqua 100units/ml / 33micrograms/ml solution for injection 3ml pre-filled SoloStar pens (Sanofi) (product),Diabetes,0
3.66305E+16,Insulin glargine 100units/ml / Lixisenatide 33micrograms/ml solution for injection 3ml pre-filled disposable devices (product),Diabetes,0
3.66306E+16,Insulin glargine 100units/ml / Lixisenatide 50micrograms/ml solution for injection 3ml pre-filled disposable devices (product),Diabetes,0
3.69113E+16,Toujeo 300units/ml solution for injection 3ml pre-filled DoubleStar pens (Sanofi) (product),Diabetes,0
3.69149E+16,Gliclazide 160mg tablets (product),Diabetes,0
3.69318E+16,Insulin glargine 300units/ml solution for injection 3ml pre-filled disposable devices (product),Diabetes,0
3.74391E+16,Humalog KwikPen 100units/ml solution for injection 3ml pre-filled pens (CST Pharma Ltd) (product),Diabetes,0
3.76187E+16,Bilxona 60mg modified-release tablets (Accord Healthcare Ltd) (product),Diabetes,0
3.80605E+16,Bydureon BCise 2mg/0.85ml prolonged-release suspension for injection pre-filled pens (AstraZeneca UK Ltd) (product),Diabetes,0
3.80828E+16,Exenatide 2mg/0.85ml prolonged-release suspension for injection pre-filled disposable devices (product),Diabetes,0
3.82381E+16,Sukkarto SR 750mg tablets (Morningside Healthcare Ltd) (product),Diabetes,0
3.84561E+16,Lyumjev 100units/ml solution for injection 3ml cartridges (Eli Lilly and Company Ltd) (product),Diabetes,0
3.84569E+16,Lyumjev 100units/ml solution for injection 10ml vials (Eli Lilly and Company Ltd) (product),Diabetes,0
3.84658E+16,Lyumjev KwikPen 100units/ml solution for injection 3ml pre-filled pens (Eli Lilly and Company Ltd) (product),Diabetes,0
3.87491E+16,Glucorex SR 500mg tablets (GlucoRx Ltd) (product),Diabetes,0
3.88937E+16,Metformin 1g modified-release tablets (product),Diabetes,0
3.88938E+16,Metformin 750mg modified-release tablets (product),Diabetes,0
3.88962E+16,Gliclazide 30mg modified-release tablets (product),Diabetes,0
3.88969E+16,Insulin glargine 100units/ml solution for injection 3ml cartridges (product),Diabetes,0
3.8897E+16,Insulin glargine 100units/ml solution for injection 3ml pre-filled disposable devices (product),Diabetes,0
3.91135E+16,Metformin 500mg modified-release tablets (product),Diabetes,0
3.92324E+16,Trulicity 3mg/0.5ml solution for injection pre-filled pens (Eli Lilly and Company Ltd) (product),Diabetes,0
3.92326E+16,Trulicity 4.5mg/0.5ml solution for injection pre-filled pens (Eli Lilly and Company Ltd) (product),Diabetes,0
3.92334E+16,Dulaglutide 3mg/0.5ml solution for injection pre-filled disposable devices (product),Diabetes,0
3.92335E+16,Dulaglutide 4.5mg/0.5ml solution for injection pre-filled disposable devices (product),Diabetes,0
5.30559E+17,Atypical diabetes mellitus (disorder),Diabetes,0
241006,Epilepsia partialis continua (disorder),Epilepsy and CND,0
1212005,Childhood type dermatomyositis (disorder),Epilepsy and CND,0
4223005,Parkinsonism caused by drug (disorder),Epilepsy and CND,0
5262007,Spinal muscular atrophy (disorder),Epilepsy and CND,0
7033004,Petit mal status (disorder),Epilepsy and CND,0
7379000,Pseudobulbar palsy (disorder),Epilepsy and CND,0
10394003,Friedreich's ataxia (disorder),Epilepsy and CND,0
13973009,Grand mal status (disorder),Epilepsy and CND,0
14289006,Myopathy in hypopituitarism (disorder),Epilepsy and CND,0
16851005,Mitochondrial myopathy (disorder),Epilepsy and CND,0
16873003,Musicogenic seizure (finding),Epilepsy and CND,0
19598007,Generalized epilepsy (disorder),Epilepsy and CND,0
21764004,Renal carnitine transport defect (disorder),Epilepsy and CND,0
22886006,"Glutaric aciduria, type 2 (disorder)",Epilepsy and CND,0
26111005,Metabolic myopathy (disorder),Epilepsy and CND,0
28055006,West syndrome (disorder),Epilepsy and CND,0
29570005,Leigh's disease (disorder),Epilepsy and CND,0
31097004,Post poliomyelitis syndrome (disorder),Epilepsy and CND,0
31384009,Polymyositis (disorder),Epilepsy and CND,0
34253008,Myopathy in Addison's disease (disorder),Epilepsy and CND,0
37340000,Motor neuron disease (disorder),Epilepsy and CND,0
37356005,Myoclonic seizure (disorder),Epilepsy and CND,0
39912006,Hereditary spastic paraplegia (disorder),Epilepsy and CND,0
41574007,Paramyotonia congenita (disorder),Epilepsy and CND,0
49049000,Parkinson's disease (disorder),Epilepsy and CND,0
50967008,Gangliosidosis (disorder),Epilepsy and CND,0
53509000,Myopathy in Cushing's disease (disorder),Epilepsy and CND,0
54280009,Kugelberg-Welander disease (disorder),Epilepsy and CND,0
54304004,Progressive bulbar palsy (disorder),Epilepsy and CND,0
56989000,Eaton-Lambert syndrome (disorder),Epilepsy and CND,0
57938005,"Congenital myotonia, autosomal dominant form (disorder)",Epilepsy and CND,0
57958006,Endocrine myopathy (disorder),Epilepsy and CND,0
58756001,Huntington's chorea (disorder),Epilepsy and CND,0
58795000,Distal muscular dystrophy (disorder),Epilepsy and CND,0
60738003,Secondary myopathy (disorder),Epilepsy and CND,0
63135006,Amyotonia congenita (disorder),Epilepsy and CND,0
64383006,Werdnig-Hoffmann disease (disorder),Epilepsy and CND,0
64764001,"Acute paralytic poliomyelitis, bulbar (disorder)",Epilepsy and CND,0
65120008,Generalized convulsive epilepsy (disorder),Epilepsy and CND,0
67747009,Ocular muscular dystrophy (disorder),Epilepsy and CND,0
68437005,Thyrotoxic myopathy (disorder),Epilepsy and CND,0
71831005,Symptomatic generalized epilepsy (disorder),Epilepsy and CND,0
73297009,Muscular dystrophy (disorder),Epilepsy and CND,0
75023009,Post-traumatic epilepsy (disorder),Epilepsy and CND,0
75072002,Nemaline myopathy (disorder),Epilepsy and CND,0
76670001,Duchenne muscular dystrophy (disorder),Epilepsy and CND,0
77097004,Oculopharyngeal muscular dystrophy (disorder),Epilepsy and CND,0
77956009,Steinert myotonic dystrophy syndrome (disorder),Epilepsy and CND,0
78468005,Erb's muscular dystrophy (disorder),Epilepsy and CND,0
79745005,Reflex epilepsy (disorder),Epilepsy and CND,0
81211007,Primary lateral sclerosis (disorder),Epilepsy and CND,0
82077006,Myotubular myopathy (disorder),Epilepsy and CND,0
84757009,Epilepsy (disorder),Epilepsy and CND,0
85505000,Adult spinal muscular atrophy (disorder),Epilepsy and CND,0
85672005,Anterior horn cell disease (disorder),Epilepsy and CND,0
86044005,Amyotrophic lateral sclerosis (disorder),Epilepsy and CND,0
88923002,Progressive muscular atrophy (disorder),Epilepsy and CND,0
89525009,Gelastic seizure (disorder),Epilepsy and CND,0
91637004,Myasthenia gravis (disorder),Epilepsy and CND,0
93153005,Limb-girdle muscular dystrophy (disorder),Epilepsy and CND,0
95208000,Photogenic epilepsy (disorder),Epilepsy and CND,0
110270004,Sequela of infection caused by Human poliovirus (disorder),Epilepsy and CND,0
111501005,Congenital hereditary muscular dystrophy (disorder),Epilepsy and CND,0
111508004,Emery-Dreifuss muscular dystrophy (disorder),Epilepsy and CND,0
128212001,"Spinal muscular atrophy, type II (disorder)",Epilepsy and CND,0
128213006,Neuromuscular junction disorder (disorder),Epilepsy and CND,0
128596003,Medium-chain acyl-coenzyme A dehydrogenase deficiency (disorder),Epilepsy and CND,0
134537008,Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug),Epilepsy and CND,0
134538003,Product containing precisely valproic acid (as valproate semisodium) 250 milligram/1 each gastro-resistant oral tablet (clinical drug),Epilepsy and CND,0
162658001,Epilepsy resolved (finding),Epilepsy and CND,1
170707004,Fit frequency (observable entity),Epilepsy and CND,0
186476008,Acute paralytic non-bulbar poliomyelitis (disorder),Epilepsy and CND,0
186479001,"Acute paralytic poliomyelitis, wild virus, imported (disorder)",Epilepsy and CND,0
186480003,"Acute paralytic poliomyelitis, wild virus, indigenous (disorder)",Epilepsy and CND,0
191382009,Chronic congestive splenomegaly (disorder),Epilepsy and CND,0
191397007,Pseudocholinesterase deficiency (disorder),Epilepsy and CND,0
192686004,Polioencephalitis (disorder),Epilepsy and CND,0
192845009,Myoclonic encephalopathy (disorder),Epilepsy and CND,0
192979009,Generalized non-convulsive epilepsy (disorder),Epilepsy and CND,0
192981006,Epileptic seizures - atonic (finding),Epilepsy and CND,0
192982004,Epileptic seizures - akinetic (finding),Epilepsy and CND,0
192991000,Epileptic seizures - clonic (finding),Epilepsy and CND,0
192992007,Epileptic seizures - myoclonic (disorder),Epilepsy and CND,0
192993002,Epileptic seizures - tonic (finding),Epilepsy and CND,0
192999003,Partial epilepsy with impairment of consciousness (disorder),Epilepsy and CND,0
193000002,Temporal lobe epilepsy (disorder),Epilepsy and CND,0
193002005,Psychosensory epilepsy (disorder),Epilepsy and CND,0
193003000,Mesiobasal limbic epilepsy (disorder),Epilepsy and CND,0
193004006,Epileptic automatism (disorder),Epilepsy and CND,0
193008009,Somatosensory epilepsy (disorder),Epilepsy and CND,0
193009001,Partial epilepsy with autonomic symptoms (disorder),Epilepsy and CND,0
193010006,Visual reflex epilepsy (disorder),Epilepsy and CND,0
193011005,Unilateral epilepsy (situation),Epilepsy and CND,0
193022009,Localization-related(focal)(partial)idiopathic epilepsy and epileptic syndromes with seizures of localized onset (disorder),Epilepsy and CND,0
193207007,Juvenile or adult myasthenia gravis (disorder),Epilepsy and CND,0
193209005,Myasthenic syndrome due to another disorder (disorder),Epilepsy and CND,0
193212008,Myasthenic syndrome due to hypothyroidism (disorder),Epilepsy and CND,0
193214009,Myasthenic syndrome due to thyrotoxicosis (disorder),Epilepsy and CND,0
193216006,Congenital and developmental myasthenia (disorder),Epilepsy and CND,0
193225000,Hereditary progressive muscular dystrophy (disorder),Epilepsy and CND,0
193227008,Pelvic muscular dystrophy (disorder),Epilepsy and CND,0
193230001,Distal muscular dystrophy with juvenile onset (disorder),Epilepsy and CND,0
193237003,Myotonic disorder (disorder),Epilepsy and CND,0
193238008,Infantile myotonia (disorder),Epilepsy and CND,0
193246009,Symptomatic inflammatory myopathy associated with another disorder (disorder),Epilepsy and CND,0
193248005,Myopathy due to disseminated lupus erythematosus (disorder),Epilepsy and CND,0
193250002,Myopathy due to rheumatoid arthritis (disorder),Epilepsy and CND,0
193251003,Sarcoid myopathy (disorder),Epilepsy and CND,0
193252005,Myopathy due to scleroderma (disorder),Epilepsy and CND,0
195163003,Intracerebral hemorrhage (& [cerebrovascular accident due to]) (disorder),Epilepsy and CND,0
196136009,Lung disease co-occurrent with polymyositis (disorder),Epilepsy and CND,0
230191005,Rasmussen syndrome (disorder),Epilepsy and CND,0
230237004,Progressive spinocerebellar ataxia with decreased tendon reflexes (disorder),Epilepsy and CND,0
230238009,Progressive spinocerebellar ataxia with retained tendon reflexes (disorder),Epilepsy and CND,0
230250003,Facioscapulohumeral spinal muscular atrophy with sensory loss (disorder),Epilepsy and CND,0
230253001,Bulbospinal neuronopathy (disorder),Epilepsy and CND,0
230258005,Amyotrophic lateral sclerosis with dementia (disorder),Epilepsy and CND,0
230274000,Frontal lobe degeneration with motor neurone disease (disorder),Epilepsy and CND,0
230291001,Juvenile Parkinson's disease (disorder),Epilepsy and CND,0
230292008,Secondary parkinsonism (disorder),Epilepsy and CND,0
230296006,Vascular parkinsonism (disorder),Epilepsy and CND,0
230381009,Localization-related epilepsy (disorder),Epilepsy and CND,0
230387008,Benign childhood occipital epilepsy Panayiotopoulos type,Epilepsy and CND,0
230390002,Localization-related symptomatic epilepsy (disorder),Epilepsy and CND,0
230391003,Amygdalo-hippocampal epilepsy (disorder),Epilepsy and CND,0
230393000,Lateral temporal epilepsy (disorder),Epilepsy and CND,0
230394006,Frontal lobe epilepsy (disorder),Epilepsy and CND,0
230403005,Parietal lobe epilepsy (disorder),Epilepsy and CND,0
230404004,Occipital lobe epilepsy (disorder),Epilepsy and CND,0
230405003,Chronic progressive epilepsia partialis continua of childhood (disorder),Epilepsy and CND,0
230408001,Localization-related cryptogenic epilepsy (disorder),Epilepsy and CND,0
230415009,Cryptogenic generalized epilepsy (disorder),Epilepsy and CND,0
230418006,Lennox-Gastaut syndrome (disorder),Epilepsy and CND,0
230421008,Myoclonic astatic epilepsy (disorder),Epilepsy and CND,0
230422001,Myoclonic absence epilepsy (disorder),Epilepsy and CND,0
230423006,Unverricht-Lundborg syndrome (disorder),Epilepsy and CND,0
230426003,Myoclonic epilepsy with ragged red fibers,Epilepsy and CND,0
230428002,Idiopathic myoclonic epilepsy (disorder),Epilepsy and CND,0
230429005,Early infantile epileptic encephalopathy with suppression bursts (disorder),Epilepsy and CND,0
230430000,Symptomatic myoclonic epilepsy (disorder),Epilepsy and CND,0
230435005,Epilepsy undetermined whether focal or generalized (disorder),Epilepsy and CND,0
230440002,Secondary reading epilepsy (disorder),Epilepsy and CND,0
230441003,Drug-induced epilepsy (disorder),Epilepsy and CND,0
230444006,Menstrual epilepsy (disorder),Epilepsy and CND,0
230445007,Nocturnal epilepsy (disorder),Epilepsy and CND,0
230447004,Eyelid myoclonus with absences (disorder),Epilepsy and CND,0
230452009,Toothbrushing epilepsy (disorder),Epilepsy and CND,0
230456007,Status epilepticus (disorder),Epilepsy and CND,0
230459000,Non-convulsive simple partial status epilepticus (disorder),Epilepsy and CND,0
230460005,Complex partial status epilepticus (disorder),Epilepsy and CND,0
230669004,Genetically determined myasthenia (disorder),Epilepsy and CND,0
230672006,Congenital myasthenic syndrome (disorder),Epilepsy and CND,0
230685009,Myasthenia gravis associated with thymoma (disorder),Epilepsy and CND,0
230686005,Generalized myasthenia (disorder),Epilepsy and CND,0
230703006,Dysarthria-clumsy hand syndrome (disorder),Epilepsy and CND,0
230706003,Hemorrhagic cerebral infarction (disorder),Epilepsy and CND,0
230717002,Vertebrobasilar territory transient ischemic attack (disorder),Epilepsy and CND,0
237997005,Very long chain acyl-coenzyme A dehydrogenase deficiency (disorder),Epilepsy and CND,0
237999008,Mitochondrial trifunctional protein deficiency (disorder),Epilepsy and CND,0
238003000,Carnitine acylcarnitine translocase deficiency (disorder),Epilepsy and CND,0
239899000,Polymyositis associated with autoimmune disease (disorder),Epilepsy and CND,0
240046001,Muscular dystrophy with predominantly proximal limb girdle distribution (disorder),Epilepsy and CND,0
240050008,Manifesting female carrier of X-linked muscular dystrophy (disorder),Epilepsy and CND,0
240054004,Autosomal recessive muscular dystrophy with limb girdle distribution (disorder),Epilepsy and CND,0
240059009,Congenital muscular dystrophy (disorder),Epilepsy and CND,0
240072005,Benign scapuloperoneal muscular dystrophy with cardiomyopathy (disorder),Epilepsy and CND,0
240073000,Autosomal recessive muscular dystrophy not predominantly limb girdle (disorder),Epilepsy and CND,0
240074006,Scapulohumeral muscular dystrophy (disorder),Epilepsy and CND,0
240078009,Benign congenital muscular dystrophy with finger flexion contractures (disorder),Epilepsy and CND,0
240460008,Acute paralytic poliomyelitis (disorder),Epilepsy and CND,0
249892007,Progressive pseudobulbar palsy (disorder),Epilepsy and CND,0
256321009,Disorder of neuromuscular transmission (disorder),Epilepsy and CND,0
267581004,Progressive myoclonic epilepsy (disorder),Epilepsy and CND,0
267592003,Motor cortex epilepsy (disorder),Epilepsy and CND,0
281357005,Idiopathic polymyositis (disorder),Epilepsy and CND,0
281358000,Idiopathic dermatomyositis (disorder),Epilepsy and CND,0
305719002,Neuromyotonia (disorder),Epilepsy and CND,0
307127004,Isolated long chain hydroxyacyl-CoA dehydrogenase deficiency (disorder),Epilepsy and CND,0
307356008,Motor epilepsy (disorder),Epilepsy and CND,0
307357004,"Jacksonian, focal or motor epilepsy (disorder)",Epilepsy and CND,0
313307000,Epileptic seizure (finding),Epilepsy and CND,0
321272000,Product containing precisely clobazam 10 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
322863001,Product containing precisely carbamazepine 100 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
322864007,Product containing precisely carbamazepine 200 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
322865008,Product containing precisely carbamazepine 400 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
322887004,Product containing precisely carbamazepine 125 milligram/1 each conventional release rectal suppository (clinical drug),Epilepsy and CND,0
322888009,Product containing precisely carbamazepine 250 milligram/1 each conventional release rectal suppository (clinical drug),Epilepsy and CND,0
322889001,Product containing precisely carbamazepine 200 milligram/1 each conventional release chewable tablet (clinical drug),Epilepsy and CND,0
322891009,Product containing precisely carbamazepine 20 milligram/1 milliliter conventional release oral suspension (clinical drug),Epilepsy and CND,0
322897008,Product containing precisely clonazepam 500 microgram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
322898003,Product containing precisely clonazepam 2 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
322906007,Product containing precisely ethosuximide 250 milligram/1 each conventional release oral capsule (clinical drug),Epilepsy and CND,0
322908008,Product containing precisely ethosuximide 50 milligram/1 milliliter conventional release oral solution (clinical drug),Epilepsy and CND,0
322915000,Product containing precisely phenobarbital 15 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
322916004,Product containing precisely phenobarbital 30 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
322917008,Product containing precisely phenobarbital 60 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
322927002,Product containing precisely phenobarbital 3 milligram/1 milliliter conventional release oral elixir (clinical drug),Epilepsy and CND,0
322930009,Product containing precisely phenytoin 50 milligram/1 each conventional release chewable tablet (clinical drug),Epilepsy and CND,0
322931008,Product containing precisely phenytoin 6 milligram/1 milliliter conventional release oral suspension (clinical drug),Epilepsy and CND,0
322933006,Product containing precisely phenytoin sodium 50 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
322934000,Product containing precisely phenytoin sodium 100 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
322942004,Product containing precisely phenytoin sodium 300 milligram/1 each conventional release oral capsule (clinical drug),Epilepsy and CND,0
322943009,Product containing precisely phenytoin sodium 25 milligram/1 each conventional release oral capsule (clinical drug),Epilepsy and CND,0
322944003,Product containing precisely phenytoin sodium 50 milligram/1 each conventional release oral capsule (clinical drug),Epilepsy and CND,0
322945002,Phenytoin sodium 100mg m/r capsule (product),Epilepsy and CND,0
322948000,Product containing precisely primidone 250 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
322956002,Product containing precisely valproate sodium 200 milligram/1 each gastro-resistant oral tablet (clinical drug),Epilepsy and CND,0
322957006,Product containing precisely valproate sodium 500 milligram/1 each gastro-resistant oral tablet (clinical drug),Epilepsy and CND,0
322965009,Sodium valproate 200mg m/r tablet (product),Epilepsy and CND,0
322966005,Sodium valproate 300mg m/r tablet (product),Epilepsy and CND,0
322967001,Sodium valproate 500mg m/r tablet (product),Epilepsy and CND,0
322969003,Sodium valproate 100mg crushable tablet (product),Epilepsy and CND,0
322972005,Sodium valproate 200mg/5mL s/f oral liquid (product),Epilepsy and CND,0
322977004,Product containing precisely vigabatrin 500 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
322979001,Product containing precisely vigabatrin 500 milligram/1 sachet powder for conventional release oral solution (clinical drug),Epilepsy and CND,0
322981004,Product containing precisely lamotrigine 50 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
322982006,Product containing precisely lamotrigine 100 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
322985008,Product containing precisely lamotrigine 25 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
322991005,Lamotrigine 25 mg orodispersible tablet,Epilepsy and CND,0
322992003,Lamotrigine 100 mg orodispersible tablet,Epilepsy and CND,0
322994002,Product containing precisely lamotrigine 200 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
323002000,Product containing precisely piracetam 800 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
323003005,Product containing precisely piracetam 1.2 gram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
323004004,Product containing precisely piracetam 333.3 milligram/1 milliliter conventional release oral solution (clinical drug),Epilepsy and CND,0
323008001,Product containing precisely valproic acid 150 milligram/1 each gastro-resistant oral capsule (clinical drug),Epilepsy and CND,0
323009009,Product containing precisely valproic acid 300 milligram/1 each gastro-resistant oral capsule (clinical drug),Epilepsy and CND,0
323010004,Product containing precisely valproic acid 500 milligram/1 each gastro-resistant oral capsule (clinical drug),Epilepsy and CND,0
323023006,Product containing precisely topiramate 50 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
323024000,Product containing precisely topiramate 100 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
323025004,Product containing precisely topiramate 200 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
323029005,Product containing precisely topiramate 25 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
323032008,Topiramate 15mg beads in capsule (product),Epilepsy and CND,0
323036006,Product containing precisely tiagabine 5 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
323037002,Product containing precisely tiagabine 10 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
323038007,Product containing precisely tiagabine 15 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
323046008,Product containing precisely oxcarbazepine 150 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
323047004,Product containing precisely oxcarbazepine 300 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
323048009,Product containing precisely oxcarbazepine 600 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
323053004,Product containing precisely levetiracetam 1 gram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
323054005,Product containing precisely levetiracetam 500 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
323055006,Product containing precisely levetiracetam 250 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
330601002,Product containing precisely acetazolamide 250 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
352818000,Tonic-clonic epilepsy (disorder),Epilepsy and CND,0
361123003,Psychomotor epilepsy (disorder),Epilepsy and CND,0
361268000,Alcohol-induced epilepsy (disorder),Epilepsy and CND,0
371194003,Product containing precisely primidone 50 milligram/1 milliliter conventional release oral suspension (clinical drug),Epilepsy and CND,0
375136008,Product containing precisely primidone 50 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
375396003,Product containing precisely levetiracetam 750 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
387732009,Becker muscular dystrophy (disorder),Epilepsy and CND,0
396230008,Dermatomyositis (disorder),Epilepsy and CND,0
399091004,Facioscapulohumeral muscular dystrophy (disorder),Epilepsy and CND,0
407585000,Seizure free > 12 months (finding),Epilepsy and CND,0
407617005,No seizures on treatment (finding),Epilepsy and CND,0
407618000,1 to 12 seizures a year (finding),Epilepsy and CND,0
407619008,2 to 4 seizures a month (finding),Epilepsy and CND,0
407620002,1 to 7 seizures a week (finding),Epilepsy and CND,0
407621003,Daily seizures (finding),Epilepsy and CND,0
407622005,Many seizures a day (finding),Epilepsy and CND,0
407675009,Complex partial epileptic seizure (disorder),Epilepsy and CND,0
407845001,Oxcarbazepine 60mg/mL s/f oral suspension,Epilepsy and CND,0
410930002,Product containing precisely zonisamide 100 milligram/1 each conventional release oral capsule (clinical drug),Epilepsy and CND,0
413101007,Stress-induced epilepsy (disorder),Epilepsy and CND,0
417050003,Product containing precisely zonisamide 25 milligram/1 each conventional release oral capsule (clinical drug),Epilepsy and CND,0
417678003,Product containing precisely zonisamide 50 milligram/1 each conventional release oral capsule (clinical drug),Epilepsy and CND,0
441464008,Product containing precisely lacosamide 100 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
441572007,Product containing precisely rufinamide 200 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
441822003,Product containing precisely rufinamide 400 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
441836008,Product containing precisely lacosamide 200 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
441947000,Product containing precisely lacosamide 150 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
442041004,Product containing precisely lacosamide 50 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
703729002,Product containing precisely perampanel 2 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
703730007,Product containing precisely perampanel 4 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
703732004,Product containing precisely perampanel 6 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
703733009,Product containing precisely perampanel 8 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
703734003,Product containing precisely perampanel 10 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
703735002,Product containing precisely perampanel 12 milligram/1 each conventional release oral tablet (clinical drug),Epilepsy and CND,0
718572004,Bethlem myopathy (disorder),Epilepsy and CND,0
1.7111E+13,Phenytoin sodium 100mg tablets (A A H Pharmaceuticals Ltd) (product),Epilepsy and CND,0
3.0811E+13,Phenobarbital 30mg tablets (Approved Prescription Services) (product),Epilepsy and CND,0
5.5611E+13,Phenytoin sodium 100mg tablets (Approved Prescription Services) (product),Epilepsy and CND,0
5.6811E+13,Phenobarbital 15mg tablets (Kent Pharmaceuticals Ltd) (product),Epilepsy and CND,0
8.4011E+13,Sodium valproate 500mg gastro-resistant tablets (Approved Prescription Services) (product),Epilepsy and CND,0
1.00011E+14,Epilim 200mg/5ml liquid (Sanofi-Synthelabo Ltd) (product),Epilepsy and CND,0
1.22211E+14,Sodium valproate 200mg/5ml oral solution sugar free (A A H Pharmaceuticals Ltd) (product),Epilepsy and CND,0
1.38611E+14,Topamax 50mg tablets (Janssen-Cilag Ltd) (product),Epilepsy and CND,0
1.59611E+14,Neurontin 800mg tablets (Upjohn UK Ltd) (product),Epilepsy and CND,0
1.84311E+14,Sabril 500mg tablets (Aventis Pharma) (product),Epilepsy and CND,0
1.85711E+14,Epanutin 30mg/5ml oral suspension (Upjohn UK Ltd) (product),Epilepsy and CND,0
1.96211E+14,Carbamazepine 200mg tablets (Generics (UK) Ltd) (product),Epilepsy and CND,0
1.98711E+14,Epanutin 300mg capsules (Pfizer Ltd) (product),Epilepsy and CND,0
1.99451E+14,Simple partial epileptic seizure (disorder),Epilepsy and CND,0
2.10911E+14,Arbil MR 400mg tablets (Ranbaxy (UK) Ltd) (product),Epilepsy and CND,0
2.17211E+14,Sodium valproate 500mg gastro-resistant tablets (Generics (UK) Ltd) (product),Epilepsy and CND,0
2.33611E+14,Rivotril 500microgram tablets (Roche Products Ltd) (product),Epilepsy and CND,0
2.35111E+14,Topamax 200mg tablets (Janssen-Cilag Ltd) (product),Epilepsy and CND,0
2.40511E+14,Phenobarbital 30mg tablets (A A H Pharmaceuticals Ltd) (product),Epilepsy and CND,0
2.51711E+14,Epanutin Infatabs 50mg chewable tablets (Upjohn UK Ltd) (product),Epilepsy and CND,0
2.61911E+14,Tegretol Retard 200mg tablets (Novartis Pharmaceuticals UK Ltd) (product),Epilepsy and CND,0
2.90011E+14,Topamax 25mg tablets (Janssen-Cilag Ltd) (product),Epilepsy and CND,0
2.92411E+14,Sodium valproate 200mg gastro-resistant tablets (Sterwin Medicines) (product),Epilepsy and CND,0
3.02911E+14,Neurontin 400mg capsules (Upjohn UK Ltd) (product),Epilepsy and CND,0
3.04111E+14,Phenobarbital 60mg tablets (Approved Prescription Services) (product),Epilepsy and CND,0
3.69911E+14,Carbagen SR 200mg tablets (Generics (UK) Ltd) (product),Epilepsy and CND,0
4.01511E+14,Neurontin 300mg capsules (Upjohn UK Ltd) (product),Epilepsy and CND,0
4.43711E+14,Tegretol 200mg tablets (Novartis Pharmaceuticals UK Ltd) (product),Epilepsy and CND,0
4.48711E+14,Epilim 500 gastro-resistant tablets (Sanofi-Synthelabo Ltd) (product),Epilepsy and CND,0
4.51611E+14,Phenobarbital 15mg tablets (Approved Prescription Services) (product),Epilepsy and CND,0
4.59211E+14,Neurontin 100mg capsules (Upjohn UK Ltd) (product),Epilepsy and CND,0
4.62911E+14,Sodium valproate 200mg gastro-resistant tablets (A A H Pharmaceuticals Ltd) (product),Epilepsy and CND,0
4.89711E+14,Epilim Chrono 200 tablets (Sanofi-Synthelabo Ltd) (product),Epilepsy and CND,0
5.09341E+14,Petit-mal epilepsy (disorder),Epilepsy and CND,0
5.11611E+14,Neurontin 600mg tablets (Upjohn UK Ltd) (product),Epilepsy and CND,0
5.26921E+14,Contraceptive advice for patients with epilepsy (procedure),Epilepsy and CND,0
5.26941E+14,Pre-conception advice for patients with epilepsy (procedure),Epilepsy and CND,0
5.26961E+14,Pregnancy advice for patients with epilepsy (procedure),Epilepsy and CND,0
5.27001E+14,Contraceptive advice for patients with epilepsy not indicated (situation),Epilepsy and CND,0
5.27041E+14,Pregnancy advice for patients with epilepsy not indicated (situation),Epilepsy and CND,0
5.27091E+14,Contraceptive advice for patients with epilepsy declined (situation),Epilepsy and CND,0
5.27131E+14,Pregnancy advice for patients with epilepsy declined (situation),Epilepsy and CND,0
5.52511E+14,Epilim 100mg crushable tablets (Sanofi-Synthelabo Ltd) (product),Epilepsy and CND,0
5.63311E+14,Phenobarbital 60mg tablets (Accord Healthcare Ltd) (product),Epilepsy and CND,0
5.66911E+14,Phenobarbital 60mg tablets (A A H Pharmaceuticals Ltd) (product),Epilepsy and CND,0
6.12111E+14,Carbamazepine 100mg tablets (Generics (UK) Ltd) (product),Epilepsy and CND,0
6.40811E+14,Carbagen SR 400mg tablets (Generics (UK) Ltd) (product),Epilepsy and CND,0
6.62611E+14,Tegretol Retard 400mg tablets (Novartis Pharmaceuticals UK Ltd) (product),Epilepsy and CND,0
6.64611E+14,Diamox SR 250mg capsules (Goldshield Healthcare Ltd) (product),Epilepsy and CND,0
6.80511E+14,Tegretol 100mg tablets (Novartis Pharmaceuticals UK Ltd) (product),Epilepsy and CND,0
7.02711E+14,Tegretol 400mg tablets (Novartis Pharmaceuticals UK Ltd) (product),Epilepsy and CND,0
7.25911E+14,Epanutin 100mg capsules (Pfizer Ltd) (product),Epilepsy and CND,0
7.31411E+14,Sodium valproate 200mg/5ml oral solution sugar free (Sterwin Medicines) (product),Epilepsy and CND,0
7.39111E+14,Epilim Chrono 500 tablets (Sanofi-Synthelabo Ltd) (product),Epilepsy and CND,0
7.55011E+14,Sodium valproate 500mg gastro-resistant tablets (Sterwin Medicines) (product),Epilepsy and CND,0
7.60111E+14,Tegretol 100mg/5ml liquid (Novartis Pharmaceuticals UK Ltd) (product),Epilepsy and CND,0
7.81611E+14,Sodium valproate 500mg gastro-resistant tablets (A A H Pharmaceuticals Ltd) (product),Epilepsy and CND,0
7.89911E+14,Epilim Chrono 300 tablets (Sanofi-Synthelabo Ltd) (product),Epilepsy and CND,0
8.01011E+14,Diamox 250mg tablets (Goldshield Healthcare Ltd) (product),Epilepsy and CND,0
8.23811E+14,Topamax 100mg tablets (Janssen-Cilag Ltd) (product),Epilepsy and CND,0
8.39211E+14,Keppra 500mg tablets (UCB (Pharma) Ltd) (product),Epilepsy and CND,0
8.64471E+14,Anterior opercular syndrome (disorder),Epilepsy and CND,0
8.80211E+14,Sodium valproate 200mg gastro-resistant tablets (Generics (UK) Ltd) (product),Epilepsy and CND,0
8.89311E+14,Epilim 200 gastro-resistant tablets (Sanofi-Synthelabo Ltd) (product),Epilepsy and CND,0
8.92411E+14,Epilim 200mg/5ml syrup (Sanofi-Synthelabo Ltd) (product),Epilepsy and CND,0
9.18411E+14,Phenobarbital 30mg tablets (Accord Healthcare Ltd) (product),Epilepsy and CND,0
9.29411E+14,Keppra 250mg tablets (UCB (Pharma) Ltd) (product),Epilepsy and CND,0
9.29911E+14,Frisium 10mg tablets (Aventis Pharma) (product),Epilepsy and CND,0
2.92581E+15,Lamictal 25mg tablets (GlaxoSmithKline) (product),Epilepsy and CND,0
2.92771E+15,Lamictal 50mg tablets (GlaxoSmithKline) (product),Epilepsy and CND,0
2.92881E+15,Lamictal 100mg tablets (GlaxoSmithKline) (product),Epilepsy and CND,0
3.14521E+15,Lamictal 200mg tablets (GlaxoSmithKline) (product),Epilepsy and CND,0
3.14581E+15,Lamictal 5mg dispersible tablets (GlaxoSmithKline) (product),Epilepsy and CND,0
3.14641E+15,Lamictal 25mg dispersible tablets (GlaxoSmithKline) (product),Epilepsy and CND,0
3.14721E+15,Lamictal 100mg dispersible tablets (GlaxoSmithKline) (product),Epilepsy and CND,0
3.63741E+15,Keppra 1g tablets (UCB (Pharma) Ltd) (product),Epilepsy and CND,0
3.67251E+15,Trileptal 300 tablets (Novartis Pharmaceuticals UK Ltd) (product),Epilepsy and CND,0
3.78411E+15,Trileptal 600 tablets (Novartis Pharmaceuticals UK Ltd) (product),Epilepsy and CND,0
3.83991E+15,Trileptal 150 tablets (Novartis Pharmaceuticals UK Ltd) (product),Epilepsy and CND,0
3.84641E+15,Depakote 250mg gastro-resistant tablets (Sanofi-Synthelabo Ltd) (product),Epilepsy and CND,0
3.84711E+15,Depakote 500mg gastro-resistant tablets (Sanofi-Synthelabo Ltd) (product),Epilepsy and CND,0
3.89411E+15,Nootropil 1.2g tablets (UCB (Pharma) Ltd) (product),Epilepsy and CND,0
3.90181E+15,Gabitril 5mg tablets (Cephalon UK Ltd) (product),Epilepsy and CND,0
3.90211E+15,Gabitril 10mg tablets (Cephalon UK Ltd) (product),Epilepsy and CND,0
3.92091E+15,Convulex 150mg gastro-resistant capsules (G.L. Pharma UK Ltd) (product),Epilepsy and CND,0
3.92131E+15,Convulex 300mg gastro-resistant capsules (G.L. Pharma UK Ltd) (product),Epilepsy and CND,0
3.92171E+15,Convulex 500mg gastro-resistant capsules (G.L. Pharma UK Ltd) (product),Epilepsy and CND,0
4.09241E+15,Nootropil 33% oral solution (UCB (Pharma) Ltd) (product),Epilepsy and CND,0
4.19691E+15,Phenobarbital 15mg/5ml elixir (Thornton & Ross Ltd) (product),Epilepsy and CND,0
4.20501E+15,Topamax 15mg sprinkle capsules (Janssen-Cilag Ltd) (product),Epilepsy and CND,0
4.20601E+15,Topamax 25mg sprinkle capsules (Janssen-Cilag Ltd) (product),Epilepsy and CND,0
4.20641E+15,Topamax 50mg sprinkle capsules (Janssen-Cilag Ltd) (product),Epilepsy and CND,0
4.21771E+15,Clonazepam 1mg/1ml solution for injection ampoules and diluent (product),Epilepsy and CND,0
4.76591E+15,Epival CR 300mg tablets (Healthcare Pharma Ltd) (product),Epilepsy and CND,0
4.76611E+15,Epival CR 500mg tablets (Healthcare Pharma Ltd) (product),Epilepsy and CND,0
7.31521E+15,Oxcarbazepine 60mg/ml oral suspension sugar free (product),Epilepsy and CND,0
7.31541E+15,Trileptal 60mg/ml oral suspension sugar free (Novartis Pharmaceuticals UK Ltd) (product),Epilepsy and CND,0
7.66251E+15,Clonazepam 2.5mg/ml drops sugar free (product),Epilepsy and CND,0
7.88941E+15,Lyrica 25mg capsules (Upjohn UK Ltd) (product),Epilepsy and CND,0
7.89021E+15,Lyrica 50mg capsules (Upjohn UK Ltd) (product),Epilepsy and CND,0
7.89051E+15,Lyrica 75mg capsules (Upjohn UK Ltd) (product),Epilepsy and CND,0
7.89081E+15,Lyrica 100mg capsules (Upjohn UK Ltd) (product),Epilepsy and CND,0
7.89121E+15,Lyrica 150mg capsules (Upjohn UK Ltd) (product),Epilepsy and CND,0
7.89161E+15,Lyrica 200mg capsules (Upjohn UK Ltd) (product),Epilepsy and CND,0
7.89211E+15,Lyrica 300mg capsules (Upjohn UK Ltd) (product),Epilepsy and CND,0
8.17111E+15,Keppra 750mg tablets (UCB (Pharma) Ltd) (product),Epilepsy and CND,0
8.17661E+15,Keppra 100mg/ml oral solution (UCB (Pharma) Ltd) (product),Epilepsy and CND,0
8.27091E+15,Acetazolamide 250mg/5ml oral suspension (product),Epilepsy and CND,0
8.28551E+15,Levetiracetam 100mg/ml oral solution sugar free (product),Epilepsy and CND,0
8.35491E+15,Carbamazepine 500mg/5ml oral suspension (product),Epilepsy and CND,0
8.36071E+15,Clobazam 10mg/5ml oral solution (product),Epilepsy and CND,0
8.36081E+15,Clobazam 10mg/5ml oral suspension (product),Epilepsy and CND,0
8.36131E+15,Clobazam 2.5mg/5ml oral suspension (product),Epilepsy and CND,0
8.36661E+15,Clobazam 25mg/5ml oral suspension (product),Epilepsy and CND,0
8.36861E+15,Clobazam 5mg/5ml oral solution (product),Epilepsy and CND,0
8.36881E+15,Clobazam 5mg/5ml oral suspension (product),Epilepsy and CND,0
8.39571E+15,Clonazepam 250micrograms/5ml oral solution (product),Epilepsy and CND,0
8.39591E+15,Clonazepam 2mg/5ml oral solution (product),Epilepsy and CND,0
8.39721E+15,Clonazepam 500micrograms/5ml oral suspension (product),Epilepsy and CND,0
8.58261E+15,Lamotrigine 50mg/5ml oral suspension (product),Epilepsy and CND,0
8.58381E+15,Levetiracetam 300mg/5ml oral solution (product),Epilepsy and CND,0
8.72381E+15,Topiramate 50mg/5ml oral suspension (product),Epilepsy and CND,0
8.72391E+15,Topiramate 25mg/5ml oral suspension (product),Epilepsy and CND,0
8.79221E+15,Clobazam 2.5mg capsules (product),Epilepsy and CND,0
8.80081E+15,Phenobarbital 50mg/5ml oral suspension (product),Epilepsy and CND,0
8.80091E+15,Phenobarbital 50mg/5ml oral solution (product),Epilepsy and CND,0
8.81791E+15,Phenytoin 90mg/5ml oral suspension (product),Epilepsy and CND,0
8.81811E+15,Primidone 25mg/5ml oral suspension (product),Epilepsy and CND,0
8.81821E+15,Primidone 50mg/5ml oral suspension (product),Epilepsy and CND,0
8.81831E+15,Primidone 62.5mg/5ml oral suspension (product),Epilepsy and CND,0
8.81851E+15,Sodium valproate 300mg suppositories (product),Epilepsy and CND,0
9.30351E+15,Zonegran 25mg capsules (Eisai Ltd) (product),Epilepsy and CND,0
9.30391E+15,Zonegran 50mg capsules (Eisai Ltd) (product),Epilepsy and CND,0
9.30411E+15,Zonegran 100mg capsules (Eisai Ltd) (product),Epilepsy and CND,0
9.32741E+15,Lamotrigine 25mg tablets (Alpharma Limited) (product),Epilepsy and CND,0
9.32761E+15,Lamotrigine 50mg tablets (Alpharma Limited) (product),Epilepsy and CND,0
9.32781E+15,Lamotrigine 100mg tablets (Alpharma Limited) (product),Epilepsy and CND,0
9.32801E+15,Lamotrigine 200mg tablets (Alpharma Limited) (product),Epilepsy and CND,0
9.45071E+15,Lamotrigine 25mg tablets (Teva UK Ltd) (product),Epilepsy and CND,0
9.45091E+15,Lamotrigine 50mg tablets (Teva UK Ltd) (product),Epilepsy and CND,0
9.45121E+15,Lamotrigine 100mg tablets (Teva UK Ltd) (product),Epilepsy and CND,0
9.45141E+15,Lamotrigine 200mg tablets (Teva UK Ltd) (product),Epilepsy and CND,0
9.45181E+15,Lamotrigine 25mg dispersible tablets (Teva UK Ltd) (product),Epilepsy and CND,0
9.45201E+15,Lamotrigine 100mg dispersible tablets (Teva UK Ltd) (product),Epilepsy and CND,0
9.45861E+15,Lamotrigine 25mg dispersible tablets (A A H Pharmaceuticals Ltd) (product),Epilepsy and CND,0
9.45881E+15,Lamotrigine 100mg dispersible tablets (A A H Pharmaceuticals Ltd) (product),Epilepsy and CND,0
9.45901E+15,Lamotrigine 25mg tablets (A A H Pharmaceuticals Ltd) (product),Epilepsy and CND,0
9.45941E+15,Lamotrigine 50mg tablets (A A H Pharmaceuticals Ltd) (product),Epilepsy and CND,0
9.46001E+15,Lamotrigine 100mg tablets (A A H Pharmaceuticals Ltd) (product),Epilepsy and CND,0
9.46021E+15,Lamotrigine 200mg tablets (A A H Pharmaceuticals Ltd) (product),Epilepsy and CND,0
9.47231E+15,Lamotrigine 200mg tablets (Sandoz Ltd) (product),Epilepsy and CND,0
9.70381E+15,Acetazolamide 250mg tablets (A A H Pharmaceuticals Ltd) (product),Epilepsy and CND,0
9.75661E+15,Lamotrigine 25mg dispersible tablets (Somex Pharma) (product),Epilepsy and CND,0
9.75691E+15,Lamotrigine 100mg dispersible tablets (Somex Pharma) (product),Epilepsy and CND,0
1.02257E+16,Lamotrigine 200mg dispersible tablets (product),Epilepsy and CND,0
1.03566E+16,Clobazam 10mg tablets (A A H Pharmaceuticals Ltd) (product),Epilepsy and CND,0
1.04468E+16,Keppra 500mg/5ml concentrate for solution for infusion vials (UCB (Pharma) Ltd) (product),Epilepsy and CND,0
1.04512E+16,Lamotrigine 100mg tablets (Arrow Generics Ltd) (product),Epilepsy and CND,0
1.10894E+16,Sodium valproate 300mg/3ml solution for injection ampoules (product),Epilepsy and CND,0
1.14751E+16,Sodium valproate 150mg modified-release capsules (product),Epilepsy and CND,0
1.14752E+16,Sodium valproate 300mg modified-release capsules (product),Epilepsy and CND,0
1.14753E+16,Sodium valproate 500mg modified-release granules sachets sugar free (product),Epilepsy and CND,0
1.14754E+16,Sodium valproate 1g modified-release granules sachets sugar free (product),Epilepsy and CND,0
1.14756E+16,Episenta 150mg modified-release capsules (Beacon Pharmaceuticals Ltd) (product),Epilepsy and CND,0
1.14759E+16,Episenta 300mg modified-release capsules (Beacon Pharmaceuticals Ltd) (product),Epilepsy and CND,0
1.14762E+16,Episenta 500mg modified-release granules sachets (Beacon Pharmaceuticals Ltd) (product),Epilepsy and CND,0
1.14765E+16,Episenta 1000mg modified-release granules sachets (Beacon Pharmaceuticals Ltd) (product),Epilepsy and CND,0
1.15007E+16,Lamotrigine 25mg dispersible tablets (Actavis UK Ltd) (product),Epilepsy and CND,0
1.15009E+16,Lamotrigine 100mg dispersible tablets (Actavis UK Ltd) (product),Epilepsy and CND,0
1.15326E+16,Lamotrigine 25mg dispersible tablets (Sandoz Ltd) (product),Epilepsy and CND,0
1.19447E+16,Clonazepam 125micrograms/5ml oral suspension (product),Epilepsy and CND,0
1.21866E+16,Phenobarbital 10mg/5ml oral solution (product),Epilepsy and CND,0
1.21881E+16,Phenobarbital 20mg/5ml oral solution (product),Epilepsy and CND,0
1.22132E+16,Phenobarbital 25mg/5ml oral suspension (product),Epilepsy and CND,0
1.22994E+16,Phenobarbital 100mg tablets (product),Epilepsy and CND,0
1.26454E+16,Levetiracetam 250mg/5ml oral solution (product),Epilepsy and CND,0
1.28652E+16,Rufinamide 100mg tablets (product),Epilepsy and CND,0
1.3076E+16,Lyrica 225mg capsules (Upjohn UK Ltd) (product),Epilepsy and CND,0
1.31239E+16,Inovelon 200mg tablets (Eisai Ltd) (product),Epilepsy and CND,0
1.31242E+16,Inovelon 400mg tablets (Eisai Ltd) (product),Epilepsy and CND,0
1.33008E+16,Sodium valproate 10mg/5ml oral solution (product),Epilepsy and CND,0
1.3301E+16,Sodium valproate 20mg/5ml oral solution (product),Epilepsy and CND,0
1.33245E+16,Topiramate 100mg/5ml oral suspension (product),Epilepsy and CND,0
1.33552E+16,Topiramate 100mg/5ml oral solution (product),Epilepsy and CND,0
1.34111E+16,Stiripentol 250mg capsules (product),Epilepsy and CND,0
1.34112E+16,Stiripentol 250mg oral powder sachets (product),Epilepsy and CND,0
1.34113E+16,Stiripentol 500mg capsules (product),Epilepsy and CND,0
1.34114E+16,Stiripentol 500mg oral powder sachets (product),Epilepsy and CND,0
1.34367E+16,Lamotrigine 25mg dispersible tablets sugar free (Generics (UK) Ltd) (product),Epilepsy and CND,0
1.34374E+16,Oxcarbazepine 150mg tablets (Generics (UK) Ltd) (product),Epilepsy and CND,0
1.34376E+16,Oxcarbazepine 300mg tablets (Generics (UK) Ltd) (product),Epilepsy and CND,0
1.34378E+16,Oxcarbazepine 600mg tablets (Generics (UK) Ltd) (product),Epilepsy and CND,0
1.36532E+16,Clonazepam 500microgram tablets (A A H Pharmaceuticals Ltd) (product),Epilepsy and CND,0
1.36558E+16,Clonazepam 2mg tablets (A A H Pharmaceuticals Ltd) (product),Epilepsy and CND,0
1.36654E+16,Epilim Chronosphere MR 100mg granules sachets (sanofi-aventis) (product),Epilepsy and CND,0
1.36657E+16,Epilim Chronosphere MR 250mg granules sachets (sanofi-aventis) (product),Epilepsy and CND,0
1.36659E+16,Epilim Chronosphere MR 500mg granules sachets (sanofi-aventis) (product),Epilepsy and CND,0
1.36663E+16,Epilim Chronosphere MR 750mg granules sachets (sanofi-aventis) (product),Epilepsy and CND,0
1.36666E+16,Epilim Chronosphere MR 50mg granules sachets (sanofi-aventis) (product),Epilepsy and CND,0
1.37186E+16,Sodium valproate 100mg modified-release granules sachets sugar free (product),Epilepsy and CND,0
1.37187E+16,Sodium valproate 250mg modified-release granules sachets sugar free (product),Epilepsy and CND,0
1.37188E+16,Sodium valproate 50mg modified-release granules sachets sugar free (product),Epilepsy and CND,0
1.37189E+16,Sodium valproate 750mg modified-release granules sachets sugar free (product),Epilepsy and CND,0
1.38939E+16,Phenytoin 90mg/5ml oral solution (product),Epilepsy and CND,0
1.39323E+16,Clonazepam 500microgram tablets (UniChem Ltd) (product),Epilepsy and CND,0
1.41944E+16,Vimpat 200mg tablets (UCB Pharma Ltd) (product),Epilepsy and CND,0
1.41949E+16,Vimpat 50mg tablets (UCB Pharma Ltd) (product),Epilepsy and CND,0
1.41969E+16,Vimpat 150mg tablets (UCB Pharma Ltd) (product),Epilepsy and CND,0
1.41995E+16,Vimpat 100mg tablets (UCB Pharma Ltd) (product),Epilepsy and CND,0
1.47702E+16,Phenytoin sodium 100mg tablets (Wockhardt UK Ltd) (product),Epilepsy and CND,0
1.4943E+16,Ethosuximide 250mg capsules (Essential Generics Ltd) (product),Epilepsy and CND,0
1.54394E+16,Epilim Chronosphere MR 1000mg granules sachets (sanofi-aventis) (product),Epilepsy and CND,0
1.56275E+16,Clonazepam 2mg tablets (Auden McKenzie (Pharma Division) Ltd) (product),Epilepsy and CND,0
1.56277E+16,Clonazepam 500microgram tablets (Auden McKenzie (Pharma Division) Ltd) (product),Epilepsy and CND,0
1.61024E+16,Valproic acid 500mg/5ml oral suspension (product),Epilepsy and CND,0
1.6177E+16,Topiramate 25mg capsules (Teva UK Ltd) (product),Epilepsy and CND,0
1.61772E+16,Topiramate 50mg capsules (Teva UK Ltd) (product),Epilepsy and CND,0
1.61774E+16,Topiramate 25mg tablets (Teva UK Ltd) (product),Epilepsy and CND,0
1.61776E+16,Topiramate 50mg tablets (Teva UK Ltd) (product),Epilepsy and CND,0
1.61779E+16,Topiramate 100mg tablets (Teva UK Ltd) (product),Epilepsy and CND,0
1.61781E+16,Topiramate 200mg tablets (Teva UK Ltd) (product),Epilepsy and CND,0
1.61786E+16,Zebinix 800mg tablets (Eisai Ltd) (product),Epilepsy and CND,0
1.61858E+16,Topiramate 25mg capsules (A A H Pharmaceuticals Ltd) (product),Epilepsy and CND,0
1.6186E+16,Topiramate 50mg capsules (A A H Pharmaceuticals Ltd) (product),Epilepsy and CND,0
1.61862E+16,Topiramate 25mg tablets (A A H Pharmaceuticals Ltd) (product),Epilepsy and CND,0
1.61864E+16,Topiramate 50mg tablets (A A H Pharmaceuticals Ltd) (product),Epilepsy and CND,0
1.61866E+16,Topiramate 100mg tablets (A A H Pharmaceuticals Ltd) (product),Epilepsy and CND,0
1.61868E+16,Topiramate 200mg tablets (A A H Pharmaceuticals Ltd) (product),Epilepsy and CND,0
1.61974E+16,Eslicarbazepine 800mg tablets (product),Epilepsy and CND,0
1.66258E+16,Topiramate 200mg tablets (Generics (UK) Ltd) (product),Epilepsy and CND,0
1.6627E+16,Topiramate 25mg tablets (Generics (UK) Ltd) (product),Epilepsy and CND,0
1.66281E+16,Topiramate 50mg tablets (Generics (UK) Ltd) (product),Epilepsy and CND,0
1.75756E+16,Topiramate 25mg capsules (Arrow Generics Ltd) (product),Epilepsy and CND,0
1.79665E+16,Clonazepam 500microgram tablets (Almus Pharmaceuticals Ltd) (product),Epilepsy and CND,0
1.79668E+16,Clonazepam 2mg tablets (Almus Pharmaceuticals Ltd) (product),Epilepsy and CND,0
1.80784E+16,Lamotrigine 25mg tablets (Fannin (UK) Ltd) (product),Epilepsy and CND,0
1.80786E+16,Lamotrigine 50mg tablets (Fannin (UK) Ltd) (product),Epilepsy and CND,0
1.80788E+16,Lamotrigine 100mg tablets (Fannin (UK) Ltd) (product),Epilepsy and CND,0
1.8079E+16,Lamotrigine 200mg tablets (Fannin (UK) Ltd) (product),Epilepsy and CND,0
1.80842E+16,Zonisamide 50mg/5ml oral suspension (product),Epilepsy and CND,0
1.83897E+16,Clobazam 10mg tablets (Teva UK Ltd) (product),Epilepsy and CND,0
1.87812E+16,Phenytoin sodium 100mg tablets (Accord Healthcare Ltd) (product),Epilepsy and CND,0
1.94721E+16,Levetiracetam 100mg/ml oral solution sugar free (A A H Pharmaceuticals Ltd) (product),Epilepsy and CND,0
1.94723E+16,Levetiracetam 1g tablets (A A H Pharmaceuticals Ltd) (product),Epilepsy and CND,0
1.94725E+16,Levetiracetam 250mg tablets (A A H Pharmaceuticals Ltd) (product),Epilepsy and CND,0
1.94727E+16,Levetiracetam 500mg tablets (A A H Pharmaceuticals Ltd) (product),Epilepsy and CND,0
1.94729E+16,Levetiracetam 750mg tablets (A A H Pharmaceuticals Ltd) (product),Epilepsy and CND,0
1.94847E+16,Levetiracetam 250mg tablets (Teva UK Ltd) (product),Epilepsy and CND,0
1.94849E+16,Levetiracetam 500mg tablets (Teva UK Ltd) (product),Epilepsy and CND,0
1.94851E+16,Levetiracetam 750mg tablets (Teva UK Ltd) (product),Epilepsy and CND,0
1.94917E+16,Carbamazepine 100mg/5ml oral suspension sugar free (Accord Healthcare Ltd) (product),Epilepsy and CND,0
1.96325E+16,Levetiracetam 500mg tablets (Actavis UK Ltd) (product),Epilepsy and CND,0
1.96329E+16,Levetiracetam 1g tablets (Actavis UK Ltd) (product),Epilepsy and CND,0
1.96331E+16,Levetiracetam 250mg tablets (Actavis UK Ltd) (product),Epilepsy and CND,0
1.96573E+16,Sodium valproate 200mg/5ml oral solution sugar free (Wockhardt UK Ltd) (product),Epilepsy and CND,0
1.96648E+16,Sodium valproate 500mg gastro-resistant tablets (Wockhardt UK Ltd) (product),Epilepsy and CND,0
1.96652E+16,Sodium valproate 200mg gastro-resistant tablets (Wockhardt UK Ltd) (product),Epilepsy and CND,0
1.98175E+16,Carbamazepine 100mg tablets (Almus Pharmaceuticals Ltd) (product),Epilepsy and CND,0
1.98216E+16,Lacosamide 10mg/ml oral solution sugar free (product),Epilepsy and CND,0
1.98434E+16,Levetiracetam 100mg/ml oral solution sugar free (Actavis UK Ltd) (product),Epilepsy and CND,0
1.99779E+16,Sodium valproate 500mg/5ml oral suspension (product),Epilepsy and CND,0
2.00656E+16,Clonazepam 2mg/5ml oral solution sugar free (product),Epilepsy and CND,0
2.01282E+16,Clonazepam 500micrograms/5ml oral solution sugar free (product),Epilepsy and CND,0
2.03438E+16,Inovelon 40mg/ml oral suspension (Eisai Ltd) (product),Epilepsy and CND,0
2.03532E+16,Rufinamide 40mg/ml oral suspension sugar free (product),Epilepsy and CND,0
2.03537E+16,Vimpat 10mg/ml syrup (UCB Pharma Ltd) (product),Epilepsy and CND,0
2.05365E+16,Acetazolamide 250mg tablets (Mercury Pharma Group Ltd) (product),Epilepsy and CND,0
2.05458E+16,Lyrica 20mg/ml oral solution (Upjohn UK Ltd) (product),Epilepsy and CND,0
2.10251E+16,Phenytoin sodium 100mg tablets (Milpharm Ltd) (product),Epilepsy and CND,0
2.12005E+16,Phenytoin sodium 25mg capsules (Flynn Pharma Ltd) (product),Epilepsy and CND,0
2.12007E+16,Phenytoin sodium 50mg capsules (Flynn Pharma Ltd) (product),Epilepsy and CND,0
2.12009E+16,Phenytoin sodium 100mg capsules (Flynn Pharma Ltd) (product),Epilepsy and CND,0
2.12011E+16,Phenytoin sodium 300mg capsules (Flynn Pharma Ltd) (product),Epilepsy and CND,0
2.12121E+16,Fycompa 2mg tablets (Eisai Ltd) (product),Epilepsy and CND,0
2.12126E+16,Fycompa 4mg tablets (Eisai Ltd) (product),Epilepsy and CND,0
2.1213E+16,Fycompa 6mg tablets (Eisai Ltd) (product),Epilepsy and CND,0
2.12133E+16,Fycompa 8mg tablets (Eisai Ltd) (product),Epilepsy and CND,0
2.12136E+16,Fycompa 10mg tablets (Eisai Ltd) (product),Epilepsy and CND,0
2.12139E+16,Fycompa 12mg tablets (Eisai Ltd) (product),Epilepsy and CND,0
2.13494E+16,Phenytoin sodium 100mg capsules (Alliance Healthcare (Distribution) Ltd) (product),Epilepsy and CND,0
2.15195E+16,Levetiracetam 500mg/5ml solution for infusion vials (Sun Pharmaceuticals UK Ltd) (product),Epilepsy and CND,0
2.17307E+16,Desitrend 250mg granules sachets (Desitin Pharma Ltd) (product),Epilepsy and CND,0
2.17311E+16,Desitrend 500mg granules sachets (Desitin Pharma Ltd) (product),Epilepsy and CND,0
2.17316E+16,Desitrend 1000mg granules sachets (Desitin Pharma Ltd) (product),Epilepsy and CND,0
2.17332E+16,Levetiracetam 1g granules sachets sugar free (product),Epilepsy and CND,0
2.17333E+16,Levetiracetam 250mg granules sachets sugar free (product),Epilepsy and CND,0
2.17334E+16,Levetiracetam 500mg granules sachets sugar free (product),Epilepsy and CND,0
2.18028E+16,Tapclob 5mg/5ml oral suspension (Martindale Pharmaceuticals Ltd) (product),Epilepsy and CND,0
2.18036E+16,Tapclob 10mg/5ml oral suspension (Martindale Pharmaceuticals Ltd) (product),Epilepsy and CND,0
2.18564E+16,Clobazam 10mg/5ml oral suspension sugar free (product),Epilepsy and CND,0
2.18565E+16,Clobazam 5mg/5ml oral suspension sugar free (product),Epilepsy and CND,0
2.26639E+16,Sodium valproate 400mg/4ml solution for injection ampoules (product),Epilepsy and CND,0
2.31674E+16,Desitrend 100mg/ml oral solution (Desitin Pharma Ltd) (product),Epilepsy and CND,0
2.33057E+16,Primidone 250mg tablets (Auden McKenzie (Pharma Division) Ltd) (product),Epilepsy and CND,0
2.33059E+16,Primidone 50mg tablets (Auden McKenzie (Pharma Division) Ltd) (product),Epilepsy and CND,0
2.34665E+16,Clonazepam 2.5mg/ml drops (product),Epilepsy and CND,0
2.35953E+16,Phenytoin sodium 100mg capsules (Accord Healthcare Ltd) (product),Epilepsy and CND,0
2.36408E+16,Primidone 50mg tablets (A A H Pharmaceuticals Ltd) (product),Epilepsy and CND,0
2.41083E+16,Carbagen 100mg tablets (Generics (UK) Ltd) (product),Epilepsy and CND,0
2.41088E+16,Carbagen 200mg tablets (Generics (UK) Ltd) (product),Epilepsy and CND,0
2.41092E+16,Carbagen 400mg tablets (Generics (UK) Ltd) (product),Epilepsy and CND,0
2.4194E+16,Eytazox 250mg modified-release capsules (Auden McKenzie (Pharma Division) Ltd) (product),Epilepsy and CND,0
2.45955E+16,Zonisamide 25mg/5ml oral suspension (product),Epilepsy and CND,0
2.80014E+16,Levetiracetam 100mg/ml oral solution sugar free (Teva UK Ltd) (product),Epilepsy and CND,0
2.86458E+16,Desitrend 500mg/5ml concentrate for solution for infusion ampoules (Desitin Pharma Ltd) (product),Epilepsy and CND,0
2.87362E+16,Rewisca 100mg capsules (Consilient Health Ltd) (product),Epilepsy and CND,0
2.87367E+16,Rewisca 25mg capsules (Consilient Health Ltd) (product),Epilepsy and CND,0
2.87376E+16,Rewisca 50mg capsules (Consilient Health Ltd) (product),Epilepsy and CND,0
2.87382E+16,Rewisca 75mg capsules (Consilient Health Ltd) (product),Epilepsy and CND,0
2.87387E+16,Rewisca 150mg capsules (Consilient Health Ltd) (product),Epilepsy and CND,0
2.87391E+16,Rewisca 200mg capsules (Consilient Health Ltd) (product),Epilepsy and CND,0
2.87402E+16,Rewisca 225mg capsules (Consilient Health Ltd) (product),Epilepsy and CND,0
2.87421E+16,Rewisca 300mg capsules (Consilient Health Ltd) (product),Epilepsy and CND,0
2.89097E+16,Lecaent 25mg capsules (Accord Healthcare Ltd) (product),Epilepsy and CND,0
2.891E+16,Lecaent 50mg capsules (Accord Healthcare Ltd) (product),Epilepsy and CND,0
2.89106E+16,Lecaent 150mg capsules (Accord Healthcare Ltd) (product),Epilepsy and CND,0
2.89112E+16,Lecaent 300mg capsules (Actavis UK Ltd) (product),Epilepsy and CND,0
2.89473E+16,Levetiracetam 500mg/5ml solution for infusion ampoules (product),Epilepsy and CND,0
2.89964E+16,Alzain 25mg capsules (Dr Reddy's Laboratories (UK) Ltd) (product),Epilepsy and CND,0
2.89966E+16,Alzain 50mg capsules (Dr Reddy's Laboratories (UK) Ltd) (product),Epilepsy and CND,0
2.89969E+16,Alzain 75mg capsules (Dr Reddy's Laboratories (UK) Ltd) (product),Epilepsy and CND,0
2.89971E+16,Alzain 100mg capsules (Dr Reddy's Laboratories (UK) Ltd) (product),Epilepsy and CND,0
2.89973E+16,Alzain 150mg capsules (Dr Reddy's Laboratories (UK) Ltd) (product),Epilepsy and CND,0
2.89975E+16,Alzain 200mg capsules (Dr Reddy's Laboratories (UK) Ltd) (product),Epilepsy and CND,0
2.89977E+16,Alzain 225mg capsules (Dr Reddy's Laboratories (UK) Ltd) (product),Epilepsy and CND,0
2.89979E+16,Alzain 300mg capsules (Dr Reddy's Laboratories (UK) Ltd) (product),Epilepsy and CND,0
3.07642E+16,Phenytoin sodium 100mg tablets (Almus Pharmaceuticals Ltd) (product),Epilepsy and CND,0
3.07711E+16,Acetazolamide 250mg tablets (Accord Healthcare Ltd) (product),Epilepsy and CND,0
3.08541E+16,Primidone 50mg tablets (Actavis UK Ltd) (product),Epilepsy and CND,0
3.08543E+16,Primidone 250mg tablets (Actavis UK Ltd) (product),Epilepsy and CND,0
3.09216E+16,Zonisamide 50mg capsules (Teva UK Ltd) (product),Epilepsy and CND,0
3.33822E+16,Acetazolamide 250mg tablets (Teva UK Ltd) (product),Epilepsy and CND,0
3.34937E+16,Ethosuximide 250mg/5ml syrup (Essential Pharma Ltd) (product),Epilepsy and CND,0
3.3677E+16,Carbamazepine 250mg suppositories (Essential Pharma Ltd) (product),Epilepsy and CND,0
3.37091E+16,Axalid 25mg capsules (Kent Pharmaceuticals Ltd) (product),Epilepsy and CND,0
3.37097E+16,Axalid 50mg capsules (Kent Pharmaceuticals Ltd) (product),Epilepsy and CND,0
3.37103E+16,Axalid 75mg capsules (Kent Pharmaceuticals Ltd) (product),Epilepsy and CND,0
3.37105E+16,Axalid 100mg capsules (Kent Pharmaceuticals Ltd) (product),Epilepsy and CND,0
3.37121E+16,Axalid 150mg capsules (Kent Pharmaceuticals Ltd) (product),Epilepsy and CND,0
3.37125E+16,Axalid 200mg capsules (Kent Pharmaceuticals Ltd) (product),Epilepsy and CND,0
3.37155E+16,Axalid 225mg capsules (Kent Pharmaceuticals Ltd) (product),Epilepsy and CND,0
3.37159E+16,Axalid 300mg capsules (Kent Pharmaceuticals Ltd) (product),Epilepsy and CND,0
3.41769E+16,Zonisamide 50mg capsules (Accord Healthcare Ltd) (product),Epilepsy and CND,0
3.42467E+16,Zacco 5mg/5ml oral suspension (Thame Laboratories Ltd) (product),Epilepsy and CND,0
3.4247E+16,Zacco 10mg/5ml oral suspension (Thame Laboratories Ltd) (product),Epilepsy and CND,0
3.45817E+16,Zebinix 200mg tablets (Eisai Ltd) (product),Epilepsy and CND,0
3.46066E+16,Eslicarbazepine 200mg tablets (product),Epilepsy and CND,0
3.55998E+16,Sodium valproate 200mg/ml oral solution (product),Epilepsy and CND,0
3.58919E+16,Acetazolamide 250mg modified-release capsules (product),Epilepsy and CND,0
3.59199E+16,Topiramate 15mg capsules (product),Epilepsy and CND,0
3.592E+16,Topiramate 25mg capsules (product),Epilepsy and CND,0
3.59201E+16,Topiramate 50mg capsules (product),Epilepsy and CND,0
3.5928E+16,Sodium valproate 100mg tablets (product),Epilepsy and CND,0
3.59281E+16,Sodium valproate 200mg modified-release tablets (product),Epilepsy and CND,0
3.59282E+16,Sodium valproate 200mg/5ml oral solution (product),Epilepsy and CND,0
3.59283E+16,Sodium valproate 200mg/5ml oral solution sugar free (product),Epilepsy and CND,0
3.59284E+16,Sodium valproate 300mg modified-release tablets (product),Epilepsy and CND,0
3.59286E+16,Sodium valproate 500mg modified-release tablets (product),Epilepsy and CND,0
3.59392E+16,Phenobarbital 200mg/1ml solution for injection ampoules (product),Epilepsy and CND,0
3.59394E+16,Phenobarbital 60mg/1ml solution for injection ampoules (product),Epilepsy and CND,0
3.60156E+16,Phenytoin sodium 250mg/5ml solution for injection ampoules (product),Epilepsy and CND,0
3.60377E+16,Lamotrigine 2mg dispersible tablets sugar free (product),Epilepsy and CND,0
3.60384E+16,Levetiracetam 500mg/5ml solution for infusion vials (product),Epilepsy and CND,0
3.61073E+16,Ethosuximide 250mg/5ml oral solution sugar free (product),Epilepsy and CND,0
3.65112E+16,Eslicarbazepine 50mg/1ml oral suspension sugar free (product),Epilepsy and CND,0
3.65618E+16,Levetiracetam 1g/100ml infusion bags (product),Epilepsy and CND,0
3.65619E+16,Levetiracetam 500mg/100ml infusion bags (product),Epilepsy and CND,0
3.65666E+16,Lamotrigine 5mg dispersible tablets sugar free (product),Epilepsy and CND,0
3.65961E+16,Sodium valproate 60mg/5ml oral suspension (product),Epilepsy and CND,0
3.67531E+16,Topiramate 100mg/5ml oral suspension sugar free (product),Epilepsy and CND,0
3.67532E+16,Topiramate 50mg/5ml oral suspension sugar free (product),Epilepsy and CND,0
3.67768E+16,Fycompa 0.5mg/ml oral suspension (Eisai Ltd) (product),Epilepsy and CND,0
3.69151E+16,Perampanel 500micrograms/ml oral suspension sugar free (product),Epilepsy and CND,0
3.70824E+16,Carbamazepine 200mg modified-release tablets (product),Epilepsy and CND,0
3.70825E+16,Carbamazepine 400mg modified-release tablets (product),Epilepsy and CND,0
3.73226E+16,Dilantin Infatabs 50mg chewable tablets (Imported (Canada)) (product),Epilepsy and CND,0
3.81607E+16,Carbamazepine 400mg tablets (Medreich Plc) (product),Epilepsy and CND,0
3.81609E+16,Carbamazepine 200mg tablets (Medreich Plc) (product),Epilepsy and CND,0
3.81611E+16,Carbamazepine 100mg tablets (Medreich Plc) (product),Epilepsy and CND,0
3.82861E+16,Vigabatrin 500mg soluble tablets sugar free (product),Epilepsy and CND,0
3.87526E+16,Oxcarbazepine 60mg/ml oral suspension sugar free (product),Epilepsy and CND,0
3.89981E+16,Dyzantil 200mg modified-release tablets (Aspire Pharma Ltd) (product),Epilepsy and CND,0
3.90256E+16,Phenytoin sodium 100mg capsules (product),Epilepsy and CND,0
3.91078E+16,Sodium valproate 100mg tablets (product),Epilepsy and CND,0
3.91082E+16,Sodium valproate 200mg modified-release tablets (product),Epilepsy and CND,0
3.91083E+16,Sodium valproate 300mg modified-release tablets (product),Epilepsy and CND,0
3.91084E+16,Sodium valproate 500mg modified-release tablets (product),Epilepsy and CND,0
,Guillain-Barr syndrome (disorder),Epilepsy and CND,0
,Myopathy due to Sjgren's disease (disorder),Epilepsy and CND,0
1201005,Benign essential hypertension (disorder),Hypertension,0
10725009,Benign hypertension (disorder),Hypertension,0
31992008,Secondary hypertension (disorder),Hypertension,0
38341003,"Hypertensive disorder, systemic arterial (disorder)",Hypertension,0
48146000,Diastolic hypertension (disorder),Hypertension,0
56218007,Systolic hypertension (disorder),Hypertension,0
59621000,Essential hypertension (disorder),Hypertension,0
67359005,Pre-eclampsia added to pre-existing hypertension (disorder),Hypertension,0
70272006,Malignant hypertension (disorder),Hypertension,0
73410007,Benign secondary renovascular hypertension (disorder),Hypertension,0
78975002,Malignant essential hypertension (disorder),Hypertension,0
86041002,Pre-existing hypertension in obstetric context (disorder),Hypertension,0
89242004,Malignant secondary hypertension (disorder),Hypertension,0
123799005,Renovascular hypertension (disorder),Hypertension,0
162659009,Hypertension resolved (finding),Hypertension,1
169465000,Hypertension caused by oral contraceptive pill (disorder),Hypertension,0
185719002,Hypertension monitoring first letter (procedure),Hypertension,0
185720008,Hypertension monitoring second letter (procedure),Hypertension,0
185721007,Hypertension monitoring third letter (procedure),Hypertension,0
185722000,Hypertension monitoring verbal invite (procedure),Hypertension,0
185723005,Hypertension monitoring telephone invite (procedure),Hypertension,0
194783001,Secondary malignant renovascular hypertension (disorder),Hypertension,0
194785008,Secondary benign hypertension (disorder),Hypertension,0
194788005,Hypertension secondary to endocrine disorder (disorder),Hypertension,0
194791005,Hypertension caused by drug (disorder),Hypertension,0
198942000,"Benign essential hypertension complicating pregnancy, childbirth and the puerperium (disorder)",Hypertension,0
198944004,"Benign essential hypertension complicating pregnancy, childbirth and the puerperium - delivered (disorder)",Hypertension,0
198945003,"Benign essential hypertension complicating pregnancy, childbirth and the puerperium - delivered with postnatal complication (disorder)",Hypertension,0
198946002,"Benign essential hypertension complicating pregnancy, childbirth and the puerperium - not delivered (disorder)",Hypertension,0
198947006,"Benign essential hypertension complicating pregnancy, childbirth and the puerperium with postnatal complication (disorder)",Hypertension,0
198949009,"Renal hypertension complicating pregnancy, childbirth and the puerperium (disorder)",Hypertension,0
198951008,"Renal hypertension complicating pregnancy, childbirth and the puerperium - delivered (disorder)",Hypertension,0
198952001,"Renal hypertension complicating pregnancy, childbirth and the puerperium - delivered with postnatal complication (disorder)",Hypertension,0
198954000,"Renal hypertension complicating pregnancy, childbirth and the puerperium with postnatal complication (disorder)",Hypertension,0
198997005,Pre-eclampsia or eclampsia with pre-existing hypertension (disorder),Hypertension,0
198999008,Pre-eclampsia or eclampsia with pre-existing hypertension - delivered (disorder),Hypertension,0
199000005,Pre-eclampsia or eclampsia with pre-existing hypertension - delivered with postnatal complication (disorder),Hypertension,0
199002002,Pre-eclampsia or eclampsia with pre-existing hypertension - not delivered (disorder),Hypertension,0
199003007,Pre-eclampsia or eclampsia with pre-existing hypertension with postnatal complication (disorder),Hypertension,0
199005000,"Pre-existing hypertension complicating pregnancy, childbirth and puerperium (disorder)",Hypertension,0
199007008,"Pre-existing hypertensive heart and renal disease complicating pregnancy, childbirth and the puerperium (disorder)",Hypertension,0
199008003,"Pre-existing secondary hypertension complicating pregnancy, childbirth and puerperium (disorder)",Hypertension,0
310427004,Hypertension monitoring invitation (procedure),Hypertension,0
712832005,Supine hypertension (disorder),Hypertension,0
1.32721E+14,Hypertensive emergency (disorder),Hypertension,0
1.43421E+14,Quality and Outcomes Framework hypertension quality indicator-related care invitation using preferred method of communication (procedure),Hypertension,0
7.16771E+14,Excepted from hypertension quality indicators - informed dissent (finding),Hypertension,0
7.16821E+14,Excepted from hypertension quality indicators - patient unsuitable (finding),Hypertension,0
8.43821E+14,Stage 1 hypertension (National Institute for Health and Clinical Excellence 2011) (disorder),Hypertension,0
8.43841E+14,Severe hypertension (National Institute for Health and Clinical Excellence 2011) (disorder),Hypertension,0
8.45891E+14,Hypertension resistant to drug therapy (disorder),Hypertension,0
8.46371E+14,Stage 2 hypertension (National Institute for Health and Clinical Excellence 2011) (disorder),Hypertension,0
8.63191E+14,Nocturnal hypertension (disorder),Hypertension,0
9.08631E+14,Stage 1 hypertension (National Institute for Health and Clinical Excellence 2011) without evidence of end organ damage (disorder),Hypertension,0
9.08651E+14,Stage 1 hypertension (National Institute for Health and Clinical Excellence 2011) with evidence of end organ damage (disorder),Hypertension,0
1.06694E+15,Hypertension monitoring invitation short message service text message (procedure),Hypertension,0
1.06695E+15,Hypertension monitoring short message service text message first invitation (procedure),Hypertension,0
1.06696E+15,Hypertension monitoring short message service text message second invitation (procedure),Hypertension,0
1.06697E+15,Hypertension monitoring short message service text message third invitation (procedure),Hypertension,0
1.0831E+15,Hypertension monitoring invitation email (procedure),Hypertension,0
1.11094E+15,Quality and Outcomes Framework hypertension quality indicator-related care invitation (procedure),Hypertension,0
2593002,Dubowitz's syndrome (disorder),Learning disability,0
5619004,Bardet-Biedl syndrome (disorder),Learning disability,0
10007009,Coffin-Siris syndrome (disorder),Learning disability,0
15182000,Coffin-Lowry syndrome (disorder),Learning disability,0
17122004,4p partial monosomy syndrome (disorder),Learning disability,0
17827007,Cross syndrome (disorder),Learning disability,0
21111006,Complete trisomy 13 syndrome (disorder),Learning disability,0
21634003,Borjeson-Forssman-Lehmann syndrome (disorder),Learning disability,0
31216003,Profound intellectual disability (disorder),Learning disability,0
40354009,De Lange syndrome (disorder),Learning disability,0
40700009,Severe intellectual disability (disorder),Learning disability,0
41040004,Complete trisomy 21 syndrome (disorder),Learning disability,0
51500006,Complete trisomy 18 syndrome (disorder),Learning disability,0
56604005,Cohen syndrome (disorder),Learning disability,0
57917004,Seckel syndrome (disorder),Learning disability,0
61152003,Moderate intellectual disability (disorder),Learning disability,0
65327002,Mucopolysaccharidosis type I-H (disorder),Learning disability,0
68618008,Rett's disorder (disorder),Learning disability,0
70173007,5p partial monosomy syndrome (disorder),Learning disability,0
76880004,Angelman syndrome (disorder),Learning disability,0
79385002,Lowe syndrome (disorder),Learning disability,0
86765009,Mild intellectual disability (disorder),Learning disability,0
89392001,Prader-Willi syndrome (disorder),Learning disability,0
110359009,Intellectual disability (disorder),Learning disability,0
205614001,(Down's syndrome - trisomy 21) or (mongolism) or (trisomy 21) or (trisomy 22) (disorder),Learning disability,0
205615000,Trisomy 21- meiotic nondisjunction (disorder),Learning disability,0
205616004,Trisomy 21- mitotic nondisjunction mosaicism (disorder),Learning disability,0
205617008,Partial trisomy 21 in Down's syndrome (disorder),Learning disability,0
205824006,Noonan's syndrome (disorder),Learning disability,0
253176002,Gillespie syndrome (disorder),Learning disability,0
254264002,Partial trisomy 21 in Down's syndrome (disorder),Learning disability,0
254268004,Partial trisomy 13 in Patau's syndrome (disorder),Learning disability,0
401315004,Smith-Magenis syndrome (disorder),Learning disability,0
412787009,"Intellectual disability, congenital heart disease, blepharophimosis, blepharoptosis and hypoplastic teeth (disorder)",Learning disability,0
413126003,Learning disabilities health assessment (procedure),Learning disability,0
416075005,On learning disability register (finding),Learning disability,0
442127005,Examination of learning disabled patient (procedure),Learning disability,0
702344008,Pitt-Hopkins syndrome (disorder),Learning disability,0
702816000,Methyl-cytosine phosphate guanine binding protein-2 duplication syndrome (disorder),Learning disability,0
703535000,Mowat-Wilson syndrome (disorder),Learning disability,0
724207001,Kleefstra syndrome (disorder),Learning disability,0
763618001,Wiedemann Steiner syndrome (disorder),Learning disability,0
1.99751E+14,Learning disabilities annual health assessment (procedure),Learning disability,0
5.08171E+14,Severe learning disability (disorder),Learning disability,0
9.31001E+14,Significant learning disability (disorder),Learning disability,0
9.84661E+14,Mild learning disability (disorder),Learning disability,0
9.84671E+14,Moderate learning disability (disorder),Learning disability,0
9.84681E+14,Profound learning disability (disorder),Learning disability,0
1.09399E+15,Mild intellectual development disorder with impairment of behaviour (disorder),Learning disability,0
4434006,Bloom syndrome (disorder),Malignancy and immunosuppression ,0
5876000,Acquired pancytopenia (disorder),Malignancy and immunosuppression ,0
9893005,Immunodeficiency with thymoma (disorder),Malignancy and immunosuppression ,0
11603001,Sickle cell retinopathy (disorder),Malignancy and immunosuppression ,0
13886001,Sickle cell nephropathy (disorder),Malignancy and immunosuppression ,0
14333004,Alloimmune neonatal neutropenia (disorder),Malignancy and immunosuppression ,0
14534009,Splenic vein thrombosis (disorder),Malignancy and immunosuppression ,0
16196000,Cytomegaloviral mononucleosis (disorder),Malignancy and immunosuppression ,0
16341002,Parapsoriasis lichenoides (disorder),Malignancy and immunosuppression ,0
17182001,Agranulocytosis (disorder),Malignancy and immunosuppression ,0
18027006,Transplantation of liver (procedure),Malignancy and immunosuppression ,0
19636003,Monocytosis (disorder),Malignancy and immunosuppression ,0
22996003,Splenic infarction (disorder),Malignancy and immunosuppression ,0
23132008,Amyloid light-chain amyloidosis (disorder),Malignancy and immunosuppression ,0
23238000,Common variable agammaglobulinemia (disorder),Malignancy and immunosuppression ,0
23719005,Transplantation of bone marrow (procedure),Malignancy and immunosuppression ,0
23761004,Hyposplenism (disorder),Malignancy and immunosuppression ,0
23833000,Poisoning caused by antineoplastic AND/OR immunosuppressive drug (disorder),Malignancy and immunosuppression ,0
24743004,Complement deficiency disease (disorder),Malignancy and immunosuppression ,0
25472008,Sickle cell-hemoglobin D disease (disorder),Malignancy and immunosuppression ,0
28880005,Rheumatoid carditis (disorder),Malignancy and immunosuppression ,0
28975000,Constitutional aplastic anemia (disorder),Malignancy and immunosuppression ,0
29120000,Eosinophilic colitis (disorder),Malignancy and immunosuppression ,0
30575002,Fanconi anemia,Malignancy and immunosuppression ,0
30664006,"Multiple endocrine neoplasia, type 1 (disorder)",Malignancy and immunosuppression ,0
30981000,Secondary eosinophilia (disorder),Malignancy and immunosuppression ,0
31047003,Lymphomatoid papulosis (disorder),Malignancy and immunosuppression ,0
31323000,Severe combined immunodeficiency disease (disorder),Malignancy and immunosuppression ,0
32278006,Myeloma kidney (disorder),Malignancy and immunosuppression ,0
32413006,Transplantation of heart (procedure),Malignancy and immunosuppression ,0
32477003,Heart-lung transplant with recipient cardiectomy-pneumonectomy (procedure),Malignancy and immunosuppression ,0
33286000,Secondary immune deficiency disorder (disorder),Malignancy and immunosuppression ,0
33719002,Subcutaneous rheumatoid nodule (disorder),Malignancy and immunosuppression ,0
35434009,Sickle cell-hemoglobin C disease (disorder),Malignancy and immunosuppression ,0
35868009,Carcinoid syndrome (disorder),Malignancy and immunosuppression ,0
36070007,Wiskott-Aldrich syndrome (disorder),Malignancy and immunosuppression ,0
36752001,Congenital splenomegaly (disorder),Malignancy and immunosuppression ,0
36760000,Hepatosplenomegaly (disorder),Malignancy and immunosuppression ,0
37465004,Plasmacytosis (disorder),Malignancy and immunosuppression ,0
43355006,Eosinopenia (disorder),Malignancy and immunosuppression ,0
44940001,Adenosine deaminase deficiency (disorder),Malignancy and immunosuppression ,0
45259000,Celiac infantilism (disorder),Malignancy and immunosuppression ,0
45841007,Kappa light chain disease (disorder),Malignancy and immunosuppression ,0
46280001,Autologous bone marrow transplant with purging (procedure),Malignancy and immunosuppression ,0
46359005,Neutropenia associated with infectious disease (disorder),Malignancy and immunosuppression ,0
47024008,Sickle cell-hemoglobin E disease (disorder),Malignancy and immunosuppression ,0
47318007,Drug-induced neutropenia (disorder),Malignancy and immunosuppression ,0
47986005,Genetic anomaly of leukocyte (disorder),Malignancy and immunosuppression ,0
48813009,Lymphocytopenia (disorder),Malignancy and immunosuppression ,0
50926003,Job's syndrome (disorder),Malignancy and immunosuppression ,0
51577008,Wilson-Mikity syndrome (disorder),Malignancy and immunosuppression ,0
52967002,Myelofibrosis (disorder),Malignancy and immunosuppression ,0
54097007,White blood cell disorder (disorder),Malignancy and immunosuppression ,0
55444004,Transient neonatal neutropenia (disorder),Malignancy and immunosuppression ,0
55602000,Nezelof's syndrome (disorder),Malignancy and immunosuppression ,0
55907008,Acquired aplastic anemia (disorder),Malignancy and immunosuppression ,0
56478004,Leukemoid reaction (disorder),Malignancy and immunosuppression ,0
57160007,Felty's syndrome (disorder),Malignancy and immunosuppression ,0
58381000,Hypersplenism (disorder),Malignancy and immunosuppression ,0
58390007,Allogeneic bone marrow transplantation (procedure),Malignancy and immunosuppression ,0
58606001,Primary immune deficiency disorder (disorder),Malignancy and immunosuppression ,0
58776007,Autologous bone marrow transplant (procedure),Malignancy and immunosuppression ,0
62438007,Transplantation of pancreas (procedure),Malignancy and immunosuppression ,0
62479008,Acquired immune deficiency syndrome (disorder),Malignancy and immunosuppression ,0
64249002,Allergic eosinophilia (disorder),Malignancy and immunosuppression ,0
65399007,Langerhans cell histiocytosis (disorder),Malignancy and immunosuppression ,0
65623009,Immune neutropenia (disorder),Malignancy and immunosuppression ,0
65880007,X-linked agammaglobulinemia (disorder),Malignancy and immunosuppression ,0
67023009,Lymphocytosis (disorder),Malignancy and immunosuppression ,0
68504005,Ataxia-telangiectasia syndrome (disorder),Malignancy and immunosuppression ,0
69408002,Gorlin syndrome (disorder),Malignancy and immunosuppression ,0
69896004,Rheumatoid arthritis (disorder),Malignancy and immunosuppression ,0
70536003,Transplant of kidney (procedure),Malignancy and immunosuppression ,0
71985006,Carcinomatous myopathic syndrome (disorder),Malignancy and immunosuppression ,0
77121009,X-linked lymphoproliferative syndrome (disorder),Malignancy and immunosuppression ,0
79268002,"Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome (disorder)",Malignancy and immunosuppression ,0
80255009,Maternal transfer neutropenia (disorder),Malignancy and immunosuppression ,0
80914001,Anaplasia of cervix (disorder),Malignancy and immunosuppression ,0
81166004,Properdin deficiency disease (disorder),Malignancy and immunosuppression ,0
82053000,Splenic abscess (disorder),Malignancy and immunosuppression ,0
82286005,Hyperimmunoglobulin M syndrome (disorder),Malignancy and immunosuppression ,0
82893001,Splenic atrophy (disorder),Malignancy and immunosuppression ,0
82966003,Hereditary angioedema (disorder),Malignancy and immunosuppression ,0
83270006,Neoplastic pleural effusion (disorder),Malignancy and immunosuppression ,0
84828003,Leukopenia (disorder),Malignancy and immunosuppression ,0
86406008,Human immunodeficiency virus infection (disorder),Malignancy and immunosuppression ,0
86553008,Immunosuppressive therapy (procedure),Malignancy and immunosuppression ,0
88039007,Transplant of lung (procedure),Malignancy and immunosuppression ,0
89454001,Shwachman syndrome (disorder),Malignancy and immunosuppression ,0
89655007,Congenital neutropenia (disorder),Malignancy and immunosuppression ,0
91637004,Myasthenia gravis (disorder),Malignancy and immunosuppression ,0
91855006,"Acute leukemia, disease (disorder)",Malignancy and immunosuppression ,0
91857003,"Acute lymphoid leukemia, disease (disorder)",Malignancy and immunosuppression ,0
91861009,"Acute myeloid leukemia, disease (disorder)",Malignancy and immunosuppression ,0
91867008,Adult form of celiac disease (disorder),Malignancy and immunosuppression ,0
91947003,Asymptomatic human immunodeficiency virus infection (disorder),Malignancy and immunosuppression ,0
92767001,Carcinoma in situ of thyroid gland (disorder),Malignancy and immunosuppression ,0
92812005,"Chronic leukemia, disease (disorder)",Malignancy and immunosuppression ,0
92814006,"Chronic lymphoid leukemia, disease (disorder)",Malignancy and immunosuppression ,0
92818009,"Chronic myeloid leukemia, disease (disorder)",Malignancy and immunosuppression ,0
93030006,Congenital absence of spleen (disorder),Malignancy and immunosuppression ,0
93135004,Letterer-Siwe disease of intrathoracic lymph nodes (disorder),Malignancy and immunosuppression ,0
93143009,"Leukemia, disease (disorder)",Malignancy and immunosuppression ,0
93184007,Malignant histiocytosis of intrathoracic lymph nodes (disorder),Malignancy and immunosuppression ,0
93191005,Malignant lymphoma of intra-abdominal lymph nodes (disorder),Malignancy and immunosuppression ,0
93193008,Malignant lymphoma of intrathoracic lymph nodes (disorder),Malignancy and immunosuppression ,0
93194002,Malignant lymphoma of lymph nodes of axilla AND/OR upper limb (disorder),Malignancy and immunosuppression ,0
93195001,"Malignant lymphoma of lymph nodes of head, face AND/OR neck (disorder)",Malignancy and immunosuppression ,0
93196000,Malignant lymphoma of lymph nodes of inguinal region AND/OR lower limb (disorder),Malignancy and immunosuppression ,0
93198004,Malignant lymphoma of spleen (disorder),Malignancy and immunosuppression ,0
93209006,Malignant melanoma of perianal skin (disorder),Malignancy and immunosuppression ,0
93217003,Malignant melanoma of skin of cheek (disorder),Malignancy and immunosuppression ,0
93223008,Malignant melanoma of skin of eyebrow (disorder),Malignancy and immunosuppression ,0
93225001,Malignant melanoma of skin of face (disorder),Malignancy and immunosuppression ,0
93451002,"Erythroleukemia, FAB M6 (disorder)",Malignancy and immunosuppression ,0
93494007,"Hodgkin's disease, lymphocytic-histiocytic predominance of intrapelvic lymph nodes (disorder)",Malignancy and immunosuppression ,0
93495008,"Hodgkin's disease, lymphocytic-histiocytic predominance of intrathoracic lymph nodes (disorder)",Malignancy and immunosuppression ,0
93520007,Hodgkin's disease of intra-abdominal lymph nodes (disorder),Malignancy and immunosuppression ,0
93522004,Hodgkin's disease of intrathoracic lymph nodes (disorder),Malignancy and immunosuppression ,0
93524003,"Hodgkin's disease of lymph nodes of head, face AND/OR neck (disorder)",Malignancy and immunosuppression ,0
93525002,Hodgkin's disease of lymph nodes of inguinal region AND/OR lower limb (disorder),Malignancy and immunosuppression ,0
93526001,Hodgkin's disease of lymph nodes of multiple sites (disorder),Malignancy and immunosuppression ,0
93527005,Hodgkin's disease of spleen (disorder),Malignancy and immunosuppression ,0
93643005,Malignant melanoma of skin of nose (disorder),Malignancy and immunosuppression ,0
93651008,Malignant melanoma of skin of trunk (disorder),Malignancy and immunosuppression ,0
93655004,Malignant melanoma of skin (disorder),Malignancy and immunosuppression ,0
93669004,Primary malignant neoplasm of anal canal (disorder),Malignancy and immunosuppression ,0
93680004,Primary malignant neoplasm of areola of female breast (disorder),Malignancy and immunosuppression ,0
93681000,Primary malignant neoplasm of areola of male breast (disorder),Malignancy and immunosuppression ,0
93689003,Primary malignant neoplasm of bladder (disorder),Malignancy and immunosuppression ,0
93757004,Primary malignant neoplasm of clavicle (disorder),Malignancy and immunosuppression ,0
93759001,Primary malignant neoplasm of coccygeal body (disorder),Malignancy and immunosuppression ,0
93761005,Primary malignant neoplasm of colon (disorder),Malignancy and immunosuppression ,0
93763008,Primary malignant neoplasm of common bile duct (disorder),Malignancy and immunosuppression ,0
93770008,Primary malignant neoplasm of cystic duct (disorder),Malignancy and immunosuppression ,0
93771007,Primary malignant neoplasm of descending colon (disorder),Malignancy and immunosuppression ,0
93775003,Primary malignant neoplasm of duodenum (disorder),Malignancy and immunosuppression ,0
93779009,Primary malignant neoplasm of endocervix (disorder),Malignancy and immunosuppression ,0
93781006,Primary malignant neoplasm of endometrium (disorder),Malignancy and immunosuppression ,0
93798006,Primary malignant neoplasm of femur (disorder),Malignancy and immunosuppression ,0
93799003,Primary malignant neoplasm of fibula (disorder),Malignancy and immunosuppression ,0
93814004,Primary malignant neoplasm of glomus jugulare (disorder),Malignancy and immunosuppression ,0
93827000,Primary malignant neoplasm of hilus of lung (disorder),Malignancy and immunosuppression ,0
93841009,Primary malignant neoplasm of intrathoracic organs (disorder),Malignancy and immunosuppression ,0
93842002,Primary malignant neoplasm of ischium (disorder),Malignancy and immunosuppression ,0
93870000,Malignant neoplasm of liver (disorder),Malignancy and immunosuppression ,0
93880001,Primary malignant neoplasm of lung (disorder),Malignancy and immunosuppression ,0
93888008,Primary malignant neoplasm of maxilla (disorder),Malignancy and immunosuppression ,0
93916003,Primary malignant neoplasm of nasal bone (disorder),Malignancy and immunosuppression ,0
93924008,Primary malignant neoplasm of nipple of female breast (disorder),Malignancy and immunosuppression ,0
93934004,Primary malignant neoplasm of ovary (disorder),Malignancy and immunosuppression ,0
93947009,Primary malignant neoplasm of parietal peritoneum (disorder),Malignancy and immunosuppression ,0
93956001,Primary malignant neoplasm of perianal skin (disorder),Malignancy and immunosuppression ,0
93973004,Primary malignant neoplasm of presacral region (disorder),Malignancy and immunosuppression ,0
93974005,Primary malignant neoplasm of prostate (disorder),Malignancy and immunosuppression ,0
93975006,Primary malignant neoplasm of pubis (disorder),Malignancy and immunosuppression ,0
93979000,Primary malignant neoplasm of radius (disorder),Malignancy and immunosuppression ,0
93980002,Primary malignant neoplasm of rectosigmoid junction (disorder),Malignancy and immunosuppression ,0
93984006,Primary malignant neoplasm of rectum (disorder),Malignancy and immunosuppression ,0
93985007,Primary malignant neoplasm of renal pelvis (disorder),Malignancy and immunosuppression ,0
93990005,Primary malignant neoplasm of rib (disorder),Malignancy and immunosuppression ,0
93995000,Primary malignant neoplasm of sacrococcygeal region (disorder),Malignancy and immunosuppression ,0
93997008,Primary malignant neoplasm of scapula (disorder),Malignancy and immunosuppression ,0
94000008,Primary malignant neoplasm of sebaceous gland (disorder),Malignancy and immunosuppression ,0
94006002,Primary malignant neoplasm of sigmoid colon (disorder),Malignancy and immunosuppression ,0
94066004,Primary malignant neoplasm of sphenoid bone (disorder),Malignancy and immunosuppression ,0
94073009,Primary malignant neoplasm of sternum (disorder),Malignancy and immunosuppression ,0
94081005,Primary malignant neoplasm of sweat gland (disorder),Malignancy and immunosuppression ,0
94085001,Primary malignant neoplasm of temporal bone (disorder),Malignancy and immunosuppression ,0
94098005,Primary malignant neoplasm of thyroid gland (disorder),Malignancy and immunosuppression ,0
94099002,Primary malignant neoplasm of tibia (disorder),Malignancy and immunosuppression ,0
94101009,Primary malignant neoplasm of tongue (disorder),Malignancy and immunosuppression ,0
94112009,Primary malignant neoplasm of ulna (disorder),Malignancy and immunosuppression ,0
94134006,Primary malignant neoplasm of ventral surface of tongue (disorder),Malignancy and immunosuppression ,0
94161006,Secondary malignant neoplasm of adrenal gland (disorder),Malignancy and immunosuppression ,0
94181007,Secondary malignant neoplasm of axillary lymph nodes (disorder),Malignancy and immunosuppression ,0
94186002,Secondary malignant neoplasm of bladder (disorder),Malignancy and immunosuppression ,0
94217008,Secondary malignant neoplasm of bone marrow (disorder),Malignancy and immunosuppression ,0
94222008,Secondary malignant neoplasm of bone (disorder),Malignancy and immunosuppression ,0
94225005,Secondary malignant neoplasm of brain (disorder),Malignancy and immunosuppression ,0
94227002,Secondary malignant neoplasm of bronchopulmonary lymph nodes (disorder),Malignancy and immunosuppression ,0
94233006,Secondary malignant neoplasm of bronchus (disorder),Malignancy and immunosuppression ,0
94248000,Secondary malignant neoplasm of cerebrum (disorder),Malignancy and immunosuppression ,0
94254004,Secondary malignant neoplasm of choroid (disorder),Malignancy and immunosuppression ,0
94260004,Secondary malignant neoplasm of colon (disorder),Malignancy and immunosuppression ,0
94264008,Secondary malignant neoplasm of soft tissues (disorder),Malignancy and immunosuppression ,0
94275007,Secondary malignant neoplasm of duodenum (disorder),Malignancy and immunosuppression ,0
94280003,Secondary malignant neoplasm of endocrine gland (disorder),Malignancy and immunosuppression ,0
94292003,Secondary malignant neoplasm of eye (disorder),Malignancy and immunosuppression ,0
94297009,Secondary malignant neoplasm of female breast (disorder),Malignancy and immunosuppression ,0
94298004,Secondary malignant neoplasm of female genital organ (disorder),Malignancy and immunosuppression ,0
94312000,Secondary malignant neoplasm of gallbladder (disorder),Malignancy and immunosuppression ,0
94313005,Secondary malignant neoplasm of gastrointestinal tract (disorder),Malignancy and immunosuppression ,0
94336001,Secondary malignant neoplasm of iliac lymph nodes (disorder),Malignancy and immunosuppression ,0
94338000,Secondary malignant neoplasm of infraclavicular lymph nodes (disorder),Malignancy and immunosuppression ,0
94347008,Secondary malignant neoplasm of intra-abdominal lymph nodes (disorder),Malignancy and immunosuppression ,0
94350006,Secondary malignant neoplasm of intrapelvic lymph nodes (disorder),Malignancy and immunosuppression ,0
94351005,Secondary malignant neoplasm of intrathoracic lymph nodes (disorder),Malignancy and immunosuppression ,0
94360002,Secondary malignant neoplasm of kidney (disorder),Malignancy and immunosuppression ,0
94365007,Secondary malignant neoplasm of large intestine (disorder),Malignancy and immunosuppression ,0
94381002,Secondary malignant neoplasm of liver (disorder),Malignancy and immunosuppression ,0
94391008,Secondary malignant neoplasm of lung (disorder),Malignancy and immunosuppression ,0
94392001,Secondary malignant neoplasm of lymph node (disorder),Malignancy and immunosuppression ,0
94395004,Secondary malignant neoplasm of lymph nodes of lower limb (disorder),Malignancy and immunosuppression ,0
94396003,Secondary malignant neoplasm of lymph nodes of multiple sites (disorder),Malignancy and immunosuppression ,0
94398002,Secondary malignant neoplasm of lymph nodes of upper limb (disorder),Malignancy and immunosuppression ,0
94408005,Secondary malignant neoplasm of mediastinal lymph nodes (disorder),Malignancy and immunosuppression ,0
94409002,Secondary malignant neoplasm of mediastinum (disorder),Malignancy and immunosuppression ,0
94410007,Secondary malignant neoplasm of mesenteric lymph nodes (disorder),Malignancy and immunosuppression ,0
94432003,Secondary malignant neoplasm of muscle (disorder),Malignancy and immunosuppression ,0
94453007,Secondary malignant neoplasm of orbit proper (disorder),Malignancy and immunosuppression ,0
94455000,Secondary malignant neoplasm of ovary (disorder),Malignancy and immunosuppression ,0
94459006,Secondary malignant neoplasm of pancreas (disorder),Malignancy and immunosuppression ,0
94475009,Secondary malignant neoplasm of parotid lymph nodes (disorder),Malignancy and immunosuppression ,0
94481001,Secondary malignant neoplasm of penis (disorder),Malignancy and immunosuppression ,0
94493005,Secondary malignant neoplasm of pleura (disorder),Malignancy and immunosuppression ,0
94494004,Secondary malignant neoplasm of popliteal lymph nodes (disorder),Malignancy and immunosuppression ,0
94503003,Secondary malignant neoplasm of prostate (disorder),Malignancy and immunosuppression ,0
94513006,Secondary malignant neoplasm of rectum (disorder),Malignancy and immunosuppression ,0
94514000,Secondary malignant neoplasm of renal pelvis (disorder),Malignancy and immunosuppression ,0
94515004,Secondary malignant neoplasm of respiratory tract (disorder),Malignancy and immunosuppression ,0
94521000,Secondary malignant neoplasm of rib (disorder),Malignancy and immunosuppression ,0
94527001,Secondary malignant neoplasm of sacrum (disorder),Malignancy and immunosuppression ,0
94537006,Secondary malignant neoplasm of shoulder (disorder),Malignancy and immunosuppression ,0
94544002,Secondary malignant neoplasm of skin of breast (disorder),Malignancy and immunosuppression ,0
94566009,Secondary malignant neoplasm of skin of neck (disorder),Malignancy and immunosuppression ,0
94575006,Secondary malignant neoplasm of skin of trunk (disorder),Malignancy and immunosuppression ,0
94579000,Secondary malignant neoplasm of skin (disorder),Malignancy and immunosuppression ,0
94580002,Secondary malignant neoplasm of small intestine (disorder),Malignancy and immunosuppression ,0
94600009,Secondary malignant neoplasm of spinal cord (disorder),Malignancy and immunosuppression ,0
94602001,Secondary malignant neoplasm of vertebral column (disorder),Malignancy and immunosuppression ,0
94603006,Secondary malignant neoplasm of spleen (disorder),Malignancy and immunosuppression ,0
94623007,Secondary malignant neoplasm of testis (disorder),Malignancy and immunosuppression ,0
94626004,Secondary malignant neoplasm of omentum (disorder),Malignancy and immunosuppression ,0
94627008,Secondary malignant neoplasm of peritoneum (disorder),Malignancy and immunosuppression ,0
94628003,Secondary malignant neoplasm of retroperitoneum (disorder),Malignancy and immunosuppression ,0
94632009,Secondary malignant neoplasm of thymus (disorder),Malignancy and immunosuppression ,0
94634005,Secondary malignant neoplasm of thyroid gland (disorder),Malignancy and immunosuppression ,0
94641004,Secondary malignant neoplasm of trachea (disorder),Malignancy and immunosuppression ,0
94642006,Secondary malignant neoplasm of tracheobronchial lymph nodes (disorder),Malignancy and immunosuppression ,0
94659001,Secondary malignant neoplasm of ureter (disorder),Malignancy and immunosuppression ,0
94661005,Secondary malignant neoplasm of urethra (disorder),Malignancy and immunosuppression ,0
94663008,Secondary malignant neoplasm of urinary system (disorder),Malignancy and immunosuppression ,0
94665001,Secondary malignant neoplasm of uterus (disorder),Malignancy and immunosuppression ,0
94668004,Secondary malignant neoplasm of vagina (disorder),Malignancy and immunosuppression ,0
94681006,Secondary malignant neoplasm of vulva (disorder),Malignancy and immunosuppression ,0
94719007,"Myeloid sarcoma, disease (disorder)",Malignancy and immunosuppression ,0
95111006,Neoplasm of uncertain behavior of spleen (disorder),Malignancy and immunosuppression ,0
95193005,Nodular lymphoma of spleen (disorder),Malignancy and immunosuppression ,0
95210003,"Plasma cell leukemia, disease (disorder)",Malignancy and immunosuppression ,0
95214007,Primary malignant neoplasm of liver (disorder),Malignancy and immunosuppression ,0
95892003,Persistent generalized lymphadenopathy (disorder),Malignancy and immunosuppression ,0
109264009,Overlapping malignant neoplasm of skin (disorder),Malignancy and immunosuppression ,0
109347009,Overlapping malignant neoplasm of bone and articular cartilage (disorder),Malignancy and immunosuppression ,0
109348004,Overlapping malignant neoplasm of bone and articular cartilage of limbs (disorder),Malignancy and immunosuppression ,0
109368005,Overlapping malignant neoplasm of hypopharynx (disorder),Malignancy and immunosuppression ,0
109369002,Overlapping malignant neoplasm of larynx (disorder),Malignancy and immunosuppression ,0
109371002,Overlapping malignant neoplasm of bronchus and lung (disorder),Malignancy and immunosuppression ,0
109378008,"Mesothelioma (malignant, clinical disorder) (disorder)",Malignancy and immunosuppression ,0
109383000,Malignant mesothelioma of pericardium (disorder),Malignancy and immunosuppression ,0
109384006,"Overlapping malignant neoplasm of heart, mediastinum and pleura (disorder)",Malignancy and immunosuppression ,0
109385007,Kaposi's sarcoma (disorder),Malignancy and immunosuppression ,0
109386008,Kaposi's sarcoma of skin (disorder),Malignancy and immunosuppression ,0
109388009,Kaposi's sarcoma of palate (disorder),Malignancy and immunosuppression ,0
109391009,Kaposi's sarcoma of lymph nodes (disorder),Malignancy and immunosuppression ,0
109392002,Kaposi's sarcoma of multiple organs (disorder),Malignancy and immunosuppression ,0
109835005,Overlapping malignant neoplasm of esophagus (disorder),Malignancy and immunosuppression ,0
109837002,Overlapping malignant neoplasm of small intestine (disorder),Malignancy and immunosuppression ,0
109841003,Liver cell carcinoma (disorder),Malignancy and immunosuppression ,0
109843000,Hepatoblastoma (disorder),Malignancy and immunosuppression ,0
109844006,Angiosarcoma of liver (disorder),Malignancy and immunosuppression ,0
109847004,Overlapping malignant neoplasm of biliary tract (disorder),Malignancy and immunosuppression ,0
109848009,Overlapping malignant neoplasm of pancreas (disorder),Malignancy and immunosuppression ,0
109853004,Malignant mesothelioma of peritoneum (disorder),Malignancy and immunosuppression ,0
109874003,Overlapping malignant neoplasm of male genital organs (disorder),Malignancy and immunosuppression ,0
109876001,Primary malignant neoplasm of descended testis (disorder),Malignancy and immunosuppression ,0
109878000,Overlapping malignant neoplasm of female genital organs (disorder),Malignancy and immunosuppression ,0
109911004,Overlapping malignant neoplasm of brain and other parts of the central nervous system (disorder),Malignancy and immunosuppression ,0
109912006,Overlapping malignant neoplasm of brain (disorder),Malignancy and immunosuppression ,0
109948008,"Overlapping malignant neoplasm of eye and adnexa, primary (disorder)",Malignancy and immunosuppression ,0
109962001,Diffuse non-Hodgkin's lymphoma (disorder),Malignancy and immunosuppression ,0
109965004,"Diffuse non-Hodgkin's lymphoma, lymphoblastic (disorder)",Malignancy and immunosuppression ,0
109966003,"Diffuse non-Hodgkin's lymphoma, immunoblastic (disorder)",Malignancy and immunosuppression ,0
109969005,"Diffuse non-Hodgkin's lymphoma, large cell (disorder)",Malignancy and immunosuppression ,0
109971005,"Follicular non-Hodgkin's lymphoma, mixed small cleaved cell and large cell (disorder)",Malignancy and immunosuppression ,0
109975001,T-zone lymphoma (disorder),Malignancy and immunosuppression ,0
109976000,Lymphoepithelioid lymphoma (disorder),Malignancy and immunosuppression ,0
109977009,Peripheral T-cell lymphoma (disorder),Malignancy and immunosuppression ,0
109978004,T-cell lymphoma (disorder),Malignancy and immunosuppression ,0
109979007,B-cell lymphoma (disorder),Malignancy and immunosuppression ,0
109980005,Malignant immunoproliferative disease (disorder),Malignancy and immunosuppression ,0
109982002,Alpha heavy chain disease (disorder),Malignancy and immunosuppression ,0
109983007,Monoclonal paraproteinemia,Malignancy and immunosuppression ,0
109984001,Gamma heavy chain disease (disorder),Malignancy and immunosuppression ,0
109988003,Histiocytic sarcoma (disorder),Malignancy and immunosuppression ,0
109989006,Multiple myeloma (disorder),Malignancy and immunosuppression ,0
109991003,Acute myelofibrosis (disorder),Malignancy and immunosuppression ,0
109992005,Polycythemia vera (disorder),Malignancy and immunosuppression ,0
109994006,Essential thrombocythemia (disorder),Malignancy and immunosuppression ,0
109995007,Myelodysplastic syndrome (disorder),Malignancy and immunosuppression ,0
109996008,"Myelodysplastic syndrome: Refractory anemia, without ringed sideroblasts, without excess blasts (disorder)",Malignancy and immunosuppression ,0
109998009,Refractory anemia with ringed sideroblasts (disorder),Malignancy and immunosuppression ,0
110002002,Mast cell leukemia (disorder),Malignancy and immunosuppression ,0
110004001,"Acute promyelocytic leukemia, FAB M3 (disorder)",Malignancy and immunosuppression ,0
110005000,"Acute myelomonocytic leukemia, FAB M4 (disorder)",Malignancy and immunosuppression ,0
110006004,Prolymphocytic leukemia (disorder),Malignancy and immunosuppression ,0
110007008,Adult T-cell leukemia/lymphoma (disorder),Malignancy and immunosuppression ,0
111583006,Leukocytosis (disorder),Malignancy and immunosuppression ,0
111584000,Reticular dysgenesis (disorder),Malignancy and immunosuppression ,0
111880001,Acute human immunodeficiency virus infection (disorder),Malignancy and immunosuppression ,0
118599009,Hodgkin's disease (disorder),Malignancy and immunosuppression ,0
118600007,Malignant lymphoma (disorder),Malignancy and immunosuppression ,0
118601006,Non-Hodgkin's lymphoma (disorder),Malignancy and immunosuppression ,0
118602004,Hodgkin's granuloma (disorder),Malignancy and immunosuppression ,0
118605002,"Hodgkin lymphoma, nodular lymphocyte predominance (disorder)",Malignancy and immunosuppression ,0
118606001,Hodgkin's sarcoma (disorder),Malignancy and immunosuppression ,0
118607005,"Hodgkin lymphoma, lymphocyte-rich (disorder)",Malignancy and immunosuppression ,0
118608000,"Hodgkin's disease, nodular sclerosis (disorder)",Malignancy and immunosuppression ,0
118609008,"Hodgkin's disease, mixed cellularity (disorder)",Malignancy and immunosuppression ,0
118610003,"Hodgkin's disease, lymphocytic depletion (disorder)",Malignancy and immunosuppression ,0
118612006,Malignant histiocytosis (disorder),Malignancy and immunosuppression ,0
118613001,Leukemic reticuloendotheliosis,Malignancy and immunosuppression ,0
118614007,"Langerhans cell histiocytosis, disseminated (disorder)",Malignancy and immunosuppression ,0
118615008,Malignant mast cell tumor (disorder),Malignancy and immunosuppression ,0
118617000,Burkitt's lymphoma (disorder),Malignancy and immunosuppression ,0
118618005,Mycosis fungoides (disorder),Malignancy and immunosuppression ,0
119249001,Agammaglobulinemia (finding),Malignancy and immunosuppression ,0
119250001,Hypogammaglobulinemia (finding),Malignancy and immunosuppression ,0
123845008,Adenocarcinoma of endometrium (disorder),Malignancy and immunosuppression ,0
127034005,Pancytopenia (disorder),Malignancy and immunosuppression ,0
127040003,Hereditary hemoglobinopathy disorder homozygous for hemoglobin S,Malignancy and immunosuppression ,0
127041004,Sickle cell-beta-thalassemia (disorder),Malignancy and immunosuppression ,0
127225006,Chronic myelomonocytic leukemia (disorder),Malignancy and immunosuppression ,0
127230005,Neoplasm of spleen (disorder),Malignancy and immunosuppression ,0
127388009,Hypergammaglobulinemia (finding),Malignancy and immunosuppression ,0
128462008,Secondary malignant neoplastic disease (disorder),Malignancy and immunosuppression ,0
128531006,Islet cell transplant (procedure),Malignancy and immunosuppression ,0
128875000,Primary cutaneous CD30 antigen positive large T-cell lymphoma (disorder),Malignancy and immunosuppression ,0
129000002,"Langerhans cell histiocytosis, unifocal (disorder)",Malignancy and immunosuppression ,0
134421000,Pathological fracture due to metastatic bone disease (disorder),Malignancy and immunosuppression ,0
134622004,Product containing precisely capecitabine 500 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
134623009,Product containing precisely capecitabine 150 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
134640000,Product containing precisely sirolimus 1 milligram/1 milliliter conventional release oral solution (clinical drug),Malignancy and immunosuppression ,0
161436008,History of leukemia,Malignancy and immunosuppression ,0
161626009,History of splenectomy (situation),Malignancy and immunosuppression ,0
161665007,History of renal transplant (situation),Malignancy and immunosuppression ,0
161666008,History of heart recipient (situation),Malignancy and immunosuppression ,0
161668009,History of skin recipient (situation),Malignancy and immunosuppression ,0
161669001,History of bone tissue recipient (situation),Malignancy and immunosuppression ,0
161671001,History of liver recipient (situation),Malignancy and immunosuppression ,0
161672008,History of being lung transplant recipient (situation),Malignancy and immunosuppression ,0
164165007,On examination - moderate splenomegaly (disorder),Malignancy and immunosuppression ,0
164166008,On examination - gross splenomegaly (disorder),Malignancy and immunosuppression ,0
164167004,On examination - painful splenomegaly (disorder),Malignancy and immunosuppression ,0
165531008,Lymphocytosis - absolute (disorder),Malignancy and immunosuppression ,0
165816005,Human immunodeficiency virus positive (finding),Malignancy and immunosuppression ,0
168520004,Radiotherapy for immunosuppression (procedure),Malignancy and immunosuppression ,0
169335009,External beam - surgery with chemotherapy (procedure),Malignancy and immunosuppression ,0
169336005,External beam with chemotherapy (procedure),Malignancy and immunosuppression ,0
169396008,Radiomimetic chemotherapy (procedure),Malignancy and immunosuppression ,0
169397004,Radiochemotherapy: local infiltration (procedure),Malignancy and immunosuppression ,0
169399001,Radiochemotherapy: oral route (procedure),Malignancy and immunosuppression ,0
169401007,Radiochemotherapy: for immunosuppression (procedure),Malignancy and immunosuppression ,0
169403005,Radiochemotherapy: into cavity (procedure),Malignancy and immunosuppression ,0
174425003,Orthotopic liver transplant (procedure),Malignancy and immunosuppression ,0
174426002,Heterotopic liver transplant (procedure),Malignancy and immunosuppression ,0
174427006,Replacement of previous liver transplant (procedure),Malignancy and immunosuppression ,0
174692003,Whole organ pancreatic transplant (procedure),Malignancy and immunosuppression ,0
174693008,Transplantation of tail of pancreas (procedure),Malignancy and immunosuppression ,0
174694002,Renewal of transplanted pancreatic tissue (procedure),Malignancy and immunosuppression ,0
174776001,Total splenectomy (procedure),Malignancy and immunosuppression ,0
174778000,Total splenectomy and reimplantation of fragments (procedure),Malignancy and immunosuppression ,0
174802006,Allotransplant of heart and lung (procedure),Malignancy and immunosuppression ,0
174803001,Revision of transplantation of heart and lung (procedure),Malignancy and immunosuppression ,0
175901007,Live donor renal transplant (procedure),Malignancy and immunosuppression ,0
183023001,Transplant immunosuppression (procedure),Malignancy and immunosuppression ,0
183651009,Chemotherapy follow-up (procedure),Malignancy and immunosuppression ,0
186706006,Human immunodeficiency virus infection constitutional disease (disorder),Malignancy and immunosuppression ,0
186708007,Human immunodeficiency virus infection with secondary clinical infectious disease (disorder),Malignancy and immunosuppression ,0
186792002,Plasmodium vivax malaria with rupture of spleen (disorder),Malignancy and immunosuppression ,0
187601000,"Malignant neoplasm of upper lip, lipstick area (disorder)",Malignancy and immunosuppression ,0
187604008,"Malignant neoplasm of lower lip, external (disorder)",Malignancy and immunosuppression ,0
187622006,Malignant tumor of labial mucosa (disorder),Malignancy and immunosuppression ,0
187631006,Malignant neoplasm of base of tongue dorsal surface (disorder),Malignancy and immunosuppression ,0
187633009,Malignant neoplasm of dorsal surface of tongue (disorder),Malignancy and immunosuppression ,0
187634003,Malignant tumor of anterior two-thirds of tongue - dorsal surface (disorder),Malignancy and immunosuppression ,0
187637005,"Malignant neoplasm of tongue, tip and lateral border (disorder)",Malignancy and immunosuppression ,0
187640005,Malignant tumor of anterior two-thirds of tongue - ventral surface (disorder),Malignancy and immunosuppression ,0
187652003,Malignant tumor of anterior floor of mouth (disorder),Malignancy and immunosuppression ,0
187653008,Malignant tumor of lateral floor of mouth (disorder),Malignancy and immunosuppression ,0
187658004,Malignant tumor of vestibule of mouth (disorder),Malignancy and immunosuppression ,0
187660002,Malignant tumor of lower buccal sulcus (disorder),Malignancy and immunosuppression ,0
187666008,Malignant neoplasm of junction of hard and soft palate (disorder),Malignancy and immunosuppression ,0
187675005,Malignant tumor of tonsillar pillar (disorder),Malignancy and immunosuppression ,0
187681002,Malignant neoplasm of anterior epiglottis (disorder),Malignancy and immunosuppression ,0
187682009,"Malignant neoplasm of epiglottis, free border (disorder)",Malignancy and immunosuppression ,0
187685006,Malignant neoplasm of junctional region of epiglottis (disorder),Malignancy and immunosuppression ,0
187692001,Malignant tumor of nasopharynx (disorder),Malignancy and immunosuppression ,0
187694000,Malignant tumor of adenoid (disorder),Malignancy and immunosuppression ,0
187697007,Malignant tumor of pharyngeal recess (disorder),Malignancy and immunosuppression ,0
187700006,Malignant tumor of anterior wall of nasopharynx (disorder),Malignancy and immunosuppression ,0
187702003,Malignant tumor of nasopharyngeal soft palate surface (disorder),Malignancy and immunosuppression ,0
187708004,Malignant tumor aryepiglottic fold - hypopharyngeal aspect (disorder),Malignancy and immunosuppression ,0
187709007,Malignant neoplasm of posterior pharynx (disorder),Malignancy and immunosuppression ,0
187722004,Malignant tumor of cervical part of esophagus (disorder),Malignancy and immunosuppression ,0
187724003,Malignant tumor of abdominal part of esophagus (disorder),Malignancy and immunosuppression ,0
187725002,Malignant tumor of upper third of esophagus (disorder),Malignancy and immunosuppression ,0
187726001,Malignant tumor of middle third of esophagus (disorder),Malignancy and immunosuppression ,0
187727005,Malignant tumor of lower third of esophagus (disorder),Malignancy and immunosuppression ,0
187732006,Malignant tumor of cardia (disorder),Malignancy and immunosuppression ,0
187734007,Malignant neoplasm of cardioesophageal junction of stomach (disorder),Malignancy and immunosuppression ,0
187736009,Malignant tumor of pylorus (disorder),Malignancy and immunosuppression ,0
187738005,Malignant neoplasm of pyloric canal of stomach (disorder),Malignancy and immunosuppression ,0
187740000,Malignant tumor of pyloric antrum (disorder),Malignancy and immunosuppression ,0
187741001,Malignant tumor of fundus of stomach (disorder),Malignancy and immunosuppression ,0
187742008,Malignant tumor of body of stomach (disorder),Malignancy and immunosuppression ,0
187752007,Malignant tumor of Meckel diverticulum,Malignancy and immunosuppression ,0
187757001,"Malignant neoplasm, overlapping lesion of colon (disorder)",Malignancy and immunosuppression ,0
187760008,"Malignant neoplasm of rectum, rectosigmoid junction and anus (disorder)",Malignancy and immunosuppression ,0
187767006,Malignant neoplasm of liver and intrahepatic bile ducts (disorder),Malignancy and immunosuppression ,0
187769009,Primary carcinoma of liver (disorder),Malignancy and immunosuppression ,0
187773007,Malignant neoplasm of interlobular bile ducts (disorder),Malignancy and immunosuppression ,0
187776004,Malignant neoplasm of intrahepatic canaliculi (disorder),Malignancy and immunosuppression ,0
187777008,Malignant neoplasm of intrahepatic gall duct (disorder),Malignancy and immunosuppression ,0
187784000,Malignant neoplasm of hepatic duct (disorder),Malignancy and immunosuppression ,0
187786003,Malignant neoplasm of sphincter of Oddi (disorder),Malignancy and immunosuppression ,0
187791002,Malignant tumor of body of pancreas (disorder),Malignancy and immunosuppression ,0
187792009,Malignant tumor of tail of pancreas (disorder),Malignancy and immunosuppression ,0
187793004,Malignant tumor of pancreatic duct (disorder),Malignancy and immunosuppression ,0
187794005,Malignant tumor of Islets of Langerhans (disorder),Malignancy and immunosuppression ,0
187798008,Malignant neoplasm of ectopic pancreatic tissue (disorder),Malignancy and immunosuppression ,0
187801002,Malignant tumor of peritoneum and retroperitoneum (disorder),Malignancy and immunosuppression ,0
187804005,Malignant neoplasm of retrocecal tissue (disorder),Malignancy and immunosuppression ,0
187808008,Malignant neoplasm of specified parts of peritoneum (disorder),Malignancy and immunosuppression ,0
187811009,Malignant neoplasm of mesorectum (disorder),Malignancy and immunosuppression ,0
187821001,Angiosarcoma of spleen (disorder),Malignancy and immunosuppression ,0
187822008,Fibrosarcoma of spleen (disorder),Malignancy and immunosuppression ,0
187828007,"Malignant neoplasm of nasal cavities, middle ear and accessory sinuses (disorder)",Malignancy and immunosuppression ,0
187829004,Malignant neoplasm of cartilage of nose (disorder),Malignancy and immunosuppression ,0
187831008,Malignant tumor of nasal vestibule (disorder),Malignancy and immunosuppression ,0
187833006,"Malignant neoplasm of auditory tube, middle ear and mastoid air cells (disorder)",Malignancy and immunosuppression ,0
187841006,Malignant tumor of glottis (disorder),Malignancy and immunosuppression ,0
187842004,Malignant tumor of supraglottis (disorder),Malignancy and immunosuppression ,0
187844003,Malignant neoplasm of cricoid cartilage (disorder),Malignancy and immunosuppression ,0
187846001,Malignant neoplasm of thyroid cartilage (disorder),Malignancy and immunosuppression ,0
187857006,Malignant neoplasm of carina of bronchus (disorder),Malignancy and immunosuppression ,0
187861000,Malignant neoplasm of upper lobe bronchus (disorder),Malignancy and immunosuppression ,0
187862007,Malignant neoplasm of upper lobe of lung (disorder),Malignancy and immunosuppression ,0
187864008,"Malignant neoplasm of middle lobe, bronchus or lung (disorder)",Malignancy and immunosuppression ,0
187866005,Malignant neoplasm of middle lobe of lung (disorder),Malignancy and immunosuppression ,0
187868006,"Malignant neoplasm of lower lobe, bronchus or lung (disorder)",Malignancy and immunosuppression ,0
187869003,Malignant neoplasm of lower lobe bronchus (disorder),Malignancy and immunosuppression ,0
187870002,Malignant neoplasm of lower lobe of lung (disorder),Malignancy and immunosuppression ,0
187881004,"Malignant neoplasm of thymus, heart and mediastinum (disorder)",Malignancy and immunosuppression ,0
187900002,Malignant neoplasm of bones of skull and face (disorder),Malignancy and immunosuppression ,0
187916000,Malignant neoplasm of cervical vertebra (disorder),Malignancy and immunosuppression ,0
187917009,Malignant neoplasm of thoracic vertebra (disorder),Malignancy and immunosuppression ,0
187918004,Malignant neoplasm of lumbar vertebra (disorder),Malignancy and immunosuppression ,0
187920001,Malignant neoplasm of ribs and/or sternum and/or clavicle (disorder),Malignancy and immunosuppression ,0
187925006,Malignant neoplasm of costal cartilage (disorder),Malignancy and immunosuppression ,0
187929000,Malignant neoplasm of scapula and long bones of upper arm (disorder),Malignancy and immunosuppression ,0
187932002,Malignant neoplasm of humerus (disorder),Malignancy and immunosuppression ,0
187938003,Malignant neoplasm of carpal bone - lunate (disorder),Malignancy and immunosuppression ,0
187950009,Malignant neoplasm of phalanges of hand (disorder),Malignancy and immunosuppression ,0
187952001,"Malignant neoplasm of pelvic bones, sacrum and coccyx (disorder)",Malignancy and immunosuppression ,0
187956003,Malignant neoplasm of sacral vertebra (disorder),Malignancy and immunosuppression ,0
187957007,Malignant neoplasm of coccygeal vertebra (disorder),Malignancy and immunosuppression ,0
187987001,Malignant neoplasm of cartilage of ear (disorder),Malignancy and immunosuppression ,0
187988006,Malignant neoplasm of tarsus of eyelid (disorder),Malignancy and immunosuppression ,0
187989003,Malignant neoplasm soft tissues of cervical spine (disorder),Malignancy and immunosuppression ,0
187991006,Malignant neoplasm of connective and soft tissue of upper limb and shoulder (disorder),Malignancy and immunosuppression ,0
187992004,Malignant neoplasm of connective and soft tissue of shoulder (disorder),Malignancy and immunosuppression ,0
187993009,"Malignant neoplasm of connective and soft tissue, upper arm (disorder)",Malignancy and immunosuppression ,0
187994003,Malignant neoplasm of connective and soft tissue of forearm (disorder),Malignancy and immunosuppression ,0
187995002,Malignant neoplasm of connective and soft tissue of hand (disorder),Malignancy and immunosuppression ,0
187996001,Malignant neoplasm of connective and soft tissue of finger (disorder),Malignancy and immunosuppression ,0
187999008,Malignant neoplasm of connective and soft tissue of hip and lower limb (disorder),Malignancy and immunosuppression ,0
188000002,Malignant neoplasm of connective and soft tissue of hip (disorder),Malignancy and immunosuppression ,0
188001003,Malignant neoplasm of connective and soft tissue of thigh and upper leg (disorder),Malignancy and immunosuppression ,0
188003000,Malignant neoplasm of connective and soft tissue of lower leg (disorder),Malignancy and immunosuppression ,0
188004006,Malignant neoplasm of connective and soft tissue of foot (disorder),Malignancy and immunosuppression ,0
188005007,Malignant neoplasm of connective and soft tissue of toe (disorder),Malignancy and immunosuppression ,0
188009001,Malignant neoplasm of connective and soft tissue of thorax (disorder),Malignancy and immunosuppression ,0
188010006,Malignant neoplasm of connective and soft tissue of axilla (disorder),Malignancy and immunosuppression ,0
188015001,Malignant neoplasm of connective and soft tissue of abdomen (disorder),Malignancy and immunosuppression ,0
188016000,Malignant neoplasm of connective and soft tissue of abdominal wall (disorder),Malignancy and immunosuppression ,0
188017009,Malignant neoplasm of connective and soft tissues of lumbar spine (disorder),Malignancy and immunosuppression ,0
188019007,Malignant neoplasm of connective and soft tissue of pelvis (disorder),Malignancy and immunosuppression ,0
188020001,Malignant neoplasm of connective and soft tissue of buttock (disorder),Malignancy and immunosuppression ,0
188021002,Malignant neoplasm of connective and soft tissue of inguinal region (disorder),Malignancy and immunosuppression ,0
188022009,Malignant neoplasm of connective and soft tissue of perineum (disorder),Malignancy and immunosuppression ,0
188023004,Malignant neoplasm of connective and soft tissue of sacrum or coccyx (disorder),Malignancy and immunosuppression ,0
188029000,Kaposi's sarcoma of soft tissue (disorder),Malignancy and immunosuppression ,0
188030005,Malignant melanoma of lip (disorder),Malignancy and immunosuppression ,0
188032002,Malignant melanoma of ear and/or external auditory canal (disorder),Malignancy and immunosuppression ,0
188033007,Malignant melanoma of auricle (ear) (disorder),Malignancy and immunosuppression ,0
188034001,Malignant melanoma of external auditory meatus (disorder),Malignancy and immunosuppression ,0
188038003,Malignant melanoma of chin (disorder),Malignancy and immunosuppression ,0
188040008,Malignant melanoma of forehead (disorder),Malignancy and immunosuppression ,0
188042000,Malignant melanoma of temple (disorder),Malignancy and immunosuppression ,0
188044004,Malignant melanoma of scalp and/or neck (disorder),Malignancy and immunosuppression ,0
188045003,Malignant melanoma of scalp (disorder),Malignancy and immunosuppression ,0
188046002,Malignant melanoma of neck (disorder),Malignancy and immunosuppression ,0
188049009,Malignant melanoma of axilla (disorder),Malignancy and immunosuppression ,0
188050009,Malignant melanoma of breast (disorder),Malignancy and immunosuppression ,0
188051008,Malignant melanoma of buttock (disorder),Malignancy and immunosuppression ,0
188052001,Malignant melanoma of groin (disorder),Malignancy and immunosuppression ,0
188054000,Malignant melanoma of perineum (disorder),Malignancy and immunosuppression ,0
188055004,Malignant melanoma of umbilicus (disorder),Malignancy and immunosuppression ,0
188060000,Malignant melanoma of shoulder (disorder),Malignancy and immunosuppression ,0
188061001,Malignant melanoma of upper arm (disorder),Malignancy and immunosuppression ,0
188062008,Malignant melanoma of forearm (disorder),Malignancy and immunosuppression ,0
188063003,Malignant melanoma of hand (disorder),Malignancy and immunosuppression ,0
188064009,Malignant melanoma of finger (disorder),Malignancy and immunosuppression ,0
188065005,Malignant melanoma of thumb (disorder),Malignancy and immunosuppression ,0
188067002,Malignant melanoma of lower limb and hip (disorder),Malignancy and immunosuppression ,0
188068007,Malignant melanoma of hip (disorder),Malignancy and immunosuppression ,0
188069004,Malignant melanoma of thigh (disorder),Malignancy and immunosuppression ,0
188070003,Malignant melanoma of knee (disorder),Malignancy and immunosuppression ,0
188071004,Malignant melanoma of popliteal fossa area (disorder),Malignancy and immunosuppression ,0
188072006,Malignant melanoma of lower leg (disorder),Malignancy and immunosuppression ,0
188073001,Malignant melanoma of ankle (disorder),Malignancy and immunosuppression ,0
188074007,Malignant melanoma of heel (disorder),Malignancy and immunosuppression ,0
188075008,Malignant melanoma of foot (disorder),Malignancy and immunosuppression ,0
188076009,Malignant melanoma of toe (disorder),Malignancy and immunosuppression ,0
188077000,Malignant melanoma of great toe (disorder),Malignancy and immunosuppression ,0
188102008,Malignant neoplasm of scalp and/or skin of neck (disorder),Malignancy and immunosuppression ,0
188147009,Malignant neoplasm of nipple and areola of female breast (disorder),Malignancy and immunosuppression ,0
188151006,Malignant neoplasm of central part of female breast (disorder),Malignancy and immunosuppression ,0
188152004,Malignant neoplasm of upper-inner quadrant of female breast (disorder),Malignancy and immunosuppression ,0
188153009,Malignant neoplasm of lower-inner quadrant of female breast (disorder),Malignancy and immunosuppression ,0
188154003,Malignant neoplasm of upper-outer quadrant of female breast (disorder),Malignancy and immunosuppression ,0
188155002,Malignant neoplasm of lower-outer quadrant of female breast (disorder),Malignancy and immunosuppression ,0
188156001,Malignant neoplasm of axillary tail of female breast (disorder),Malignancy and immunosuppression ,0
188157005,"Malignant neoplasm, overlapping lesion of breast (disorder)",Malignancy and immunosuppression ,0
188163001,Malignant neoplasm of nipple and areola of male breast (disorder),Malignancy and immunosuppression ,0
188176007,Malignant neoplasm of endocervical canal (disorder),Malignancy and immunosuppression ,0
188177003,Malignant neoplasm of endocervical gland (disorder),Malignancy and immunosuppression ,0
188180002,"Malignant neoplasm, overlapping lesion of cervix uteri (disorder)",Malignancy and immunosuppression ,0
188183000,Malignant neoplasm of cervical stump (disorder),Malignancy and immunosuppression ,0
188184006,Malignant neoplasm of squamocolumnar junction of cervix (disorder),Malignancy and immunosuppression ,0
188188009,Choriocarcinoma (disorder),Malignancy and immunosuppression ,0
188189001,"Malignant neoplasm of corpus uteri, excluding isthmus (disorder)",Malignancy and immunosuppression ,0
188190005,Malignant neoplasm of cornu of corpus uteri (disorder),Malignancy and immunosuppression ,0
188191009,Malignant neoplasm of fundus of corpus uteri (disorder),Malignancy and immunosuppression ,0
188192002,Malignant neoplasm of endometrium of corpus uteri (disorder),Malignancy and immunosuppression ,0
188193007,Malignant neoplasm of myometrium of corpus uteri (disorder),Malignancy and immunosuppression ,0
188195000,Malignant neoplasm of isthmus of uterine body (disorder),Malignancy and immunosuppression ,0
188198003,Malignant neoplasm of overlapping lesion of corpus uteri (disorder),Malignancy and immunosuppression ,0
188209005,Malignant neoplasm of vaginal vault (disorder),Malignancy and immunosuppression ,0
188211001,Malignant neoplasm of greater vestibular (Bartholin's) gland (disorder),Malignancy and immunosuppression ,0
188219004,Malignant tumor of undescended testis (disorder),Malignancy and immunosuppression ,0
188220005,Malignant tumor of ectopic testis (disorder),Malignancy and immunosuppression ,0
188230001,Malignant tumor of body of penis (disorder),Malignancy and immunosuppression ,0
188234005,Malignant tumor of seminal vesicle (disorder),Malignancy and immunosuppression ,0
188239000,Malignant tumor of trigone of urinary bladder (disorder),Malignancy and immunosuppression ,0
188240003,Malignant tumor of vault of bladder (disorder),Malignancy and immunosuppression ,0
188241004,Malignant neoplasm of lateral wall of urinary bladder (disorder),Malignancy and immunosuppression ,0
188242006,Malignant neoplasm of anterior wall of urinary bladder (disorder),Malignancy and immunosuppression ,0
188243001,Malignant neoplasm of posterior wall of urinary bladder (disorder),Malignancy and immunosuppression ,0
188244007,Malignant tumor of bladder neck (disorder),Malignancy and immunosuppression ,0
188245008,Malignant tumor of ureteric orifice (disorder),Malignancy and immunosuppression ,0
188247000,"Malignant neoplasm, overlapping lesion of bladder (disorder)",Malignancy and immunosuppression ,0
188250002,Malignant tumor of kidney parenchyma (disorder),Malignancy and immunosuppression ,0
188252005,Malignant tumor of renal calyx (disorder),Malignancy and immunosuppression ,0
188253000,Malignant tumor of pelviureteric junction (disorder),Malignancy and immunosuppression ,0
188256008,Malignant neoplasm of overlapping lesion of urinary organs (disorder),Malignancy and immunosuppression ,0
188261005,"Malignant neoplasm of eyeball excluding conjunctiva, cornea, retina and choroid (disorder)",Malignancy and immunosuppression ,0
188263008,Malignant tumor of ciliary body (disorder),Malignancy and immunosuppression ,0
188264002,Malignant tumor of iris (disorder),Malignancy and immunosuppression ,0
188269007,Malignant neoplasm of extraocular muscle of orbit (disorder),Malignancy and immunosuppression ,0
188272000,Malignant tumor of lacrimal gland (disorder),Malignancy and immunosuppression ,0
188273005,Malignant neoplasm of lacrimal sac (disorder),Malignancy and immunosuppression ,0
188274004,Malignant neoplasm of nasolacrimal duct (disorder),Malignancy and immunosuppression ,0
188280007,Malignant neoplasm of cerebrum (excluding lobes and ventricles) (disorder),Malignancy and immunosuppression ,0
188281006,Malignant neoplasm of basal ganglia (disorder),Malignancy and immunosuppression ,0
188285002,Malignant neoplasm of globus pallidus (disorder),Malignancy and immunosuppression ,0
188286001,Malignant tumor of hypothalamus (disorder),Malignancy and immunosuppression ,0
188287005,Malignant neoplasm of thalamus (disorder),Malignancy and immunosuppression ,0
188289008,Malignant neoplasm of hippocampus (disorder),Malignancy and immunosuppression ,0
188292007,Malignant tumor of choroid plexus (disorder),Malignancy and immunosuppression ,0
188295009,Malignant neoplasm of cerebral peduncle (disorder),Malignancy and immunosuppression ,0
188301005,Malignant neoplasm of corpus callosum (disorder),Malignancy and immunosuppression ,0
188321006,Malignant neoplasm of peripheral nerves and autonomic nervous system (disorder),Malignancy and immunosuppression ,0
188322004,"Malignant neoplasm of peripheral nerves of head, face and neck (disorder)",Malignancy and immunosuppression ,0
188325002,Malignant neoplasm of peripheral nerve of thorax (disorder),Malignancy and immunosuppression ,0
188326001,Malignant neoplasm of peripheral nerve of abdomen (disorder),Malignancy and immunosuppression ,0
188339002,Malignant neoplasm of pituitary gland and craniopharyngeal duct (disorder),Malignancy and immunosuppression ,0
188340000,Malignant tumor of craniopharyngeal duct (disorder),Malignancy and immunosuppression ,0
188353002,"Malignant neoplasm of head, neck and face (disorder)",Malignancy and immunosuppression ,0
188361007,Malignant neoplasm of thorax (disorder),Malignancy and immunosuppression ,0
188366002,Malignant neoplasm of abdomen (disorder),Malignancy and immunosuppression ,0
188445006,Secondary malignant neoplasm of retroperitoneum and peritoneum (disorder),Malignancy and immunosuppression ,0
188454009,Secondary malignant neoplasm of skin of head (disorder),Malignancy and immunosuppression ,0
188458007,Secondary malignant neoplasm of skin of shoulder and arm (disorder),Malignancy and immunosuppression ,0
188462001,Secondary malignant neoplasm of brain and spinal cord (disorder),Malignancy and immunosuppression ,0
188469005,Secondary malignant neoplasm of cervix uteri (disorder),Malignancy and immunosuppression ,0
188478004,Malignant neoplasms of independent (primary) multiple sites (disorder),Malignancy and immunosuppression ,0
188492005,Reticulosarcoma of lymph nodes of axilla and upper limb (disorder),Malignancy and immunosuppression ,0
188498009,Lymphosarcoma (disorder),Malignancy and immunosuppression ,0
188501009,Lymphosarcoma of intrathoracic lymph nodes (disorder),Malignancy and immunosuppression ,0
188502002,Lymphosarcoma of intra-abdominal lymph nodes (disorder),Malignancy and immunosuppression ,0
188510001,"Burkitt's lymphoma of lymph nodes of head, face and neck (disorder)",Malignancy and immunosuppression ,0
188512009,Burkitt's tumor of intra-abdominal lymph nodes,Malignancy and immunosuppression ,0
188512009,Burkitt tumor of intra-abdominal lymph nodes,Malignancy and immunosuppression ,0
188514005,Burkitt's lymphoma of lymph nodes of inguinal region and lower limb (disorder),Malignancy and immunosuppression ,0
188517003,Burkitt tumor of lymph nodes of multiple sites,Malignancy and immunosuppression ,0
188534006,"Hodgkin's granuloma of lymph nodes of head, face and neck (disorder)",Malignancy and immunosuppression ,0
188538009,Hodgkin's granuloma of lymph nodes of inguinal region and lower limb (disorder),Malignancy and immunosuppression ,0
188554007,"Hodgkin's disease, lymphocytic-histiocytic predominance of lymph nodes of head, face and neck (disorder)",Malignancy and immunosuppression ,0
188558005,"Hodgkin's disease, lymphocytic-histiocytic predominance of lymph nodes of axilla and upper limb (disorder)",Malignancy and immunosuppression ,0
188565002,"Hodgkin's disease, nodular sclerosis of lymph nodes of head, face and neck (disorder)",Malignancy and immunosuppression ,0
188566001,"Hodgkin's disease, nodular sclerosis of intrathoracic lymph nodes (disorder)",Malignancy and immunosuppression ,0
188568000,"Hodgkin's disease, nodular sclerosis of lymph nodes of axilla and upper limb (disorder)",Malignancy and immunosuppression ,0
188572001,"Hodgkin's disease, nodular sclerosis of lymph nodes of multiple sites (disorder)",Malignancy and immunosuppression ,0
188575004,"Hodgkin's disease, mixed cellularity of lymph nodes of head, face and neck (disorder)",Malignancy and immunosuppression ,0
188578002,"Hodgkin's disease, mixed cellularity of lymph nodes of axilla and upper limb (disorder)",Malignancy and immunosuppression ,0
188579005,"Hodgkin's disease, mixed cellularity of lymph nodes of inguinal region and lower limb (disorder)",Malignancy and immunosuppression ,0
188585003,"Hodgkin's disease, lymphocytic depletion of lymph nodes of head, face and neck (disorder)",Malignancy and immunosuppression ,0
188589009,"Hodgkin's disease, lymphocytic depletion of lymph nodes of axilla and upper limb (disorder)",Malignancy and immunosuppression ,0
188592008,"Hodgkin's disease, lymphocytic depletion of spleen (disorder)",Malignancy and immunosuppression ,0
188593003,"Hodgkin's disease, lymphocytic depletion of lymph nodes of multiple sites (disorder)",Malignancy and immunosuppression ,0
188609000,"Nodular lymphoma of lymph nodes of head, face and neck (disorder)",Malignancy and immunosuppression ,0
188640007,"Malignant histiocytosis of lymph nodes of head, face and neck (disorder)",Malignancy and immunosuppression ,0
188660004,Malignant mast cell tumors (disorder),Malignancy and immunosuppression ,0
188665009,Mast cell malignancy of lymph nodes of axilla and upper limb (disorder),Malignancy and immunosuppression ,0
188672005,Follicular non-Hodgkin's mixed small cleaved and large cell lymphoma (disorder),Malignancy and immunosuppression ,0
188674006,Diffuse malignant lymphoma - small non-cleaved cell (disorder),Malignancy and immunosuppression ,0
188675007,Malignant lymphoma - small cleaved cell (disorder),Malignancy and immunosuppression ,0
188676008,Malignant lymphoma - mixed small and large cell (disorder),Malignancy and immunosuppression ,0
188679001,Diffuse non-Hodgkin's lymphoma undifferentiated (diffuse) (disorder),Malignancy and immunosuppression ,0
188718006,"Malignant plasma cell neoplasm, extramedullary plasmacytoma (disorder)",Malignancy and immunosuppression ,0
188725004,Lymphoid leukemia (disorder),Malignancy and immunosuppression ,0
188729005,Adult T-cell leukemia (disorder),Malignancy and immunosuppression ,0
188732008,Myeloid leukemia (disorder),Malignancy and immunosuppression ,0
188734009,Chronic neutrophilic leukemia (disorder),Malignancy and immunosuppression ,0
188736006,Subacute myeloid leukemia (disorder),Malignancy and immunosuppression ,0
188737002,Chloroma (disorder),Malignancy and immunosuppression ,0
188738007,Granulocytic sarcoma (disorder),Malignancy and immunosuppression ,0
188744006,Monocytic leukemia (disorder),Malignancy and immunosuppression ,0
188745007,Chronic monocytic leukemia (disorder),Malignancy and immunosuppression ,0
188754005,Megakaryocytic leukemia (disorder),Malignancy and immunosuppression ,0
188768003,Myelomonocytic leukemia (disorder),Malignancy and immunosuppression ,0
189509003,"Refractory anemia without sideroblasts, so stated (disorder)",Malignancy and immunosuppression ,0
190808009,Polyclonal hypergammaglobulinemia (disorder),Malignancy and immunosuppression ,0
190817009,Macroglobulinemia (disorder),Malignancy and immunosuppression ,0
190923000,Sporadic primary amyloidosis (disorder),Malignancy and immunosuppression ,0
190955000,Histiocytosis X syndrome (disorder),Malignancy and immunosuppression ,0
190959006,Hemophagocytic lymphohistiocytosis due to infection (disorder),Malignancy and immunosuppression ,0
190979003,Selective immunoglobulin A deficiency (disorder),Malignancy and immunosuppression ,0
190980000,Selective immunoglobulin M deficiency (disorder),Malignancy and immunosuppression ,0
190981001,Selective immunoglobulin G deficiency (disorder),Malignancy and immunosuppression ,0
190986006,Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia (finding),Malignancy and immunosuppression ,0
190993005,Autosomal recessive severe combined immunodeficiency (disorder),Malignancy and immunosuppression ,0
190996002,Severe combined immunodeficiency with reticular dysgenesis (disorder),Malignancy and immunosuppression ,0
190997006,Severe combined immunodeficiency with low T- and B-cell numbers (disorder),Malignancy and immunosuppression ,0
191001007,Major histocompatibility complex class I deficiency (disorder),Malignancy and immunosuppression ,0
191008001,Immunodeficiency following hereditary defective response to Epstein-Barr virus (disorder),Malignancy and immunosuppression ,0
191011000,Common variable immunodeficiency with predominant abnormalities of B-cell numbers and functions (disorder),Malignancy and immunosuppression ,0
191012007,Common variable immunodeficiency with predominant immunoregulatory T-cell disorders (disorder),Malignancy and immunosuppression ,0
191244003,Aplastic anemia due to chronic disease (disorder),Malignancy and immunosuppression ,0
191246001,Aplastic anemia due to infection (disorder),Malignancy and immunosuppression ,0
191256002,Idiopathic aplastic anemia (disorder),Malignancy and immunosuppression ,0
191347008,Cyclical neutropenia (disorder),Malignancy and immunosuppression ,0
191357009,Eosinophilic disorder (disorder),Malignancy and immunosuppression ,0
191360002,Drug-induced eosinophilia (disorder),Malignancy and immunosuppression ,0
191382009,Chronic congestive splenomegaly (disorder),Malignancy and immunosuppression ,0
193370005,Proliferative retinopathy due to sickle cell disease (disorder),Malignancy and immunosuppression ,0
195136004,Rheumatoid myocarditis (disorder),Malignancy and immunosuppression ,0
197478000,Congenital celiac disease (disorder),Malignancy and immunosuppression ,0
197479008,Acquired celiac disease (disorder),Malignancy and immunosuppression ,0
197747000,Renal tubulo-interstitial disorders in transplant rejection (disorder),Malignancy and immunosuppression ,0
201764007,Rheumatoid arthritis of cervical spine (disorder),Malignancy and immunosuppression ,0
201766009,Rheumatoid arthritis of shoulder (disorder),Malignancy and immunosuppression ,0
201767000,Rheumatoid arthritis of sternoclavicular joint (disorder),Malignancy and immunosuppression ,0
201768005,Rheumatoid arthritis of acromioclavicular joint (disorder),Malignancy and immunosuppression ,0
201769002,Rheumatoid arthritis of elbow (disorder),Malignancy and immunosuppression ,0
201770001,Rheumatoid arthritis of distal radioulnar joint (disorder),Malignancy and immunosuppression ,0
201771002,Rheumatoid arthritis of wrist (disorder),Malignancy and immunosuppression ,0
201772009,Rheumatoid arthritis of metacarpophalangeal joint (disorder),Malignancy and immunosuppression ,0
201773004,Rheumatoid arthritis of proximal interphalangeal joint of finger (disorder),Malignancy and immunosuppression ,0
201774005,Rheumatoid arthritis of distal interphalangeal joint of finger (disorder),Malignancy and immunosuppression ,0
201775006,Rheumatoid arthritis of hip (disorder),Malignancy and immunosuppression ,0
201776007,Rheumatoid arthritis of sacroiliac joint (disorder),Malignancy and immunosuppression ,0
201777003,Rheumatoid arthritis of knee (disorder),Malignancy and immunosuppression ,0
201778008,Rheumatoid arthritis of tibiofibular joint (disorder),Malignancy and immunosuppression ,0
201779000,Rheumatoid arthritis of ankle (disorder),Malignancy and immunosuppression ,0
201780002,Rheumatoid arthritis of subtalar joint (disorder),Malignancy and immunosuppression ,0
201781003,Rheumatoid arthritis of talonavicular joint (disorder),Malignancy and immunosuppression ,0
201783000,Rheumatoid arthritis of first metatarsophalangeal joint (disorder),Malignancy and immunosuppression ,0
201784006,Rheumatoid arthritis of lesser metatarsophalangeal joint (disorder),Malignancy and immunosuppression ,0
201785007,Rheumatoid arthritis of interphalangeal joint of toe (disorder),Malignancy and immunosuppression ,0
201791009,Flare of rheumatoid arthritis (disorder),Malignancy and immunosuppression ,0
205735005,Hypoplasia of spleen (disorder),Malignancy and immunosuppression ,0
210180009,Closed injury of spleen (disorder),Malignancy and immunosuppression ,0
213148006,Transplanted organ rejection (disorder),Malignancy and immunosuppression ,0
213150003,Kidney transplant failure and rejection (disorder),Malignancy and immunosuppression ,0
213151004,Heart transplant failure and rejection (disorder),Malignancy and immunosuppression ,0
213153001,Liver transplant failure and rejection (disorder),Malignancy and immunosuppression ,0
230156002,Malignant meningitis (disorder),Malignancy and immunosuppression ,0
230598008,Neuropathy caused by human immunodeficiency virus (disorder),Malignancy and immunosuppression ,0
231829006,Malignant neoplasm of eyelid (disorder),Malignancy and immunosuppression ,0
231831002,Squamous cell carcinoma of eyelid (disorder),Malignancy and immunosuppression ,0
231833004,Sebaceous adenocarcinoma of eyelid (disorder),Malignancy and immunosuppression ,0
231834005,Malignant melanoma of eyelid (disorder),Malignancy and immunosuppression ,0
232033003,Sickle cell-hemoglobin C retinopathy (disorder),Malignancy and immunosuppression ,0
232657004,Single lung transplant (procedure),Malignancy and immunosuppression ,0
232658009,Double lung transplant (procedure),Malignancy and immunosuppression ,0
232660006,Bilateral sequential single lung transplant (procedure),Malignancy and immunosuppression ,0
232973007,Allotransplant of heart (procedure),Malignancy and immunosuppression ,0
232974001,Orthotopic allotransplant of heart (procedure),Malignancy and immunosuppression ,0
233691007,Asthmatic pulmonary eosinophilia (disorder),Malignancy and immunosuppression ,0
233692000,Cryptogenic pulmonary eosinophilia (disorder),Malignancy and immunosuppression ,0
233932001,Cardiac transplant disorder (disorder),Malignancy and immunosuppression ,0
233940007,Pulmonary tumor embolism (disorder),Malignancy and immunosuppression ,0
234319005,Splenectomy (procedure),Malignancy and immunosuppression ,0
234331007,Syngeneic bone marrow transplant (procedure),Malignancy and immunosuppression ,0
234334004,Allogeneic related bone marrow transplant (procedure),Malignancy and immunosuppression ,0
234335003,Allogeneic unrelated bone marrow transplant (procedure),Malignancy and immunosuppression ,0
234336002,Hemopoietic stem cell transplant (procedure),Malignancy and immunosuppression ,0
234367000,Pancytopenia with pancreatitis (disorder),Malignancy and immunosuppression ,0
234391009,Sickle cell anemia with high hemoglobin F (disorder),Malignancy and immunosuppression ,0
234417006,T-cell lymphocytosis (disorder),Malignancy and immunosuppression ,0
234423001,Chronic benign neutropenia (disorder),Malignancy and immunosuppression ,0
234424007,Metabolic neutropenia (disorder),Malignancy and immunosuppression ,0
234425008,Autoimmune neutropenia (disorder),Malignancy and immunosuppression ,0
234426009,Corticosteroid-induced neutrophilia (disorder),Malignancy and immunosuppression ,0
234427000,Monocytoid disorder (disorder),Malignancy and immunosuppression ,0
234428005,Lymphocytoid disorder (disorder),Malignancy and immunosuppression ,0
234433009,Myeloperoxidase deficiency (disorder),Malignancy and immunosuppression ,0
234434003,Alders syndrome (disorder),Malignancy and immunosuppression ,0
234437005,Hemophagocytic syndrome,Malignancy and immunosuppression ,0
234503004,Hydatid cyst of spleen caused by Echinococcus (disorder),Malignancy and immunosuppression ,0
234511009,Post-splenectomy disorder (disorder),Malignancy and immunosuppression ,0
234512002,Post-splenectomy thrombocytosis (disorder),Malignancy and immunosuppression ,0
234519006,Bone marrow transplant rejection (disorder),Malignancy and immunosuppression ,0
234520000,Bone marrow transplant failure (disorder),Malignancy and immunosuppression ,0
234522008,Disease relapse in transplant marrow (disorder),Malignancy and immunosuppression ,0
234532001,Immunodeficiency disorder (disorder),Malignancy and immunosuppression ,0
234539005,Immunoglobulin heavy chain deficiency (disorder),Malignancy and immunosuppression ,0
234540007,Selective immunoglobulin E deficiency (disorder),Malignancy and immunosuppression ,0
234544003,Immunoglobulin subclass deficiency (disorder),Malignancy and immunosuppression ,0
234546001,Immunoglobulin G2 deficiency (disorder),Malignancy and immunosuppression ,0
234547005,Combined immunoglobulin G2 and G4 deficiency (disorder),Malignancy and immunosuppression ,0
234548000,Immunoglobulin G3 deficiency (disorder),Malignancy and immunosuppression ,0
234549008,Immunoglobulin G4 deficiency (disorder),Malignancy and immunosuppression ,0
234550008,Immunoglobulin G1 deficiency (disorder),Malignancy and immunosuppression ,0
234551007,Immunoglobulin A1 deficiency (disorder),Malignancy and immunosuppression ,0
234552000,Immunoglobulin A2 deficiency (disorder),Malignancy and immunosuppression ,0
234556002,Specific antibody deficiency (disorder),Malignancy and immunosuppression ,0
234559009,Anti-pneumococcal polysaccharide antibody deficiency (disorder),Malignancy and immunosuppression ,0
234571003,"Warts, hypogammaglobulinemia, infections, and myelokathexis (disorder)",Malignancy and immunosuppression ,0
234576008,Chronic familial neutropenia (disorder),Malignancy and immunosuppression ,0
234579001,Mannan-binding protein deficiency (disorder),Malignancy and immunosuppression ,0
234603007,Complement 3 deficiency (disorder),Malignancy and immunosuppression ,0
234619000,Hereditary C1 esterase inhibitor deficiency - deficient factor (disorder),Malignancy and immunosuppression ,0
234620006,Hereditary C1 esterase inhibitor deficiency - dysfunctional factor (disorder),Malignancy and immunosuppression ,0
234621005,Factor I deficiency (disorder),Malignancy and immunosuppression ,0
234631003,Immunodeficiency with major anomalies (disorder),Malignancy and immunosuppression ,0
234634006,Chromosome 18 syndromes and antibody deficiency (disorder),Malignancy and immunosuppression ,0
234639001,"Triple X syndrome, epilepsy, and hypogammaglobulinemia (disorder)",Malignancy and immunosuppression ,0
234645009,Drug-induced immunodeficiency (disorder),Malignancy and immunosuppression ,0
234646005,Graft-versus-host disease (disorder),Malignancy and immunosuppression ,0
235458006,Exploration of liver transplant (procedure),Malignancy and immunosuppression ,0
235910007,Liver transplant disorder (disorder),Malignancy and immunosuppression ,0
235911006,Liver transplant rejection (disorder),Malignancy and immunosuppression ,0
236005001,Malignant ascites (disorder),Malignancy and immunosuppression ,0
236138007,Xenograft renal transplant (procedure),Malignancy and immunosuppression ,0
236406007,Acquired immune deficiency syndrome-related nephropathy (disorder),Malignancy and immunosuppression ,0
236436003,End stage renal failure with renal transplant (disorder),Malignancy and immunosuppression ,0
236513009,Lymphoma of kidney (disorder),Malignancy and immunosuppression ,0
236569000,Primary non-function of renal transplant (disorder),Malignancy and immunosuppression ,0
236570004,Renal transplant rejection (disorder),Malignancy and immunosuppression ,0
236571000,Hyperacute rejection of renal transplant (disorder),Malignancy and immunosuppression ,0
236573002,Very mild acute rejection of renal transplant (disorder),Malignancy and immunosuppression ,0
236574008,Acute rejection of renal transplant (disorder),Malignancy and immunosuppression ,0
236575009,Acute rejection of renal transplant - grade I (disorder),Malignancy and immunosuppression ,0
236576005,Acute rejection of renal transplant - grade II (disorder),Malignancy and immunosuppression ,0
236578006,Chronic rejection of renal transplant (disorder),Malignancy and immunosuppression ,0
236580000,Chronic rejection of renal transplant - grade II (disorder),Malignancy and immunosuppression ,0
236582008,Acute-on-chronic rejection of renal transplant (disorder),Malignancy and immunosuppression ,0
236583003,Failed renal transplant (disorder),Malignancy and immunosuppression ,0
236585005,De novo transplant disease (disorder),Malignancy and immunosuppression ,0
236587002,Transplant glomerulopathy (disorder),Malignancy and immunosuppression ,0
236589004,Transplant glomerulopathy - late form (disorder),Malignancy and immunosuppression ,0
237252008,Placental site trophoblastic tumor (disorder),Malignancy and immunosuppression ,0
237833006,Carcinoid crisis (disorder),Malignancy and immunosuppression ,0
238931006,Eosinophilic cellulitis (disorder),Malignancy and immunosuppression ,0
239791005,Seropositive rheumatoid arthritis (disorder),Malignancy and immunosuppression ,0
239792003,Seronegative rheumatoid arthritis (disorder),Malignancy and immunosuppression ,0
239793008,Rheumatoid arthritis with organ / system involvement (disorder),Malignancy and immunosuppression ,0
239795001,Rheumatoid arthritis with multisystem involvement (disorder),Malignancy and immunosuppression ,0
239942007,Systemic rheumatoid vasculitis (disorder),Malignancy and immunosuppression ,0
239943002,Necrotizing rheumatoid vasculitis (disorder),Malignancy and immunosuppression ,0
240790002,Schistosomal hepatomegaly (disorder),Malignancy and immunosuppression ,0
248693006,Chronic idiopathic neutropenia (disorder),Malignancy and immunosuppression ,0
253000007,Neuroendocrine carcinoma (disorder),Malignancy and immunosuppression ,0
253001006,Merkel cell carcinoma (disorder),Malignancy and immunosuppression ,0
253003009,Carcinoid bronchial adenoma (disorder),Malignancy and immunosuppression ,0
253017000,Klatskin tumor,Malignancy and immunosuppression ,0
253042009,Myxoid dermatofibrosarcoma protuberans (disorder),Malignancy and immunosuppression ,0
254290004,Lymphoproliferative disorder following transplantation (disorder),Malignancy and immunosuppression ,0
254427006,Carcinoma of anterior part of floor of mouth (disorder),Malignancy and immunosuppression ,0
254434008,Carcinoma of hard palate (disorder),Malignancy and immunosuppression ,0
254435009,Carcinoma of soft palate (disorder),Malignancy and immunosuppression ,0
254437001,Squamous cell carcinoma of buccal mucosa (disorder),Malignancy and immunosuppression ,0
254457002,Carcinoma of retromolar area (disorder),Malignancy and immunosuppression ,0
254459004,Malignant tumor of anterior pillar of fauces (disorder),Malignancy and immunosuppression ,0
254462001,Carcinoma of parotid gland (disorder),Malignancy and immunosuppression ,0
254465004,Carcinoma of submandibular gland (disorder),Malignancy and immunosuppression ,0
254551004,Carcinoma of lower third of esophagus (disorder),Malignancy and immunosuppression ,0
254553001,Carcinoma of cardia (disorder),Malignancy and immunosuppression ,0
254557000,Carcinoma of body of stomach (disorder),Malignancy and immunosuppression ,0
254559002,Carcinoma of pyloric antrum (disorder),Malignancy and immunosuppression ,0
254563009,Carcinoma of lesser curve of stomach (disorder),Malignancy and immunosuppression ,0
254570009,Carcinoma of duodenum (disorder),Malignancy and immunosuppression ,0
254582000,Adenocarcinoma of rectum (disorder),Malignancy and immunosuppression ,0
254586002,Malignant tumor of anorectal junction (disorder),Malignancy and immunosuppression ,0
254601002,Sarcoma of liver (disorder),Malignancy and immunosuppression ,0
254609000,Carcinoma of ampulla of Vater (disorder),Malignancy and immunosuppression ,0
254611009,Malignant tumor of endocrine pancreas (disorder),Malignancy and immunosuppression ,0
254612002,Carcinoma of endocrine pancreas (disorder),Malignancy and immunosuppression ,0
254619006,Adenoid cystic carcinoma of trachea (disorder),Malignancy and immunosuppression ,0
254620000,Squamous cell carcinoma of trachea (disorder),Malignancy and immunosuppression ,0
254622008,Squamous cell carcinoma of bronchus (disorder),Malignancy and immunosuppression ,0
254625005,Malignant tumor of lung parenchyma (disorder),Malignancy and immunosuppression ,0
254626006,Adenocarcinoma of lung (disorder),Malignancy and immunosuppression ,0
254627002,Carcinoid tumor of lung (disorder),Malignancy and immunosuppression ,0
254628007,Carcinoma of lung parenchyma (disorder),Malignancy and immunosuppression ,0
254629004,Large cell carcinoma of lung (disorder),Malignancy and immunosuppression ,0
254632001,Small cell carcinoma of lung (disorder),Malignancy and immunosuppression ,0
254634000,Squamous cell carcinoma of lung (disorder),Malignancy and immunosuppression ,0
254635004,Epithelioid hemangioendothelioma of lung (disorder),Malignancy and immunosuppression ,0
254637007,Non-small cell lung cancer (disorder),Malignancy and immunosuppression ,0
254638002,Pancoast tumor (disorder),Malignancy and immunosuppression ,0
254645002,Malignant mesothelioma of pleura (disorder),Malignancy and immunosuppression ,0
254653005,Spindle cell squamous carcinoma of skin (disorder),Malignancy and immunosuppression ,0
254707006,Malignant skin tumor with eccrine differentiation (disorder),Malignancy and immunosuppression ,0
254708001,Eccrine porocarcinoma of skin (disorder),Malignancy and immunosuppression ,0
254709009,Digital papillary eccrine carcinoma of skin (disorder),Malignancy and immunosuppression ,0
254711000,Adenoid cystic eccrine carcinoma of skin (disorder),Malignancy and immunosuppression ,0
254712007,Microcystic adnexal carcinoma of skin (disorder),Malignancy and immunosuppression ,0
254713002,Mucoepidermoid carcinoma of skin (disorder),Malignancy and immunosuppression ,0
254714008,Mucinous eccrine carcinoma of skin (disorder),Malignancy and immunosuppression ,0
254730000,Superficial spreading malignant melanoma of skin (disorder),Malignancy and immunosuppression ,0
254731001,Nodular malignant melanoma of skin (disorder),Malignancy and immunosuppression ,0
254732008,Acral lentiginous malignant melanoma of skin (disorder),Malignancy and immunosuppression ,0
254733003,Malignant melanoma arising in intradermal nevus (disorder),Malignancy and immunosuppression ,0
254748009,Cutaneous fibrosarcoma (disorder),Malignancy and immunosuppression ,0
254771006,Cutaneous leiomyosarcoma (disorder),Malignancy and immunosuppression ,0
254794007,Angiosarcoma of skin (disorder),Malignancy and immunosuppression ,0
254800003,Epithelioid cell sarcoma of skin (disorder),Malignancy and immunosuppression ,0
254824006,Malignant tumor of mesothelial tissue (disorder),Malignancy and immunosuppression ,0
254828009,Malignant lipomatous tumor (disorder),Malignancy and immunosuppression ,0
254829001,Liposarcoma (disorder),Malignancy and immunosuppression ,0
254837009,Malignant neoplasm of breast (disorder),Malignancy and immunosuppression ,0
254838004,Carcinoma of breast (disorder),Malignancy and immunosuppression ,0
254839007,Scirrhous carcinoma of breast (disorder),Malignancy and immunosuppression ,0
254840009,Inflammatory carcinoma of breast (disorder),Malignancy and immunosuppression ,0
254843006,Familial cancer of breast (disorder),Malignancy and immunosuppression ,0
254844000,Malignant phyllodes tumor of breast (disorder),Malignancy and immunosuppression ,0
254849005,Malignant epithelial tumor of ovary (disorder),Malignancy and immunosuppression ,0
254850005,Serous papillary cystadenocarcinoma ovary (disorder),Malignancy and immunosuppression ,0
254851009,Mucinous cystadenocarcinoma of ovary (disorder),Malignancy and immunosuppression ,0
254852002,Endometrioid carcinoma ovary (disorder),Malignancy and immunosuppression ,0
254856004,Undifferentiated carcinoma of ovary (disorder),Malignancy and immunosuppression ,0
254861002,Malignant granulosa cell tumor of ovary (disorder),Malignancy and immunosuppression ,0
254863004,Malignant granulosa cell tumor of ovary,Malignancy and immunosuppression ,0
254869000,Malignant germ cell tumor of ovary (disorder),Malignancy and immunosuppression ,0
254871000,Immature teratoma of ovary (disorder),Malignancy and immunosuppression ,0
254874008,Dysgerminoma of ovary (disorder),Malignancy and immunosuppression ,0
254876005,Endodermal sinus tumor of ovary (disorder),Malignancy and immunosuppression ,0
254877001,Sarcoma of uterus (disorder),Malignancy and immunosuppression ,0
254878006,Endometrial carcinoma (disorder),Malignancy and immunosuppression ,0
254886006,Squamous cell carcinoma of cervix (disorder),Malignancy and immunosuppression ,0
254887002,Adenocarcinoma of cervix (disorder),Malignancy and immunosuppression ,0
254888007,Adenosquamous carcinoma of cervix (disorder),Malignancy and immunosuppression ,0
254889004,Carcinoma of cervix stage 0 (disorder),Malignancy and immunosuppression ,0
254893005,Carcinoma of vagina (disorder),Malignancy and immunosuppression ,0
254895003,Squamous cell carcinoma of vulva (disorder),Malignancy and immunosuppression ,0
254896002,Malignant melanoma of vulva (disorder),Malignancy and immunosuppression ,0
254897006,Sarcoma of vulva (disorder),Malignancy and immunosuppression ,0
254900004,Carcinoma of prostate (disorder),Malignancy and immunosuppression ,0
254904008,Carcinoma of glans penis (disorder),Malignancy and immunosuppression ,0
254912000,Regressed malignant testicular tumor (disorder),Malignancy and immunosuppression ,0
254915003,Clear cell carcinoma of kidney (disorder),Malignancy and immunosuppression ,0
254918001,Sarcoma of kidney (disorder),Malignancy and immunosuppression ,0
254938000,Astrocytoma of brain (disorder),Malignancy and immunosuppression ,0
254940005,Oligodendroglioma of brain (disorder),Malignancy and immunosuppression ,0
254948003,Astrocytoma of spinal cord (disorder),Malignancy and immunosuppression ,0
254955001,Pituitary carcinoma (disorder),Malignancy and immunosuppression ,0
254975005,Malignant meningioma of optic nerve sheath (disorder),Malignancy and immunosuppression ,0
254980001,Malignant tumor of acoustic vestibular nerve (disorder),Malignancy and immunosuppression ,0
254986007,Malignant tumor of peripheral nerve (disorder),Malignancy and immunosuppression ,0
254987003,Adenoid cystic carcinoma of lacrimal gland (disorder),Malignancy and immunosuppression ,0
254990009,Mucoepidermoid tumor of lacrimal gland (disorder),Malignancy and immunosuppression ,0
254994000,Rhabdomyosarcoma of orbit (disorder),Malignancy and immunosuppression ,0
254996003,Malignant fibrous histiocytoma of orbit (disorder),Malignancy and immunosuppression ,0
255003007,Squamous cell carcinoma of conjunctiva (disorder),Malignancy and immunosuppression ,0
255004001,Malignant melanoma of conjunctiva (disorder),Malignancy and immunosuppression ,0
255012009,Malignant melanoma of iris (disorder),Malignancy and immunosuppression ,0
255015006,Malignant melanoma of ciliary body (disorder),Malignancy and immunosuppression ,0
255021005,Malignant melanoma of choroid (disorder),Malignancy and immunosuppression ,0
255028004,FTC - follicular thyroid carcinoma,Malignancy and immunosuppression ,0
255029007,PTC - papillary thyroid carcinoma,Malignancy and immunosuppression ,0
255030002,Mixed follicular and papillary thyroid carcinoma (disorder),Malignancy and immunosuppression ,0
255031003,Anaplastic thyroid carcinoma (disorder),Malignancy and immunosuppression ,0
255032005,Medullary thyroid carcinoma (disorder),Malignancy and immunosuppression ,0
255035007,Adrenal carcinoma (disorder),Malignancy and immunosuppression ,0
255037004,Parathyroid carcinoma (disorder),Malignancy and immunosuppression ,0
255052006,Malignant neoplasm of unknown origin (disorder),Malignancy and immunosuppression ,0
255056009,Malignant tumor of head and/or neck (disorder),Malignancy and immunosuppression ,0
255066001,Carcinoma of genitourinary organ (disorder),Malignancy and immunosuppression ,0
255067005,Sarcoma of bone and connective tissue (disorder),Malignancy and immunosuppression ,0
255068000,"Carcinoma of bone, connective tissue, skin and breast (disorder)",Malignancy and immunosuppression ,0
255069008,"Carcinoma of lip, oral cavity and/or pharynx (disorder)",Malignancy and immunosuppression ,0
255071008,Squamous cell carcinoma of lip (disorder),Malignancy and immunosuppression ,0
255072001,Malignant tumor of salivary gland (disorder),Malignancy and immunosuppression ,0
255073006,"Malignant tumor of ear, nose and throat (disorder)",Malignancy and immunosuppression ,0
255074000,Malignant tumor of nasal cavity and nasopharynx (disorder),Malignancy and immunosuppression ,0
255077007,Malignant tumor of digestive organ (disorder),Malignancy and immunosuppression ,0
255081007,Carcinoma of cecum (disorder),Malignancy and immunosuppression ,0
255083005,Malignant tumor of anus and anal canal (disorder),Malignancy and immunosuppression ,0
255084004,Squamous cell carcinoma of anal margin (disorder),Malignancy and immunosuppression ,0
255086002,Carcinoma common bile duct (disorder),Malignancy and immunosuppression ,0
255087006,Malignant polyp of biliary tract (disorder),Malignancy and immunosuppression ,0
255088001,Malignant tumor of exocrine pancreas (disorder),Malignancy and immunosuppression ,0
255102004,Angioendotheliomatosis (disorder),Malignancy and immunosuppression ,0
255107005,Seminoma of testis (disorder),Malignancy and immunosuppression ,0
255108000,Carcinoma of bladder (disorder),Malignancy and immunosuppression ,0
255109008,Transitional cell carcinoma of bladder (disorder),Malignancy and immunosuppression ,0
255110003,Adenocarcinoma of bladder (disorder),Malignancy and immunosuppression ,0
255111004,Squamous cell carcinoma of bladder (disorder),Malignancy and immunosuppression ,0
255118005,Secondary lymphangitic carcinoma (disorder),Malignancy and immunosuppression ,0
255119002,Lymphangitis carcinomatosa (disorder),Malignancy and immunosuppression ,0
255121007,Carcinomatosis of peritoneal cavity (disorder),Malignancy and immunosuppression ,0
255127006,Local tumor spread (disorder),Malignancy and immunosuppression ,0
255128001,Malignant infiltration of peripheral nerve (disorder),Malignancy and immunosuppression ,0
262819007,Intraparenchymal hematoma of spleen (disorder),Malignancy and immunosuppression ,0
262823004,Capsular tear of spleen (disorder),Malignancy and immunosuppression ,0
263661007,Complement 5 dysfunction (disorder),Malignancy and immunosuppression ,0
265760000,Intravenous chemotherapy (procedure),Malignancy and immunosuppression ,0
265761001,Intramuscular chemotherapy (procedure),Malignancy and immunosuppression ,0
265762008,Subcutaneous chemotherapy (procedure),Malignancy and immunosuppression ,0
266719004,Oral chemotherapy (procedure),Malignancy and immunosuppression ,0
267440005,Monoclonal paraproteinemia (disorder),Malignancy and immunosuppression ,0
267454002,Acatalasemia (disorder),Malignancy and immunosuppression ,0
267460002,Congenital hypogammaglobulinemia (finding),Malignancy and immunosuppression ,0
267527002,Aplastic anemia due to drugs (disorder),Malignancy and immunosuppression ,0
267540007,Neutropenia caused by irradiation (disorder),Malignancy and immunosuppression ,0
267543009,Functional disorders of polymorphonuclear neutrophils (disorder),Malignancy and immunosuppression ,0
268500004,Prophylactic chemotherapy (procedure),Malignancy and immunosuppression ,0
269295009,Transplanted organ failure (disorder),Malignancy and immunosuppression ,0
269459004,Malignant tumor of lesser curve of stomach (disorder),Malignancy and immunosuppression ,0
269460009,Malignant tumor of greater curve of stomach (disorder),Malignancy and immunosuppression ,0
269464000,"Malignant neoplasm of upper lobe, bronchus or lung (disorder)",Malignancy and immunosuppression ,0
269467007,Malignant neoplasm of hand bones (disorder),Malignancy and immunosuppression ,0
269469005,Malignant neoplasm of soft tissue (disorder),Malignancy and immunosuppression ,0
269473008,Secondary malignant neoplasm of respiratory and digestive systems (disorder),Malignancy and immunosuppression ,0
269475001,"Malignant tumor of lymphoid, hemopoietic AND/OR related tissue (disorder)",Malignancy and immunosuppression ,0
269476000,Nodular lymphoma (disorder),Malignancy and immunosuppression ,0
269515006,Carcinoma of lip (disorder),Malignancy and immunosuppression ,0
269516007,Tongue carcinoma (disorder),Malignancy and immunosuppression ,0
269533000,Carcinoma of colon (disorder),Malignancy and immunosuppression ,0
269544008,Carcinoma of the rectosigmoid junction (disorder),Malignancy and immunosuppression ,0
269578002,Malignant melanoma of head and neck (disorder),Malignancy and immunosuppression ,0
269579005,Malignant melanoma of trunk (disorder),Malignancy and immunosuppression ,0
269580008,Malignant melanoma of upper limb (disorder),Malignancy and immunosuppression ,0
269581007,Malignant melanoma of lower limb (disorder),Malignancy and immunosuppression ,0
269616004,Secondary nodes - axilla/arm (disorder),Malignancy and immunosuppression ,0
271323007,"Malignant neoplasm of lip, oral cavity and/or pharynx (disorder)",Malignancy and immunosuppression ,0
271467005,"Malignant neoplasm of bone, connective tissue, skin and breast (disorder)",Malignancy and immunosuppression ,0
271468000,Malignant neoplasm of genitourinary organ (disorder),Malignancy and immunosuppression ,0
271558008,Infectious mononucleosis (disorder),Malignancy and immunosuppression ,0
271568003,Malignant tumor of lower labial mucosa (disorder),Malignancy and immunosuppression ,0
271943005,Carcinoma of base of tongue (disorder),Malignancy and immunosuppression ,0
274084007,Palate carcinoma (disorder),Malignancy and immunosuppression ,0
274085008,Tonsil carcinoma (disorder),Malignancy and immunosuppression ,0
274087000,Malignant melanoma of eye (disorder),Malignancy and immunosuppression ,0
274088005,Secondary malignant neoplasm of unknown site (disorder),Malignancy and immunosuppression ,0
274902006,Combined hepatocellular carcinoma and cholangiocarcinoma (disorder),Malignancy and immunosuppression ,0
275266006,Metastasis to digestive organs (disorder),Malignancy and immunosuppression ,0
275399006,Malignant tumor of lipstick area of lip (disorder),Malignancy and immunosuppression ,0
275419009,Primary vulval cancer (disorder),Malignancy and immunosuppression ,0
275524009,Immunoproliferative neoplasm (disorder),Malignancy and immunosuppression ,0
275828002,Preventing infection of immunocompromised patient (procedure),Malignancy and immunosuppression ,0
275830000,Reverse barrier nursing (procedure),Malignancy and immunosuppression ,0
276666007,Congenital human immunodeficiency virus positive status syndrome (disorder),Malignancy and immunosuppression ,0
276751004,Amelanotic malignant melanoma of skin (disorder),Malignancy and immunosuppression ,0
276799004,DFSP - dermatofibrosarcoma protuberans,Malignancy and immunosuppression ,0
276803003,Adenocarcinoma of esophagus (disorder),Malignancy and immunosuppression ,0
276804009,Squamous cell carcinoma of esophagus (disorder),Malignancy and immunosuppression ,0
276808007,Carcinoid tumor of stomach (disorder),Malignancy and immunosuppression ,0
276809004,Early gastric cancer (disorder),Malignancy and immunosuppression ,0
276810009,Late gastric cancer (disorder),Malignancy and immunosuppression ,0
276811008,Gastric lymphoma (disorder),Malignancy and immunosuppression ,0
276815004,Lymphoma of intestine (disorder),Malignancy and immunosuppression ,0
276821000,Malignant melanoma of anus (disorder),Malignancy and immunosuppression ,0
276822007,Malignant melanoma of rectum (disorder),Malignancy and immunosuppression ,0
276826005,Malignant glioma of brain (disorder),Malignancy and immunosuppression ,0
276828006,Glioblastoma multiforme of brain (disorder),Malignancy and immunosuppression ,0
276836002,Primary cerebral lymphoma (disorder),Malignancy and immunosuppression ,0
276870001,Carcinoma of fallopian tube (disorder),Malignancy and immunosuppression ,0
276876007,Carcinoma of Bartholin's gland (disorder),Malignancy and immunosuppression ,0
276952000,Squamous cell carcinoma of tongue (disorder),Malignancy and immunosuppression ,0
276953005,Squamous cell carcinoma of gum (disorder),Malignancy and immunosuppression ,0
276954004,Squamous cell carcinoma of floor of mouth (disorder),Malignancy and immunosuppression ,0
276962007,Squamous cell carcinoma of palate (disorder),Malignancy and immunosuppression ,0
276975007,Carcinoma of larynx (disorder),Malignancy and immunosuppression ,0
277010001,Unexplained episode of renal transplant dysfunction (disorder),Malignancy and immunosuppression ,0
277156006,Malignant tumor of external ear (disorder),Malignancy and immunosuppression ,0
277461004,Anaplastic astrocytoma of brain (disorder),Malignancy and immunosuppression ,0
277466009,Lymphoproliferative disorder (disorder),Malignancy and immunosuppression ,0
277473004,B-cell chronic lymphocytic leukemia (disorder),Malignancy and immunosuppression ,0
277474005,B-cell chronic lymphocytic leukemia variant (disorder),Malignancy and immunosuppression ,0
277505007,Medulloblastoma of cerebellum (disorder),Malignancy and immunosuppression ,0
277543005,Malignant white blood cell disorder (disorder),Malignancy and immunosuppression ,0
277545003,T-cell chronic lymphocytic leukemia (disorder),Malignancy and immunosuppression ,0
277549009,Chronic lymphocytic prolymphocytic leukemia syndrome (disorder),Malignancy and immunosuppression ,0
277551008,Splenic lymphoma with villous lymphocytes (disorder),Malignancy and immunosuppression ,0
277567002,T-cell prolymphocytic leukemia (disorder),Malignancy and immunosuppression ,0
277568007,Hairy cell leukemia variant (disorder),Malignancy and immunosuppression ,0
277569004,Large granular lymphocytic leukemia (disorder),Malignancy and immunosuppression ,0
277571004,B-cell acute lymphoblastic leukemia (disorder),Malignancy and immunosuppression ,0
277572006,Precursor B-cell acute lymphoblastic leukemia,Malignancy and immunosuppression ,0
277573001,Common acute lymphoblastic leukemia (disorder),Malignancy and immunosuppression ,0
277575008,T-cell acute lymphoblastic leukemia (disorder),Malignancy and immunosuppression ,0
277577000,Monoclonal gammopathy of uncertain significance (disorder),Malignancy and immunosuppression ,0
277579002,Light chain myeloma (disorder),Malignancy and immunosuppression ,0
277589003,Atypical chronic myeloid leukemia (disorder),Malignancy and immunosuppression ,0
277597005,Myelodysplastic syndrome with isolated del(5q) (disorder),Malignancy and immunosuppression ,0
277601005,Acute monoblastic leukemia (disorder),Malignancy and immunosuppression ,0
277605001,Tumor lysis syndrome (disorder),Malignancy and immunosuppression ,0
277610002,"Hodgkin's disease, nodular sclerosis - lymphocytic predominance (disorder)",Malignancy and immunosuppression ,0
277613000,Cutaneous/peripheral T-cell lymphoma (disorder),Malignancy and immunosuppression ,0
277615007,Low grade B-cell lymphoma (disorder),Malignancy and immunosuppression ,0
277616008,Diffuse low grade B-cell lymphoma (disorder),Malignancy and immunosuppression ,0
277617004,High grade B-cell lymphoma (disorder),Malignancy and immunosuppression ,0
277618009,Follicular low grade B-cell lymphoma (disorder),Malignancy and immunosuppression ,0
277622004,Mucosa-associated lymphoma (disorder),Malignancy and immunosuppression ,0
277623009,Monocytoid B-cell lymphoma (disorder),Malignancy and immunosuppression ,0
277624003,Follicular malignant lymphoma - mixed cell type (disorder),Malignancy and immunosuppression ,0
277625002,Follicular malignant lymphoma - small cleaved cell (disorder),Malignancy and immunosuppression ,0
277626001,Diffuse high grade B-cell lymphoma (disorder),Malignancy and immunosuppression ,0
277629008,Diffuse malignant lymphoma - large non-cleaved cell (disorder),Malignancy and immunosuppression ,0
277637000,Large cell anaplastic lymphoma (disorder),Malignancy and immunosuppression ,0
277641001,Follicular malignant lymphoma - large cell (disorder),Malignancy and immunosuppression ,0
277642008,Low grade T-cell lymphoma (disorder),Malignancy and immunosuppression ,0
277643003,High grade T-cell lymphoma (disorder),Malignancy and immunosuppression ,0
277653002,Peripheral T-cell lymphoma - pleomorphic medium and large cell (disorder),Malignancy and immunosuppression ,0
277654008,Enteropathy-associated T-cell lymphoma (disorder),Malignancy and immunosuppression ,0
277664004,Malignant lymphoma of testis (disorder),Malignancy and immunosuppression ,0
277782009,Malignant peritoneal local recurrence (disorder),Malignancy and immunosuppression ,0
278042005,Malignant teratoma of mediastinum (disorder),Malignancy and immunosuppression ,0
278043000,Malignant seminoma of mediastinum (disorder),Malignancy and immunosuppression ,0
278046008,Sarcoma of bladder (disorder),Malignancy and immunosuppression ,0
278050001,Sarcoma of breast (disorder),Malignancy and immunosuppression ,0
278051002,Malignant lymphoma of thyroid gland (disorder),Malignancy and immunosuppression ,0
278052009,Malignant lymphoma of breast (disorder),Malignancy and immunosuppression ,0
278053004,Intraductal carcinoma of breast (disorder),Malignancy and immunosuppression ,0
278054005,Lobular carcinoma of breast (disorder),Malignancy and immunosuppression ,0
278055006,Malignant Leydig cell tumor of testis (disorder),Malignancy and immunosuppression ,0
278057003,Sertoli cell tumor of testis (disorder),Malignancy and immunosuppression ,0
278065000,Pancoast's syndrome (disorder),Malignancy and immunosuppression ,0
278257006,Peripheral blood stem cell graft (procedure),Malignancy and immunosuppression ,0
278433008,Malignant infiltration of soft tissue (disorder),Malignancy and immunosuppression ,0
278453007,Acute biphenotypic leukemia (disorder),Malignancy and immunosuppression ,0
278484009,Tropical pulmonary eosinophilia (disorder),Malignancy and immunosuppression ,0
278491007,Mixed seminoma teratoma of testis (disorder),Malignancy and immunosuppression ,0
281562007,Adrenal neuroblastoma (disorder),Malignancy and immunosuppression ,0
281563002,Thoracic neuroblastoma (disorder),Malignancy and immunosuppression ,0
281564008,Pelvic neuroblastoma (disorder),Malignancy and immunosuppression ,0
281565009,Paraspinal neuroblastoma (disorder),Malignancy and immunosuppression ,0
281566005,Abdominothoracic neuroblastoma (disorder),Malignancy and immunosuppression ,0
281702006,Tibial adamantinoma (disorder),Malignancy and immunosuppression ,0
285310000,Carcinoma of anal canal (disorder),Malignancy and immunosuppression ,0
285312008,Carcinoma of sigmoid colon (disorder),Malignancy and immunosuppression ,0
285420006,Immunoglobulin A myeloma (disorder),Malignancy and immunosuppression ,0
285421005,Immunoglobulin G myeloma (disorder),Malignancy and immunosuppression ,0
285422003,Immunoglobulin D myeloma (disorder),Malignancy and immunosuppression ,0
285423008,Immunoglobulin A monoclonal gammopathy of uncertain significance (disorder),Malignancy and immunosuppression ,0
285424002,Immunoglobulin G monoclonal gammopathy of uncertain significance (disorder),Malignancy and immunosuppression ,0
285426000,Immunoglobulin M monoclonal gammopathy of uncertain significance (disorder),Malignancy and immunosuppression ,0
285428004,Immunoglobulin D monoclonal gammopathy of uncertain significance (disorder),Malignancy and immunosuppression ,0
285430002,Light chain monoclonal gammopathy of uncertain significance (disorder),Malignancy and immunosuppression ,0
285432005,Carcinoma of cervix (disorder),Malignancy and immunosuppression ,0
285604008,Metastasis to lung of unknown primary (disorder),Malignancy and immunosuppression ,0
285605009,Metastasis to pleura of unknown primary (disorder),Malignancy and immunosuppression ,0
285609003,Metastasis to small intestine of unknown primary (disorder),Malignancy and immunosuppression ,0
285610008,Metastasis to large intestine of unknown primary (disorder),Malignancy and immunosuppression ,0
285611007,Metastasis to colon of unknown primary (disorder),Malignancy and immunosuppression ,0
285613005,Metastasis to liver of unknown primary (disorder),Malignancy and immunosuppression ,0
285614004,Metastasis to pancreas of unknown primary (disorder),Malignancy and immunosuppression ,0
285616002,Metastasis to peritoneum of unknown primary (disorder),Malignancy and immunosuppression ,0
285617006,Metastasis to retroperitoneum of unknown primary (disorder),Malignancy and immunosuppression ,0
285618001,Metastasis to bone of unknown primary (disorder),Malignancy and immunosuppression ,0
285619009,Metastasis to vertebral column of unknown primary (disorder),Malignancy and immunosuppression ,0
285637005,Metastasis to ovary of unknown primary (disorder),Malignancy and immunosuppression ,0
285641009,Metastasis to brain of unknown primary (disorder),Malignancy and immunosuppression ,0
285644001,Metastasis to lymph node of unknown primary (disorder),Malignancy and immunosuppression ,0
285645000,Disseminated malignancy of unknown primary (disorder),Malignancy and immunosuppression ,0
285776004,Intermediate grade B-cell lymphoma (disorder),Malignancy and immunosuppression ,0
286887005,Carcinoma liver and/or biliary system (disorder),Malignancy and immunosuppression ,0
286893002,"Carcinoma of breast - upper, inner quadrant (disorder)",Malignancy and immunosuppression ,0
286894008,"Carcinoma of breast - lower, inner quadrant (disorder)",Malignancy and immunosuppression ,0
286895009,"Carcinoma of breast - upper, outer quadrant (disorder)",Malignancy and immunosuppression ,0
286896005,"Carcinoma breast - lower, outer quadrant (disorder)",Malignancy and immunosuppression ,0
286897001,Carcinoma of breast - axillary tail (disorder),Malignancy and immunosuppression ,0
287006005,Rheumatoid arthritis of multiple joints (disorder),Malignancy and immunosuppression ,0
287007001,Rheumatoid arthritis of hand joint (disorder),Malignancy and immunosuppression ,0
287008006,Rheumatoid arthritis of ankle and/or foot (disorder),Malignancy and immunosuppression ,0
287239002,Thymus transplantation (procedure),Malignancy and immunosuppression ,0
300564004,Spleen absent (finding),Malignancy and immunosuppression ,0
300988009,Transitional cell carcinoma of ureter (disorder),Malignancy and immunosuppression ,0
301756000,Adenocarcinoma of sigmoid colon (disorder),Malignancy and immunosuppression ,0
302816009,"Malignant tumor of soft tissue of head, face and neck (disorder)",Malignancy and immunosuppression ,0
302817000,Malignant tumor of unknown origin or ill-defined site (disorder),Malignancy and immunosuppression ,0
302835009,Chromaffin tumor,Malignancy and immunosuppression ,0
302837001,Lentigo maligna melanoma (disorder),Malignancy and immunosuppression ,0
302841002,Malignant lymphoma - small lymphocytic (disorder),Malignancy and immunosuppression ,0
302847003,Rhabdomyosarcoma (disorder),Malignancy and immunosuppression ,0
302849000,Nephroblastoma (disorder),Malignancy and immunosuppression ,0
302851001,Synovial sarcoma (disorder),Malignancy and immunosuppression ,0
302874002,Phagocytic cell dysfunction (disorder),Malignancy and immunosuppression ,0
303011007,Neutropenic disorder (disorder),Malignancy and immunosuppression ,0
303012000,Malignant tumor of posterior wall of hypopharynx (disorder),Malignancy and immunosuppression ,0
303017006,"Malignant lymphoma, convoluted cell type (disorder)",Malignancy and immunosuppression ,0
303055001,"Malignant lymphoma, follicular center cell (disorder)",Malignancy and immunosuppression ,0
303194003,Metastasis to head and neck lymph node (disorder),Malignancy and immunosuppression ,0
303201005,Metastasis to multiple lymph nodes (disorder),Malignancy and immunosuppression ,0
304545002,Adenocarcinoma of ileum (disorder),Malignancy and immunosuppression ,0
306058006,Aplastic anemia (disorder),Malignancy and immunosuppression ,0
307219002,Retroperitoneal sarcoma (disorder),Malignancy and immunosuppression ,0
307226002,Metastatic adenocarcinoma of unknown origin (disorder),Malignancy and immunosuppression ,0
307340003,Monosomy 7 syndrome (disorder),Malignancy and immunosuppression ,0
307341004,Atypical hairy cell leukemia (disorder),Malignancy and immunosuppression ,0
307502000,Squamous cell carcinoma of mouth (disorder),Malignancy and immunosuppression ,0
307576001,Osteosarcoma of bone (disorder),Malignancy and immunosuppression ,0
307593001,Carcinomatosis (disorder),Malignancy and immunosuppression ,0
307599002,Sebaceous adenocarcinoma (disorder),Malignancy and immunosuppression ,0
307601000,Pseudomyxoma peritonei (disorder),Malignancy and immunosuppression ,0
307603002,Malignant blue nevus of skin (disorder),Malignancy and immunosuppression ,0
307608006,Ewing's sarcoma of bone (disorder),Malignancy and immunosuppression ,0
307623001,Malignant lymphoma - lymphoplasmacytic (disorder),Malignancy and immunosuppression ,0
307646004,"Malignant lymphoma, lymphocytic, poorly differentiated, nodular (disorder)",Malignancy and immunosuppression ,0
307649006,Microglioma (disorder),Malignancy and immunosuppression ,0
307651005,Myelosclerosis with myeloid metaplasia (disorder),Malignancy and immunosuppression ,0
308121000,Follicular non-Hodgkin's lymphoma (disorder),Malignancy and immunosuppression ,0
308143008,Seropositive erosive rheumatoid arthritis (disorder),Malignancy and immunosuppression ,0
308683001,Transluminal right ventricular biopsy after heart transplant (procedure),Malignancy and immunosuppression ,0
309245001,Adenocarcinoma of uterus (disorder),Malignancy and immunosuppression ,0
310498001,Malignant melanoma of back (disorder),Malignancy and immunosuppression ,0
310504009,Primary malignant neoplasm of unknown site (disorder),Malignancy and immunosuppression ,0
310599006,Malignant neoplasm of canthus (disorder),Malignancy and immunosuppression ,0
312104005,Cholangiocarcinoma of biliary tract (disorder),Malignancy and immunosuppression ,0
312111009,Carcinoma of ascending colon (disorder),Malignancy and immunosuppression ,0
312112002,Carcinoma of transverse colon (disorder),Malignancy and immunosuppression ,0
312113007,Carcinoma of descending colon (disorder),Malignancy and immunosuppression ,0
312114001,Carcinoma of hepatic flexure (disorder),Malignancy and immunosuppression ,0
312115000,Carcinoma of splenic flexure (disorder),Malignancy and immunosuppression ,0
312603000,Lung transplant rejection (disorder),Malignancy and immunosuppression ,0
313030004,Donor renal transplantation (procedure),Malignancy and immunosuppression ,0
313248004,Malignant melanoma of chest wall (disorder),Malignancy and immunosuppression ,0
313249007,Malignant neoplasm of upper eyelid (disorder),Malignancy and immunosuppression ,0
313250007,Malignant neoplasm of lower eyelid (disorder),Malignancy and immunosuppression ,0
313353007,Squamous cell carcinoma of bronchus in left lower lobe (disorder),Malignancy and immunosuppression ,0
313354001,Squamous cell carcinoma of bronchus in left upper lobe (disorder),Malignancy and immunosuppression ,0
313355000,Squamous cell carcinoma of bronchus in right lower lobe (disorder),Malignancy and immunosuppression ,0
313356004,Squamous cell carcinoma of bronchus in right middle lobe (disorder),Malignancy and immunosuppression ,0
313357008,Squamous cell carcinoma of bronchus in right upper lobe (disorder),Malignancy and immunosuppression ,0
313427003,Lambda light chain myeloma (disorder),Malignancy and immunosuppression ,0
313428008,Seminoma of undescended testis (disorder),Malignancy and immunosuppression ,0
313429000,Seminoma of descended testis (disorder),Malignancy and immunosuppression ,0
314118002,Laparoscopic total splenectomy (procedure),Malignancy and immunosuppression ,0
314191009,Cystadenocarcinoma of ovary (disorder),Malignancy and immunosuppression ,0
314418005,Leukemic infiltrate of retina (disorder),Malignancy and immunosuppression ,0
314951005,Local recurrence of malignant tumor of tongue (disorder),Malignancy and immunosuppression ,0
314952003,Local recurrence of malignant tumor of buccal cavity (disorder),Malignancy and immunosuppression ,0
314953008,Local recurrence of malignant tumor of thyroid gland (disorder),Malignancy and immunosuppression ,0
314954002,Local recurrence of malignant tumor of lung (disorder),Malignancy and immunosuppression ,0
314955001,Local recurrence of malignant tumor of breast (disorder),Malignancy and immunosuppression ,0
314960002,Local recurrence of malignant tumor of esophagus (disorder),Malignancy and immunosuppression ,0
314962005,Local recurrence of malignant tumor of gallbladder (disorder),Malignancy and immunosuppression ,0
314963000,Local recurrence of malignant tumor of liver (disorder),Malignancy and immunosuppression ,0
314964006,Local recurrence of malignant tumor of pancreas (disorder),Malignancy and immunosuppression ,0
314965007,Local recurrence of malignant tumor of colon (disorder),Malignancy and immunosuppression ,0
314966008,Local recurrence of malignant tumor of rectum (disorder),Malignancy and immunosuppression ,0
314967004,Local recurrence of malignant tumor of kidney (disorder),Malignancy and immunosuppression ,0
314968009,Local recurrence of malignant tumor of urinary bladder (disorder),Malignancy and immunosuppression ,0
314969001,Local recurrence of malignant tumor of prostate (disorder),Malignancy and immunosuppression ,0
314970000,Local recurrence of malignant tumor of cervix (disorder),Malignancy and immunosuppression ,0
314973003,Local recurrence of malignant tumor of bone (disorder),Malignancy and immunosuppression ,0
314974009,Local recurrence of malignant tumor of soft tissue (disorder),Malignancy and immunosuppression ,0
314976006,Local recurrence of malignant melanoma of skin (disorder),Malignancy and immunosuppression ,0
314987003,Metastasis from malignant melanoma of skin (disorder),Malignancy and immunosuppression ,0
314988008,Metastasis from malignant tumor of skin (disorder),Malignancy and immunosuppression ,0
314989000,Metastasis from malignant tumor of soft tissues (disorder),Malignancy and immunosuppression ,0
314990009,Metastasis from malignant tumor of bone (disorder),Malignancy and immunosuppression ,0
314992001,Metastasis from malignant tumor of cervix (disorder),Malignancy and immunosuppression ,0
314993006,Metastasis from malignant tumor of uterus (disorder),Malignancy and immunosuppression ,0
314994000,Metastasis from malignant tumor of prostate (disorder),Malignancy and immunosuppression ,0
314995004,Metastasis from malignant tumor of bladder (disorder),Malignancy and immunosuppression ,0
314996003,Metastasis from malignant tumor of kidney (disorder),Malignancy and immunosuppression ,0
314997007,Metastasis from malignant tumor of rectum (disorder),Malignancy and immunosuppression ,0
314998002,Metastasis from malignant tumor of colon (disorder),Malignancy and immunosuppression ,0
314999005,Metastasis from malignant tumor of pancreas (disorder),Malignancy and immunosuppression ,0
315000005,Metastasis from malignant tumor of liver (disorder),Malignancy and immunosuppression ,0
315001009,Metastasis from malignant tumor of gallbladder (disorder),Malignancy and immunosuppression ,0
315002002,Metastasis from malignant tumor of stomach (disorder),Malignancy and immunosuppression ,0
315003007,Metastasis from malignant tumor of esophagus (disorder),Malignancy and immunosuppression ,0
315004001,Metastasis from malignant tumor of breast (disorder),Malignancy and immunosuppression ,0
315005000,Metastasis from malignant tumor of bronchus (disorder),Malignancy and immunosuppression ,0
315006004,Metastasis from malignant neoplasm of lung,Malignancy and immunosuppression ,0
315007008,Metastasis from malignant tumor of thyroid (disorder),Malignancy and immunosuppression ,0
315009006,Metastasis from malignant tumor of tongue (disorder),Malignancy and immunosuppression ,0
315058005,Hereditary nonpolyposis colon cancer (disorder),Malignancy and immunosuppression ,0
315601005,Ambulatory chemotherapy (procedure),Malignancy and immunosuppression ,0
320150004,Idiopathic eosinophilia (disorder),Malignancy and immunosuppression ,0
326072005,Carcinoma of head of pancreas (disorder),Malignancy and immunosuppression ,0
326723005,Product containing precisely busulfan 2 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
326729009,Product containing precisely chlorambucil 2 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
326731000,Product containing precisely cyclophosphamide 50 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
326734008,Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug),Malignancy and immunosuppression ,0
326735009,Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug),Malignancy and immunosuppression ,0
326755005,Product containing precisely ifosfamide 1 gram/1 vial powder for conventional release solution for injection (clinical drug),Malignancy and immunosuppression ,0
326760009,Product containing precisely lomustine 40 milligram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
326766003,Product containing precisely melphalan 2 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
326814002,Product containing precisely mitomycin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug),Malignancy and immunosuppression ,0
326816000,Product containing precisely mitomycin 2 milligram/1 vial powder for conventional release solution for injection (clinical drug),Malignancy and immunosuppression ,0
326873001,Product containing precisely mercaptopurine 50 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
326874007,Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
326875008,Product containing precisely methotrexate 10 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
326908005,Product containing precisely tioguanine 40 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
326909002,Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug),Malignancy and immunosuppression ,0
326916001,Product containing precisely raltitrexed 2 milligram/1 vial powder for conventional release solution for injection (clinical drug),Malignancy and immunosuppression ,0
326924006,Product containing precisely etoposide (as etoposide phosphate) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug),Malignancy and immunosuppression ,0
326925007,Product containing precisely etoposide 50 milligram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
326991007,Product containing precisely hydroxycarbamide 500 milligram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
327008000,Product containing precisely pentostatin 10 milligram/1 vial powder for conventional release solution for injection (clinical drug),Malignancy and immunosuppression ,0
327035009,Product containing precisely oxaliplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug),Malignancy and immunosuppression ,0
327042009,Product containing precisely temozolomide 5 milligram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
327043004,Product containing precisely temozolomide 20 milligram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
327044005,Product containing precisely temozolomide 100 milligram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
327070006,Product containing precisely azathioprine 50 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
327071005,Product containing precisely azathioprine 25 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
327072003,Product containing precisely azathioprine 50 milligram/1 vial powder for conventional release solution for injection (clinical drug),Malignancy and immunosuppression ,0
327082002,Product containing precisely ciclosporin 25 milligram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
327083007,Product containing precisely ciclosporin 100 milligram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
327085000,Product containing precisely ciclosporin 50 milligram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
327090002,Product containing precisely ciclosporin 10 milligram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
327096008,Product containing precisely tacrolimus 1 milligram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
327097004,Product containing precisely tacrolimus 5 milligram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
327103006,Product containing precisely tacrolimus 500 microgram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
327104000,Product containing precisely mycophenolate mofetil 250 milligram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
327106003,Product containing precisely mycophenolate mofetil 500 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
327109005,Product containing precisely mycophenolate mofetil (as mycophenolate mofetil hydrochloride) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug),Malignancy and immunosuppression ,0
327399009,Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection (clinical drug),Malignancy and immunosuppression ,0
330026007,Product containing precisely penicillamine 125 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
330027003,Product containing precisely penicillamine 250 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
330057007,Product containing precisely leflunomide 10 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
330058002,Product containing precisely leflunomide 20 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
361195001,Pulmonary fibroplasia (disorder),Malignancy and immunosuppression ,0
363346000,Malignant neoplastic disease (disorder),Malignancy and immunosuppression ,0
363348004,Malignant tumor of lip (disorder),Malignancy and immunosuppression ,0
363349007,Malignant tumor of stomach (disorder),Malignancy and immunosuppression ,0
363350007,Malignant tumor of cecum (disorder),Malignancy and immunosuppression ,0
363351006,Malignant tumor of rectum (disorder),Malignancy and immunosuppression ,0
363352004,Malignant tumor of anal canal (disorder),Malignancy and immunosuppression ,0
363353009,Malignant tumor of gallbladder (disorder),Malignancy and immunosuppression ,0
363354003,Malignant tumor of cervix (disorder),Malignancy and immunosuppression ,0
363355002,Malignant tumor of adrenal gland (disorder),Malignancy and immunosuppression ,0
363357005,Malignant neoplasm of ill-defined site (disorder),Malignancy and immunosuppression ,0
363358000,Malignant tumor of lung (disorder),Malignancy and immunosuppression ,0
363360003,Malignant tumor of anterior two-thirds of tongue (disorder),Malignancy and immunosuppression ,0
363363001,Malignant tumor of soft tissue of shoulder (disorder),Malignancy and immunosuppression ,0
363366009,Malignant tumor of soft tissue of pelvis (disorder),Malignancy and immunosuppression ,0
363367000,Malignant tumor of vulva (disorder),Malignancy and immunosuppression ,0
363369002,Carcinoma of tail of pancreas (disorder),Malignancy and immunosuppression ,0
363370001,Malignant neoplasm of mesentery (disorder),Malignancy and immunosuppression ,0
363373004,Malignant tumor of vermilion border of lower lip (disorder),Malignancy and immunosuppression ,0
363375006,Malignant tumor of tongue (disorder),Malignancy and immunosuppression ,0
363376007,Malignant tumor of base of tongue (disorder),Malignancy and immunosuppression ,0
363377003,Malignant tumor of lingual tonsil (disorder),Malignancy and immunosuppression ,0
363378008,Malignant tumor of major salivary gland (disorder),Malignancy and immunosuppression ,0
363379000,Malignant tumor of parotid gland (disorder),Malignancy and immunosuppression ,0
363380002,Malignant tumor of submandibular gland (disorder),Malignancy and immunosuppression ,0
363381003,Malignant tumor of sublingual gland (disorder),Malignancy and immunosuppression ,0
363382005,Malignant tumor of gum (disorder),Malignancy and immunosuppression ,0
363383000,Malignant tumor of upper gingiva (disorder),Malignancy and immunosuppression ,0
363384006,Malignant tumor of lower gingiva (disorder),Malignancy and immunosuppression ,0
363385007,Malignant tumor of floor of mouth (disorder),Malignancy and immunosuppression ,0
363386008,Malignant tumor of buccal mucosa (disorder),Malignancy and immunosuppression ,0
363387004,Malignant tumor of hard palate (disorder),Malignancy and immunosuppression ,0
363388009,Malignant tumor of soft palate (disorder),Malignancy and immunosuppression ,0
363389001,Malignant tumor of uvula (disorder),Malignancy and immunosuppression ,0
363390005,Malignant tumor of palate (disorder),Malignancy and immunosuppression ,0
363391009,Malignant tumor of retromolar area (disorder),Malignancy and immunosuppression ,0
363392002,Malignant tumor of oropharynx (disorder),Malignancy and immunosuppression ,0
363393007,Malignant tumor of tonsil (disorder),Malignancy and immunosuppression ,0
363394001,Malignant tumor of tonsillar fossa (disorder),Malignancy and immunosuppression ,0
363396004,Malignant tumor of branchial cleft (disorder),Malignancy and immunosuppression ,0
363399006,Malignant tumor of hypopharynx (disorder),Malignancy and immunosuppression ,0
363400004,Malignant tumor of postcricoid region (disorder),Malignancy and immunosuppression ,0
363401000,Malignant tumor of pyriform fossa (disorder),Malignancy and immunosuppression ,0
363402007,Malignant tumor of esophagus (disorder),Malignancy and immunosuppression ,0
363403002,Malignant tumor of duodenum (disorder),Malignancy and immunosuppression ,0
363404008,Malignant tumor of jejunum (disorder),Malignancy and immunosuppression ,0
363405009,Malignant tumor of ileum (disorder),Malignancy and immunosuppression ,0
363406005,Malignant neoplasm of colon (disorder),Malignancy and immunosuppression ,0
363407001,Malignant tumor of hepatic flexure (disorder),Malignancy and immunosuppression ,0
363408006,Malignant tumor of transverse colon (disorder),Malignancy and immunosuppression ,0
363409003,Malignant tumor of descending colon (disorder),Malignancy and immunosuppression ,0
363410008,Malignant tumor of sigmoid colon (disorder),Malignancy and immunosuppression ,0
363411007,Malignant tumor of appendix (disorder),Malignancy and immunosuppression ,0
363412000,Malignant tumor of ascending colon (disorder),Malignancy and immunosuppression ,0
363413005,Malignant tumor of splenic flexure (disorder),Malignancy and immunosuppression ,0
363414004,Malignant tumor of rectosigmoid junction (disorder),Malignancy and immunosuppression ,0
363415003,Malignant tumor of biliary tract (disorder),Malignancy and immunosuppression ,0
363416002,Malignant tumor of extrahepatic bile duct (disorder),Malignancy and immunosuppression ,0
363417006,Malignant tumor of ampulla of Vater (disorder),Malignancy and immunosuppression ,0
363418001,Malignant tumor of pancreas (disorder),Malignancy and immunosuppression ,0
363419009,Malignant tumor of head of pancreas (disorder),Malignancy and immunosuppression ,0
363420003,Malignant retroperitoneal tumor (disorder),Malignancy and immunosuppression ,0
363421004,Malignant neoplasm of omentum (disorder),Malignancy and immunosuppression ,0
363422006,Malignant tumor of nasal cavity (disorder),Malignancy and immunosuppression ,0
363423001,Malignant tumor of nasal septum (disorder),Malignancy and immunosuppression ,0
363425008,Malignant tumor of maxillary sinus (disorder),Malignancy and immunosuppression ,0
363426009,Malignant tumor of ethmoid sinus (disorder),Malignancy and immunosuppression ,0
363427000,Malignant tumor of frontal sinus (disorder),Malignancy and immunosuppression ,0
363428005,Malignant tumor of sphenoid sinus (disorder),Malignancy and immunosuppression ,0
363429002,Malignant tumor of larynx (disorder),Malignancy and immunosuppression ,0
363430007,Malignant tumor of subglottis (disorder),Malignancy and immunosuppression ,0
363431006,Malignant tumor of laryngeal cartilage (disorder),Malignancy and immunosuppression ,0
363432004,Malignant tumor of trachea (disorder),Malignancy and immunosuppression ,0
363433009,Malignant tumor of pleura (disorder),Malignancy and immunosuppression ,0
363434003,Malignant tumor of thymus (disorder),Malignancy and immunosuppression ,0
363436001,Malignant tumor of endocardium (disorder),Malignancy and immunosuppression ,0
363438000,Malignant tumor of vertebral column (disorder),Malignancy and immunosuppression ,0
363439008,Malignant tumor of soft tissue of head (disorder),Malignancy and immunosuppression ,0
363440005,Malignant tumor of soft tissue of face (disorder),Malignancy and immunosuppression ,0
363441009,Malignant tumor of soft tissue of neck (disorder),Malignancy and immunosuppression ,0
363443007,Malignant tumor of ovary (disorder),Malignancy and immunosuppression ,0
363444001,Malignant tumor of fallopian tube (disorder),Malignancy and immunosuppression ,0
363445000,Malignant tumor of vagina (disorder),Malignancy and immunosuppression ,0
363446004,Malignant neoplasm of labia majora (disorder),Malignancy and immunosuppression ,0
363447008,Malignant neoplasm of labia minora (disorder),Malignancy and immunosuppression ,0
363449006,Malignant tumor of testis (disorder),Malignancy and immunosuppression ,0
363451005,Malignant tumor of glans penis (disorder),Malignancy and immunosuppression ,0
363453008,Malignant tumor of spermatic cord (disorder),Malignancy and immunosuppression ,0
363454002,Malignant tumor of scrotum (disorder),Malignancy and immunosuppression ,0
363456000,Malignant tumor of urachus (disorder),Malignancy and immunosuppression ,0
363457009,Malignant tumor of renal pelvis (disorder),Malignancy and immunosuppression ,0
363458004,Malignant tumor of ureter (disorder),Malignancy and immunosuppression ,0
363459007,Malignant tumor of urethra (disorder),Malignancy and immunosuppression ,0
363460002,Malignant tumor of paraurethral gland (disorder),Malignancy and immunosuppression ,0
363461003,Malignant tumor of eye (disorder),Malignancy and immunosuppression ,0
363462005,Malignant tumor of orbit (disorder),Malignancy and immunosuppression ,0
363463000,Malignant tumor of conjunctiva (disorder),Malignancy and immunosuppression ,0
363465007,Malignant tumor of retina (disorder),Malignancy and immunosuppression ,0
363466008,Malignant tumor of choroid (disorder),Malignancy and immunosuppression ,0
363467004,Malignant neoplasm of frontal lobe (disorder),Malignancy and immunosuppression ,0
363468009,Malignant neoplasm of temporal lobe (disorder),Malignancy and immunosuppression ,0
363469001,Malignant neoplasm of parietal lobe (disorder),Malignancy and immunosuppression ,0
363471001,Malignant neoplasm of cerebral ventricles (disorder),Malignancy and immunosuppression ,0
363473003,Malignant neoplasm of brainstem (disorder),Malignancy and immunosuppression ,0
363474009,Malignant neoplasm of cerebral meninges (disorder),Malignancy and immunosuppression ,0
363475005,Malignant tumor of spinal cord (disorder),Malignancy and immunosuppression ,0
363476006,Malignant neoplasm of spinal meninges (disorder),Malignancy and immunosuppression ,0
363477002,Malignant neoplasm of cauda equina (disorder),Malignancy and immunosuppression ,0
363478007,Malignant tumor of thyroid gland (disorder),Malignancy and immunosuppression ,0
363481002,Malignant tumor of parathyroid gland (disorder),Malignancy and immunosuppression ,0
363482009,Malignant tumor of pituitary gland (disorder),Malignancy and immunosuppression ,0
363483004,Malignant tumor of pineal gland (disorder),Malignancy and immunosuppression ,0
363484005,Malignant tumor of pelvis (disorder),Malignancy and immunosuppression ,0
363485006,Malignant tumor of minor salivary gland (disorder),Malignancy and immunosuppression ,0
363486007,Malignant tumor of vocal cord (disorder),Malignancy and immunosuppression ,0
363487003,Malignant tumor of aryepiglottic fold - laryngeal aspect (disorder),Malignancy and immunosuppression ,0
363489000,Malignant tumor of neck (disorder),Malignancy and immunosuppression ,0
363490009,Malignant tumor of anus (disorder),Malignancy and immunosuppression ,0
363491008,Malignant tumor of cloacogenic zone (disorder),Malignancy and immunosuppression ,0
363492001,Malignant tumor of peritoneum (disorder),Malignancy and immunosuppression ,0
363493006,Malignant tumor of bronchus (disorder),Malignancy and immunosuppression ,0
363494000,Malignant tumor of mediastinum (disorder),Malignancy and immunosuppression ,0
363495004,Malignant tumor of muscle (disorder),Malignancy and immunosuppression ,0
363497007,Malignant tumor of meninges (disorder),Malignancy and immunosuppression ,0
363498002,Malignant tumor of optic nerve (disorder),Malignancy and immunosuppression ,0
363499005,Malignant tumor of spleen (disorder),Malignancy and immunosuppression ,0
363500001,Multiple malignancy (disorder),Malignancy and immunosuppression ,0
363501002,Malignant tumor of face (disorder),Malignancy and immunosuppression ,0
363502009,Malignant tumor of axilla (disorder),Malignancy and immunosuppression ,0
363503004,Malignant tumor of upper limb (disorder),Malignancy and immunosuppression ,0
363504005,Malignant tumor of lower limb (disorder),Malignancy and immunosuppression ,0
363505006,Malignant tumor of oral cavity (disorder),Malignancy and immunosuppression ,0
363506007,Malignant tumor of nasal sinuses (disorder),Malignancy and immunosuppression ,0
363507003,Malignant neoplasm of pharynx (disorder),Malignancy and immunosuppression ,0
363508008,Malignant tumor of intestine (disorder),Malignancy and immunosuppression ,0
363509000,Malignant tumor of small intestine (disorder),Malignancy and immunosuppression ,0
363510005,Malignant tumor of large intestine (disorder),Malignancy and immunosuppression ,0
363514001,Malignant tumor of female genital organ (disorder),Malignancy and immunosuppression ,0
363515000,Malignant tumor of male genital organ (disorder),Malignancy and immunosuppression ,0
363516004,Malignant tumor of penis (disorder),Malignancy and immunosuppression ,0
363518003,Malignant tumor of kidney (disorder),Malignancy and immunosuppression ,0
363688001,Administration of antineoplastic agent (procedure),Malignancy and immunosuppression ,0
367336001,Chemotherapy (procedure),Malignancy and immunosuppression ,0
370388006,Patient immunocompromised (finding),Malignancy and immunosuppression ,0
370391006,Patient immunosuppressed (finding),Malignancy and immunosuppression ,0
370967009,Retinoblastoma (disorder),Malignancy and immunosuppression ,0
371964008,Malignant neoplasm of adrenal cortex (disorder),Malignancy and immunosuppression ,0
371965009,Malignant neoplasm of adrenal medulla (disorder),Malignancy and immunosuppression ,0
371972005,Malignant neoplasm of body of uterus (disorder),Malignancy and immunosuppression ,0
371973000,Malignant neoplasm of uterus (disorder),Malignancy and immunosuppression ,0
371979001,Malignant neoplasm of clitoris (disorder),Malignancy and immunosuppression ,0
371982006,Malignant neoplasm of endocrine gland (disorder),Malignancy and immunosuppression ,0
372003004,Primary malignant neoplasm of pancreas (disorder),Malignancy and immunosuppression ,0
372016004,Primary malignant neoplasm of the peritoneum (disorder),Malignancy and immunosuppression ,0
372062007,Malignant neoplasm of central nervous system (disorder),Malignancy and immunosuppression ,0
372063002,Malignant neoplasm of nervous system (disorder),Malignancy and immunosuppression ,0
372064008,Malignant neoplasm of female breast (disorder),Malignancy and immunosuppression ,0
372065009,Malignant neoplasm of main bronchus (disorder),Malignancy and immunosuppression ,0
372087000,Primary malignant neoplasm (disorder),Malignancy and immunosuppression ,0
372094002,Malignant neoplasm of axillary tail of breast (disorder),Malignancy and immunosuppression ,0
372095001,Malignant neoplasm of male breast (disorder),Malignancy and immunosuppression ,0
372097009,Malignant neoplasm of endocervix (disorder),Malignancy and immunosuppression ,0
372099007,Malignant neoplasm of exocervix (disorder),Malignancy and immunosuppression ,0
372100004,Carcinoma of exocervix (disorder),Malignancy and immunosuppression ,0
372111007,"Carcinoma of lower lobe, bronchus or lung (disorder)",Malignancy and immunosuppression ,0
372113005,"Carcinoma of middle lobe, bronchus or lung (disorder)",Malignancy and immunosuppression ,0
372119009,Primary malignant neoplasm of head of pancreas (disorder),Malignancy and immunosuppression ,0
372136001,"Carcinoma of upper lobe, bronchus or lung (disorder)",Malignancy and immunosuppression ,0
372137005,Primary malignant neoplasm of breast (disorder),Malignancy and immunosuppression ,0
372138000,Carcinoma of esophagus (disorder),Malignancy and immunosuppression ,0
372140005,Carcinoma of gallbladder (disorder),Malignancy and immunosuppression ,0
372141009,Carcinoma of vocal cord (disorder),Malignancy and immunosuppression ,0
372142002,Carcinoma of pancreas (disorder),Malignancy and immunosuppression ,0
372143007,Carcinoma of stomach (disorder),Malignancy and immunosuppression ,0
372244006,Malignant melanoma (disorder),Malignancy and immunosuppression ,0
373168002,Reticulosarcoma (disorder),Malignancy and immunosuppression ,0
374369007,Product containing precisely mitotane 500 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
374572004,Product containing precisely anagrelide hydrochloride 500 microgram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
374872005,Product containing precisely bexarotene 75 milligram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
387759001,Chronic granulomatous disease (disorder),Malignancy and immunosuppression ,0
394894008,Pre-operative chemotherapy (procedure),Malignancy and immunosuppression ,0
394895009,Postoperative chemotherapy (procedure),Malignancy and immunosuppression ,0
394934009,Combined pre-operative chemotherapy and radiotherapy (procedure),Malignancy and immunosuppression ,0
394935005,Combined post-operative chemotherapy and radiotherapy (procedure),Malignancy and immunosuppression ,0
395278001,Product containing precisely sirolimus 1 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
396331005,Celiac disease (disorder),Malignancy and immunosuppression ,0
397009000,Mast cell malignancy (disorder),Malignancy and immunosuppression ,0
397016004,Systemic mast cell disease (disorder),Malignancy and immunosuppression ,0
398055000,T-lymphocyte deficiency (finding),Malignancy and immunosuppression ,0
398250003,Genetic haemophagocytic lymphohistiocytosis,Malignancy and immunosuppression ,0
398250003,Genetic hemophagocytic lymphohistiocytosis,Malignancy and immunosuppression ,0
398271008,Predominantly T-cell defect (finding),Malignancy and immunosuppression ,0
398329009,Human immunodeficiency virus encephalitis (disorder),Malignancy and immunosuppression ,0
398623004,Refractory anemia with excess blasts (disorder),Malignancy and immunosuppression ,0
398640008,Rheumatoid pneumoconiosis (disorder),Malignancy and immunosuppression ,0
398670003,Pigmented dermatofibrosarcoma protuberans of skin (disorder),Malignancy and immunosuppression ,0
398726004,Rheumatoid lung disease (disorder),Malignancy and immunosuppression ,0
399042005,Chemotherapy cycle (procedure),Malignancy and immunosuppression ,0
399068003,Malignant tumor of prostate (disorder),Malignancy and immunosuppression ,0
399326009,Malignant tumor of urinary bladder (disorder),Malignancy and immunosuppression ,0
399490008,Adenocarcinoma of prostate (disorder),Malignancy and immunosuppression ,0
399923009,Rheumatoid arteritis (disorder),Malignancy and immunosuppression ,0
400001003,Primary cutaneous lymphoma (disorder),Malignancy and immunosuppression ,0
400054000,Rheumatoid vasculitis (disorder),Malignancy and immunosuppression ,0
400122007,Primary cutaneous T-cell lymphoma (disorder),Malignancy and immunosuppression ,0
400565002,Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug),Malignancy and immunosuppression ,0
400687000,Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug),Malignancy and immunosuppression ,0
402355000,Acute graft-versus-host disease (disorder),Malignancy and immunosuppression ,0
402356004,Chronic graft-versus-host disease (disorder),Malignancy and immunosuppression ,0
402815007,Squamous cell carcinoma (disorder),Malignancy and immunosuppression ,0
403900000,Spindle cell squamous cell carcinoma (disorder),Malignancy and immunosuppression ,0
403906006,Metastatic squamous cell carcinoma (disorder),Malignancy and immunosuppression ,0
404037002,Malignant neurilemoma,Malignancy and immunosuppression ,0
404133000,Subcutaneous panniculitic cutaneous T-cell lymphoma (disorder),Malignancy and immunosuppression ,0
405843009,Widespread metastatic malignant neoplastic disease (disorder),Malignancy and immunosuppression ,0
405945003,Malignant neoplasm of metatarsal bone of foot (disorder),Malignancy and immunosuppression ,0
407101003,Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
407797002,Product containing precisely imatinib 100 milligram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
408155001,Product containing precisely sirolimus 2 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
408643008,Infiltrating duct carcinoma of breast (disorder),Malignancy and immunosuppression ,0
408645001,Adenocarcinoma of large intestine (disorder),Malignancy and immunosuppression ,0
409089005,Febrile neutropenia (disorder),Malignancy and immunosuppression ,0
410950003,Product containing precisely imatinib 400 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
413441006,"Acute monocytic leukemia, FAB M5b (disorder)",Malignancy and immunosuppression ,0
413587002,Smoldering myeloma (disorder),Malignancy and immunosuppression ,0
413738001,Cancer monitoring first letter (procedure),Malignancy and immunosuppression ,0
413739009,Cancer monitoring invitation (procedure),Malignancy and immunosuppression ,0
413740006,Cancer monitoring second letter (procedure),Malignancy and immunosuppression ,0
413741005,Cancer monitoring third letter (procedure),Malignancy and immunosuppression ,0
413842007,Chronic myeloid leukemia in lymphoid blast crisis (disorder),Malignancy and immunosuppression ,0
413843002,Chronic myeloid leukemia in myeloid blast crisis (disorder),Malignancy and immunosuppression ,0
414029004,Disorder of immune function (disorder),Malignancy and immunosuppression ,0
414124007,Product containing precisely erlotinib (as erlotinib hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
414126009,Product containing precisely erlotinib (as erlotinib hydrochloride) 25 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
414166008,"Extranodal natural killer/T-cell lymphoma, nasal type (disorder)",Malignancy and immunosuppression ,0
414461007,Product containing precisely imatinib 100 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
414462000,Product containing precisely imatinib 400 milligram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
414553000,Kappa light chain myeloma (disorder),Malignancy and immunosuppression ,0
415082004,Personal history of primary malignant neoplasm of lung (situation),Malignancy and immunosuppression ,0
415112005,Plasmacytoma (disorder),Malignancy and immunosuppression ,0
416180004,Hemoglobin SS disease without crisis (disorder),Malignancy and immunosuppression ,0
416402001,Gestational trophoblastic disease (disorder),Malignancy and immunosuppression ,0
416669000,Invasive hydatidiform mole (disorder),Malignancy and immunosuppression ,0
416712009,Clear cell (mesonephric) neoplasm of ovary (disorder),Malignancy and immunosuppression ,0
416769008,Malignant teratoma of testis (disorder),Malignancy and immunosuppression ,0
416842003,Malignant sacral teratoma (disorder),Malignancy and immunosuppression ,0
417084004,Cancer monitoring verbal invitation (procedure),Malignancy and immunosuppression ,0
417279003,Hemoglobin S sickling disorder with crisis (disorder),Malignancy and immunosuppression ,0
417357006,Sickling disorder due to hemoglobin S (disorder),Malignancy and immunosuppression ,0
417417007,Malignant teratoma of undescended testis (disorder),Malignancy and immunosuppression ,0
417425009,Hemoglobin SS disease with crisis (disorder),Malignancy and immunosuppression ,0
417554000,Malignant teratoma of descended testis (disorder),Malignancy and immunosuppression ,0
417570003,Gestational choriocarcinoma (disorder),Malignancy and immunosuppression ,0
419052002,Malignant tumor of urinary system (disorder),Malignancy and immunosuppression ,0
420403001,Pneumocystosis associated with acquired immunodeficiency syndrome (disorder),Malignancy and immunosuppression ,0
420524008,Kaposi's sarcoma associated with acquired immunodeficiency syndrome (disorder),Malignancy and immunosuppression ,0
420637003,Product containing precisely sunitinib (as sunitinib malate) 25 milligram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
420788006,Intraocular non-Hodgkin malignant lymphoma (disorder),Malignancy and immunosuppression ,0
420818005,Mycobacteriosis associated with acquired immunodeficiency syndrome (disorder),Malignancy and immunosuppression ,0
420897004,Product containing precisely sunitinib (as sunitinib malate) 12.5 milligram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
420966002,Product containing precisely lenalidomide 10 milligram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
420994005,Product containing precisely sorafenib (as sorafenib tosylate) 200 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
421249001,Malignant tumor of vermilion border of lip (disorder),Malignancy and immunosuppression ,0
421398007,Product containing precisely sunitinib (as sunitinib malate) 50 milligram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
421671002,Pneumonia associated with acquired immunodeficiency syndrome (disorder),Malignancy and immunosuppression ,0
422003001,Cachexia associated with acquired immunodeficiency syndrome (finding),Malignancy and immunosuppression ,0
422330004,Product containing precisely lenalidomide 5 milligram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
423294001,Idiopathic hypereosinophilic syndrome (disorder),Malignancy and immunosuppression ,0
424058002,Product containing precisely dasatinib 20 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
424254006,Product containing precisely dasatinib 50 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
424952003,Sarcoma of soft tissue (disorder),Malignancy and immunosuppression ,0
425066001,"Carcinoma of urinary bladder, invasive (disorder)",Malignancy and immunosuppression ,0
425333006,Myeloproliferative disorder (disorder),Malignancy and immunosuppression ,0
425616008,Transplantation of ileum (procedure),Malignancy and immunosuppression ,0
425688002,Philadelphia chromosome-positive acute lymphoblastic leukemia (disorder),Malignancy and immunosuppression ,0
425843001,Allogeneic peripheral blood stem cell transplant (procedure),Malignancy and immunosuppression ,0
425983008,Autologous peripheral blood stem cell transplant (procedure),Malignancy and immunosuppression ,0
426202004,Immune reconstitution syndrome (disorder),Malignancy and immunosuppression ,0
426336007,Solitary osseous myeloma (disorder),Malignancy and immunosuppression ,0
426356008,Orthotopic transplantation of whole liver (procedure),Malignancy and immunosuppression ,0
426425001,Allograft of bone marrow from sibling donor (procedure),Malignancy and immunosuppression ,0
427423003,Allograft of bone marrow from matched unrelated donor (procedure),Malignancy and immunosuppression ,0
427492003,Hormone refractory prostate cancer (disorder),Malignancy and immunosuppression ,0
427685000,Human epidermal growth factor 2 positive carcinoma of breast (disorder),Malignancy and immunosuppression ,0
427962003,Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
428061005,Malignant neoplasm of brain (disorder),Malignancy and immunosuppression ,0
428100006,Malignant neoplasm of thoracic cavity structure (disorder),Malignancy and immunosuppression ,0
428281000,Malignant neoplasm of bone (disorder),Malignancy and immunosuppression ,0
428322007,Malignant neoplasm of uterine adnexa (disorder),Malignancy and immunosuppression ,0
428403002,Product containing precisely topotecan 250 microgram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
428645009,Examination of recipient after kidney transplant (procedure),Malignancy and immunosuppression ,0
428905002,Malignant neoplasm of gastrointestinal tract (disorder),Malignancy and immunosuppression ,0
429033009,Malignant neoplasm of cerebrum (disorder),Malignancy and immunosuppression ,0
429054002,Disorder related to transplantation (disorder),Malignancy and immunosuppression ,0
429192004,Rheumatoid arthritis of foot (disorder),Malignancy and immunosuppression ,0
429332008,Transplantation of single lobe of lung (procedure),Malignancy and immunosuppression ,0
429451003,Disorder related to renal transplantation (disorder),Malignancy and immunosuppression ,0
429490004,Disorder affecting transplanted structure (disorder),Malignancy and immunosuppression ,0
430478003,Macrophage activation syndrome (disorder),Malignancy and immunosuppression ,0
430556008,Malignant neoplasm of genital structure (disorder),Malignancy and immunosuppression ,0
430621000,Malignant neoplasm of lower respiratory tract (disorder),Malignancy and immunosuppression ,0
441313008,Indolent multiple myeloma (disorder),Malignancy and immunosuppression ,0
441482006,History of sickle cell anemia (situation),Malignancy and immunosuppression ,0
441726005,Product containing precisely everolimus 5 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
441953000,Product containing precisely everolimus 10 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
442537007,Non-Hodgkin lymphoma associated with Human immunodeficiency virus infection (disorder),Malignancy and immunosuppression ,0
443487006,Mantle cell lymphoma (disorder),Malignancy and immunosuppression ,0
443488001,Malignant neoplasm of anorectum (disorder),Malignancy and immunosuppression ,0
443493003,Metastatic malignant melanoma (disorder),Malignancy and immunosuppression ,0
443520009,Chondrosarcoma (disorder),Malignancy and immunosuppression ,0
443675005,Seminoma (disorder),Malignancy and immunosuppression ,0
443679004,Malignant neoplasm of skeletal system (disorder),Malignancy and immunosuppression ,0
443785004,Product containing precisely pazopanib 200 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
443997005,Product containing precisely pazopanib 400 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
444108000,Acute sickle cell splenic sequestration crisis (disorder),Malignancy and immunosuppression ,0
444604002,Carcinoma of breast with ductal and lobular features (disorder),Malignancy and immunosuppression ,0
444712000,Mucinous carcinoma of breast (disorder),Malignancy and immunosuppression ,0
444910004,Primary mediastinal (thymic) large B-cell lymphoma (disorder),Malignancy and immunosuppression ,0
445105005,Blastic plasmacytoid dendritic cell neoplasm (disorder),Malignancy and immunosuppression ,0
445269007,Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (disorder),Malignancy and immunosuppression ,0
445406001,Hepatosplenic T-cell lymphoma (disorder),Malignancy and immunosuppression ,0
445448008,Acute myeloid leukemia with myelodysplasia-related changes (disorder),Malignancy and immunosuppression ,0
445738007,Myelodysplastic/myeloproliferative disease (disorder),Malignancy and immunosuppression ,0
446643000,Sarcoma of dendritic cells (accessory cells) (disorder),Malignancy and immunosuppression ,0
447132004,Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
447883002,Malignant neoplasm of carotid body (disorder),Malignancy and immunosuppression ,0
447949005,Malignant epithelial neoplasm of cheek (disorder),Malignancy and immunosuppression ,0
448212009,Anaplastic lymphoma kinase negative anaplastic large cell lymphoma (disorder),Malignancy and immunosuppression ,0
448233000,Malignant neoplasm of urinary organ (disorder),Malignancy and immunosuppression ,0
448668007,Malignant neoplasm of mandible (disorder),Malignancy and immunosuppression ,0
448868009,Malignant neoplasm of lateral wall of oropharynx (disorder),Malignancy and immunosuppression ,0
448952004,Infiltrating duct carcinoma of female breast (disorder),Malignancy and immunosuppression ,0
448992002,Malignant epithelial neoplasm of appendix (disorder),Malignancy and immunosuppression ,0
448993007,Malignant epithelial neoplasm of lung (disorder),Malignancy and immunosuppression ,0
449066004,Malignant neoplasm of upper respiratory tract (disorder),Malignancy and immunosuppression ,0
449067008,Malignant neoplasm of parietal pleura (disorder),Malignancy and immunosuppression ,0
449096009,Malignant neoplasm of respiratory system (disorder),Malignancy and immunosuppression ,0
449108003,Philadelphia chromosome positive chronic myelogenous leukemia (disorder),Malignancy and immunosuppression ,0
449187006,Kappa light chain deficiency (disorder),Malignancy and immunosuppression ,0
449220000,Diffuse follicle center lymphoma (disorder),Malignancy and immunosuppression ,0
449224009,Malignant neoplasm of anterior mediastinum (disorder),Malignancy and immunosuppression ,0
449308006,Malignant neoplasm of visceral pleura (disorder),Malignancy and immunosuppression ,0
449377002,Malignant neoplasm of pelvic peritoneum (disorder),Malignancy and immunosuppression ,0
449386007,Philadelphia chromosome negative chronic myelogenous leukemia (disorder),Malignancy and immunosuppression ,0
449420002,Malignant neoplasm of cerebellum (disorder),Malignancy and immunosuppression ,0
449627008,Malignant neoplasm of long bone of lower limb (disorder),Malignancy and immunosuppression ,0
699005005,History of malignant hematologic neoplasm (situation),Malignancy and immunosuppression ,0
700423003,Adenocarcinoma of pancreas (disorder),Malignancy and immunosuppression ,0
702391001,Renal cell carcinoma (disorder),Malignancy and immunosuppression ,0
703423002,Combined chemotherapy and radiation therapy (procedure),Malignancy and immunosuppression ,0
703538003,Mannose-binding lectin deficiency (disorder),Malignancy and immunosuppression ,0
703581000,Product containing precisely afatinib dimaleate 20 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
703583002,Product containing precisely afatinib dimaleate 30 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
703584008,Product containing precisely afatinib dimaleate 40 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
703587001,Product containing precisely bosutinib monohydrate 100 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
703588006,Product containing precisely bosutinib monohydrate 500 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
703639002,Product containing precisely crizotinib 200 milligram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
703647002,Dabrafenib (as dabrafenib mesilate) 50 mg oral capsule,Malignancy and immunosuppression ,0
703648007,Dabrafenib (as dabrafenib mesilate) 75 mg oral capsule,Malignancy and immunosuppression ,0
703780001,Product containing precisely ruxolitinib 5 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
703781002,Product containing precisely ruxolitinib 10 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
703788008,Product containing precisely teriflunomide 14 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
703791008,Product containing precisely pomalidomide 1 milligram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
703792001,Product containing precisely pomalidomide 2 milligram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
703793006,Product containing precisely pomalidomide 3 milligram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
703794000,Product containing precisely pomalidomide 4 milligram/1 each conventional release oral capsule (clinical drug),Malignancy and immunosuppression ,0
703799005,Product containing precisely ponatinib (as ponatinib hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
703800009,Product containing precisely ponatinib (as ponatinib hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
703809005,Product containing precisely regorafenib 40 milligram/1 each conventional release oral tablet (clinical drug),Malignancy and immunosuppression ,0
707147002,Asplenia (disorder),Malignancy and immunosuppression ,0
707311008,Immunosuppressant drug therapy (procedure),Malignancy and immunosuppression ,0
707358000,Primary squamous cell carcinoma of larynx (disorder),Malignancy and immunosuppression ,0
708921005,Carcinoma of central portion of breast (disorder),Malignancy and immunosuppression ,0
711411006,Allotransplantation of kidney from beating heart cadaver (procedure),Malignancy and immunosuppression ,0
711413009,Allotransplantation of kidney from non-beating heart cadaver (procedure),Malignancy and immunosuppression ,0
711414003,Primary clear cell adenocarcinoma of lung (disorder),Malignancy and immunosuppression ,0
711446003,Transplantation of kidney regime (regime/therapy),Malignancy and immunosuppression ,0
712525007,Malignant neoplasm of short bone of lower limb (disorder),Malignancy and immunosuppression ,0
712750007,Malignant neoplasm of chest wall (disorder),Malignancy and immunosuppression ,0
712849003,Primary malignant neoplasm of prostate metastatic to bone (disorder),Malignancy and immunosuppression ,0
713517003,Infliximab therapy (procedure),Malignancy and immunosuppression ,0
713609000,Invasive carcinoma of breast (disorder),Malignancy and immunosuppression ,0
713897006,Burkitt lymphoma co-occurrent with human immunodeficiency virus infection (disorder),Malignancy and immunosuppression ,0
716872004,Antineoplastic chemotherapy regimen (regime/therapy),Malignancy and immunosuppression ,0
717780007,Monoclonal B-cell lymphocytosis (disorder),Malignancy and immunosuppression ,0
721567004,Primary malignant neoplasm of placenta (disorder),Malignancy and immunosuppression ,0
721576006,Primary angiosarcoma of breast (disorder),Malignancy and immunosuppression ,0
721629005,Linitis plastica of stomach (disorder),Malignancy and immunosuppression ,0
721696009,Primary adenocarcinoma of transverse colon (disorder),Malignancy and immunosuppression ,0
722103009,Hormone sensitive prostate cancer (disorder),Malignancy and immunosuppression ,0
722491009,"Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen (regime/therapy)",Malignancy and immunosuppression ,0
722528008,Primary malignant neuroendocrine neoplasm of lung (disorder),Malignancy and immunosuppression ,0
722685004,Primary high grade serous adenocarcinoma of ovary (disorder),Malignancy and immunosuppression ,0
723301009,Squamous non-small cell lung cancer (disorder),Malignancy and immunosuppression ,0
724159000,Rituximab therapy (procedure),Malignancy and immunosuppression ,0
737295003,Transplanted kidney present (finding),Malignancy and immunosuppression ,0
737297006,Transplanted liver present (finding),Malignancy and immunosuppression ,0
738770003,Anaplastic lymphoma kinase positive anaplastic large cell lymphoma (disorder),Malignancy and immunosuppression ,0
762690000,Classical Hodgkin lymphoma (disorder),Malignancy and immunosuppression ,0
769167005,Vaso-occlusive pain co-occurrent and due to sickle cell disease (disorder),Malignancy and immunosuppression ,0
81000119104,Symptomatic human immunodeficiency virus infection (disorder),Malignancy and immunosuppression ,0
1.651E+12,Primary adenocarcinoma of pancreas (disorder),Malignancy and immunosuppression ,0
6.471E+12,Transplantation of kidney and pancreas (procedure),Malignancy and immunosuppression ,0
1.3711E+13,Distamine 250mg tablets (Alliance Pharmaceuticals Ltd) (product),Malignancy and immunosuppression ,0
4.1411E+13,Penicillamine 250mg tablets (Generics (UK) Ltd) (product),Malignancy and immunosuppression ,0
4.1911E+13,Azathioprine 50mg tablets (A A H Pharmaceuticals Ltd) (product),Malignancy and immunosuppression ,0
8.8611E+13,Sandimmun 250mg/5ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) (product),Malignancy and immunosuppression ,0
9.4361E+13,Breast cancer detected by national screening programme (disorder),Malignancy and immunosuppression ,0
1.07691E+14,Non-seminomatous germ cell neoplasm of testis (disorder),Malignancy and immunosuppression ,0
1.72611E+14,Sandimmun 100mg capsules (Novartis Pharmaceuticals UK Ltd) (product),Malignancy and immunosuppression ,0
1.84781E+14,Primary adenocarcinoma of cervix uteri (disorder),Malignancy and immunosuppression ,0
2.01811E+14,Methotrexate 2.5mg tablets (A A H Pharmaceuticals Ltd) (product),Malignancy and immunosuppression ,0
2.09911E+14,Prograf 1mg capsules (Fujisawa Ltd) (product),Malignancy and immunosuppression ,0
2.28311E+14,Allograft of bone marrow from haploidentical donor (procedure),Malignancy and immunosuppression ,0
2.32681E+14,Chemotherapy delivery (procedure),Malignancy and immunosuppression ,0
2.35331E+14,Delivery of oral chemotherapy for neoplasm (regime/therapy),Malignancy and immunosuppression ,0
2.35391E+14,Delivery of chemotherapy for neoplasm (procedure),Malignancy and immunosuppression ,0
2.38841E+14,Delivery of complex chemotherapy for neoplasm including prolonged infusional treatment at first attendance (procedure),Malignancy and immunosuppression ,0
2.38851E+14,Delivery of complex parenteral chemotherapy for neoplasm at first attendance (procedure),Malignancy and immunosuppression ,0
2.39071E+14,Delivery of subsequent element of cycle of chemotherapy for neoplasm (procedure),Malignancy and immunosuppression ,0
2.48331E+14,Cancer monitoring telephone invitation (procedure),Malignancy and immunosuppression ,0
2.84711E+14,Imuran 25mg tablets (GlaxoSmithKline) (product),Malignancy and immunosuppression ,0
2.94301E+14,Bowel cancer detected by national screening programme (disorder),Malignancy and immunosuppression ,0
3.03511E+14,Neoral 10mg capsules (Novartis Pharmaceuticals UK Ltd) (product),Malignancy and immunosuppression ,0
3.19211E+14,Neoral 50mg capsules (Novartis Pharmaceuticals UK Ltd) (product),Malignancy and immunosuppression ,0
3.22011E+14,Maxtrex 10mg tablets (Pfizer Ltd) (product),Malignancy and immunosuppression ,0
3.36111E+14,Penicillamine 250mg tablets (A A H Pharmaceuticals Ltd) (product),Malignancy and immunosuppression ,0
3.39911E+14,Azathioprine 50mg tablets (Alpharma Limited) (product),Malignancy and immunosuppression ,0
3.42511E+14,Siewert type II adenocarcinoma (disorder),Malignancy and immunosuppression ,0
3.42561E+14,Siewert type III adenocarcinoma (disorder),Malignancy and immunosuppression ,0
3.42571E+14,Siewert type I adenocarcinoma (disorder),Malignancy and immunosuppression ,0
3.47811E+14,Sandimmun 25mg capsules (Novartis Pharmaceuticals UK Ltd) (product),Malignancy and immunosuppression ,0
3.54361E+14,Primary malignant neoplasm of right kidney (disorder),Malignancy and immunosuppression ,0
3.78841E+14,Allograft of bone marrow from unmatched unrelated donor (procedure),Malignancy and immunosuppression ,0
4.28011E+14,Azathioprine 50mg tablets (Sandoz Ltd) (product),Malignancy and immunosuppression ,0
4.56811E+14,Neoral 100mg capsules (Novartis Pharmaceuticals UK Ltd) (product),Malignancy and immunosuppression ,0
4.62401E+14,"[X]Malignant neoplasms of lymphoid, haematopoietic and related tissue (disorder)",Malignancy and immunosuppression ,0
4.99111E+14,Arava 10mg tablets (Aventis Pharma) (product),Malignancy and immunosuppression ,0
5.44611E+14,Azathioprine 25mg tablets (Generics (UK) Ltd) (product),Malignancy and immunosuppression ,0
6.44711E+14,Maxtrex 2.5mg tablets (Pfizer Ltd) (product),Malignancy and immunosuppression ,0
6.56111E+14,Prograf 500microgram capsules (Fujisawa Ltd) (product),Malignancy and immunosuppression ,0
6.60811E+14,Neoral 25mg capsules (Novartis Pharmaceuticals UK Ltd) (product),Malignancy and immunosuppression ,0
6.75711E+14,Imuran 50mg tablets (GlaxoSmithKline) (product),Malignancy and immunosuppression ,0
6.79611E+14,Myocrisin 10mg/0.5ml solution for injection ampoules (JHC Healthcare Ltd) (product),Malignancy and immunosuppression ,0
6.83611E+14,Methotrexate 2.5mg tablets (Wyeth Laboratories) (product),Malignancy and immunosuppression ,0
7.08911E+14,Hydrea 500mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) (product),Malignancy and immunosuppression ,0
7.15511E+14,Azathioprine 50mg tablets (Approved Prescription Services) (product),Malignancy and immunosuppression ,0
7.44711E+14,Azathioprine 25mg tablets (A A H Pharmaceuticals Ltd) (product),Malignancy and immunosuppression ,0
7.52211E+14,Prograf 5mg capsules (Fujisawa Ltd) (product),Malignancy and immunosuppression ,0
7.86611E+14,Myocrisin 50mg/0.5ml solution for injection ampoules (JHC Healthcare Ltd) (product),Malignancy and immunosuppression ,0
8.05961E+14,Excepted from rheumatoid arthritis quality indicators - patient unsuitable (finding),Malignancy and immunosuppression ,0
8.05981E+14,Excepted from rheumatoid arthritis quality indicators - informed dissent (finding),Malignancy and immunosuppression ,0
8.13671E+14,Secondary malignant neoplasm of liver and intrahepatic bile duct (disorder),Malignancy and immunosuppression ,0
8.15011E+14,Anaplastic lymphoma kinase positive anaplastic large cell lymphoma (disorder),Malignancy and immunosuppression ,0
8.18621E+14,Immunosuppression resolved (finding),Malignancy and immunosuppression ,1
8.20601E+14,Refractory anaemia with multilineage dysplasia (disorder),Malignancy and immunosuppression ,0
8.29591E+14,Neoadjuvant chemotherapy (procedure),Malignancy and immunosuppression ,0
8.43311E+14,Azathioprine 50mg tablets (Generics (UK) Ltd) (product),Malignancy and immunosuppression ,0
8.43671E+14,Electrochemotherapy (procedure),Malignancy and immunosuppression ,0
8.43691E+14,Urological complication of renal transplant (disorder),Malignancy and immunosuppression ,0
8.44661E+14,Vascular complication of renal transplant (disorder),Malignancy and immunosuppression ,0
8.47261E+14,Rheumatoid arthritis annual review (regime/therapy),Malignancy and immunosuppression ,0
8.47481E+14,Follicular lymphoma grade 1 (disorder),Malignancy and immunosuppression ,0
8.47631E+14,Follicular lymphoma grade 2 (disorder),Malignancy and immunosuppression ,0
8.47651E+14,Follicular lymphoma grade 3 (disorder),Malignancy and immunosuppression ,0
8.47691E+14,Follicular lymphoma grade 3a (disorder),Malignancy and immunosuppression ,0
8.47701E+14,Follicular lymphoma grade 3b (disorder),Malignancy and immunosuppression ,0
8.47741E+14,Diffuse large B-cell lymphoma (disorder),Malignancy and immunosuppression ,0
8.47881E+14,Stenosis of vein of transplanted kidney (disorder),Malignancy and immunosuppression ,0
8.53761E+14,Living donor liver transplantation (procedure),Malignancy and immunosuppression ,0
8.61371E+14,Acquired absence of spleen (disorder),Malignancy and immunosuppression ,0
8.63111E+14,Azathioprine 50mg tablets (Kent Pharmaceuticals Ltd) (product),Malignancy and immunosuppression ,0
8.63741E+14,Clinical stage A chronic lymphocytic leukaemia (disorder),Malignancy and immunosuppression ,0
8.63761E+14,Clinical stage B chronic lymphocytic leukaemia (disorder),Malignancy and immunosuppression ,0
8.63781E+14,Clinical stage C chronic lymphocytic leukaemia (disorder),Malignancy and immunosuppression ,0
8.64311E+14,Thrombosis of vein of transplanted kidney (disorder),Malignancy and immunosuppression ,0
8.66901E+14,Eosinophilic bronchitis (disorder),Malignancy and immunosuppression ,0
8.82321E+14,Rheumatoid arthritis monitoring invitation (procedure),Malignancy and immunosuppression ,0
8.82401E+14,Rheumatoid arthritis monitoring invitation first letter (procedure),Malignancy and immunosuppression ,0
8.82421E+14,Rheumatoid arthritis monitoring invitation second letter (procedure),Malignancy and immunosuppression ,0
8.82441E+14,Rheumatoid arthritis monitoring invitation third letter (procedure),Malignancy and immunosuppression ,0
8.82461E+14,Rheumatoid arthritis monitoring verbal invitation (procedure),Malignancy and immunosuppression ,0
8.82481E+14,Rheumatoid arthritis monitoring telephone invitation (procedure),Malignancy and immunosuppression ,0
8.84601E+14,Bowel scope (flexible sigmoidoscopy) screen: cancer detected (finding),Malignancy and immunosuppression ,0
9.00111E+14,Penicillamine 125mg tablets (A A H Pharmaceuticals Ltd) (product),Malignancy and immunosuppression ,0
9.28011E+14,Methotrexate 10mg tablets (A A H Pharmaceuticals Ltd) (product),Malignancy and immunosuppression ,0
9.43041E+14,Human immunodeficiency virus disease resulting in haematological and immunological abnormalities (disorder),Malignancy and immunosuppression ,0
9.56331E+14,Malignant melanoma stage IA (finding),Malignancy and immunosuppression ,0
9.56351E+14,Malignant melanoma stage IB (finding),Malignancy and immunosuppression ,0
9.56371E+14,Malignant melanoma stage IIA (finding),Malignancy and immunosuppression ,0
9.56391E+14,Malignant melanoma stage IIB (finding),Malignancy and immunosuppression ,0
9.56411E+14,Malignant melanoma stage IIC (finding),Malignancy and immunosuppression ,0
9.56431E+14,Malignant melanoma stage IIIA (finding),Malignancy and immunosuppression ,0
9.56451E+14,Malignant melanoma stage IIIB (finding),Malignancy and immunosuppression ,0
9.56471E+14,Malignant melanoma stage IIIC (finding),Malignancy and immunosuppression ,0
9.56511E+14,Malignant melanoma stage IV M1a (finding),Malignancy and immunosuppression ,0
9.56531E+14,Malignant melanoma stage IV M1b (finding),Malignancy and immunosuppression ,0
9.68171E+14,Provision of high dose inhaled corticosteroid safety card (procedure),Malignancy and immunosuppression ,0
1.06699E+15,Rheumatoid arthritis monitoring invitation by short message service text messaging (procedure),Malignancy and immunosuppression ,0
1.067E+15,Rheumatoid arthritis monitoring short message service text message first invitation (procedure),Malignancy and immunosuppression ,0
1.06701E+15,Rheumatoid arthritis monitoring short message service text message second invitation (procedure),Malignancy and immunosuppression ,0
1.06702E+15,Rheumatoid arthritis monitoring short message service text message third invitation (procedure),Malignancy and immunosuppression ,0
1.08308E+15,Rheumatoid arthritis monitoring invitation email (procedure),Malignancy and immunosuppression ,0
1.09008E+15,Secondary malignant neoplasm of paratracheal lymph nodes (disorder),Malignancy and immunosuppression ,0
1.09009E+15,Secondary malignant neoplasm of internal mammary lymph nodes (disorder),Malignancy and immunosuppression ,0
1.09012E+15,Secondary malignant neoplasm of deep cervical lymph nodes (disorder),Malignancy and immunosuppression ,0
1.09013E+15,Secondary malignant neoplasm of anterior cervical lymph nodes (disorder),Malignancy and immunosuppression ,0
1.09014E+15,Secondary malignant neoplasm of superficial cervical lymph nodes (disorder),Malignancy and immunosuppression ,0
1.09016E+15,Secondary malignant neoplasm of diaphragmatic lymph nodes (disorder),Malignancy and immunosuppression ,0
1.09019E+15,Secondary malignant neoplasm of coeliac lymph nodes (disorder),Malignancy and immunosuppression ,0
1.0902E+15,Secondary malignant neoplasm of deep inguinal lymph nodes (disorder),Malignancy and immunosuppression ,0
1.09024E+15,Angioimmunoblastic T-cell lymphoma with dysproteinaemia (disorder),Malignancy and immunosuppression ,0
1.09025E+15,Malignant neoplasm of nose (disorder),Malignancy and immunosuppression ,0
1.09026E+15,Malignant neoplasm of descended testis (disorder),Malignancy and immunosuppression ,0
1.09027E+15,Malignant neoplasm of ventral surface of tongue (disorder),Malignancy and immunosuppression ,0
1.09082E+15,Malignant neoplasm of bone and articular cartilage (disorder),Malignancy and immunosuppression ,0
1.09087E+15,Malignant neoplasm of bone and articular cartilage of limb (disorder),Malignancy and immunosuppression ,0
1.09088E+15,Malignant neoplasm of bronchus or lung (disorder),Malignancy and immunosuppression ,0
1.09089E+15,Malignant neoplasm of connective and soft tissues of trunk (disorder),Malignancy and immunosuppression ,0
1.0909E+15,Malignant neoplasm of peripheral nerves of trunk (disorder),Malignancy and immunosuppression ,0
1.09092E+15,Malignant neoplasm of jaw (disorder),Malignancy and immunosuppression ,0
1.09094E+15,Malignant neoplasm of inguinal region (disorder),Malignancy and immunosuppression ,0
1.09095E+15,Malignant neoplasm of supraclavicular fossa (disorder),Malignancy and immunosuppression ,0
1.09096E+15,Malignant neoplasm of soft tissues of lower limb (disorder),Malignancy and immunosuppression ,0
1.09186E+15,"Follicular lymphoma, cutaneous follicle centre (disorder)",Malignancy and immunosuppression ,0
1.09192E+15,B-cell non-Hodgkin's lymphoma (disorder),Malignancy and immunosuppression ,0
1.09283E+15,Overlapping malignant neoplasm of mouth (disorder),Malignancy and immunosuppression ,0
1.11087E+15,Quality and Outcomes Framework cancer quality indicator-related care invitation (procedure),Malignancy and immunosuppression ,0
1.11096E+15,Quality and Outcomes Framework rheumatoid arthritis quality indicator-related care invitation (procedure),Malignancy and immunosuppression ,0
3.49041E+15,Neoral 100mg/ml oral solution (Novartis Pharmaceuticals UK Ltd) (product),Malignancy and immunosuppression ,0
3.49071E+15,Sandimmun 100mg/ml oral solution (Novartis Pharmaceuticals UK Ltd) (product),Malignancy and immunosuppression ,0
3.61461E+15,Methotrexate 5mg/2ml solution for injection vials (Mayne Pharma Plc) (product),Malignancy and immunosuppression ,0
3.61561E+15,Methotrexate 50mg/2ml solution for injection vials (Goldshield Healthcare Ltd) (product),Malignancy and immunosuppression ,0
3.61641E+15,Methotrexate 5g/50ml solution for injection vials (Mayne Pharma Plc) (product),Malignancy and immunosuppression ,0
3.61921E+15,Methotrexate 1g/10ml solution for injection vials (Mayne Pharma Plc) (product),Malignancy and immunosuppression ,0
3.65991E+15,CellCept 250mg capsules (Roche Products Ltd) (product),Malignancy and immunosuppression ,0
3.66161E+15,CellCept 500mg tablets (Roche Products Ltd) (product),Malignancy and immunosuppression ,0
4.09141E+15,Rapamune 1mg tablets (Wyeth Laboratories) (product),Malignancy and immunosuppression ,0
4.15661E+15,Enbrel 25mg powder and solvent for solution for injection vials (Wyeth Laboratories) (product),Malignancy and immunosuppression ,0
4.39801E+15,Remicade 100mg powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) (product),Malignancy and immunosuppression ,0
4.48871E+15,Cisplatin 10mg/10ml solution for injection vials (product),Malignancy and immunosuppression ,0
4.56471E+15,Rapamune 2mg tablets (Wyeth Laboratories) (product),Malignancy and immunosuppression ,0
4.63801E+15,Paclitaxel 30mg/5ml solution for injection vials (product),Malignancy and immunosuppression ,0
4.63931E+15,Carboplatin 150mg/15ml solution for injection vials (product),Malignancy and immunosuppression ,0
4.63941E+15,Carboplatin 450mg/45ml solution for injection vials (product),Malignancy and immunosuppression ,0
4.65181E+15,Carboplatin 50mg/5ml solution for injection vials (product),Malignancy and immunosuppression ,0
4.65191E+15,Carboplatin 600mg/60ml solution for injection vials (product),Malignancy and immunosuppression ,0
4.69431E+15,"Bleomycin 15,000unit powder for solution for injection vials (product)",Malignancy and immunosuppression ,0
4.70061E+15,Doxorubicin 10mg/5ml solution for injection vials (product),Malignancy and immunosuppression ,0
4.74871E+15,Kineret 100mg/0.67ml solution for injection pre-filled syringes (Amgen Ltd) (product),Malignancy and immunosuppression ,0
4.75171E+15,Anakinra 100mg/0.67ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
4.80301E+15,Herceptin 150mg powder for solution for injection vials (Roche Products Ltd) (product),Malignancy and immunosuppression ,0
4.84611E+15,Fludara 50mg powder for solution for injection vials (Schering Health Care Ltd) (product),Malignancy and immunosuppression ,0
4.88131E+15,CellCept 1g/5ml oral suspension (Roche Products Ltd) (product),Malignancy and immunosuppression ,0
4.89781E+15,Mycophenolate mofetil 1g/5ml oral suspension sugar free (product),Malignancy and immunosuppression ,0
4.96981E+15,Fluorouracil 5g/100ml solution for injection vials (product),Malignancy and immunosuppression ,0
5.00751E+15,Humira 40mg/0.8ml solution for injection pre-filled syringes (Abbott Laboratories Ltd) (product),Malignancy and immunosuppression ,0
7.30931E+15,Tomudex 2mg powder for solution for injection vials (AstraZeneca) (product),Malignancy and immunosuppression ,0
7.31981E+15,Glivec 400mg tablets (Novartis Pharmaceuticals UK Ltd) (product),Malignancy and immunosuppression ,0
7.32271E+15,Dacarbazine 100mg powder for solution for injection vials (product),Malignancy and immunosuppression ,0
7.51301E+15,Velcade 3.5mg powder for solution for injection vials (Ortho Biotech) (product),Malignancy and immunosuppression ,0
7.52571E+15,Bortezomib 3.5mg powder for solution for injection vials (product),Malignancy and immunosuppression ,0
7.59191E+15,DepoCyte 50mg/5ml intrathecal suspension for injection vials (Napp Pharmaceuticals Ltd) (product),Malignancy and immunosuppression ,0
7.69571E+15,MabThera 100mg/10ml solution for injection vials (Roche Products Ltd) (product),Malignancy and immunosuppression ,0
8.07691E+15,Mycophenolic acid 180mg gastro-resistant tablets (product),Malignancy and immunosuppression ,0
8.07701E+15,Mycophenolic acid 360mg gastro-resistant tablets (product),Malignancy and immunosuppression ,0
8.07751E+15,Myfortic 180mg gastro-resistant tablets (Novartis Pharmaceuticals UK Ltd) (product),Malignancy and immunosuppression ,0
8.07781E+15,Myfortic 360mg gastro-resistant tablets (Novartis Pharmaceuticals UK Ltd) (product),Malignancy and immunosuppression ,0
8.08961E+15,Glivec 100mg tablets (Novartis Pharmaceuticals UK Ltd) (product),Malignancy and immunosuppression ,0
8.28201E+15,Azathioprine 100mg/5ml oral suspension (product),Malignancy and immunosuppression ,0
8.28411E+15,Azathioprine 25mg/5ml oral suspension (product),Malignancy and immunosuppression ,0
8.30781E+15,Azathioprine 75mg/5ml oral suspension (product),Malignancy and immunosuppression ,0
8.30841E+15,Azathioprine 50mg/5ml oral suspension (product),Malignancy and immunosuppression ,0
8.30851E+15,Azathioprine 50mg/5ml oral solution (product),Malignancy and immunosuppression ,0
8.38861E+15,Azathioprine 25mg tablets (Approved Prescription Services) (product),Malignancy and immunosuppression ,0
8.66361E+15,Mercaptopurine 100mg/5ml oral suspension (product),Malignancy and immunosuppression ,0
8.66491E+15,Methotrexate 10mg/5ml oral solution (product),Malignancy and immunosuppression ,0
8.66511E+15,Methotrexate 12.5mg/5ml oral solution (product),Malignancy and immunosuppression ,0
8.66571E+15,Methotrexate 2.5mg/5ml oral suspension (product),Malignancy and immunosuppression ,0
8.66611E+15,Methotrexate 7.5mg/5ml oral suspension (product),Malignancy and immunosuppression ,0
8.72621E+15,Tacrolimus 2.5mg/5ml oral solution (product),Malignancy and immunosuppression ,0
8.79131E+15,Azathioprine 10mg capsules (product),Malignancy and immunosuppression ,0
8.79141E+15,Azathioprine 30mg capsules (product),Malignancy and immunosuppression ,0
8.79661E+15,Mercaptopurine 10mg capsules (product),Malignancy and immunosuppression ,0
8.82301E+15,Tacrolimus 5mg/5ml oral suspension (product),Malignancy and immunosuppression ,0
9.15291E+15,Avastin 100mg/4ml solution for injection vials (Roche Products Ltd) (product),Malignancy and immunosuppression ,0
9.18801E+15,Alemtuzumab 30mg/1ml solution for injection vials (product),Malignancy and immunosuppression ,0
9.46821E+15,Methotrexate 10mg/0.4ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
9.46831E+15,Methotrexate 12.5mg/0.5ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
9.46841E+15,Methotrexate 15mg/0.6ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
9.46851E+15,Methotrexate 17.5mg/0.7ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
9.46861E+15,Methotrexate 20mg/0.8ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
9.46871E+15,Methotrexate 22.5mg/0.9ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
9.46881E+15,Methotrexate 25mg/1ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
9.46941E+15,Methotrexate 5mg/0.2ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
9.46951E+15,Methotrexate 7.5mg/0.3ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
9.52691E+15,Vinorelbine 20mg capsules (product),Malignancy and immunosuppression ,0
1.02469E+16,Oxaliplatin 50mg/10ml solution for injection vials (product),Malignancy and immunosuppression ,0
1.02473E+16,Oxaliplatin 100mg/20ml solution for injection vials (product),Malignancy and immunosuppression ,0
1.06157E+16,Hydroxycarbamide 500mg capsules (medac UK) (product),Malignancy and immunosuppression ,0
1.06263E+16,Tysabri 300mg/15ml concentrate for solution for infusion vials (Biogen Ltd) (product),Malignancy and immunosuppression ,0
1.06732E+16,Metoject 15mg/1.5ml solution for injection pre-filled syringes (medac UK) (product),Malignancy and immunosuppression ,0
1.06735E+16,Metoject 20mg/2ml solution for injection pre-filled syringes (medac UK) (product),Malignancy and immunosuppression ,0
1.0674E+16,Metoject 25mg/2.5ml solution for injection pre-filled syringes (medac UK) (product),Malignancy and immunosuppression ,0
1.06756E+16,Methotrexate 10mg/1ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
1.06757E+16,Methotrexate 15mg/1.5ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
1.06758E+16,Methotrexate 20mg/2ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
1.06759E+16,Methotrexate 25mg/2.5ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
1.0676E+16,Methotrexate 7.5mg/0.75ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
1.09677E+16,Enbrel 50mg/1ml solution for injection pre-filled syringes (Wyeth Pharmaceuticals) (product),Malignancy and immunosuppression ,0
1.09702E+16,Etanercept 50mg/1ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
1.09865E+16,Hydroxycarbamide 500mg capsules (A A H Pharmaceuticals Ltd) (product),Malignancy and immunosuppression ,0
1.10264E+16,Methotrexate 2.5mg tablets (Wockhardt UK Ltd) (product),Malignancy and immunosuppression ,0
1.10335E+16,Enbrel 25mg/0.5ml solution for injection pre-filled syringes (Wyeth Pharmaceuticals) (product),Malignancy and immunosuppression ,0
1.10345E+16,Etanercept 25mg/0.5ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
1.1188E+16,Humira 40mg/0.8ml solution for injection pre-filled pens (AbbVie Ltd) (product),Malignancy and immunosuppression ,0
1.12369E+16,Adalimumab 40mg/0.8ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
1.14943E+16,Cetuximab 100mg/20ml solution for injection vials (product),Malignancy and immunosuppression ,0
1.16192E+16,Advagraf 0.5mg modified-release capsules (Astellas Pharma Ltd) (product),Malignancy and immunosuppression ,0
1.16196E+16,Advagraf 1mg modified-release capsules (Astellas Pharma Ltd) (product),Malignancy and immunosuppression ,0
1.162E+16,Advagraf 5mg modified-release capsules (Astellas Pharma Ltd) (product),Malignancy and immunosuppression ,0
1.16495E+16,Tacrolimus 1mg modified-release capsules (product),Malignancy and immunosuppression ,0
1.16496E+16,Tacrolimus 500microgram modified-release capsules (product),Malignancy and immunosuppression ,0
1.16497E+16,Tacrolimus 5mg modified-release capsules (product),Malignancy and immunosuppression ,0
1.17552E+16,Revlimid 5mg capsules (Celgene Europe Ltd) (product),Malignancy and immunosuppression ,0
1.17557E+16,Revlimid 10mg capsules (Celgene Europe Ltd) (product),Malignancy and immunosuppression ,0
1.17565E+16,Revlimid 25mg capsules (Celgene Europe Ltd) (product),Malignancy and immunosuppression ,0
1.1762E+16,Abatacept 250mg powder for solution for injection vials (product),Malignancy and immunosuppression ,0
1.17629E+16,Lenalidomide 15mg capsules (product),Malignancy and immunosuppression ,0
1.1763E+16,Lenalidomide 25mg capsules (product),Malignancy and immunosuppression ,0
1.18125E+16,Soliris 300mg/30ml concentrate for solution for infusion vials (Almac Pharma Services Ltd) (product),Malignancy and immunosuppression ,0
1.22407E+16,Long term systemic steroid user (finding),Malignancy and immunosuppression ,0
1.25642E+16,Temozolomide 140mg capsules (product),Malignancy and immunosuppression ,0
1.25643E+16,Temozolomide 180mg capsules (product),Malignancy and immunosuppression ,0
1.28139E+16,Methotrexate 12mg/5ml oral solution (product),Malignancy and immunosuppression ,0
1.30003E+16,Mycophenolate mofetil 100mg/5ml oral suspension (product),Malignancy and immunosuppression ,0
1.30004E+16,Mycophenolate mofetil 125mg/5ml oral suspension (product),Malignancy and immunosuppression ,0
1.30005E+16,Mycophenolate mofetil 250mg/5ml oral suspension (product),Malignancy and immunosuppression ,0
1.30007E+16,Mycophenolate mofetil 500mg/5ml oral suspension (product),Malignancy and immunosuppression ,0
1.33033E+16,Tacrolimus 2mg/5ml oral suspension (product),Malignancy and immunosuppression ,0
1.33867E+16,Azathioprine 50mg tablets (Arrow Generics Ltd) (product),Malignancy and immunosuppression ,0
1.35734E+16,Tacrolimus 500micrograms/5ml oral suspension (product),Malignancy and immunosuppression ,0
1.37407E+16,Azathioprine 25mg tablets (Tillomed Laboratories Ltd) (product),Malignancy and immunosuppression ,0
1.37409E+16,Azathioprine 50mg tablets (Tillomed Laboratories Ltd) (product),Malignancy and immunosuppression ,0
1.39614E+16,Busulfan 25mg capsules (product),Malignancy and immunosuppression ,0
1.39679E+16,Hydroxycarbamide 1g tablets (product),Malignancy and immunosuppression ,0
1.46757E+16,Alimta 100mg powder for concentrate for solution for infusion vials (Eli Lilly and Company Ltd) (product),Malignancy and immunosuppression ,0
1.46808E+16,Pemetrexed 100mg powder for solution for injection vials (product),Malignancy and immunosuppression ,0
1.46967E+16,Panitumumab 400mg/20ml solution for injection vials (product),Malignancy and immunosuppression ,0
1.5117E+16,Stelara 45mg/0.5ml solution for injection vials (Janssen-Cilag Ltd) (product),Malignancy and immunosuppression ,0
1.51255E+16,Ustekinumab 45mg/0.5ml solution for injection vials (product),Malignancy and immunosuppression ,0
1.52425E+16,Azacitidine 100mg powder for suspension for injection vials (product),Malignancy and immunosuppression ,0
1.54104E+16,Dasatinib 100mg tablets (product),Malignancy and immunosuppression ,0
1.55137E+16,Metoject 15mg/0.3ml solution for injection pre-filled syringes (medac UK) (product),Malignancy and immunosuppression ,0
1.5514E+16,Metoject 25mg/0.5ml solution for injection pre-filled syringes (medac UK) (product),Malignancy and immunosuppression ,0
1.55143E+16,Metoject 20mg/0.4ml solution for injection pre-filled syringes (medac UK) (product),Malignancy and immunosuppression ,0
1.55179E+16,Methotrexate 10mg/0.2ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
1.5518E+16,Methotrexate 15mg/0.3ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
1.55181E+16,Methotrexate 20mg/0.4ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
1.55182E+16,Methotrexate 25mg/0.5ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
1.55183E+16,Methotrexate 7.5mg/0.15ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
1.56038E+16,Advagraf 3mg modified-release capsules (Astellas Pharma Ltd) (product),Malignancy and immunosuppression ,0
1.56145E+16,Tacrolimus 3mg modified-release capsules (product),Malignancy and immunosuppression ,0
1.59803E+16,Enbrel 50mg/1ml solution for injection pre-filled MyClic pens (Pfizer Ltd) (product),Malignancy and immunosuppression ,0
1.59871E+16,Etanercept 50mg/1ml solution for injection 1ml pre-filled disposable devices (product),Malignancy and immunosuppression ,0
1.60359E+16,Azathioprine 250mg/5ml oral solution (product),Malignancy and immunosuppression ,0
1.61019E+16,Tocilizumab 200mg/10ml solution for infusion vials (product),Malignancy and immunosuppression ,0
1.6102E+16,Tocilizumab 400mg/20ml solution for infusion vials (product),Malignancy and immunosuppression ,0
1.61021E+16,Tocilizumab 80mg/4ml solution for infusion vials (product),Malignancy and immunosuppression ,0
1.63065E+16,Deximune 25mg capsules (Dexcel-Pharma Ltd) (product),Malignancy and immunosuppression ,0
1.63067E+16,Deximune 50mg capsules (Dexcel-Pharma Ltd) (product),Malignancy and immunosuppression ,0
1.63069E+16,Deximune 100mg capsules (Dexcel-Pharma Ltd) (product),Malignancy and immunosuppression ,0
1.66582E+16,Tacrolimus 200microgram granules sachets (product),Malignancy and immunosuppression ,0
1.66584E+16,Modigraf 0.2mg granules sachets (Astellas Pharma Ltd) (product),Malignancy and immunosuppression ,0
1.66588E+16,Modigraf 1mg granules sachets (Astellas Pharma Ltd) (product),Malignancy and immunosuppression ,0
1.73158E+16,Certolizumab pegol 200mg/1ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
1.7316E+16,Cimzia 200mg/1ml solution for injection pre-filled syringes (UCB Pharma Ltd) (product),Malignancy and immunosuppression ,0
1.7431E+16,Docetaxel 20mg/1ml solution for infusion vials (product),Malignancy and immunosuppression ,0
1.74311E+16,Docetaxel 80mg/4ml solution for infusion vials (product),Malignancy and immunosuppression ,0
1.74627E+16,Stelara 45mg/0.5ml solution for injection pre-filled syringes (Janssen-Cilag Ltd) (product),Malignancy and immunosuppression ,0
1.7484E+16,Ustekinumab 45mg/0.5ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
1.76656E+16,Capimune 50mg capsules (Generics (UK) Ltd) (product),Malignancy and immunosuppression ,0
1.76658E+16,Capimune 100mg capsules (Generics (UK) Ltd) (product),Malignancy and immunosuppression ,0
1.76669E+16,Capimune 25mg capsules (Generics (UK) Ltd) (product),Malignancy and immunosuppression ,0
1.78714E+16,Bendamustine 25mg powder for solution for infusion vials (product),Malignancy and immunosuppression ,0
1.78724E+16,Bendamustine 100mg powder for solution for infusion vials (product),Malignancy and immunosuppression ,0
1.80355E+16,Simponi 50mg/0.5ml solution for injection pre-filled syringes (Merck Sharp & Dohme (UK) Ltd) (product),Malignancy and immunosuppression ,0
1.80358E+16,Simponi 50mg/0.5ml solution for injection pre-filled pens (Merck Sharp & Dohme (UK) Ltd) (product),Malignancy and immunosuppression ,0
1.8038E+16,Golimumab 50mg/0.5ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
1.80381E+16,Golimumab 50mg/0.5ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
1.80442E+16,Adoport 5mg capsules (Sandoz Ltd) (product),Malignancy and immunosuppression ,0
1.80444E+16,Adoport 1mg capsules (Sandoz Ltd) (product),Malignancy and immunosuppression ,0
1.80448E+16,Adoport 0.5mg capsules (Sandoz Ltd) (product),Malignancy and immunosuppression ,0
1.81639E+16,Myfenax 500mg tablets (Teva UK Ltd) (product),Malignancy and immunosuppression ,0
1.81641E+16,Myfenax 250mg capsules (Teva UK Ltd) (product),Malignancy and immunosuppression ,0
1.81643E+16,Mycophenolate mofetil 250mg capsules (Actavis UK Ltd) (product),Malignancy and immunosuppression ,0
1.81645E+16,Mycophenolate Mofetil 500mg tablets (Actavis UK Ltd) (product),Malignancy and immunosuppression ,0
1.81727E+16,Leflunomide 10mg tablets (medac UK) (product),Malignancy and immunosuppression ,0
1.81729E+16,Leflunomide 20mg tablets (medac UK) (product),Malignancy and immunosuppression ,0
1.83008E+16,Docetaxel 140mg/7ml solution for infusion vials (product),Malignancy and immunosuppression ,0
1.8306E+16,Docetaxel 20mg/2ml solution for infusion vials (product),Malignancy and immunosuppression ,0
1.83106E+16,Mycophenolate mofetil 500mg tablets (A A H Pharmaceuticals Ltd) (product),Malignancy and immunosuppression ,0
1.84306E+16,Mercaptopurine 10mg tablets (product),Malignancy and immunosuppression ,0
1.84308E+16,Sirolimus 500microgram tablets (product),Malignancy and immunosuppression ,0
1.84682E+16,Nilotinib 150mg capsules (product),Malignancy and immunosuppression ,0
1.84703E+16,Dasatinib 140mg tablets (product),Malignancy and immunosuppression ,0
1.84704E+16,Dasatinib 80mg tablets (product),Malignancy and immunosuppression ,0
1.84975E+16,Azathioprine 50mg tablets (Almus Pharmaceuticals Ltd) (product),Malignancy and immunosuppression ,0
1.8741E+16,Gilenya 0.5mg capsules (Novartis Pharmaceuticals UK Ltd) (product),Malignancy and immunosuppression ,0
1.8748E+16,Fingolimod 500microgram capsules (product),Malignancy and immunosuppression ,0
1.87811E+16,Eribulin 880micrograms/2ml solution for injection vials (product),Malignancy and immunosuppression ,0
1.88126E+16,Leflunomide 20mg tablets (Teva UK Ltd) (product),Malignancy and immunosuppression ,0
1.91778E+16,Cabazitaxel 60mg/1.5ml solution for infusion vials (product),Malignancy and immunosuppression ,0
1.92246E+16,Metoject 12.5mg/0.25ml solution for injection pre-filled syringes (medac UK) (product),Malignancy and immunosuppression ,0
1.92251E+16,Metoject 17.5mg/0.35ml solution for injection pre-filled syringes (medac UK) (product),Malignancy and immunosuppression ,0
1.92313E+16,Methotrexate 12.5mg/0.25ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
1.92314E+16,Methotrexate 17.5mg/0.35ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
1.92315E+16,Methotrexate 22.5mg/0.45ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
1.93458E+16,Hydroxycarbamide 100mg tablets (product),Malignancy and immunosuppression ,0
1.93769E+16,Capsorin 100mg capsules (Morningside Healthcare Ltd) (product),Malignancy and immunosuppression ,0
1.93771E+16,Capsorin 50mg capsules (Morningside Healthcare Ltd) (product),Malignancy and immunosuppression ,0
1.93773E+16,Capsorin 25mg capsules (Morningside Healthcare Ltd) (product),Malignancy and immunosuppression ,0
1.94485E+16,Ipilimumab 200mg/40ml solution for infusion vials (product),Malignancy and immunosuppression ,0
1.94486E+16,Ipilimumab 50mg/10ml solution for infusion vials (product),Malignancy and immunosuppression ,0
1.94647E+16,Belatacept 250mg powder for solution for infusion vials (product),Malignancy and immunosuppression ,0
1.9482E+16,Belimumab 120mg powder for solution for infusion vials (product),Malignancy and immunosuppression ,0
1.94821E+16,Belimumab 400mg powder for solution for infusion vials (product),Malignancy and immunosuppression ,0
1.96873E+16,Humira 40mg/0.8ml solution for injection vials (Abbott Laboratories Ltd) (product),Malignancy and immunosuppression ,0
1.96977E+16,Adalimumab 40mg/0.8ml solution for injection vials (product),Malignancy and immunosuppression ,0
1.9744E+16,Everolimus 2.5mg tablets (product),Malignancy and immunosuppression ,0
1.99468E+16,Etanercept 10mg powder and solvent for solution for injection vials (product),Malignancy and immunosuppression ,0
1.9976E+16,Methotrexate 20mg/1ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
1.99761E+16,Methotrexate 25mg/1.25ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
2.0114E+16,Vemurafenib 240mg tablets (product),Malignancy and immunosuppression ,0
2.01589E+16,Abraxane 100mg powder for suspension for infusion vials (Celgene Ltd) (product),Malignancy and immunosuppression ,0
2.01772E+16,Paclitaxel albumin 100mg powder for suspension for infusion vials (product),Malignancy and immunosuppression ,0
2.04782E+16,Doxorubicin liposomal pegylated 20mg/10ml solution for infusion vials (product),Malignancy and immunosuppression ,0
2.05563E+16,Mercaptopurine 25mg tablets (product),Malignancy and immunosuppression ,0
2.12907E+16,Ruxolitinib 15mg tablets (product),Malignancy and immunosuppression ,0
2.12908E+16,Ruxolitinib 20mg tablets (product),Malignancy and immunosuppression ,0
2.13057E+16,Tacrolimus 800micrograms/5ml oral solution (product),Malignancy and immunosuppression ,0
2.15102E+16,Axitinib 1mg tablets (product),Malignancy and immunosuppression ,0
2.15103E+16,Axitinib 5mg tablets (product),Malignancy and immunosuppression ,0
2.15723E+16,Brentuximab vedotin 50mg powder for solution for infusion vials (product),Malignancy and immunosuppression ,0
2.16996E+16,Orencia 125mg/1ml solution for injection pre-filled syringes (Bristol-Myers Squibb Pharmaceuticals Ltd) (product),Malignancy and immunosuppression ,0
2.17047E+16,Abatacept 125mg/1ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
2.21548E+16,Pertuzumab 420mg/14ml solution for infusion vials (product),Malignancy and immunosuppression ,0
2.22221E+16,Methotrexate 10mg tablets (Teva UK Ltd) (product),Malignancy and immunosuppression ,0
2.22223E+16,Methotrexate 2.5mg tablets (Teva UK Ltd) (product),Malignancy and immunosuppression ,0
2.2343E+16,Pirfenidone 267mg capsules (product),Malignancy and immunosuppression ,0
2.24445E+16,Epirubicin 90mg/45ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
2.24597E+16,Cyclophosphamide 1g/50ml solution for infusion pre-filled syringes (product),Malignancy and immunosuppression ,0
2.24609E+16,Cyclophosphamide 500mg/25ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
2.25198E+16,Mercaptopurine 50mg tablets (Aspen Pharma Trading Ltd) (product),Malignancy and immunosuppression ,0
2.31573E+16,Herceptin 600mg/5ml solution for injection vials (Roche Products Ltd) (product),Malignancy and immunosuppression ,0
2.32049E+16,Trastuzumab 600mg/5ml solution for injection vials (product),Malignancy and immunosuppression ,0
2.32854E+16,Imnovid 2mg capsules (Celgene Ltd) (product),Malignancy and immunosuppression ,0
2.33074E+16,Revlimid 2.5mg capsules (Celgene Ltd) (product),Malignancy and immunosuppression ,0
2.33445E+16,Lenalidomide 2.5mg capsules (product),Malignancy and immunosuppression ,0
2.36038E+16,Gemcitabine 200mg/2ml solution for infusion vials (product),Malignancy and immunosuppression ,0
2.36121E+16,Tacrolimus 900micrograms/5ml oral suspension (product),Malignancy and immunosuppression ,0
2.39648E+16,Kadcyla 100mg powder for concentrate for solution for infusion vials (Roche Products Ltd) (product),Malignancy and immunosuppression ,0
2.39828E+16,Simponi 100mg/1ml solution for injection pre-filled pens (Merck Sharp & Dohme (UK) Ltd) (product),Malignancy and immunosuppression ,0
2.39847E+16,Golimumab 100mg/1ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
2.39854E+16,Trastuzumab emtansine 100mg powder for solution for infusion vials (product),Malignancy and immunosuppression ,0
2.39855E+16,Trastuzumab emtansine 160mg powder for solution for infusion vials (product),Malignancy and immunosuppression ,0
2.44076E+16,Capecitabine 300mg tablets (product),Malignancy and immunosuppression ,0
2.4408E+16,Leflunomide 15mg tablets (product),Malignancy and immunosuppression ,0
2.45046E+16,Aubagio 14mg tablets (Genzyme Therapeutics Ltd) (product),Malignancy and immunosuppression ,0
2.4509E+16,Axitinib 3mg tablets (product),Malignancy and immunosuppression ,0
2.45091E+16,Axitinib 7mg tablets (product),Malignancy and immunosuppression ,0
2.45095E+16,Docetaxel 20mg/0.72ml solution for infusion vials and diluent (product),Malignancy and immunosuppression ,0
2.45618E+16,Lemtrada 12mg/1.2ml concentrate for solution for infusion vials (Genzyme Therapeutics Ltd) (product),Malignancy and immunosuppression ,0
2.45657E+16,Alemtuzumab 12mg/1.2ml solution for infusion vials (product),Malignancy and immunosuppression ,0
2.45884E+16,Metoject PEN 7.5mg/0.15ml solution for injection pre-filled pens (medac UK) (product),Malignancy and immunosuppression ,0
2.45887E+16,Metoject PEN 30mg/0.6ml solution for injection pre-filled pens (medac UK) (product),Malignancy and immunosuppression ,0
2.45893E+16,Metoject PEN 25mg/0.5ml solution for injection pre-filled pens (medac UK) (product),Malignancy and immunosuppression ,0
2.45896E+16,Metoject PEN 15mg/0.3ml solution for injection pre-filled pens (medac UK) (product),Malignancy and immunosuppression ,0
2.45899E+16,Metoject PEN 12.5mg/0.25ml solution for injection pre-filled pens (medac UK) (product),Malignancy and immunosuppression ,0
2.45902E+16,Metoject PEN 10mg/0.2ml solution for injection pre-filled pens (medac UK) (product),Malignancy and immunosuppression ,0
2.45904E+16,Metoject PEN 22.5mg/0.45ml solution for injection pre-filled pens (medac UK) (product),Malignancy and immunosuppression ,0
2.45908E+16,Metoject PEN 20mg/0.4ml solution for injection pre-filled pens (medac UK) (product),Malignancy and immunosuppression ,0
2.45911E+16,Metoject PEN 17.5mg/0.35ml solution for injection pre-filled pens (medac UK) (product),Malignancy and immunosuppression ,0
2.45943E+16,Methotrexate 10mg/0.2ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
2.45944E+16,Methotrexate 12.5mg/0.25ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
2.45945E+16,Methotrexate 15mg/0.3ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
2.45946E+16,Methotrexate 17.5mg/0.35ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
2.45947E+16,Methotrexate 20mg/0.4ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
2.45948E+16,Methotrexate 22.5mg/0.45ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
2.45949E+16,Methotrexate 25mg/0.5ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
2.4595E+16,Methotrexate 27.5mg/0.55ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
2.45951E+16,Methotrexate 30mg/0.6ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
2.45952E+16,Methotrexate 7.5mg/0.15ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
2.46578E+16,Entyvio 300mg powder for concentrate for solution for infusion vials (Takeda UK Ltd) (product),Malignancy and immunosuppression ,0
2.46702E+16,Vedolizumab 300mg powder for solution for infusion vials (product),Malignancy and immunosuppression ,0
2.47808E+16,RoActemra 162mg/0.9ml solution for injection pre-filled syringes (Roche Products Ltd) (product),Malignancy and immunosuppression ,0
2.48565E+16,Rituximab 1.4g/11.7ml solution for injection vials (product),Malignancy and immunosuppression ,0
2.48569E+16,Tocilizumab 162mg/0.9ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
2.55035E+16,Obinutuzumab 1g/40ml solution for infusion vials (product),Malignancy and immunosuppression ,0
2.59645E+16,Trametinib 2mg tablets (product),Malignancy and immunosuppression ,0
2.79467E+16,Idelalisib 100mg tablets (product),Malignancy and immunosuppression ,0
2.79471E+16,Idelalisib 150mg tablets (product),Malignancy and immunosuppression ,0
2.80123E+16,Cabozantinib 20mg capsules (product),Malignancy and immunosuppression ,0
2.82824E+16,Imbruvica 140mg capsules (Janssen-Cilag Ltd) (product),Malignancy and immunosuppression ,0
2.83359E+16,Vanquoral 25mg capsules (Teva UK Ltd) (product),Malignancy and immunosuppression ,0
2.83374E+16,Vanquoral 50mg capsules (Teva UK Ltd) (product),Malignancy and immunosuppression ,0
2.83389E+16,Vanquoral 100mg capsules (Teva UK Ltd) (product),Malignancy and immunosuppression ,0
2.8395E+16,Ibrutinib 140mg capsules (product),Malignancy and immunosuppression ,0
2.84153E+16,Mercaptopurine 75mg tablets (product),Malignancy and immunosuppression ,0
2.87706E+16,Otezla 30mg tablets (Amgen Ltd) (product),Malignancy and immunosuppression ,0
2.87892E+16,Apremilast 30mg tablets (product),Malignancy and immunosuppression ,0
2.87902E+16,Nintedanib 100mg capsules (product),Malignancy and immunosuppression ,0
2.87903E+16,Nintedanib 150mg capsules (product),Malignancy and immunosuppression ,0
2.87918E+16,Envarsus 1mg modified-release tablets (Chiesi Ltd) (product),Malignancy and immunosuppression ,0
2.87921E+16,Envarsus 750microgram modified-release tablets (Chiesi Ltd) (product),Malignancy and immunosuppression ,0
2.87924E+16,Envarsus 4mg modified-release tablets (Chiesi Ltd) (product),Malignancy and immunosuppression ,0
2.88006E+16,Adoport 0.75mg capsules (Sandoz Ltd) (product),Malignancy and immunosuppression ,0
2.88009E+16,Adoport 2mg capsules (Sandoz Ltd) (product),Malignancy and immunosuppression ,0
2.88037E+16,Remsima 100mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd) (product),Malignancy and immunosuppression ,0
2.88088E+16,Tacrolimus 1mg modified-release tablets (product),Malignancy and immunosuppression ,0
2.88089E+16,Tacrolimus 4mg modified-release tablets (product),Malignancy and immunosuppression ,0
2.8809E+16,Tacrolimus 750microgram modified-release tablets (product),Malignancy and immunosuppression ,0
2.89432E+16,Inflectra 100mg powder for concentrate for solution for infusion vials (Hospira UK Ltd) (product),Malignancy and immunosuppression ,0
2.89476E+16,Tacrolimus 2mg capsules (product),Malignancy and immunosuppression ,0
2.89477E+16,Tacrolimus 750microgram capsules (product),Malignancy and immunosuppression ,0
2.92116E+16,Secukinumab 150mg/1ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
2.92125E+16,Cosentyx 150mg/1ml solution for injection pre-filled pens (Novartis Pharmaceuticals UK Ltd) (product),Malignancy and immunosuppression ,0
2.92127E+16,Secukinumab 150mg/1ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
2.92129E+16,Cosentyx 150mg/1ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) (product),Malignancy and immunosuppression ,0
2.96992E+16,Certican 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) (product),Malignancy and immunosuppression ,0
2.96994E+16,Certican 0.75mg tablets (Novartis Pharmaceuticals UK Ltd) (product),Malignancy and immunosuppression ,0
2.9767E+16,Abatacept 125mg/1ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
2.97688E+16,Olaparib 50mg capsules (product),Malignancy and immunosuppression ,0
2.9865E+16,Lenvima 4mg capsules (Eisai Ltd) (product),Malignancy and immunosuppression ,0
2.98891E+16,Nivolumab 100mg/10ml solution for infusion vials (product),Malignancy and immunosuppression ,0
2.98892E+16,Nivolumab 40mg/4ml solution for infusion vials (product),Malignancy and immunosuppression ,0
2.99037E+16,Lenalidomide 20mg capsules (product),Malignancy and immunosuppression ,0
2.99038E+16,Lenalidomide 7.5mg capsules (product),Malignancy and immunosuppression ,0
2.99346E+16,Vanquoral 10mg capsules (Teva UK Ltd) (product),Malignancy and immunosuppression ,0
3.0033E+16,Pembrolizumab 50mg powder for solution for infusion vials (product),Malignancy and immunosuppression ,0
3.05951E+16,Methotrexate 2mg/ml oral solution sugar free (Rosemont Pharmaceuticals Ltd) (product),Malignancy and immunosuppression ,0
3.07999E+16,Methotrexate 10mg/5ml oral solution sugar free (product),Malignancy and immunosuppression ,0
3.08163E+16,Stelara 90mg/1ml solution for injection pre-filled syringes (Janssen-Cilag Ltd) (product),Malignancy and immunosuppression ,0
3.09204E+16,Ustekinumab 90mg/1ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
3.10885E+16,Trametinib 500micrograms tablets (product),Malignancy and immunosuppression ,0
3.14067E+16,Zlatal 20mg/0.8ml solution for injection pre-filled syringes (Nordic Pharma Ltd) (product),Malignancy and immunosuppression ,0
3.14072E+16,Zlatal 22.5mg/0.9ml solution for injection pre-filled syringes (Nordic Pharma Ltd) (product),Malignancy and immunosuppression ,0
3.14074E+16,Zlatal 25mg/1ml solution for injection pre-filled syringes (Nordic Pharma Ltd) (product),Malignancy and immunosuppression ,0
3.14079E+16,Zlatal 10mg/0.4ml solution for injection pre-filled syringes (Nordic Pharma Ltd) (product),Malignancy and immunosuppression ,0
3.1409E+16,Zlatal 12.5mg/0.5ml solution for injection pre-filled syringes (Nordic Pharma Ltd) (product),Malignancy and immunosuppression ,0
3.14096E+16,Zlatal 15mg/0.6ml solution for injection pre-filled syringes (Nordic Pharma Ltd) (product),Malignancy and immunosuppression ,0
3.22271E+16,Benepali 50mg/1ml solution for injection pre-filled syringes (Biogen Idec Ltd) (product),Malignancy and immunosuppression ,0
3.22301E+16,Benepali 50mg/1ml solution for injection pre-filled pens (Biogen Idec Ltd) (product),Malignancy and immunosuppression ,0
3.28817E+16,Humira 40mg/0.4ml solution for injection pre-filled pens (AbbVie Ltd) (product),Malignancy and immunosuppression ,0
3.2882E+16,Humira 40 mg/0.4ml solution for injection pre-filled syringes (AbbVie Ltd) (product),Malignancy and immunosuppression ,0
3.28881E+16,Adalimumab 40mg/0.4ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
3.28882E+16,Adalimumab 40mg/0.4ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
3.30874E+16,Flixabi 100mg powder for concentrate for solution for infusion vials (Biogen Idec Ltd) (product),Malignancy and immunosuppression ,0
3.35118E+16,Cimzia 200mg/1ml solution for injection pre-filled pens (UCB Pharma Ltd) (product),Malignancy and immunosuppression ,0
3.35237E+16,Certolizumab pegol 200mg/1ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
3.36309E+16,Cabozantinib 20mg tablets (product),Malignancy and immunosuppression ,0
3.3631E+16,Cabozantinib 40mg tablets (product),Malignancy and immunosuppression ,0
3.36573E+16,Cabozantinib 60mg tablets (product),Malignancy and immunosuppression ,0
3.37498E+16,Ustekinumab 130mg/26ml solution for infusion vials (product),Malignancy and immunosuppression ,0
3.41558E+16,Irinotecan pegylated liposomal 43mg/10ml solution for infusion vials (product),Malignancy and immunosuppression ,0
3.41617E+16,Nordimet 7.5mg/0.3ml solution for injection pre-filled pens (Nordic Pharma Ltd) (product),Malignancy and immunosuppression ,0
3.41626E+16,Nordimet 10mg/0.4ml solution for injection pre-filled pens (Nordic Pharma Ltd) (product),Malignancy and immunosuppression ,0
3.41629E+16,Nordimet 12.5mg/0.5ml solution for injection pre-filled pens (Nordic Pharma Ltd) (product),Malignancy and immunosuppression ,0
3.41632E+16,Nordimet 15mg/0.6ml solution for injection pre-filled pens (Nordic Pharma Ltd) (product),Malignancy and immunosuppression ,0
3.41635E+16,Nordimet 17.5mg/0.7ml solution for injection pre-filled pens (Nordic Pharma Ltd) (product),Malignancy and immunosuppression ,0
3.41638E+16,Nordimet 20mg/0.8ml solution for injection pre-filled pens (Nordic Pharma Ltd) (product),Malignancy and immunosuppression ,0
3.41641E+16,Nordimet 22.5mg/0.9ml solution for injection pre-filled pens (Nordic Pharma Ltd) (product),Malignancy and immunosuppression ,0
3.41644E+16,Nordimet 25mg/1ml solution for injection pre-filled pens (Nordic Pharma Ltd) (product),Malignancy and immunosuppression ,0
3.41656E+16,Truxima 500mg/50ml concentrate for solution for infusion vials (Napp Pharmaceuticals Ltd) (product),Malignancy and immunosuppression ,0
3.41674E+16,Everolimus 3mg dispersible tablets sugar free (product),Malignancy and immunosuppression ,0
3.41675E+16,Everolimus 5mg dispersible tablets sugar free (product),Malignancy and immunosuppression ,0
3.41677E+16,Methotrexate 10mg/0.4ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
3.41678E+16,Methotrexate 12.5mg/0.5ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
3.41679E+16,Methotrexate 15mg/0.6ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
3.4168E+16,Methotrexate 17.5mg/0.7ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
3.41681E+16,Methotrexate 20mg/0.8ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
3.41682E+16,Methotrexate 22.5mg/0.9ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
3.41683E+16,Methotrexate 25mg/1ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
3.41684E+16,Methotrexate 7.5mg/0.3ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
3.43784E+16,Pembrolizumab 100mg/4ml solution for infusion vials (product),Malignancy and immunosuppression ,0
3.45305E+16,Carfilzomib 10mg powder for solution for infusion vials (product),Malignancy and immunosuppression ,0
3.46091E+16,Benepali 25mg/0.5ml solution for injection pre-filled syringes (Biogen Idec Ltd) (product),Malignancy and immunosuppression ,0
3.46137E+16,Truxima 100mg/10ml concentrate for solution for infusion vials (Napp Pharmaceuticals Ltd) (product),Malignancy and immunosuppression ,0
3.46232E+16,Esbriet 267mg tablets (Roche Products Ltd) (product),Malignancy and immunosuppression ,0
3.46255E+16,Pirfenidone 267mg tablets (product),Malignancy and immunosuppression ,0
3.46256E+16,Pirfenidone 801mg tablets (product),Malignancy and immunosuppression ,0
3.46333E+16,Mitomycin 40mg powder and solvent for intravesical solution vials (product),Malignancy and immunosuppression ,0
3.46337E+16,Erelzi 25mg/0.5ml solution for injection pre-filled syringes (Sandoz Ltd) (product),Malignancy and immunosuppression ,0
3.46339E+16,Erelzi 50mg/1ml solution for injection pre-filled syringes (Sandoz Ltd) (product),Malignancy and immunosuppression ,0
3.46341E+16,Erelzi 50mg/1ml solution for injection pre-filled pens (Sandoz Ltd) (product),Malignancy and immunosuppression ,0
3.46343E+16,Rixathon 100mg/10ml concentrate for solution for infusion vials (Sandoz Ltd) (product),Malignancy and immunosuppression ,0
3.46346E+16,Rixathon 500mg/50ml concentrate for solution for infusion vials (Sandoz Ltd) (product),Malignancy and immunosuppression ,0
3.47764E+16,Methofill 7.5mg/0.15ml solution for injection pre-filled injector (Accord Healthcare Ltd) (product),Malignancy and immunosuppression ,0
3.47769E+16,Methofill 10mg/0.2ml solution for injection pre-filled injector (Accord Healthcare Ltd) (product),Malignancy and immunosuppression ,0
3.47771E+16,Methofill 15mg/0.3ml solution for injection pre-filled injector (Accord Healthcare Ltd) (product),Malignancy and immunosuppression ,0
3.47773E+16,Methofill 12.5mg/0.25ml solution for injection pre-filled injector (Accord Healthcare Ltd) (product),Malignancy and immunosuppression ,0
3.47776E+16,Methofill 17.5mg/0.35ml solution for injection pre-filled injector (Accord Healthcare Ltd) (product),Malignancy and immunosuppression ,0
3.47778E+16,Methofill 20mg/0.4ml solution for injection pre-filled injector (Accord Healthcare Ltd) (product),Malignancy and immunosuppression ,0
3.47782E+16,Methofill 25mg/0.5ml solution for injection pre-filled injector (Accord Healthcare Ltd) (product),Malignancy and immunosuppression ,0
3.4791E+16,Mavenclad 10mg tablets (Merck Serono Ltd) (product),Malignancy and immunosuppression ,0
3.47967E+16,Cladribine 10mg tablets (product),Malignancy and immunosuppression ,0
3.48092E+16,Ceptava 180mg gastro-resistant tablets (Sandoz Ltd) (product),Malignancy and immunosuppression ,0
3.48094E+16,Ceptava 360mg gastro-resistant tablets (Sandoz Ltd) (product),Malignancy and immunosuppression ,0
3.4819E+16,Ponatinib 30mg tablets (product),Malignancy and immunosuppression ,0
3.4834E+16,Enbrel 25mg/0.5ml solution for injection pre-filled MyClic pens (Pfizer Ltd) (product),Malignancy and immunosuppression ,0
3.48405E+16,Etanercept 25mg/0.5ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
3.48712E+16,Cosentyx 150mg/1ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) (product),Malignancy and immunosuppression ,0
3.49566E+16,Methotrexate 2.5mg tablets (Almus Pharmaceuticals Ltd) (product),Malignancy and immunosuppression ,0
3.50861E+16,Canakinumab 150mg/1ml solution for injection vials (product),Malignancy and immunosuppression ,0
3.53153E+16,Humira 20mg/0.2ml solution for injection pre-filled syringes (AbbVie Ltd) (product),Malignancy and immunosuppression ,0
3.53188E+16,Adalimumab 20mg/0.2ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
3.54103E+16,RoActemra 162mg/0.9ml solution for injection pre-filled pens (Roche Products Ltd) (product),Malignancy and immunosuppression ,0
3.54316E+16,Tocilizumab 162mg/0.9ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
3.55148E+16,Olaparib 100mg tablets (product),Malignancy and immunosuppression ,0
3.55149E+16,Olaparib 150mg tablets (product),Malignancy and immunosuppression ,0
3.55418E+16,Nivolumab 240mg/24ml solution for infusion vials (product),Malignancy and immunosuppression ,0
3.55997E+16,Bosutinib 400mg tablets (product),Malignancy and immunosuppression ,0
3.56012E+16,Doxorubicin 20mg/10ml solution for infusion vials (product),Malignancy and immunosuppression ,0
3.58944E+16,Adalimumab 40mg/0.8ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
3.59062E+16,Basiliximab 10mg powder and solvent for solution for injection vials (product),Malignancy and immunosuppression ,0
3.59111E+16,Bevacizumab 100mg/4ml solution for infusion vials (product),Malignancy and immunosuppression ,0
3.59146E+16,Tacrolimus 5mg/1ml solution for infusion ampoules (product),Malignancy and immunosuppression ,0
3.59245E+16,Sodium aurothiomalate 10mg/0.5ml solution for injection ampoules (product),Malignancy and immunosuppression ,0
3.59247E+16,Sodium aurothiomalate 50mg/0.5ml solution for injection ampoules (product),Malignancy and immunosuppression ,0
3.59347E+16,Rituximab 100mg/10ml solution for infusion vials (product),Malignancy and immunosuppression ,0
3.59348E+16,Rituximab 500mg/50ml solution for infusion vials (product),Malignancy and immunosuppression ,0
3.60049E+16,Amgevita 40mg/0.8ml solution for injection pre-filled syringes (Amgen Ltd) (product),Malignancy and immunosuppression ,0
3.60051E+16,Amgevita 40mg/0.8ml solution for injection pre-filled pens (Amgen Ltd) (product),Malignancy and immunosuppression ,0
3.60236E+16,Paclitaxel 100mg/16.7ml solution for infusion vials (product),Malignancy and immunosuppression ,0
3.60237E+16,Paclitaxel 150mg/25ml solution for infusion vials (product),Malignancy and immunosuppression ,0
3.60253E+16,Panitumumab 100mg/5ml solution for infusion vials (product),Malignancy and immunosuppression ,0
3.60303E+16,Natalizumab 300mg/15ml solution for infusion vials (product),Malignancy and immunosuppression ,0
3.60329E+16,Methotrexate 1g/10ml solution for injection vials (product),Malignancy and immunosuppression ,0
3.6033E+16,Methotrexate 1g/40ml solution for injection vials (product),Malignancy and immunosuppression ,0
3.60332E+16,Methotrexate 500mg/20ml solution for injection vials (product),Malignancy and immunosuppression ,0
3.60333E+16,Methotrexate 50mg/2ml solution for injection vials (product),Malignancy and immunosuppression ,0
3.60335E+16,Methotrexate 5g/50ml solution for infusion vials (product),Malignancy and immunosuppression ,0
3.60336E+16,Methotrexate 5mg/2ml solution for injection vials (product),Malignancy and immunosuppression ,0
3.60496E+16,Irinotecan 40mg/2ml solution for infusion vials (product),Malignancy and immunosuppression ,0
3.60656E+16,Etanercept 25mg powder and solvent for solution for injection vials (product),Malignancy and immunosuppression ,0
3.60683E+16,Fluorouracil 250mg/10ml solution for injection vials (product),Malignancy and immunosuppression ,0
3.60684E+16,Fluorouracil 500mg/10ml solution for injection vials (product),Malignancy and immunosuppression ,0
3.60715E+16,Eculizumab 300mg/30ml solution for infusion vials (product),Malignancy and immunosuppression ,0
3.60724E+16,Epirubicin 10mg/5ml solution for injection vials (product),Malignancy and immunosuppression ,0
3.60726E+16,Epirubicin 50mg/25ml solution for injection vials (product),Malignancy and immunosuppression ,0
3.6092E+16,Cytarabine 100mg/1ml solution for injection vials (product),Malignancy and immunosuppression ,0
3.61393E+16,Ciclosporin 100mg/ml oral solution sugar free (product),Malignancy and immunosuppression ,0
3.61395E+16,Ciclosporin 250mg/5ml solution for infusion ampoules (product),Malignancy and immunosuppression ,0
3.61403E+16,Ciclosporin 50mg/1ml solution for infusion ampoules (product),Malignancy and immunosuppression ,0
3.61499E+16,Vinblastine 10mg/10ml solution for injection vials (product),Malignancy and immunosuppression ,0
3.615E+16,Vincristine 1mg/1ml solution for injection vials (product),Malignancy and immunosuppression ,0
3.61501E+16,Vincristine 2mg/2ml solution for injection vials (product),Malignancy and immunosuppression ,0
3.61504E+16,Vinorelbine 10mg/1ml solution for infusion vials (product),Malignancy and immunosuppression ,0
3.62343E+16,Hyrimoz 40mg/0.8ml solution for injection pre-filled pens (Sandoz Ltd) (product),Malignancy and immunosuppression ,0
3.62345E+16,Hyrimoz 40mg/0.8ml solution for injection pre-filled syringes (Sandoz Ltd) (product),Malignancy and immunosuppression ,0
3.64356E+16,Amgevita 20mg/0.4ml solution for injection pre-filled syringes (Amgen Ltd) (product),Malignancy and immunosuppression ,0
3.64417E+16,Adalimumab 20mg/0.4ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
3.6442E+16,Imraldi 40mg/0.8ml solution for injection pre-filled pens (Biogen Idec Ltd) (product),Malignancy and immunosuppression ,0
3.64579E+16,Adalimumab 80mg/0.8ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
3.6458E+16,Adalimumab 80mg/0.8ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
3.64602E+16,Imraldi 40mg/0.8ml solution for injection pre-filled syringes (Biogen Idec Ltd) (product),Malignancy and immunosuppression ,0
3.6584E+16,Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd) (product),Malignancy and immunosuppression ,0
3.66274E+16,Bendamustine 180mg/4ml solution for infusion vials (product),Malignancy and immunosuppression ,0
3.71719E+16,Nilotinib 50mg capsules (product),Malignancy and immunosuppression ,0
3.7223E+16,Abatacept 50mg/0.4ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
3.72231E+16,Abatacept 87.5mg/0.7ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
3.72362E+16,Fingolimod 250microgram capsules (product),Malignancy and immunosuppression ,0
3.72386E+16,Arsenic 10mg/10ml solution for infusion vials (product),Malignancy and immunosuppression ,0
3.74932E+16,Imbruvica 280mg tablets (Janssen-Cilag Ltd) (product),Malignancy and immunosuppression ,0
3.74934E+16,Ibrutinib 140mg tablets (product),Malignancy and immunosuppression ,0
3.74935E+16,Ibrutinib 280mg tablets (product),Malignancy and immunosuppression ,0
3.74936E+16,Ibrutinib 420mg tablets (product),Malignancy and immunosuppression ,0
3.74937E+16,Ibrutinib 560mg tablets (product),Malignancy and immunosuppression ,0
3.75641E+16,Bortezomib 1mg powder for solution for injection vials (product),Malignancy and immunosuppression ,0
3.75711E+16,Methofill 7.5mg/0.15ml solution for injection pre-filled syringes (Accord Healthcare Ltd) (product),Malignancy and immunosuppression ,0
3.75713E+16,Methofill 10mg/0.2ml solution for injection pre-filled syringes (Accord Healthcare Ltd) (product),Malignancy and immunosuppression ,0
3.75715E+16,Methofill 12.5mg/0.25ml solution for injection pre-filled syringes (Accord Healthcare Ltd) (product),Malignancy and immunosuppression ,0
3.75717E+16,Methofill 15mg/0.3ml solution for injection pre-filled syringes (Accord Healthcare Ltd) (product),Malignancy and immunosuppression ,0
3.75719E+16,Methofill 17.5mg/0.35ml solution for injection pre-filled syringes (Accord Healthcare Ltd) (product),Malignancy and immunosuppression ,0
3.75721E+16,Hanixol 50mg tablets (Fontus Health Ltd) (product),Malignancy and immunosuppression ,0
3.75723E+16,Methofill 20mg/0.4ml solution for injection pre-filled syringes (Accord Healthcare Ltd) (product),Malignancy and immunosuppression ,0
3.75727E+16,Methofill 25mg/0.5ml solution for injection pre-filled syringes (Accord Healthcare Ltd) (product),Malignancy and immunosuppression ,0
3.76003E+16,Bortezomib 2.5mg powder for solution for injection vials (product),Malignancy and immunosuppression ,0
3.76004E+16,Hydroxycarbamide 500mg/5ml oral solution sugar free (product),Malignancy and immunosuppression ,0
3.7847E+16,Cimzia 200mg/1ml solution for injection in a dose-dispenser cartridge (UCB Pharma Ltd) (product),Malignancy and immunosuppression ,0
3.78548E+16,Certolizumab pegol 200mg/1ml solution for injection cartridges (product),Malignancy and immunosuppression ,0
3.79399E+16,Dailiport 1mg modified-release capsules (Sandoz Ltd) (product),Malignancy and immunosuppression ,0
3.7941E+16,Dailiport 2mg modified-release capsules (Sandoz Ltd) (product),Malignancy and immunosuppression ,0
3.80045E+16,Remsima 120mg/1ml solution for injection pre-filled syringes (Celltrion Healthcare UK Ltd) (product),Malignancy and immunosuppression ,0
3.80048E+16,Remsima 120mg/1ml solution for injection pre-filled pens (Celltrion Healthcare UK Ltd) (product),Malignancy and immunosuppression ,0
3.80077E+16,Ceritinib 150mg tablets (product),Malignancy and immunosuppression ,0
3.8196E+16,Infliximab 120mg/1ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
3.81961E+16,Infliximab 120mg/1ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
3.82898E+16,Entyvio 108mg/0.68ml solution for injection pre-filled pens (Takeda UK Ltd) (product),Malignancy and immunosuppression ,0
3.8362E+16,Vedolizumab 108mg/0.68ml solution for injection pre-filled disposable devices (product),Malignancy and immunosuppression ,0
3.83622E+16,Vedolizumab 108mg/0.68ml solution for injection pre-filled syringes (product),Malignancy and immunosuppression ,0
3.83676E+16,Idacio 40mg/0.8ml solution for injection pre-filled pens (Fresenius Kabi Ltd) (product),Malignancy and immunosuppression ,0
,Waldenstrm macroglobulinemia (disorder),Malignancy and immunosuppression ,0
,Szary's disease (disorder),Malignancy and immunosuppression ,0
,Chdiak-Higashi syndrome (disorder),Malignancy and immunosuppression ,0
,Pelger-Hut anomaly (disorder),Malignancy and immunosuppression ,0
,Lffler's syndrome (disorder),Malignancy and immunosuppression ,0
,Hand-Schller-Christian disease (disorder),Malignancy and immunosuppression ,0
162004,Severe manic bipolar I disorder without psychotic features (disorder),Mental health,0
4441000,Severe bipolar disorder with psychotic features (disorder),Mental health,0
4926007,Schizophrenia in remission (disorder),Mental health,0
5464005,Brief reactive psychosis (disorder),Mental health,0
12939007,Chronic disorganized schizophrenia (disorder),Mental health,0
13313007,Mild bipolar disorder (disorder),Mental health,0
13746004,Bipolar disorder (disorder),Mental health,0
16506000,Mixed bipolar I disorder (disorder),Mental health,0
16990005,Subchronic schizophrenia (disorder),Mental health,0
23560001,Asperger's disorder (disorder),Mental health,0
26025008,Residual schizophrenia (disorder),Mental health,0
26472000,Paraphrenia (disorder),Mental health,0
28475009,Severe recurrent major depression with psychotic features (disorder),Mental health,0
31027006,Schizotypal personality disorder (disorder),Mental health,0
31373002,Disorganized schizophrenia in remission (disorder),Mental health,0
31446002,"Bipolar I disorder, most recent episode hypomanic (disorder)",Mental health,0
31658008,Chronic paranoid schizophrenia (disorder),Mental health,0
33323008,Somatic delusion disorder (disorder),Mental health,0
35252006,Disorganized schizophrenia (disorder),Mental health,0
35919005,Pervasive developmental disorder (disorder),Mental health,0
38295006,Involutional paraphrenia (disorder),Mental health,0
41836007,Bipolar disorder in full remission (disorder),Mental health,0
42868002,Subchronic catatonic schizophrenia (disorder),Mental health,0
43614003,Autistic disorder of childhood onset (disorder),Mental health,0
48500005,Delusional disorder (disorder),Mental health,0
53049002,Severe bipolar disorder without psychotic features (disorder),Mental health,0
58214004,Schizophrenia (disorder),Mental health,0
61403008,Severe depressed bipolar I disorder without psychotic features (disorder),Mental health,0
61831009,Induced psychotic disorder (disorder),Mental health,0
63181006,Paranoid schizophrenia in remission (disorder),Mental health,0
63249007,Manic bipolar I disorder in partial remission (disorder),Mental health,0
64905009,Paranoid schizophrenia (disorder),Mental health,0
68890003,Schizoaffective disorder (disorder),Mental health,0
68995007,Chronic catatonic schizophrenia (disorder),Mental health,0
69322001,Psychotic disorder (disorder),Mental health,0
71961003,Childhood disintegrative disorder (disorder),Mental health,0
73867007,Severe major depression with psychotic features (disorder),Mental health,0
77475008,Jealous delusion disorder (disorder),Mental health,0
79584002,Moderate bipolar disorder (disorder),Mental health,0
79866005,Subchronic paranoid schizophrenia (disorder),Mental health,0
83225003,Bipolar II disorder (disorder),Mental health,0
83746006,Chronic schizophrenia (disorder),Mental health,0
84760002,"Schizoaffective disorder, depressive type (disorder)",Mental health,0
85248005,Bipolar disorder in remission (disorder),Mental health,0
88975006,Schizophreniform disorder (disorder),Mental health,0
111482003,Subchronic schizophrenia with acute exacerbations (disorder),Mental health,0
111483008,Catatonic schizophrenia in remission (disorder),Mental health,0
111484002,Undifferentiated schizophrenia (disorder),Mental health,0
134517009,Product containing precisely amisulpride 400 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
191525009,Non-organic psychosis (disorder),Mental health,0
191526005,Schizophrenic disorders (disorder),Mental health,0
191527001,Simple schizophrenia (disorder),Mental health,0
191531007,Acute exacerbation of chronic schizophrenia (disorder),Mental health,0
191542003,Catatonic schizophrenia (disorder),Mental health,0
191548004,Acute exacerbation of chronic catatonic schizophrenia (disorder),Mental health,0
191554003,Acute exacerbation of subchronic paranoid schizophrenia (disorder),Mental health,0
191555002,Acute exacerbation of chronic paranoid schizophrenia (disorder),Mental health,0
191559008,Latent schizophrenia (disorder),Mental health,0
191561004,Subchronic latent schizophrenia (disorder),Mental health,0
191562006,Chronic latent schizophrenia (disorder),Mental health,0
191563001,Acute exacerbation of subchronic latent schizophrenia (disorder),Mental health,0
191565008,Latent schizophrenia in remission (disorder),Mental health,0
191567000,Schizoaffective schizophrenia (disorder),Mental health,0
191570001,Chronic schizoaffective schizophrenia (disorder),Mental health,0
191571002,Acute exacerbation of subchronic schizoaffective schizophrenia (disorder),Mental health,0
191572009,Acute exacerbation of chronic schizoaffective schizophrenia (disorder),Mental health,0
191574005,Schizoaffective schizophrenia in remission (disorder),Mental health,0
191583000,"Single manic episode, mild (disorder)",Mental health,0
191584006,"Single manic episode, moderate (disorder)",Mental health,0
191586008,"Single manic episode, severe, with psychosis (disorder)",Mental health,0
191588009,Single manic episode in full remission (disorder),Mental health,0
191590005,Recurrent manic episodes (disorder),Mental health,0
191592002,"Recurrent manic episodes, mild (disorder)",Mental health,0
191593007,"Recurrent manic episodes, moderate (disorder)",Mental health,0
191595000,"Recurrent manic episodes, severe, with psychosis (disorder)",Mental health,0
191597008,"Recurrent manic episodes, in full remission (disorder)",Mental health,0
191604000,"Single major depressive episode, severe, with psychosis (disorder)",Mental health,0
191613003,"Recurrent major depressive episodes, severe, with psychosis (disorder)",Mental health,0
191618007,"Bipolar affective disorder, current episode manic (disorder)",Mental health,0
191620005,"Bipolar affective disorder, currently manic, mild (disorder)",Mental health,0
191621009,"Bipolar affective disorder, currently manic, moderate (disorder)",Mental health,0
191623007,"Bipolar affective disorder, currently manic, severe, with psychosis (disorder)",Mental health,0
191625000,"Bipolar affective disorder, currently manic, in full remission (disorder)",Mental health,0
191627008,"Bipolar affective disorder, current episode depression (disorder)",Mental health,0
191629006,"Bipolar affective disorder, currently depressed, mild (disorder)",Mental health,0
191630001,"Bipolar affective disorder, currently depressed, moderate (disorder)",Mental health,0
191634005,"Bipolar affective disorder, currently depressed, in full remission (disorder)",Mental health,0
191636007,Mixed bipolar affective disorder (disorder),Mental health,0
191638008,"Mixed bipolar affective disorder, mild (disorder)",Mental health,0
191639000,"Mixed bipolar affective disorder, moderate (disorder)",Mental health,0
191641004,"Mixed bipolar affective disorder, severe, with psychosis (disorder)",Mental health,0
191643001,"Mixed bipolar affective disorder, in full remission (disorder)",Mental health,0
191658009,Atypical manic disorder (disorder),Mental health,0
191668004,Simple paranoid state (disorder),Mental health,0
191670008,Shared paranoid disorder (disorder),Mental health,0
191672000,Paranoia querulans (disorder),Mental health,0
191676002,Reactive depressive psychosis (disorder),Mental health,0
191677006,Acute hysterical psychosis (disorder),Mental health,0
191680007,Psychogenic paranoid psychosis (disorder),Mental health,0
191683009,Psychogenic stupor (disorder),Mental health,0
191689008,Active infantile autism (disorder),Mental health,0
191690004,Residual infantile autism (disorder),Mental health,0
192362008,"Bipolar affective disorder, current episode mixed (disorder)",Mental health,0
231437006,Reactive psychoses (disorder),Mental health,0
231449007,Epileptic psychosis (disorder),Mental health,0
231485007,Post-schizophrenic depression (disorder),Mental health,0
231487004,Persistent delusional disorder (disorder),Mental health,0
231489001,Acute transient psychotic disorder (disorder),Mental health,0
231494001,Mania (disorder),Mental health,0
231496004,Hypomania (disorder),Mental health,0
231536004,Atypical autism (disorder),Mental health,0
238973003,Delusions of parasitosis (disorder),Mental health,0
238974009,Delusions of infestation (disorder),Mental health,0
238975005,Delusion of foul odor (disorder),Mental health,0
238977002,Delusional hyperhidrosis (disorder),Mental health,0
247804008,Schizophrenic prodrome (disorder),Mental health,0
268617001,Acute schizophrenic episode (disorder),Mental health,0
268619003,"Manic disorder, single episode (disorder)",Mental health,0
268622001,Chronic paranoid psychosis (disorder),Mental health,0
268624000,Acute paranoid reaction (disorder),Mental health,0
270901009,"Schizoaffective disorder, mixed type (disorder)",Mental health,0
271428004,"Schizoaffective disorder, manic type (disorder)",Mental health,0
274952002,Borderline schizophrenia (disorder),Mental health,0
274953007,Acute polymorphic psychotic disorder (disorder),Mental health,0
278506006,Involutional paranoid state (disorder),Mental health,0
278508007,Delusional dysmorphophobia (disorder),Mental health,0
278853003,Acute schizophrenia-like psychotic disorder (disorder),Mental health,0
280949006,Erotomania (disorder),Mental health,0
307417003,Cycloid psychosis (disorder),Mental health,0
321366002,Product containing precisely chlorpromazine hydrochloride 25 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321367006,Product containing precisely chlorpromazine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321368001,Product containing precisely chlorpromazine hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321393004,Product containing precisely benperidol 250 microgram/1 each conventional release oral tablet (clinical drug),Mental health,0
321407005,Product containing precisely flupentixol 3 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321416009,Product containing precisely haloperidol 1.5 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321417000,Product containing precisely haloperidol 5 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321418005,Product containing precisely haloperidol 10 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321420008,Product containing precisely haloperidol 2 milligram/1 milliliter conventional release oral solution (clinical drug),Mental health,0
321448008,Product containing precisely haloperidol 500 microgram/1 each conventional release oral capsule (clinical drug),Mental health,0
321450000,Product containing precisely haloperidol 1 milligram/1 milliliter conventional release oral solution (clinical drug),Mental health,0
321451001,Product containing precisely haloperidol 500 microgram/1 each conventional release oral tablet (clinical drug),Mental health,0
321460009,Methotrimeprazine hydrochloride 25mg/1mL injection,Mental health,0
321461008,Product containing precisely levomepromazine maleate 25 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321473008,Product containing precisely periciazine 2.5 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321474002,Product containing precisely periciazine 10 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321484001,Product containing precisely perphenazine 2 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321485000,Product containing precisely perphenazine 4 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321491003,Product containing precisely pimozide 4 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321498009,Product containing precisely promazine hydrochloride 25 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321499001,Product containing precisely promazine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321502002,Promazine hydrochloride 50mg/5mL syrup (product),Mental health,0
321512009,Product containing precisely sulpiride 400 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321514005,Product containing precisely sulpiride 200 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321531003,Product containing precisely thioridazine hydrochloride 25 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321532005,Product containing precisely thioridazine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321546005,Trifluoperazine 5mg/5mL sugar free syrup (product),Mental health,0
321547001,Product containing precisely trifluoperazine 1 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321548006,Product containing precisely trifluoperazine 5 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321563009,Product containing precisely zuclopenthixol 2 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321564003,Product containing precisely zuclopenthixol 10 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321565002,Product containing precisely zuclopenthixol 25 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321573006,Product containing precisely clozapine 25 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321574000,Product containing precisely clozapine 100 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321589009,Product containing precisely risperidone 1 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321590000,Product containing precisely risperidone 2 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321591001,Product containing precisely risperidone 3 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321592008,Product containing precisely risperidone 4 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321597002,Product containing precisely risperidone 1 milligram/1 milliliter conventional release oral solution (clinical drug),Mental health,0
321599004,Product containing precisely risperidone 6 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321602009,Product containing precisely risperidone 500 microgram/1 each conventional release oral tablet (clinical drug),Mental health,0
321612002,Product containing precisely olanzapine 5 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321613007,Product containing precisely olanzapine 7.5 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321614001,Product containing precisely olanzapine 10 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321618003,Product containing precisely olanzapine 2.5 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321622008,Product containing precisely olanzapine 5 milligram/1 each conventional release orodispersible tablet (clinical drug),Mental health,0
321623003,Product containing precisely olanzapine 10 milligram/1 each conventional release orodispersible tablet (clinical drug),Mental health,0
321624009,Product containing precisely quetiapine (as quetiapine fumarate) 25 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321625005,Product containing precisely quetiapine (as quetiapine fumarate) 100 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321626006,Product containing precisely quetiapine (as quetiapine fumarate) 200 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321635004,Product containing precisely quetiapine 150 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321637007,Product containing precisely amisulpride 50 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321638002,Product containing precisely amisulpride 200 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
321935002,Product containing precisely flupentixol 500 microgram/1 each conventional release oral tablet (clinical drug),Mental health,0
321936001,Product containing precisely flupentixol 1 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
371596008,Bipolar I disorder (disorder),Mental health,0
374054003,Product containing precisely olanzapine 20 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
376807001,Product containing precisely olanzapine 15 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
386213008,Product containing precisely olanzapine 20 milligram/1 each conventional release orodispersible tablet (clinical drug),Mental health,0
400645002,Product containing precisely amisulpride 100 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
406786007,Product containing precisely aripiprazole 5 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
406787003,Product containing precisely aripiprazole 10 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
406788008,Product containing precisely aripiprazole 15 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
406790009,Product containing precisely aripiprazole 30 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
408856003,Autistic disorder (disorder),Mental health,0
408857007,Infantile autism (disorder),Mental health,0
417374006,Product containing precisely aripiprazole 1 milligram/1 milliliter conventional release oral solution (clinical drug),Mental health,0
418754000,Product containing precisely clozapine 50 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
426401009,Product containing precisely quetiapine (as quetiapine fumarate) 300 milligram/1 each prolonged-release oral tablet (clinical drug),Mental health,0
426802009,Product containing precisely quetiapine (as quetiapine fumarate) 200 milligram/1 each prolonged-release oral tablet (clinical drug),Mental health,0
426954000,Product containing precisely quetiapine (as quetiapine fumarate) 400 milligram/1 each prolonged-release oral tablet (clinical drug),Mental health,0
429830008,Product containing precisely quetiapine (as quetiapine fumarate) 300 milligram/1 each conventional release oral tablet (clinical drug),Mental health,0
441704009,Affective psychosis (disorder),Mental health,0
712824002,Acute polymorphic psychotic disorder without symptoms of schizophrenia (disorder),Mental health,0
712850003,Acute polymorphic psychotic disorder co-occurrent with symptoms of schizophrenia (disorder),Mental health,0
712884004,Pathological demand avoidance (disorder),Mental health,0
765176007,Psychosis and severe depression co-occurrent and due to bipolar affective disorder (disorder),Mental health,0
767631007,"Bipolar disorder, most recent episode depression (disorder)",Mental health,0
2.4311E+13,Solian 50 tablets (Sanofi-Synthelabo Ltd) (product),Mental health,0
2.6911E+13,Haloperidol 500microgram tablets (A A H Pharmaceuticals Ltd) (product),Mental health,0
4.4411E+13,Dolmatil 200mg tablets (Sanofi-Synthelabo Ltd) (product),Mental health,0
6.3811E+13,Sulpiride 200mg tablets (Approved Prescription Services) (product),Mental health,0
8.1011E+13,Promazine 50mg/5ml oral solution (Rosemont Pharmaceuticals Ltd) (product),Mental health,0
9.1711E+13,Zyprexa 5mg Velotabs (Eli Lilly & Co Ltd) (product),Mental health,0
1.17911E+14,Haldol 2mg/ml oral solution (Janssen-Cilag Ltd) (product),Mental health,0
1.48011E+14,Trifluoperazine 5mg tablets (A A H Pharmaceuticals Ltd) (product),Mental health,0
1.53111E+14,Risperdal 6mg tablets (Janssen-Cilag Ltd) (product),Mental health,0
1.53611E+14,Clopixol 2mg tablets (Lundbeck Ltd) (product),Mental health,0
2.51811E+14,Sulpiride 400mg tablets (A A H Pharmaceuticals Ltd) (product),Mental health,0
2.90211E+14,Chlorpromazine 25mg tablets (A A H Pharmaceuticals Ltd) (product),Mental health,0
2.93211E+14,Sulpiride 200mg tablets (A A H Pharmaceuticals Ltd) (product),Mental health,0
3.20311E+14,Sulpiride 200mg tablets (Generics (UK) Ltd) (product),Mental health,0
3.21211E+14,Chlorpromazine 100mg tablets (A A H Pharmaceuticals Ltd) (product),Mental health,0
3.37311E+14,Zyprexa 2.5mg tablets (Eli Lilly & Co Ltd) (product),Mental health,0
3.40911E+14,Seroquel 100mg tablets (Luye Pharma Ltd) (product),Mental health,0
3.43311E+14,Risperdal 1mg/1ml liquid (Janssen-Cilag Ltd) (product),Mental health,0
4.16411E+14,Dolmatil 400mg tablets (Sanofi-Synthelabo Ltd) (product),Mental health,0
4.17601E+14,"[X]Schizophrenia, schizotypal and delusional disorders (disorder)",Mental health,0
4.29611E+14,Risperdal 4mg tablets (Janssen-Cilag Ltd) (product),Mental health,0
4.30911E+14,Chlorpromazine 50mg tablets (A A H Pharmaceuticals Ltd) (product),Mental health,0
4.67011E+14,Zyprexa 5mg tablets (Eli Lilly & Co Ltd) (product),Mental health,0
4.76411E+14,Seroquel 200mg tablets (Luye Pharma Ltd) (product),Mental health,0
4.86611E+14,Zyprexa 10mg tablets (Eli Lilly & Co Ltd) (product),Mental health,0
5.04611E+14,Haloperidol 5mg tablets (Approved Prescription Services) (product),Mental health,0
5.07511E+14,Fluanxol 500microgram tablets (Lundbeck Ltd) (product),Mental health,0
5.11111E+14,Zyprexa 15mg tablets (Eli Lilly & Co Ltd) (product),Mental health,0
5.18911E+14,Risperdal 3mg tablets (Janssen-Cilag Ltd) (product),Mental health,0
5.22711E+14,Serenace 500microgram capsules (IVAX Pharmaceuticals UK Ltd) (product),Mental health,0
5.26611E+14,Risperdal 500microgram tablets (Janssen-Cilag Ltd) (product),Mental health,0
5.49211E+14,Haloperidol 5mg tablets (A A H Pharmaceuticals Ltd) (product),Mental health,0
5.65711E+14,Haloperidol 1.5mg tablets (A A H Pharmaceuticals Ltd) (product),Mental health,0
5.83411E+14,Trifluoperazine 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd) (product),Mental health,0
5.89911E+14,Risperdal 1mg tablets (Janssen-Cilag Ltd) (product),Mental health,0
5.96211E+14,Seroquel 25mg tablets (Luye Pharma Ltd) (product),Mental health,0
6.18211E+14,Clopixol 25mg tablets (Lundbeck Ltd) (product),Mental health,0
6.65811E+14,Promazine 25mg/5ml oral solution (Rosemont Pharmaceuticals Ltd) (product),Mental health,0
7.01911E+14,Nozinan 25mg tablets (Link Pharmaceuticals Ltd) (product),Mental health,0
7.55311E+14,Non-organic psychosis in remission (disorder),Mental health,0
7.55321E+14,"Single major depressive episode, severe, with psychosis, psychosis in remission (disorder)",Mental health,0
7.55331E+14,"Recurrent major depressive episodes, severe, with psychosis, psychosis in remission (disorder)",Mental health,0
7.60721E+14,"Mixed bipolar affective disorder, in partial remission (disorder)",Mental health,0
7.64591E+14,"Mixed bipolar affective disorder, severe (disorder)",Mental health,0
7.64621E+14,"Recurrent manic episodes, severe (disorder)",Mental health,0
7.64641E+14,"Single manic episode, severe (disorder)",Mental health,0
7.64671E+14,"Recurrent manic episodes, in partial remission (disorder)",Mental health,0
7.64731E+14,Single manic episode in partial remission (disorder),Mental health,0
8.27511E+14,Clopixol 10mg tablets (Lundbeck Ltd) (product),Mental health,0
8.43011E+14,Fluanxol 1mg tablets (Lundbeck Ltd) (product),Mental health,0
8.58911E+14,Risperdal 2mg tablets (Janssen-Cilag Ltd) (product),Mental health,0
8.97111E+14,Zyprexa 10mg Velotabs (Eli Lilly & Co Ltd) (product),Mental health,0
1.08647E+15,"Recurrent reactive depressive episodes, severe, with psychosis (disorder)",Mental health,0
1.12719E+15,First episode psychosis (finding),Mental health,0
3.43491E+15,Olanzapine 15mg oral lyophilisates (product),Mental health,0
3.67961E+15,Depixol 3mg tablets (Lundbeck Ltd) (product),Mental health,0
3.68801E+15,Orap 4mg tablets (Eumedica Pharma Ltd) (product),Mental health,0
3.83031E+15,Clozaril 25mg tablets (Novartis Pharmaceuticals UK Ltd) (product),Mental health,0
3.83201E+15,Clozaril 100mg tablets (Novartis Pharmaceuticals UK Ltd) (product),Mental health,0
3.93381E+15,Solian 500mg/5ml oral solution (Sanofi-Synthelabo Ltd) (product),Mental health,0
4.05401E+15,Risperidone 1mg orodispersible tablets (product),Mental health,0
4.05411E+15,Risperidone 2mg orodispersible tablets (product),Mental health,0
4.18291E+15,Nozinan 25mg/1ml solution for injection ampoules (Link Pharmaceuticals Ltd) (product),Mental health,0
4.20921E+15,Promazine 25mg tablets (Approved Prescription Services) (product),Mental health,0
4.98911E+15,Seroquel 300mg tablets (Luye Pharma Ltd) (product),Mental health,0
7.63711E+15,Abilify 10mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) (product),Mental health,0
7.63741E+15,Abilify 15mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) (product),Mental health,0
7.63781E+15,Abilify 30mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) (product),Mental health,0
7.83511E+15,Amisulpride 50mg tablets (Sterwin Medicines) (product),Mental health,0
7.83561E+15,Amisulpride 100mg tablets (Sterwin Medicines) (product),Mental health,0
7.97291E+15,Denzapine 25mg tablets (Denfleet Pharma Ltd) (product),Mental health,0
7.97401E+15,Denzapine 100mg tablets (Denfleet Pharma Ltd) (product),Mental health,0
8.27721E+15,Amisulpride 25mg/5ml oral solution (product),Mental health,0
8.27731E+15,Amisulpride 25mg/5ml oral suspension (product),Mental health,0
8.35941E+15,Chlorpromazine 100mg/5ml oral solution (product),Mental health,0
8.52791E+15,Haloperidol 1mg/5ml oral solution (product),Mental health,0
8.52801E+15,Haloperidol 1mg/5ml oral suspension (product),Mental health,0
8.52831E+15,Haloperidol 500micrograms/5ml oral solution (product),Mental health,0
8.52841E+15,Haloperidol 500micrograms/5ml oral suspension (product),Mental health,0
8.58281E+15,Levomepromazine 2.5mg/5ml oral suspension (product),Mental health,0
8.83891E+15,Zaponex 25mg tablets (IVAX Pharmaceuticals UK Ltd) (product),Mental health,0
8.83951E+15,Zaponex 100mg tablets (IVAX Pharmaceuticals UK Ltd) (product),Mental health,0
8.92281E+15,Amisulpride 50mg tablets (A A H Pharmaceuticals Ltd) (product),Mental health,0
8.92341E+15,Amisulpride 400mg tablets (A A H Pharmaceuticals Ltd) (product),Mental health,0
9.03791E+15,Abilify 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) (product),Mental health,0
9.04591E+15,Risperidone 500microgram orodispersible tablets sugar free (product),Mental health,0
9.53631E+15,Levomepromazine 6mg tablets (product),Mental health,0
9.72831E+15,Amisulpride 50mg tablets (Accord Healthcare Ltd) (product),Mental health,0
9.72851E+15,Amisulpride 100mg tablets (Accord Healthcare Ltd) (product),Mental health,0
9.89101E+15,Zyprexa 20mg Velotabs (Eli Lilly & Co Ltd) (product),Mental health,0
1.06646E+16,Abilify 10mg orodispersible tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) (product),Mental health,0
1.06672E+16,Abilify 1mg/ml oral solution (Bristol-Myers Squibb Pharmaceuticals Ltd) (product),Mental health,0
1.06753E+16,Aripiprazole 10mg orodispersible tablets sugar free (product),Mental health,0
1.06754E+16,Aripiprazole 15mg orodispersible tablets sugar free (product),Mental health,0
1.06844E+16,Haloperidol 5mg/1ml solution for injection ampoules (Goldshield Pharmaceuticals Ltd) (product),Mental health,0
1.08785E+16,Zyprexa 20mg tablets (Eli Lilly & Co Ltd) (product),Mental health,0
1.10159E+16,Chlorpromazine 50mg tablets (Dr Reddy's Labs) (product),Mental health,0
1.11408E+16,Risperidone 3mg orodispersible tablets sugar free (product),Mental health,0
1.11409E+16,Risperidone 4mg orodispersible tablets sugar free (product),Mental health,0
1.1751E+16,Invega 9mg modified-release tablets (Janssen-Cilag Ltd) (product),Mental health,0
1.17632E+16,Paliperidone 3mg modified-release tablets (product),Mental health,0
1.17633E+16,Paliperidone 6mg modified-release tablets (product),Mental health,0
1.17634E+16,Paliperidone 9mg modified-release tablets (product),Mental health,0
1.25049E+16,Haloperidol 1.5mg/5ml oral solution (product),Mental health,0
1.2505E+16,Haloperidol 1.5mg/5ml oral suspension (product),Mental health,0
1.25056E+16,Haloperidol 250micrograms/5ml oral suspension (product),Mental health,0
1.25059E+16,Haloperidol 5mg/5ml oral solution (product),Mental health,0
1.26469E+16,Levomepromazine 6mg/5ml oral suspension (product),Mental health,0
1.2873E+16,Risperidone 500microgram tablets (Actavis UK Ltd) (product),Mental health,0
1.28732E+16,Risperidone 1mg tablets (Actavis UK Ltd) (product),Mental health,0
1.28737E+16,Risperidone 2mg tablets (Actavis UK Ltd) (product),Mental health,0
1.2874E+16,Risperidone 3mg tablets (Actavis UK Ltd) (product),Mental health,0
1.28742E+16,Risperidone 4mg tablets (Actavis UK Ltd) (product),Mental health,0
1.28853E+16,Risperidone 500microgram tablets (Teva UK Ltd) (product),Mental health,0
1.28855E+16,Risperidone 1mg tablets (Teva UK Ltd) (product),Mental health,0
1.28859E+16,Risperidone 2mg tablets (Teva UK Ltd) (product),Mental health,0
1.30116E+16,Quetiapine 12.5mg/5ml oral solution (product),Mental health,0
1.30117E+16,Quetiapine 12.5mg/5ml oral suspension (product),Mental health,0
1.30118E+16,Quetiapine 125mg/5ml oral solution (product),Mental health,0
1.30122E+16,Quetiapine 25mg/5ml oral solution (product),Mental health,0
1.30123E+16,Quetiapine 25mg/5ml oral suspension (product),Mental health,0
1.31206E+16,Risperidone 500microgram tablets (A A H Pharmaceuticals Ltd) (product),Mental health,0
1.31208E+16,Risperidone 1mg tablets (A A H Pharmaceuticals Ltd) (product),Mental health,0
1.31211E+16,Risperidone 2mg tablets (A A H Pharmaceuticals Ltd) (product),Mental health,0
1.31213E+16,Risperidone 3mg tablets (A A H Pharmaceuticals Ltd) (product),Mental health,0
1.31215E+16,Risperidone 4mg tablets (A A H Pharmaceuticals Ltd) (product),Mental health,0
1.31217E+16,Risperidone 6mg tablets (A A H Pharmaceuticals Ltd) (product),Mental health,0
1.31483E+16,Promazine 25mg/5ml oral suspension (product),Mental health,0
1.31534E+16,Risperidone 1mg/ml oral solution sugar free (Teva UK Ltd) (product),Mental health,0
1.33755E+16,Risperidone 1mg orodispersible tablets sugar free (A A H Pharmaceuticals Ltd) (product),Mental health,0
1.33759E+16,Risperidone 1mg/ml oral solution sugar free (A A H Pharmaceuticals Ltd) (product),Mental health,0
1.34564E+16,Aripiprazole 9.75mg/1.3ml solution for injection vials (product),Mental health,0
1.3481E+16,Chlorpromazine 25mg tablets (Almus Pharmaceuticals Ltd) (product),Mental health,0
1.34815E+16,Chlorpromazine 50mg tablets (Almus Pharmaceuticals Ltd) (product),Mental health,0
1.3587E+16,Quetiapine 400mg/5ml oral solution (product),Mental health,0
1.38445E+16,Quetiapine 75mg/5ml oral solution (product),Mental health,0
1.40158E+16,Olanzapine 2.5mg/5ml oral solution (product),Mental health,0
1.40159E+16,Olanzapine 2.5mg/5ml oral suspension (product),Mental health,0
1.40186E+16,Quetiapine 100mg/5ml oral solution (product),Mental health,0
1.40187E+16,Quetiapine 100mg/5ml oral suspension (product),Mental health,0
1.40253E+16,Seroquel XL 200mg tablets (Luye Pharma Ltd) (product),Mental health,0
1.40257E+16,Seroquel XL 400mg tablets (Luye Pharma Ltd) (product),Mental health,0
1.4026E+16,Seroquel XL 300mg tablets (Luye Pharma Ltd) (product),Mental health,0
1.40265E+16,Seroquel XL 50mg tablets (Luye Pharma Ltd) (product),Mental health,0
1.40428E+16,Quetiapine 50mg modified-release tablets (product),Mental health,0
1.4401E+16,Risperidone 500microgram tablets (Generics (UK) Ltd) (product),Mental health,0
1.44013E+16,Risperidone 1mg tablets (Generics (UK) Ltd) (product),Mental health,0
1.44023E+16,Risperidone 2mg tablets (Generics (UK) Ltd) (product),Mental health,0
1.47207E+16,Risperidone 500microgram orodispersible tablets sugar free (Teva UK Ltd) (product),Mental health,0
1.47705E+16,Risperidone 500microgram tablets (Wockhardt UK Ltd) (product),Mental health,0
1.47718E+16,Risperidone 1mg/ml oral solution sugar free (Wockhardt UK Ltd) (product),Mental health,0
1.51599E+16,Risperidone 500microgram orodispersible tablets sugar free (Generics (UK) Ltd) (product),Mental health,0
1.5452E+16,Quetiapine 50mg/5ml oral solution (product),Mental health,0
1.54521E+16,Quetiapine 50mg/5ml oral suspension (product),Mental health,0
1.54989E+16,Denzapine 50mg tablets (Merz Pharma UK Ltd) (product),Mental health,0
1.55057E+16,Denzapine 200mg tablets (Merz Pharma UK Ltd) (product),Mental health,0
1.5506E+16,Denzapine 50mg/ml oral suspension (Merz Pharma UK Ltd) (product),Mental health,0
1.55062E+16,Clozapine 200mg tablets (product),Mental health,0
1.55063E+16,Clozapine 50mg/ml oral suspension sugar free (product),Mental health,0
1.56495E+16,Olanzapine 1.25mg/5ml oral solution (product),Mental health,0
1.58617E+16,Risperidone 1mg/ml oral solution sugar free (Actavis UK Ltd) (product),Mental health,0
1.61106E+16,Quetiapine 6.25mg/5ml oral solution (product),Mental health,0
1.61284E+16,Pericyazine 2.5mg tablets (Winthrop Pharmaceuticals UK Ltd) (product),Mental health,0
1.76898E+16,Seroquel XL 150mg tablets (Luye Pharma Ltd) (product),Mental health,0
1.78286E+16,Quetiapine 150mg modified-release tablets (product),Mental health,0
1.85076E+16,Risperidone 500microgram tablets (Almus Pharmaceuticals Ltd) (product),Mental health,0
1.85078E+16,Risperidone 1mg tablets (Almus Pharmaceuticals Ltd) (product),Mental health,0
1.85081E+16,Risperidone 2mg tablets (Almus Pharmaceuticals Ltd) (product),Mental health,0
1.89529E+16,Chlorpromazine 25mg/5ml oral solution sugar free (Pinewood Healthcare) (product),Mental health,0
1.89566E+16,Chlorpromazine 25mg/5ml oral solution sugar free (product),Mental health,0
1.95043E+16,Asenapine 10mg sublingual tablets sugar free (product),Mental health,0
1.95044E+16,Asenapine 5mg sublingual tablets sugar free (product),Mental health,0
1.95572E+16,Olanzapine 2.5mg tablets (Actavis UK Ltd) (product),Mental health,0
1.95582E+16,Olanzapine 5mg tablets (Actavis UK Ltd) (product),Mental health,0
1.95584E+16,Olanzapine 7.5mg tablets (Actavis UK Ltd) (product),Mental health,0
1.95586E+16,Olanzapine 10mg tablets (Actavis UK Ltd) (product),Mental health,0
1.95594E+16,Olanzapine 15mg tablets (Actavis UK Ltd) (product),Mental health,0
1.95598E+16,Olanzapine 20mg tablets (Actavis UK Ltd) (product),Mental health,0
1.95609E+16,Olanzapine 2.5mg tablets (Teva UK Ltd) (product),Mental health,0
1.95611E+16,Olanzapine 5mg tablets (Teva UK Ltd) (product),Mental health,0
1.95613E+16,Olanzapine 7.5mg tablets (Teva UK Ltd) (product),Mental health,0
1.95615E+16,Olanzapine 10mg tablets (Teva UK Ltd) (product),Mental health,0
1.95619E+16,Olanzapine 20mg tablets (Teva UK Ltd) (product),Mental health,0
1.95917E+16,Olanzapine 2.5mg tablets (Dr Reddy's Laboratories (UK) Ltd) (product),Mental health,0
1.96091E+16,Olanzapine 10mg orodispersible tablets sugar free (product),Mental health,0
1.96093E+16,Olanzapine 15mg orodispersible tablets sugar free (product),Mental health,0
1.96094E+16,Olanzapine 20mg orodispersible tablets sugar free (product),Mental health,0
1.96095E+16,Olanzapine 5mg orodispersible tablets sugar free (product),Mental health,0
1.96236E+16,Olanzapine 5mg orodispersible tablets (Teva UK Ltd) (product),Mental health,0
1.96239E+16,Olanzapine 10mg orodispersible tablets (Teva UK Ltd) (product),Mental health,0
1.96267E+16,Olanzapine 10mg orodispersible tablets (product),Mental health,0
1.96268E+16,Olanzapine 15mg orodispersible tablets (product),Mental health,0
1.96269E+16,Olanzapine 20mg orodispersible tablets (product),Mental health,0
1.9627E+16,Olanzapine 5mg orodispersible tablets (product),Mental health,0
1.9809E+16,Levinan 6mg tablets (Archimedes Pharma UK Ltd) (product),Mental health,0
2.01563E+16,Trifluoperazine 1mg/5ml oral solution sugar free (Mercury Pharma Group Ltd) (product),Mental health,0
2.01609E+16,Quetiapine 25mg tablets (Teva UK Ltd) (product),Mental health,0
2.01611E+16,Quetiapine 100mg tablets (Teva UK Ltd) (product),Mental health,0
2.01614E+16,Quetiapine 150mg tablets (Teva UK Ltd) (product),Mental health,0
2.01617E+16,Quetiapine 200mg tablets (Teva UK Ltd) (product),Mental health,0
2.01619E+16,Quetiapine 300mg tablets (Teva UK Ltd) (product),Mental health,0
2.03548E+16,Quetiapine 25mg tablets (Actavis UK Ltd) (product),Mental health,0
2.03552E+16,Quetiapine 150mg tablets (Actavis UK Ltd) (product),Mental health,0
2.03554E+16,Quetiapine 200mg tablets (Actavis UK Ltd) (product),Mental health,0
2.03556E+16,Quetiapine 300mg tablets (Actavis UK Ltd) (product),Mental health,0
2.0356E+16,Sondate XL 50mg tablets (Teva UK Ltd) (product),Mental health,0
2.03562E+16,Sondate XL 200mg tablets (Teva UK Ltd) (product),Mental health,0
2.03564E+16,Sondate XL 300mg tablets (Teva UK Ltd) (product),Mental health,0
2.03566E+16,Sondate XL 400mg tablets (Teva UK Ltd) (product),Mental health,0
2.09665E+16,Amisulpride 100mg/ml oral solution sugar free (Focus Pharmaceuticals Ltd) (product),Mental health,0
2.17144E+16,Sondate XL 150mg tablets (Teva UK Ltd) (product),Mental health,0
2.26355E+16,Quetiapine 200mg/5ml oral suspension (product),Mental health,0
2.26585E+16,Levomepromazine 25mg/1ml solution for injection ampoules (Wockhardt UK Ltd) (product),Mental health,0
2.35614E+16,Risperidone 3mg tablets (Dexcel-Pharma Ltd) (product),Mental health,0
2.35616E+16,Risperidone 500microgram tablets (Dexcel-Pharma Ltd) (product),Mental health,0
2.58043E+16,Ebesque XL 200mg tablets (DB Ashbourne Ltd) (product),Mental health,0
2.66544E+16,Latuda 18.5mg tablets (Sunovion Pharmaceuticals Europe Ltd) (product),Mental health,0
2.66547E+16,Latuda 37mg tablets (Sunovion Pharmaceuticals Europe Ltd) (product),Mental health,0
2.6655E+16,Latuda 74mg tablets (Sunovion Pharmaceuticals Europe Ltd) (product),Mental health,0
2.66553E+16,Lurasidone 18.5mg tablets (product),Mental health,0
2.66554E+16,Lurasidone 37mg tablets (product),Mental health,0
2.66555E+16,Lurasidone 74mg tablets (product),Mental health,0
2.78422E+16,Atrolak XL 50mg tablets (Accord Healthcare Ltd) (product),Mental health,0
2.78424E+16,Atrolak XL 200mg tablets (Accord Healthcare Ltd) (product),Mental health,0
2.78426E+16,Atrolak XL 300mg tablets (Accord Healthcare Ltd) (product),Mental health,0
2.78428E+16,Atrolak XL 400mg tablets (Accord Healthcare Ltd) (product),Mental health,0
2.84002E+16,Biquelle XL 50mg tablets (Aspire Pharma Ltd) (product),Mental health,0
2.84004E+16,Biquelle XL 150mg tablets (Aspire Pharma Ltd) (product),Mental health,0
2.84006E+16,Biquelle XL 300mg tablets (Aspire Pharma Ltd) (product),Mental health,0
2.84008E+16,Biquelle XL 400mg tablets (Aspire Pharma Ltd) (product),Mental health,0
2.8401E+16,Biquelle XL 200mg tablets (Aspire Pharma Ltd) (product),Mental health,0
2.84115E+16,Zaluron XL 50mg tablets (Fontus Health Ltd) (product),Mental health,0
2.84117E+16,Zaluron XL 150mg tablets (Fontus Health Ltd) (product),Mental health,0
2.84119E+16,Zaluron XL 200mg tablets (Fontus Health Ltd) (product),Mental health,0
2.84121E+16,Zaluron XL 300mg tablets (Fontus Health Ltd) (product),Mental health,0
2.84123E+16,Zaluron XL 400mg tablets (Fontus Health Ltd) (product),Mental health,0
2.86224E+16,Aripiprazole 15mg tablets (Teva UK Ltd) (product),Mental health,0
2.8623E+16,Aripiprazole 10mg tablets (Teva UK Ltd) (product),Mental health,0
2.86237E+16,Aripiprazole 5mg tablets (Teva UK Ltd) (product),Mental health,0
2.87951E+16,Aripiprazole 5mg tablets (Actavis UK Ltd) (product),Mental health,0
2.87953E+16,Aripiprazole 10mg tablets (Actavis UK Ltd) (product),Mental health,0
2.87955E+16,Aripiprazole 15mg tablets (Actavis UK Ltd) (product),Mental health,0
2.87957E+16,Aripiprazole 30mg tablets (Actavis UK Ltd) (product),Mental health,0
2.89635E+16,Aripiprazole 10mg tablets (Dr Reddy's Laboratories (UK) Ltd) (product),Mental health,0
2.89895E+16,Haloperidol 500microgram tablets (Crescent Pharma Ltd) (product),Mental health,0
2.89947E+16,Mintreleq XL 50mg tablets (CEB Pharma Ltd) (product),Mental health,0
2.89949E+16,Mintreleq XL 150mg tablets (CEB Pharma Ltd) (product),Mental health,0
2.89951E+16,Mintreleq XL 200mg tablets (CEB Pharma Ltd) (product),Mental health,0
2.89956E+16,Mintreleq XL 300mg tablets (CEB Pharma Ltd) (product),Mental health,0
2.89958E+16,Mintreleq XL 400mg tablets (CEB Pharma Ltd) (product),Mental health,0
3.06649E+16,Aripiprazole 5mg tablets (Aspire Pharma Ltd) (product),Mental health,0
3.07996E+16,Haloperidol 1mg/5ml oral solution sugar free (product),Mental health,0
3.2504E+16,Psyquet XL 400mg tablets (Sandoz Ltd) (product),Mental health,0
3.28605E+16,Aripiprazole 1mg/ml oral solution (Wockhardt UK Ltd) (product),Mental health,0
3.32614E+16,Quetiapine 100mg/5ml oral suspension sugar free (Rosemont Pharmaceuticals Ltd) (product),Mental health,0
3.3391E+16,Quetiapine 100mg/5ml oral suspension sugar free (product),Mental health,0
3.35688E+16,Brancico XL 300mg tablets (Zentiva) (product),Mental health,0
3.3569E+16,Brancico XL 200mg tablets (Zentiva) (product),Mental health,0
3.35697E+16,Brancico XL 150mg tablets (Zentiva) (product),Mental health,0
3.35699E+16,Brancico XL 50mg tablets (Zentiva) (product),Mental health,0
3.35701E+16,Brancico XL 400mg tablets (Zentiva) (product),Mental health,0
3.36907E+16,Levomepromazine 62.5mg/5ml oral suspension (product),Mental health,0
3.44489E+16,Aripiprazole 5mg tablets (Niche Generics Ltd) (product),Mental health,0
3.47649E+16,Aripiprazole 5mg tablets (Wockhardt UK Ltd) (product),Mental health,0
3.4931E+16,Aripiprazole 5mg tablets (Accord Healthcare Ltd) (product),Mental health,0
3.49368E+16,Atrolak XL 150mg tablets (Accord Healthcare Ltd) (product),Mental health,0
3.59011E+16,Amisulpride 100mg/ml oral solution sugar free (product),Mental health,0
3.59311E+16,Sulpiride 200mg/5ml oral solution sugar free (product),Mental health,0
3.59313E+16,Promazine 25mg/5ml oral solution (product),Mental health,0
3.59314E+16,Promazine 50mg/5ml oral solution (product),Mental health,0
3.60279E+16,Pericyazine 10mg/5ml oral solution (product),Mental health,0
3.60535E+16,Haloperidol 5mg/1ml solution for injection ampoules (product),Mental health,0
3.61379E+16,Chlorpromazine 100mg/5ml oral suspension sugar free (product),Mental health,0
3.61382E+16,Chlorpromazine 25mg/1ml solution for injection ampoules (product),Mental health,0
3.61383E+16,Chlorpromazine 25mg/5ml oral solution (product),Mental health,0
3.61433E+16,Trifluoperazine 1mg/5ml oral solution sugar free (product),Mental health,0
3.68684E+16,Arpoya 5mg tablets (Torrent Pharma (UK) Ltd) (product),Mental health,0
3.6905E+16,Olanzapine 2.5mg orodispersible tablets sugar free (product),Mental health,0
3.69051E+16,Olanzapine 7.5mg orodispersible tablets sugar free (product),Mental health,0
3.7249E+16,Aripiprazole 1mg/ml oral solution sugar free (product),Mental health,0
3.76875E+16,Zaponex 25mg orodispersible tablets (Leyden Delta B.V.) (product),Mental health,0
3.76878E+16,Zaponex 50mg orodispersible tablets (Leyden Delta B.V.) (product),Mental health,0
3.76882E+16,Zaponex 100mg orodispersible tablets (Leyden Delta B.V.) (product),Mental health,0
3.76975E+16,Clozapine 100mg orodispersible tablets sugar free (product),Mental health,0
3.76977E+16,Clozapine 12.5mg orodispersible tablets sugar free (product),Mental health,0
3.76978E+16,Clozapine 200mg orodispersible tablets sugar free (product),Mental health,0
3.76979E+16,Clozapine 25mg orodispersible tablets sugar free (product),Mental health,0
3.7698E+16,Clozapine 50mg orodispersible tablets sugar free (product),Mental health,0
3.86967E+16,Risperidone 250microgram tablets (product),Mental health,0
3.87507E+16,Trifluoperazine 5mg/5ml oral solution sugar free (product),Mental health,0
3.87535E+16,Promazine 50mg/5ml oral solution (product),Mental health,0
3.88953E+16,Levomepromazine 25mg/1ml solution for injection ampoules (product),Mental health,0
3.89318E+16,Levomepromazine 50mg tablets (product),Mental health,0
3.9005E+16,Biquelle XL 600mg tablets (Aspire Pharma Ltd) (product),Mental health,0
3.90274E+16,Quetiapine 600mg modified-release tablets (product),Mental health,0
,Bouffe dlirante (disorder),Mental health,0
63491006,Intermittent claudication (finding),Peripheral vascular disease,0
233958001,Peripheral ischemia (disorder),Peripheral vascular disease,0
233961000,Lower limb ischemia (disorder),Peripheral vascular disease,0
233962007,Critical lower limb ischemia (disorder),Peripheral vascular disease,0
300917007,Ischemia of feet (disorder),Peripheral vascular disease,0
301755001,Ischemic foot (disorder),Peripheral vascular disease,0
307406004,Trash foot (disorder),Peripheral vascular disease,0
307408003,Ischemic toe (disorder),Peripheral vascular disease,0
312822006,Critical ischemia of foot (disorder),Peripheral vascular disease,0
314902007,Peripheral angiopathy due to type 2 diabetes mellitus (disorder),Peripheral vascular disease,0
399957001,Peripheral arterial occlusive disease (disorder),Peripheral vascular disease,0
400047006,Peripheral vascular disease (disorder),Peripheral vascular disease,0
8.36711E+14,Ischaemic lower limb pain at rest (finding),Peripheral vascular disease,0
8392000,Non-smoker (finding),Smoking codes,0
8517006,Ex-smoker (finding),Smoking codes,0
53896009,Tolerant ex-smoker (finding),Smoking codes,0
56578002,Moderate smoker (20 or less per day) (finding),Smoking codes,0
59978006,Cigar smoker (finding),Smoking codes,0
65568007,Cigarette smoker (finding),Smoking codes,0
77176002,Smoker (finding),Smoking codes,0
82302008,Pipe smoker (finding),Smoking codes,0
110483000,Tobacco user (finding),Smoking codes,0
134406006,Smoking reduced (finding),Smoking codes,0
160603005,Light cigarette smoker (1-9 cigs/day) (finding),Smoking codes,0
160604004,Moderate cigarette smoker (10-19 cigs/day) (finding),Smoking codes,0
160605003,Heavy cigarette smoker (20-39 cigs/day) (finding),Smoking codes,0
160606002,Very heavy cigarette smoker (40+ cigs/day) (finding),Smoking codes,0
160612007,Keeps trying to stop smoking (finding),Smoking codes,0
160613002,Admitted tobacco consumption possibly untrue (finding),Smoking codes,0
160616005,Trying to give up smoking (finding),Smoking codes,0
160617001,Stopped smoking (finding),Smoking codes,0
160619003,Rolls own cigarettes (finding),Smoking codes,0
160620009,Ex-pipe smoker (finding),Smoking codes,0
160621008,Ex-cigar smoker (finding),Smoking codes,0
160625004,Date ceased smoking (observable entity),Smoking codes,0
225323000,Smoking cessation education (procedure),Smoking codes,0
225324006,Smoking effects education (procedure),Smoking codes,0
225934006,Smokes in bed (finding),Smoking codes,0
228486009,Time since stopped smoking (observable entity),Smoking codes,0
230056004,Cigarette consumption (observable entity),Smoking codes,0
230057008,Cigar consumption (observable entity),Smoking codes,0
230058003,Pipe tobacco consumption (observable entity),Smoking codes,0
230059006,Occasional cigarette smoker (finding),Smoking codes,0
230060001,Light cigarette smoker (finding),Smoking codes,0
230062009,Moderate cigarette smoker (finding),Smoking codes,0
230063004,Heavy cigarette smoker (finding),Smoking codes,0
230064005,Very heavy cigarette smoker (finding),Smoking codes,0
230065006,Chain smoker (finding),Smoking codes,0
266918002,Tobacco smoking consumption (observable entity),Smoking codes,0
266919005,Never smoked tobacco (finding),Smoking codes,0
266920004,Trivial cigarette smoker (less than one cigarette/day) (finding),Smoking codes,0
266921000,Ex-trivial cigarette smoker (<1/day) (finding),Smoking codes,0
266922007,Ex-light cigarette smoker (1-9/day) (finding),Smoking codes,0
266923002,Ex-moderate cigarette smoker (10-19/day) (finding),Smoking codes,0
266924008,Ex-heavy cigarette smoker (20-39/day) (finding),Smoking codes,0
266925009,Ex-very heavy cigarette smoker (40+/day) (finding),Smoking codes,0
266928006,Ex-cigarette smoker amount unknown (finding),Smoking codes,0
266929003,Smoking started (finding),Smoking codes,0
281018007,Ex-cigarette smoker (finding),Smoking codes,0
308438006,Smoking restarted (finding),Smoking codes,0
313396002,Nicotine replacement therapy (situation),Smoking codes,0
315022003,Nicotine replacement therapy refused (situation),Smoking codes,0
315055008,Over the counter nicotine replacement therapy (procedure),Smoking codes,0
315232003,Referral to stop-smoking clinic (procedure),Smoking codes,0
365982000,Finding of tobacco smoking consumption (finding),Smoking codes,0
390905006,Nicotine replacement therapy provided free (procedure),Smoking codes,0
394871007,Thinking about stopping smoking (finding),Smoking codes,0
394872000,Ready to stop smoking (finding),Smoking codes,0
394873005,Not interested in stopping smoking (finding),Smoking codes,0
395700008,Referral to smoking cessation advisor (procedure),Smoking codes,0
401068004,Seen by smoking cessation advisor (finding),Smoking codes,0
401159003,Reason for restarting smoking (observable entity),Smoking codes,0
401201003,Cigarette pack-years (observable entity),Smoking codes,0
413173009,Minutes from waking to first tobacco consumption (observable entity),Smoking codes,0
446172000,Failed attempt to stop smoking (finding),Smoking codes,0
449345000,Smoked before confirmation of pregnancy (finding),Smoking codes,0
449368009,Stopped smoking during pregnancy (finding),Smoking codes,0
449369001,Stopped smoking before pregnancy (finding),Smoking codes,0
699033005,Provision of smoking cessation leaflet (procedure),Smoking codes,0
710081004,Smoking cessation therapy (regime/therapy),Smoking codes,0
713700008,Smoking cessation drug therapy (regime/therapy),Smoking codes,0
770729006,Referral for brief intervention for smoking cessation (procedure),Smoking codes,0
771155005,Brief intervention for smoking cessation (procedure),Smoking codes,0
2.21E+11,Never smoked any substance (finding),Smoking codes,0
4.8031E+13,Ex-smoker for more than 1 year (finding),Smoking codes,0
2.00211E+14,Nicotine replacement therapy provided by community pharmacist (procedure),Smoking codes,0
2.00221E+14,Smoking cessation advice provided by community pharmacist (situation),Smoking codes,0
2.03191E+14,Wants to stop smoking (finding),Smoking codes,0
2.80801E+14,Nicotine replacement therapy using nicotine gum (procedure),Smoking codes,0
2.80811E+14,Nicotine replacement therapy using nicotine inhalator (procedure),Smoking codes,0
4.28041E+14,Occasional tobacco smoker (finding),Smoking codes,0
4.92191E+14,Ex roll-up cigarette smoker (finding),Smoking codes,0
5.05281E+14,Referral to National Health Service stop smoking service (procedure),Smoking codes,0
5.06491E+14,Brief intervention for smoking cessation (procedure),Smoking codes,0
5.21721E+14,Smoking cessation leaflet given (situation),Smoking codes,0
5.27151E+14,Smoking cessation advice declined (situation),Smoking codes,0
7.12971E+14,Practice based smoking cessation programme start date (observable entity),Smoking codes,0
7.55721E+14,Consent given for follow-up by smoking cessation team (finding),Smoking codes,0
7.55741E+14,Declined consent for follow-up by smoking cessation team (finding),Smoking codes,0
7.67641E+14,Referral for smoking cessation service offered (finding),Smoking codes,0
7.83011E+14,Stop smoking service opportunity signposted (situation),Smoking codes,0
7.84481E+14,Issue of nicotine replacement therapy voucher (procedure),Smoking codes,0
7.90121E+14,Nicotine replacement therapy using nicotine patch (procedure),Smoking codes,0
7.90131E+14,Nicotine replacement therapy using nicotine lozenge (procedure),Smoking codes,0
8.22591E+14,Smoking cessation drug therapy declined (situation),Smoking codes,0
8.36001E+14,Waterpipe tobacco consumption (observable entity),Smoking codes,0
8.38131E+14,Provision of written information about smoking cessation (procedure),Smoking codes,0
8.71641E+14,Referral to smoking cessation service declined (situation),Smoking codes,0
8.71661E+14,Referral to smoking cessation service (procedure),Smoking codes,0
9.66971E+14,Varenicline smoking cessation therapy declined (situation),Smoking codes,0
9.66991E+14,Varenicline smoking cessation therapy offered (situation),Smoking codes,0
1.08438E+15,Signposting to smoking cessation service (procedure),Smoking codes,0
1.08744E+15,Smoking cessation programme declined (situation),Smoking codes,0
1.09203E+15,Ex-smoker amount unknown (finding),Smoking codes,0
1.09204E+15,Ex-very heavy smoker (40+/day) (finding),Smoking codes,0
1.09207E+15,Ex-heavy smoker (20-39/day) (finding),Smoking codes,0
1.09209E+15,Ex-moderate smoker (10-19/day) (finding),Smoking codes,0
1.09211E+15,Ex-light smoker (1-9/day) (finding),Smoking codes,0
1.09213E+15,Ex-trivial smoker (<1/day) (finding),Smoking codes,0
1.09432E+15,Referral for brief intervention for smoking cessation (procedure),Smoking codes,0
1.11079E+15,Very Brief Advice on Smoking (procedure),Smoking codes,0
7713009,Intrapontine hemorrhage (disorder),Stroke,0
15258001,Subclavian steal syndrome (disorder),Stroke,0
20059004,Occlusion of cerebral artery (disorder),Stroke,0
20908003,Subcortical cerebral hemorrhage (disorder),Stroke,0
34781003,Vertebral artery syndrome (disorder),Stroke,0
49422009,Cortical hemorrhage (disorder),Stroke,0
52201006,Internal capsule hemorrhage (disorder),Stroke,0
64009001,Basilar artery syndrome (disorder),Stroke,0
71444005,Cerebral arterial thrombosis (disorder),Stroke,0
75038005,Cerebellar hemorrhage (disorder),Stroke,0
75543006,Cerebral embolism (disorder),Stroke,0
78569004,Posterior inferior cerebellar artery syndrome (disorder),Stroke,0
95454007,Brain stem hemorrhage (disorder),Stroke,0
95457000,Brain stem infarction (disorder),Stroke,0
95460007,Cerebellar infarction (disorder),Stroke,0
195165005,Basal ganglia hemorrhage (disorder),Stroke,0
195167002,External capsule hemorrhage (disorder),Stroke,0
195168007,Intracerebral hemorrhage with intraventricular hemorrhage (disorder),Stroke,0
195169004,"Intracerebral hemorrhage, multiple localized (disorder)",Stroke,0
195185009,Cerebral infarct due to thrombosis of precerebral arteries (disorder),Stroke,0
195186005,Cerebral infarction due to embolism of precerebral arteries (disorder),Stroke,0
195189003,Cerebral infarction due to thrombosis of cerebral arteries (disorder),Stroke,0
195190007,Cerebral infarction due to embolism of cerebral arteries (disorder),Stroke,0
195199008,Vertebrobasilar artery syndrome (disorder),Stroke,0
195200006,Carotid artery syndrome hemispheric (disorder),Stroke,0
195205001,Impending cerebral ischemia (disorder),Stroke,0
195206000,Intermittent cerebral ischemia (disorder),Stroke,0
195209007,Middle cerebral artery syndrome (disorder),Stroke,0
195210002,Anterior cerebral artery syndrome (disorder),Stroke,0
195211003,Posterior cerebral artery syndrome (disorder),Stroke,0
195212005,Brainstem stroke syndrome (disorder),Stroke,0
195213000,Cerebellar stroke syndrome (disorder),Stroke,0
195216008,Left sided cerebral hemisphere cerebrovascular accident (disorder),Stroke,0
195217004,Right sided cerebral hemisphere cerebrovascular accident (disorder),Stroke,0
195230003,"Cerebral infarction due to cerebral venous thrombosis, non-pyogenic (disorder)",Stroke,0
230690007,Cerebrovascular accident (disorder),Stroke,0
230691006,Cerebrovascular accident due to occlusion of cerebral artery (disorder),Stroke,0
230692004,Infarction - precerebral (disorder),Stroke,0
230693009,Anterior cerebral circulation infarction (disorder),Stroke,0
230694003,Total anterior cerebral circulation infarction (disorder),Stroke,0
230695002,Partial anterior cerebral circulation infarction (disorder),Stroke,0
230696001,Posterior cerebral circulation infarction (disorder),Stroke,0
230698000,Lacunar infarction (disorder),Stroke,0
230699008,Pure motor lacunar infarction (disorder),Stroke,0
230700009,Pure sensory lacunar infarction (disorder),Stroke,0
230701008,Pure sensorimotor lacunar infarction (disorder),Stroke,0
230702001,Lacunar ataxic hemiparesis (disorder),Stroke,0
230704000,Multi-infarct state (disorder),Stroke,0
230706003,Hemorrhagic cerebral infarction (disorder),Stroke,0
230707007,Anterior cerebral circulation hemorrhagic infarction (disorder),Stroke,0
230708002,Posterior cerebral circulation hemorrhagic infarction (disorder),Stroke,0
230710000,Lobar cerebral hemorrhage (disorder),Stroke,0
230711001,Thalamic hemorrhage (disorder),Stroke,0
230712008,Lacunar hemorrhage (disorder),Stroke,0
230713003,Stroke of uncertain pathology (disorder),Stroke,0
230714009,Anterior circulation stroke of uncertain pathology (disorder),Stroke,0
230715005,Posterior circulation stroke of uncertain pathology (disorder),Stroke,0
230716006,Carotid territory transient ischemic attack (disorder),Stroke,0
230717002,Vertebrobasilar territory transient ischemic attack (disorder),Stroke,0
266257000,Transient ischemic attack (disorder),Stroke,0
274100004,Cerebral hemorrhage (disorder),Stroke,0
275434003,Stroke in the puerperium (disorder),Stroke,0
276219001,Occipital cerebral infarction (disorder),Stroke,0
276222004,Top of basilar syndrome (disorder),Stroke,0
276722003,Intracerebellar and posterior fossa hemorrhage (disorder),Stroke,0
281240008,Extension of cerebrovascular accident (disorder),Stroke,0
307363008,Multiple lacunar infarcts (disorder),Stroke,0
307766002,Left sided cerebral infarction (disorder),Stroke,0
307767006,Right sided cerebral infarction (disorder),Stroke,0
371041009,Embolic stroke (disorder),Stroke,0
373606000,Occlusive stroke (disorder),Stroke,0
413102000,Infarction of basal ganglia (disorder),Stroke,0
415628004,Stroke/transient ischemic attack monitoring first letter (finding),Stroke,0
415629007,Stroke/transient ischemic attack monitoring second letter (finding),Stroke,0
415631003,Stroke/transient ischemic attack monitoring third letter (finding),Stroke,0
417059002,Stroke/transient ischemic attack monitoring verbal invitation (finding),Stroke,0
417540008,Stroke/transient ischemic attack monitoring invitation (finding),Stroke,0
426107000,Acute lacunar infarction (disorder),Stroke,0
432504007,Cerebral infarction (disorder),Stroke,0
732923001,Hemorrhage of medulla oblongata (disorder),Stroke,0
1.25081E+14,Cerebral infarction due to occlusion of precerebral artery (disorder),Stroke,0
1.40921E+14,Ischemic stroke without coma (disorder),Stroke,0
3.29481E+14,Occlusion of right middle cerebral artery (disorder),Stroke,0
7.16021E+14,Excepted from stroke quality indicators - informed dissent (finding),Stroke,0
7.16581E+14,Excepted from stroke quality indicators - patient unsuitable (finding),Stroke,0
7.17241E+14,Stroke/transient ischaemic attack monitoring telephone invitation (finding),Stroke,0
7.51371E+14,Personal history of transient ischaemic attack (situation),Stroke,0
1.078E+15,Haemorrhagic stroke (disorder),Stroke,0
1.08942E+15,Cerebral infarction due to stenosis of cerebral artery (disorder),Stroke,0
1.11098E+15,Quality and Outcomes Framework stroke and transient ischaemic attack quality indicator-related care invitation (procedure),Stroke,0
1.60005E+16,Cerebrovascular accident due to occlusion of left middle cerebral artery (disorder),Stroke,0
1.6002E+16,Cerebrovascular accident due to thrombus of right middle cerebral artery (disorder),Stroke,0
1.63718E+16,Cerebellar stroke (disorder),Stroke,0